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Abstract  
 
Half of health care in sub-Saharan Africa is privately provided, however, for mental health, the 
literature is all but absent on these services. Kenya provides a useful case-study, as it has a well-
organized non-state sector and data are readily available. My thesis asks what contribution do 
non-state actors make to coverage for mental disorders in Kenya?  
Non-state mental health care is conceived along two axes: for-profit vs. not-for-profit 
and formal vs. informal. Four empirical chapters use mixed-methods to examine:  1) not-for-
profit NGO care; 2) for-profit inpatient care; 3) for-profit outpatient care; and 4) traditional and 
faith healing. Data were collected on 774 service users and 120 service providers from four 
primary sources, and two secondary sources, as well as from a wide range of key-informant 
interviews.  
The first two chapters set the research question within the context of existing knowledge 
in the fields of health economics and health services research. The third chapter provides an 
overview of methods, focusing on cost-effectiveness analysis, case study method, and cross-
cultural psychiatric epidemiology. 
The first empirical chapter presents an NGO intervention called the model for Mental 
Health and Development, evaluated qualitatively and quantitatively, using cost-effectiveness 
analysis. The second empirical chapter offers a case study of a growing private psychiatric 
hospital, using regression analysis on the effects of insurance on charge and service use. The 
third chapter is a short descriptive analysis of a questionnaire completed by psychiatric nurses 
about their participation in mental health care, and structured interviews with specialist 
outpatient providers. The final empirical chapter contains qualitative and quantitative data on 
traditional and faith healing, analysed for similarities and differences. The conclusion ties 
together findings thematically according to capacity, access and cost, estimating the degree of 
mental health care coverage offered by non-state actors in Kenya, and offering lessons for policy 
and research. 
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1. Introduction: A Burden to Bear 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1-1: Herbal advertisement in a Nairobi pharmacy, 
“Stressed? Get more out of life” 
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1.1 Background 
“Stressed? Get more out of life.” So reads an advertisement for a herbal ginseng-based remedy at 
a pharmacy in a Nairobi mall (figure 1). The language of mental health and its inverse, mental 
distress, is making its way into urban middle-class Kenya, but to what extent is the country 
covering the need for treatment of mental disorders too severe to self-medicate? To begin 
addressing this question, we must take a step back in time and away from Kenya.  
In the 1990s, research into mental disorders in low-income countries went from an 
exotic anomaly, studied mostly by anthropologists, to a field of public health with a growing 
evidence base. A major turning point for the field was the publication in 1994 of the first Global 
Burden of Disease study, which found that mental and neurological disorders accounted for a 
quarter of the burden of all disability (Murray and Lopez 1994). Depression alone was estimated 
to be the leading cause of disability worldwide and the fourth leading cause of disease burden. In 
what were loosely termed “developing countries,” neuropsychiatric disorders were estimated to 
cause 15% of years lost to disability, putting them on par in terms of their morbidity with the 
burden of infectious parasites. 
The Kenyan government faces a number of competing priorities for development, and a 
tight overall budget, as a result of which mental health care receives little investment. With a 
Human Development Index ranking of 147 out of 177, Kenya is among the bottom 17% of 
countries in terms of education, life-expectancy and per capita income (US $760) (United 
Nations Development Programme 2010). Every second person living in Kenya (46%) is living 
under the national poverty line (World Bank 2011). Economic growth and job creation are 
therefore high priorities of the State. Furthermore, nearly half (45%) of the country’s 39 million 
inhabitants are under the age of 15, making education and childhood illnesses among the leading 
concerns. Within the health sector, HIV is a high priority (Jenkins, Kiima, et al. 2010), driven in 
part by funds from donor agencies. Given these strong competing claims for a small budget, it is 
little surprise that Kenya’s public sector lacks the capacity to meet the population needs for 
mental health care.  
In this introduction, I will start by outlining some of the evidence of why mental 
disorders matter in Africa and Kenya, from both a health and economic standpoint. Next, I will 
outline the landscape of Kenya’s mental health services – in both the public and non-state 
sectors. This brings me to a discussion of the treatment gap, and a return to my initial research 
question about service coverage.  I will conclude with an overview of how the following chapters 
aim to answer that question. 
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1.2 What Are Mental Disorders and Do They Matter in Africa and in Kenya? 
 
1.1 - a) Terminology 
“Mental disorders” is a term commonly used in public health research referencing a diverse 
group of health conditions with differing prevalence rates. The Global Burden of Disease (GBD) 
nosology initially delineated fourteen conditions within the category “neuropsychiatric disorders” 
(table 1-1), which were further specified in the latest round to 20 conditions. By contrast, the 
World Health Organization (WHO) groups mental disorders into eight “priority conditions” 
(table 1-2) in their flagship Mental Health Gap Action Programme (mhGAP). The WHO’s 
classification includes a condition that is not, in fact, a condition, but an event to be prevented, 
namely suicide, as well as neurological disorders, such as epilepsy and dementia.  
The study of depression is often widened in the literature to the term “common mental 
disorders,” which includes disorders on the anxiety spectrum (panic, obsessions, and traumatic 
stress, for example), termed ‘common’ because they are commonly (i.e. frequently) found in the 
general population. Schizophrenia and psychotic disorders, including bipolar disorder, are 
sometimes referred to in the literature as “SMI” or “SMD” short-hand for either serious or 
severe mental illnesses (Stobbe et al. 2014), or severe mental distress (Kinyanda et al. 2011). This 
terminology is misleading in that these disorders exist in mild, moderate and severe forms, and a 
mild psychotic disorder can be less “serious” or “severe” than a severe depression or phobia. 
The groupings are useful from the perspective of health service planning, however, as these 
conditions require different types of care. I will therefore adopt the terminology CMD and SMD 
at various points throughout the thesis.  
Outside of the biomedical domain, the term “mental illness” is preferred by medical 
anthropologists. This term purposefully does not provide diagnostic specificity, choosing instead 
to capture the diversity of conditions under a single term. Instead, it highlights the concept of 
illness over disorder, or subjective experience over medical labelling. Still another term with 
currency among human rights activists is “persons with psycho-social disabilities”. This term 
implies that the conditions in question constitute a disability, and consequentially that people 
with these conditions are entitled to the rights enshrined in disability law. For the purposes of 
this thesis, I privilege the term mental disorders, as my work draws primarily from the field of 
health services research, however I also use the term mental illness in relation to traditional 
healing, as disease classification differs between biomedicine and traditional medical practice. 
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Table 1-1: Neuropsychiatric disorders in the Global Burden of Disease Study 
 
1. Unipolar depressive disorders 
2. Bipolar disorder 
3. Schizophrenia 
4. Epilepsy 
5. Alcohol use disorders 
6. Alzheimer and other dementias 
7. Parkinson disease 
8. Multiple sclerosis 
9. Drug use disorders 
10. Post-traumatic stress disorder 
11. Obsessive-compulsive disorder 
12. Panic disorder 
13. Insomnia (primary) 
14. Migraine 
 
 
Table 1-2: Priority conditions in the WHO’s Mental Health Gap Action Programme 
 
1. Depression  
2. Schizophrenia and other psychotic disorders 
3. Epilepsy  
4. Suicide  
5. Dementia  
6. Disorders due to use of alcohol 
7. Disorders due to use of illicit drugs 
8. Mental disorders in children 
 
1.1 - b) Health burden of mental disorders 
 
1.2.a.i Globally 
Whereas for most of the last century disease burden was calculated based on mortality, with the 
advent of the Global Burden of Disease study, morbidity and mortality merged together to form 
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a new metric, called the disability adjusted life year, or DALY. Since much of the burden of 
mental disorders is morbidity, resulting from sometimes chronic or recurring episodes of 
disabling illness, the DALY highlighted this spectrum of conditions for the first time as a global 
health priority. The Global Burden of Disease methodology underwent several revisions in its 
second and now third iterations in 2000 and 2010. As of the latest data, neuropsychiatric 
disorders account for 7.4% of disease burden worldwide (Whiteford, Degenhardt, et al. 2013). 
This represents a significant decline relative to earlier estimates of 14%, largely as a result of 
shifts in disability weights for mental disorders and adjustments for disease comorbidity. When 
the earlier data are analysed using the new method, results actually suggest an increase of 37.6% 
in mental disorders between 1990 and 2010. The change in epidemiological burden is driven by 
the demographics of ageing populations, rather than by an “epidemic” of mental illness, because 
mental and neurological disorders tend to strike most in the adult and later years. 
The importance of mental disorders in causes of disability should not eclipse their place 
in causes of mortality. Deaths from mental disorders result from both suicide and premature 
mortality.1 The World Health Organization estimates that 800,000 people die each year from 
suicide (World Health Organization 2001, 2014) – more than two and half times the number of 
women who die each year in childbirth. In sub-Saharan Africa, the suicide rate is 10 per 100,000 
people per year with rates almost three times as high among men as among women. 
Measurement of pre-mature mortality is most advanced in high-income countries. People with 
schizophrenia, for example, have a life expectancy 15-20 years shorter than the general 
population in high-income countries (Nordentoft et al. 2013). 
 
1.2.a.ii In Africa 
There is reason to believe that the prevalence of mental disorders could vary from place 
to place, and therefore be different in Africa. For example, the most recent analysis of GBD data 
estimates that the burden from eating disorders is forty-fold higher in Australia and Asia than in 
sub-Saharan Africa (Whiteford, Degenhardt, et al. 2013). The variation may be lower, however, 
for more organic disorders, such as schizophrenia and bipolar disorder. While psychiatric 
epidemiology is highly advanced in Europe and other high-income countries, however, it 
remains in its infancy in low-income settings, making data on prevalence of mental disorders 
relatively thin. A recent systematic review of community-based prevalence studies for psychiatric 
disorders reported that no studies from Africa met their inclusion criteria (Baxter et al. 2013).  
                                                 
1
 Premature mortality can result from untreated health conditions, side-effects of psychiatric medicines 
(especially the atypical antipsychotics which lead to type II diabetes and cardiac problems), and the negative 
effects of mental disorders on the progression of other diseases, including HIV  
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The best available evidence on prevalence of mental disorders in low-income settings 
pertains to common mental disorders. In a systematic review and meta-analysis published this 
year, covering the past thirty-three years of research, Zachary Steel and colleagues (Steel et al. 
2014) found eight prevalence studies from six countries in sub-Saharan Africa. Pooling data 
across 15,211 individuals, they observed a 12-month prevalence of common mental disorders of 
10.8% (with a 95% confidence interval of 7.2% - 15.9%). The lifetime prevalence of in sub-
Saharan Africa was found to be 22% (CI 12.9% - 35.0%). Steel’s review and meta-analysis raises 
puzzling findings on the varying prevalence of common mental disorders. It notes, for example, 
that these disorders are more common in English-speaking countries, though the authors qualify 
this finding, suggesting it may result from an age effect, because the English-speaking samples 
tended to be older (Steel et al. 2014). In addition, the study found that countries in North and 
South-East Asia had lower rates of depression relative to other countries.  
Moving away from pooled data, which presents significant methodological challenges, 
one of the largest single studies of common mental disorders in Africa is from the South African 
Stress and Health study (SASH), which sampled over 4,000 people. The SASH study found a 
prevalence of 30.3% common mental disorders, of which 26% were severe, suggesting that the 
prevalence of severe common mental disorders is 7.9% (Herman et al. 2009). In addition, two 
community-based studies of the prevalence of depression in Rwanda (Bolton, Neugebauer, and 
Ndogoni 2002) and rural Uganda (Bolton, Wilk, and Ndogoni 2004) found rates of 16% and 
21% respectively. Common mental disorders appear therefore to be widespread in sub-Saharan 
Africa. 
The largest study of the epidemiology of schizophrenia-spectrum disorders in Africa was 
conducted in Ethiopia. In the town of Butajira, 68,378 people were interviewed, using the 
Composite International Diagnostic Interview (CIDI), and the lifetime prevalence of 
schizophrenia was found to be 0.47% (Kebede et al. 2003). A small study from Uganda 
examined the prevalence of  “severe mental disturbances,” which the authors defined in an 
original way composed of seven categories, using both Western and local nosology (Kinyanda et 
al. 2011). The authors found a prevalence of 0.9% SMD in the general population, which 
approximates the rate found by the study of psychotic symptoms in Western Kenya. 
The evidence on cultural variation in psychiatric epidemiology, however, is riddled with 
methodological barriers (some of them addressed in chapter 3 on research methods), making it 
difficult to say with any certainty how much psychiatric epidemiology varies in Africa. 
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1.2.a.iii In Kenya 
This thesis focuses on mental disorders in Kenya. The effort to measure the prevalence of 
mental disorders in the general population in Kenya is very recent – much of it published while 
this dissertation was being researched. The first documented prevalence measures were clinic-
based (Ndetei, Khasakhala, Ongecha-Owuor, et al. 2009; Ndetei, Khasakhala, Kuria, et al. 2009), 
which are not representative of the population at large. For instance, one study sampled 2,543 
patients from ten general health facilities, ranging from primary to acute care, and found that 
23.2% of patients scored as depressed, using the Beck Depression Inventory (Ndetei, 
Khasakhala, and Mutiso 2010). Most of these (56%) had only mild depression. As this was a 
clinic-based sample, mild depression could be partially a response to being sick enough to seek 
health care. A further 10.1% of the clinic-based population, however, had moderate-to-severe 
depression. 
A study published in 2012 by Rachel Jenkins and colleagues was the first of its kind in 
Kenya to undertake basic epidemiology using household-level data (Jenkins et al. 2012). Working 
in the rural town of Maseno, near the city of Kisumu in Western Kenya, the researchers found 
that 10.8% of the population had a common mental disorder (Jenkins et al. 2012). Surprisingly, 
no gender differential was found among those diagnosed, unlike in most other countries (Steel et 
al. 2014). In addition 0.6% of the sample reported two or more symptoms of psychosis (Jenkins 
et al. 2012). Symptoms do not equate with a diagnosis, so there are currently no data on the 
prevalence of SMD in Kenya. It is possible that the prevalence of psychosis is low in this rural 
setting, because of outward migration towards city centres with more opportunities for 
treatment, or because of severe neglect leading to premature mortality. 
 
1.1 - c) Economic burden of mental disorders 
 
1.2.a.iv Poverty 
In addition to the symptoms of illness, one of the burdens of mental disorders is ensuing 
poverty. One of the strongest studies bearing evidence of economic costs of mental disorders to 
individuals and families was conducted in India and Pakistan. Chisholm et al found that one 
month with depression was associated with costs equivalent to 7-14 days of agricultural labour in 
India and 20 days of agricultural labour in Pakistan (Chisholm et al. 2000). Direct costs of 
primary and hospital based care accounted for two-thirds and three-quarters of the costs 
measured by this study in India and Pakistan, including privately provided care, which comprised 
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88% and 70% of the direct costs. The remainder were indirect costs associated with time out of 
work and unpaid work caring for an ill relative, which constituted 20% and 38% of all costs in 
India and Pakistan respectively. 
A systematic review by Crick Lund and colleagues from the Mental Health and Poverty 
Project tested the association between common mental disorders and poverty, measured by a 
number of indicators of deprivation (Lund et al. 2010). Using bivariate and multivariate analyses, 
they found that 73% and 79% of the 115 studies showed a positive association between poverty 
and common mental disorders: the poorer a person was, the more likely they were to experience 
a common mental disorder. Drilling down into which specific aspects of poverty created the 
greatest vulnerabilities, they found the strongest association with common mental disorders was 
lack of education. Strong associations were also found for socio-economic status, financial stress, 
housing, and food insecurity; however the number of studies with data on these indicators was 
small. Finally, low-income and unemployment were also associated with common mental 
disorders, though less consistently so. There were more studies analysing these two variables, 
however, creating opportunities for greater variability than for the other predictors. 
A second systematic review by Lund and colleagues examined the effect of mental health 
interventions on economic outcomes, and inversely, the effect of poverty alleviation 
interventions on mental health outcomes (Lund et al. 2011). Counter-intuitively, the authors 
found no conclusive evidence that improving a person’s economic status helped their mental 
health status. However, they did find that improving a person’s mental health status was 
associated with an improvement in economic status. This improvement was statistically 
significant in half the studies, and no studies showed a reduced economic outcome.  More 
evidence was available to address the effects of mental health interventions (9 articles) than to 
address the effects of poverty alleviation interventions (5 articles), which may have influenced 
the non-significance of the findings on poverty alleviation. 
The Mental Health and Poverty Project review is informative about what the existing 
literature tells us and where its limitations lie. African countries were the setting for only 11 of 
the 77 community-based studies reviewed, and they concentrated on only four countries: 
Ethiopia (4), South Africa (3), Nigeria (3) and Zimbabwe (1). Moreover, the great majority of 
studies (85%) were cross-sectional, so they could not inform about the direction of association 
between poverty and common mental disorders. Does being ill make people poor, or does being 
poor make people ill? Only 11 of the 115 studies reviewed were longitudinal cohort studies with 
the possibility of distinguishing the direction of influence.  
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In the absence of strong quantitative data, qualitative data has shaped the prevailing 
opinion that the relationship between mental illness and poverty is reciprocal (Patel and 
Kleinman 2003; Lund et al. 2010; Saraceno, Levav, and Kohn 2005). On one side, the social 
causation hypothesis contends that conditions and events associated with poverty create stress 
and trigger mental disorders. On the other side, the social drift hypothesis asserts that people 
with mental disorders drift into poverty, because of the costs of health care and an inability to 
stay in work.  
In addition to the two studies by Lund, a third study by Ernestina Coast and colleagues 
mapped the literature from low- and middle-income countries on the associations between 
poverty and a specific mental disorder, namely post-natal depression (Coast et al. 2012). The 
mapping exercise turned up 47 articles, both quantitative and qualitative, most of which explored 
whether poverty causes depression. The inverse causal link – whether post-natal depression 
engenders poverty – was not explored. Half of the African literature came from Nigeria alone, 
and only one study was from Kenya  (Chersich et al. 2009). The Kenyan study was a cross-
sectional survey of 500 women attending a paediatric immunization clinic in Mombasa. Five per 
cent of the women were diagnosed with depression using DSM IV criteria. Overall, the mapping 
paper found some associations between post-natal depression and variables relating to poverty – 
specifically income, socio-economic status and education – however, these associations were not 
consistent across studies. The authors noted that the studies focused almost exclusively on 
individual effects of poverty and that there is a gap in the literature on broader community-level 
effects.  
Finally, a systematic mapping of the relationship between poverty and suicide was 
presented in a conference on global mental health (Iemmi et al. 2011). Valentina Iemmi and 
colleagues located 115 articles on this subject, hoping to discern whether suicide contributes to 
household poverty, and, inversely, whether poverty contributes to suicidality. Seventeen articles 
supported the latter association (poverty contributing to suicide), while no articles investigated 
the former association. Most of the literature (74% of articles) showed unclear associations 
between the two. 
 
1.2.a.v Social costs 
Very limited research exists on the costs of mental disorders to society in Kenya or Africa. One 
study from Kenya calculated direct and indirect costs of mental disorders for all patients 
attending public hospitals (Kirigia and Sambo 2003). The cost per person hospitalised for a 
mental disorder in 1999 was US $2,351, of which 19% was lost productivity, while the remainder 
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was the direct cost of treatment and care. The investigators concluded that people 
institutionalised for mental disorders cost the Kenyan economy US $13.4 million, amounting to 
0.1% of GDP in the same year. A serious limitation of this study is that the sample was hospital-
based, and most people with mental disorders in Kenya never find their way to a hospital. 
A cost-of-illness study was conducted in Nigeria examining the economic impact of 
schizophrenia on society (Suleiman et al. 1997). Suleiman and colleagues questioned a sample of 
50 people with schizophrenia in an outpatient setting in Lagos and concluded that the total cost 
of schizophrenia was US $268.50 (5,902 Naira) per patient per year, of which 15% were indirect 
costs. The bulk of the costs in this study (52%) were attributed to the purchase of medications. 
The main limitations of this study are that it relied on a sample of only 50 people with 
schizophrenia from a single treatment facility, and that the follow-up period was only six months 
long. 
Efforts at measuring the societal costs of mental disorders in upper-income countries 
have focused predominantly on lost productivity –a form of indirect cost. A number of efforts 
have been made to measure indirect costs relating to the trio of unemployment, absenteeism, and 
presenteeism,2 as well as early retirement. In Great Britain, 40% of people with enduring mental 
disorders are unemployed (Berthoud 2008) and mental disorders recently earned the dubious 
distinction of constituting the leading cause of absenteeism, surpassing back pain (McDaid, 
Curran, and Knapp 2005). It is presenteeism, however, (though challenging to measure) that is 
estimated to outstrip unemployment and absenteeism in terms of the social costs of mental 
disorders (Kessler and Frank 1997).  
A systematic review of cost-of-illness studies for mental disorders from predominantly 
high-income countries found the negative economic impact of these illnesses far exceeds the 
direct  costs of treatment (Hu 2006). The direct costs of treatment are trumped by indirect costs. 
In addition, mental disorders are associated with hidden costs, borne by social care, education, 
housing, criminal justice and the social security systems (Knapp 2003; Dewa, McDaid, and 
Ettner 2007). Indirect costs in high-income settings are estimated to account for upwards of two 
thirds of all mental health costs (McDaid, Curran, and Knapp 2005; Thomas and Morris 2003).  
European measures of lost productivity are markedly higher than those found in the two 
African cost-of-illness studies. The African studies found that lost productivity amounted to 
15% to 19% of the total costs of illness, as compared to two-thirds of costs in Europe. One 
explanation for this could be that the social welfare system in the two African countries studied 
is less well developed than in the European countries, so fewer costs are borne by social services. 
                                                 
2
 Presenteeism is being present on the job, but under-performing due to illness. 
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But the explanation is more likely the inadequate measurement of non-wage agricultural 
productivity. 
Upper-income country studies of the cost of mental disorders as a percentage of GDP 
range from 0.5% in the Netherlands (McDaid, Curran, and Knapp 2005) to 2.5% in the United 
States (Rice et al. 1990) and 3-4% in European member states of the International Labour 
Organisation (Gabriel and Liimataine 2000). A cross-country comparison found that in the 
United States and Finland 25% and 42% of disability claims were made for mental disorders 
(Dewa, McDaid, and Ettner 2007). Because of this economic impact, mental disorders in upper-
income countries are perceived as an important agenda item not only for health care, but also for 
employment and for public policy broadly (Black 2008).  
 
1.3 Kenya’s Mental Health System 
 
1.1 - d) The public sector 
Given the significant burden of mental disorders, in terms of both health and economic factors, 
what is the availability of treatment in Kenya? The government of Kenya has long recognised the 
importance of mental health care in its policies. In 1960, three years before independence, the 
national health policy called for the creation of provincial psychiatric units in each of the 
country’s provinces (Kiima et al. 2004). These units continue to exist today in 6 of 7 provinces, 
located within general provincial hospitals (Kiima and Jenkins 2010). In 1982, the Kenyan 
government brought mental health from secondary into primary care, including it as one of nine 
essential elements guaranteed within primary care (ibid). The push for better mental health 
services continued with the passage in 1989 of the Mental Health Act, which called for a multi-
disciplinary Kenya Board of Mental Health to supervise service provision, and which created the 
post of Director of Mental Health within the health ministry (Kiima et al. 2004).  
In 1996 Kenya drafted its first national Mental Health Programme of Action, covering 
ten years, with an emphasis on community care and integration of mental health – within 
primary care and across sectors (Ministry of Health 1996). That action plan expired in 2006, and 
has yet to be replaced. Nonetheless, a commitment to provide mental health care was reaffirmed 
that year by its inclusion within the Kenya Essential Package of Health (Kiima and Jenkins 2010). 
Several new mental health documents are currently under negotiation including a new mental 
health act, and a national mental health policy (International Institute for Legislative Affairs 
2011). 
Kenya’s relatively progressive mental health policies lack the financial backing, however, 
to be put into practice.  No study has been conducted on the amount of funding available for 
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mental health within Kenya’s public sector, and the WHO ATLAS database offers no data on 
this indicator from Kenya. The regional average for mental health spending is 0.5% of total 
health expenditure (World Health Organization 2011). If neighbouring Uganda is any indication, 
then the majority of Kenya’s meagre mental health funding is being spent on mental hospitals 
(Raja et al. 2010), as is the case in most African countries (Saxena et al. 2007). In the absence of 
appropriate funding, the public mental health system is radically under-resourced and unable to 
implement its policies, particularly at the community level. Essential psychiatric medicines 
continually run out (Raja, Kippen, and Reich in press); psychiatric nurses move into general 
health care; and the Kenya Board of Mental Health has become inactive (Kiima and Jenkins 
2010).  
Despite a remarkable injection of funds into the general health system in the last decade, 
resources for mental health have not appreciably increased. Kenya’s health spending grew by 
50% from 2001 to reach Int$ 3.2 billion in 2010 (Ministry of Medical Services and Ministry of 
Public Health and Sanitation 2011). The main driver of this growth was international funds from 
donors such as the Global Fund to fight HIV, TB and Malaria and the Global Alliance for 
Vaccines and Immunizations.  
The inadequacies of public funding are revealed in a shortage of material and human 
resources for mental health care throughout Kenya. There is one psychiatric bed for every 
200,000 members of the general population, and two thirds of those beds are located in Nairobi 
in the country’s single public psychiatric hospital, Mathare Hospital (Kiima and Jenkins 2010). 
Outside of Nairobi, there are psychiatric units in six of the seven provinces, each with 22 beds, 
as per the 1960 health policy. The 1996 Mental Health Programme of Action called for 
psychiatric units to be created in each of the then 76 districts; at present, these units exist in only 
five districts.3 David Kiima, Director for Mental Health, estimated in 2010 that having an 
inpatient unit in each district hospital would enable the treatment of 1% of people with 
psychosis during acute episodes (ibid). By extension, in the absence of those beds, outside of 
Nairobi 99% of cases of acute psychosis are left untreated by the public health system. 
The supply of psychiatric medicines is little better than that of beds. Kenya’s Essential 
Drugs List contains a wide array of psychiatric medicines (17 in total), but in reality only three 
are widely available throughout the health sector: one antipsychotic (chlorpromazine); one 
anticonvulsant (phenobarbitone); and one anxiolytic (diazepam, better known as valium) (Kiima 
and Jenkins 2010). Antidepressants were only available in hospitals until 2007, and today they are 
                                                 
3
 The county is the new administrative unit of choice since the 2010 constitution, and Kenya has 47 counties. 
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rarely stocked in primary care. As a result, anxiolytics, which can be addictive, are inappropriately 
prescribed in place of antidepressants.  
Human resources for mental health are similarly “extremely overstretched” in Kenya 
(ibid). In 2004, there were only 35 public psychiatrists, serving a country of 38 million. 
Furthermore, two out of every three public psychiatrists (69%) worked in Nairobi. Thus, despite 
a national ratio of 1 psychiatrist (public and private) per 500,000 people4, the picture is far worse 
outside of the nation’s capital, reaching 1: 3,000,000 in the provinces (Kiima and Jenkins 2010). 
By contrast, psychiatrists are relatively widespread in Nairobi, with a rate of 1: 63,000 people 
(Ndetei et al. 2007). The rate of psychiatrists in Kenya has been stable for the past ten years, 
thanks to a replacement level of psychiatrists graduating from local medical schools. 
Nonetheless, because of the “brain-drain” affecting many African health systems (Jenkins, Kydd, 
et al. 2010), there are as many Kenyan psychiatrists practicing in a public health facility in Kenya 
today as there are Kenyan psychiatrists practicing overseas (Ndetei et al. 2007).  Kiima and 
Jenkins estimate that at current rates of medical diplomas, it would take 100 years to train 
enough psychiatrists so as to meet the 1996 policy target of one public sector psychiatrist per 
district. 
The human resource shortage afflicting public psychiatrists also applies to psychiatric 
nurses and other allied mental health professionals. Many psychiatric nurses do not practice 
psychiatric nursing, but work instead in surgery, obstetrics and HIV clinics (Kiima and Jenkins 
2010). One in four practicing psychiatric nurses are located in Mathare Hospital, leaving an 
estimated 180 public nurses to tend to the remaining 35.5 million Kenyans living outside of 
Nairobi. Unlike psychiatrists, psychiatric nurses are not graduating at a replacement rate, so these 
insufficient numbers are further dwindling. As with psychiatric nurses, so too with public 
medical social workers, who are present at a rate of one per province. 
 
1.1 - e) The non-state sector 
Stepping aside from the insufficiencies of the state sector, we turn to the capacity of the non-
state sector to address the mental health treatment gap. It should be noted that “private,” as it is 
employed in this thesis, is not equivalent to for-profit. In keeping with key literature in this area, 
I use the term non-state and private interchangeably. Borrowing from a report by the 
International Finance Corporation (International Finance Corporation 2007), I conceptualize 
non-state or private care along two axes: 1) for-profit vs. not-for-profit; and 2) in the formal or 
informal sectors of the economy (table 1-3).  The informal sector (or economy) is understood 
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 By comparison, according to the WHO ATLAS, the ratio in the UK is 1 psychiatrist per 9,000 population. 
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here, using the definition of British anthropologist Keith Hart, as “economic activities which 
take place outside the framework of corporate, public and private sector establishments” (Hart 
1987). Concretely, this refers to casual labour or unlicensed health care that goes untaxed and is 
not included in gross domestic product. As of the latest household survey data from 2006, over 
one third of Kenya’s working-age population (36%) participate in the informal sector, one half 
(50%) are self-employed farmers, and the remaining 14% work in the formal sector (Pollin 
2009). 
Formal for-profit providers include hospitals (small private hospitals are known in Kenya 
as “nursing homes”) and private outpatient clinics for both primary and specialist care. Formal 
not-for-profit providers refer to nongovernmental organizations (NGOs), faith-based 
organizations (FBOs) and social enterprises. The informal sector contains traditional and faith 
healers on the for-profit side (although some faith healers do not charge for services) and self-
help groups, community-based organizations and families are on the not-for-profit side.  
This thesis will sample care provided by all but the latter group of providers in the matrix 
of non-state actors, as it was not possible to collect data on community based organizations or 
self-help groups within the time and resource constraints of the field work. Some, though limited 
data are available about their influence within the context of an NGO intervention. This thesis 
will allocate a chapter to the intervention of the international NGO BasicNeeds,  a chapter to 
for-profit hospital care, using a case study of Chiromo Lane Medical Center in Nairobi, a chapter 
to for-profit outpatient care, and a chapter to traditional and faith healers. 
Table 1-3: Matrix of non-state actors in health care 
 For profit Non-profit 
Formal Hospitals, individual GPs, 
nurses, allied professionals 
NGOs, faith-based organisations, 
social-enterprises 
Informal Traditional  and faith healers Self-help groups, community-based 
organisations, families 
 
The lines between state and non-state care are sometimes blurred in Kenya.  Many of the 
people working within the private health care sector also work in the public sector. In the words 
of a Kenyan health policy maker, “In Kenya now you cannot define a doctor as public or private. 
By day they are in the public sector, and at night, they are private.”  Not only the people, but also 
the facilities are sometimes hard to define. The informant went on to note: 
“The difference between private for-profit and not-for-profit is purely 
academic. Nairobi Hospital calls it surplus, not profit, but it’s the same. 
And Aga Khan is theoretically an FBO [faith based organization]. 
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Distinguishing between for-profit and not-for-profit, in the true sense, 
requires a set of criteria, not just one.” (KI 16, 7 October 2011)  
This policy maker outlined three main criteria for defining a not-for-profit agency: 1) ownership; 
2) incorporation status (e.g. liability trust or NGO); and 3) whether they are self-financing. The 
third criteria of self-financing seemed to him most essential: if a facility is self-financing then it 
functions as a for-profit business. I have adopted this definition of a for-profit as a self-financing 
entity. 
 
1.4 Treatment gap 
 
Despite the high clinical burden of mental disorders in Kenya, they remain largely 
untreated, although the precise treatment gap in Kenya is unknown. Treatment gap calculations 
are difficult to make, because they require precise, local epidemiological data. The largest 
undertaking in this regard is the ongoing World Mental Health Survey, which has sampled over 
154,000 people across 28 countries, including two in Africa (Nigeria and South Africa). This 
study estimated that the treatment gap for “serious” mental disorders5 across low-income 
countries is 76-85% (Demyttenaere et al. 2004). In Nigeria,  they found only one in ten people 
with a diagnosable mental disorder was accessing treatment, making the treatment gap there 90% 
(Gureje and Lasebikan 2006). The gap was worse still for alcohol disorders, which were found to 
be entirely untreated. The proportion of people with mental disorders accessing specialist mental 
health services was only 1%. 
A WHO-commissioned review of the treatment gap for mental disorders (Kohn et al. 
2004) found in 2004 that only one study from Africa had been published on this topic amidst the 
37 reviewed. The African study, from Zimbabwe, measured a treatment gap of 67% for major 
depression over the previous year (Abas and Broadhead 1997). More recently, the WHO 
examined the treatment gap for schizophrenia, drawing on data from the new WHO Assessment 
Instrument for Mental Health Systems (WHO AIMS) from 50 low- and middle-income 
countries. The authors found a treatment gap in low-income countries of 89% for schizophrenia. 
Epilepsy is among the neuropsychiatric disorders with the greatest treatment gap. A study in 
rural Kenya found that three in every four people with epilepsy had never been prescribed anti-
epileptic medicine (Feksi et al. 1991). The gap in urban areas, however, is estimated to be less 
(Mbuba et al. 2008).  
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 As opposed to severe mental disorders, serious mental disorders is a marker of severity of the condition and 
can encompass the common mental disorders. 
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1.5 Framework and questions 
 
1.1 - f) Literature gaps 
The literature on mental health in Africa remains in its infancy, however it has developed a 
growing evidence base over the past two decades. The literature is vocal about the treatment gap 
for mental disorders, although the data from Africa on disease prevalence and treatment 
coverage are thin. In addition, there is a growing evidence base about the economic burden of 
these illnesses. The literature gaps are as telling as the evidence itself that mental health is an area 
largely ignored by health care planners in Africa and Kenya, despite the significant burden of 
these disorders. Non-state provision of mental health care in low-income countries represents 
the largest gap in the literature and little, if anything, is published about its ability to provide 
mental health coverage not only in sub-Saharan Africa, but across low-income countries. The 
aim of this thesis is therefore to explore the ability of non-state actors to address the treatment 
gap in Kenya by providing service coverage for mental disorders. 
 
1.1 - g) Theoretical framework 
In the last few years, a movement has been growing within global health policy to promote 
universal coverage, making “coverage” an essential concept to understand. In 2010, the World 
Health Organization’s annual World Health Report was titled “Financing health care: The path 
to universal coverage”(World Health Organization 2010).  In 2012, the United Nations issued a 
declaration on universal coverage at the General Assembly (United Nations General Assembly 
2012) and The Lancet medical journal published a special issue on universal coverage (Vega 
2013). The following year, the WHO published another World Health Report titled: “Research 
for universal coverage”(World Health Organization 2013).  Meanwhile, since the World Bank 
came under the direction of Jim Kim – a medical doctor and former leader of the HIV/AIDS 3 
by 5 initiative at the WHO – it too has spearheaded the universal coverage movement, creating a 
Universal health Coverage (UNICO) study series, and defining joint targets with the WHO. The 
targets cover financial protection and service delivery, namely: 1) reducing by half the number of 
people impoverished by health care by 2020 and 2) doubling the proportion of people with 
access to health services by 2030 (World Bank 2014). Together, the World Bank and WHO are 
pushing to make universal coverage one of the new Sustainable Development Goals, which are 
to replace the Millennium Development Goals in 2015. 
 The interest in universal coverage is not new. It first came to the fore in the 1970s, 
coming to a head in Alma Atta in 1978 at an international conference on primary health care 
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with the slogan “Health for All” (World Health Organization 1978). It was therefore in the 1970s 
that the term coverage was first rigorously defined. This thesis adopts the framework of T. 
Tanahashi, published the same year as the Alma Ata conference. Coverage is conceived of along 
five dimensions: 1) availability; 2) accessibility; 3) acceptability; 4) contact; and 5) effectiveness 
(Tanahashi 1978). Availability refers not only to the physical presence of health care resources, 
but also to their characteristics and components. Accessibility relates to both the proximity of 
services to the prospective patient, and also, importantly, to their cost. Acceptability calls into 
question attitudes of patients to providers and vice-versa, including explanatory models of illness 
and their relationship to the care on offer. Contact coverage is what some researchers might dub 
“use” or “utilization” (Shengelia et al. 2005),  meaning the degree to which patients actually come 
into contact with the service and how equitable those services are. Finally, effectiveness brings in 
a measure of care quality into the discussion of coverage. Tanahashi’s framework was originally 
set forth in 1978, and  continues to serve as a reference point in discussions of health care 
coverage (Evans, Hsu, and Boerma 2013), including mental health coverage (De Silva et al. 
2014).   
Another framework I considered adopting was that of Penchansky on health care access. 
Penchansky’s five dimensions of access, published in 1981, mirror Tanahashi’s definition of 
coverage to a considerable degree, namely: 1) availability;  2) accessibility;  3) acceptability: 4) 
accommodation; and 5) affordability. Accommodation refers to the way in which a service 
organizes its services, for example appointment systems, hours of operation, and walk-in 
facilities. Affordability has been interpreted post-hoc to be contained in Tanahashi’s dimension 
of accessibility (De Silva et al. 2014), whereas the concept of effectiveness contained in 
Tanahashi’s framework is absent from that of Penchansky. Indeed, more recent theorizations 
around access and coverage note that a weakness of the focus on access is that it is overly reliant 
on supply-side analysis and neglects questions of quality (Shengelia et al. 2005). 
 
1.1 - h) Research questions 
In response to the gaps in the literature, this thesis will address the question: What contribution do 
non-state actors make to coverage for mental disorders in Kenya?  In other words, to what degree if any can 
non-state actors be considered part of the solution, or inversely part of the obstacle, to the 
problem of universal coverage within the context of mental health care? 
 
Using Tanahashi’s definition of coverage, the over-arching research question is divided into 
sub-questions, reflecting the five dimensions of coverage: 
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1. What is the availability of non-state mental health services? 
2. How economically accessible are non-state services? 
3. How culturally acceptable are non-state services? 
4. How many and which patients are in contact with non-state services? 
5. How effective are non-state services? 
 
The thesis will look at four main actors in non-state mental health care: 1) formal sector, 
not-for-profit providers (the NGO BasicNeeds); 2) formal sector for-profit inpatient providers 
(a psychiatric hospital); 3) formal sector for-profit outpatient providers (psychiatrists and 
psychiatric nurses); and 4) informal providers (traditional and faith healers, operating on both a 
for-profit and not-for-profit basis).  These provider types form the basis of four empirical 
chapters. Each empirical chapter will focus on some, but not all, of the research sub-questions, 
as there are insufficient data to address them all. 
The thesis uses mixed methods to analyse data from multiple sources, drawing on a 
combined sample of 939 people: 774 adults with mental disorders accessing treatment and 115 
mental health service providers. Overall, I hypothesize that the non-state sector plays a 
significant role in providing health care in Kenya, despite being all but absent from the literature, 
but I hypothesize that the distribution of non-state care might not be equitable in terms of 
geography and income status.  
 
1.6 Chapter overview 
 
First (Chapter 2), the context for this research is explored by reviewing the existing literature on 
effective mental health treatments in low-income countries and Africa, and on the debate 
surrounding the desirability of non-state actors in African health care. In the methods Chapter 
(3), I explore questions surrounding the methodology of economic evaluation and case study, 
while also engaging with debates in the past century of cultural psychiatry. Methods of analysis in 
the ensuing empirical chapters include cost-effectiveness analysis (chapters 4 and 5), case study 
and multivariate regression (Chapter 6), descriptive statistics (Chapter 7), and qualitative 
framework analysis mixed with tests of binary association (Chapter 8).  
The chapter on not-for-profit provision (chapter 4) describes the model for Mental 
Health and Development delivered by the NGO BasicNeeds in rural central Kenya, and analyses 
its cost-effectiveness in relation to treatment as usual. The MHD model offers community-based 
care for people with mental disorders in low- and middle-income settings. Using a pre-post 
design, 203 consecutively enrolled participants with mixed diagnoses were followed-up at 10 and 
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20 months. Costs are analysed from societal and health system perspectives. Comparison 
outcomes are drawn from the literature. Primary data are annualized for the sake of comparison.  
The chapter on formal for-profit inpatient care (Chapter 5) uses a case study method to 
understand service use and charge in Chiromo Lane Medical Centre, a 30-bed psychiatric 
hospital in Nairobi, which forms part of one of the largest private psychiatric providers in East 
Africa. Nested within the case study, I use quantitative data shared with me by the hospital 
directors, to evaluate the effects of insurance on service use and charge, questioning implications 
on access to care. Data derive from invoices for 455 sequential patients, including 12-month 
follow-up. Multi-linear and binary logistic regressions explore the effect of private health 
insurance on readmission, cumulative length of stay, and treatment charge.  
The chapter on formal outpatient care (Chapter 6) relies on two small datasets, one 
looking at the rate of participation of psychiatric nurses in mental health at large and in the 
private sector in particular, and the other querying the costs and access to specialist private 
practice clinics, using provider data. To address the first question, a simple questionnaire was 
delivered to 50 nurses attending the mental health meeting of the National Nursing Alliance of 
Kenya in 2012, including 40 with psychiatric nursing degrees. To address the second question 
about outpatient care, 11 private practitioners (8 psychiatrists, 3 psychiatric nurses) from Nairobi 
and Central Province were interviewed using a purpose-designed structured Private Psychiatric 
Practice interview.  
In Chapter 7, I first examine the difference in characteristics between traditional and 
faith healers and the patients accessing their care. Next, I explore the capacity of these healers to 
diagnose and treat mental illness. Finally, I examine the relationship between the informal and 
formal health care system, questioning what it reveals about patient preference. The sample 
comprises 54 healers and 116 patients identified through snow-balling and purposive sampling. 
Data were gathered using three tools: the standardized Mini International Neuropsychiatric 
Interview and two purpose-designed tools, the Healing Interview and a socio-demographic 
questionnaire. 
In the conclusion (8), I explore the policy and research implications of these several 
pieces of research. Bringing together the findings from the five empirical chapters, I attempt to 
address the ability of non-state actors to address the mental health treatment gap in Kenya, based 
on the criteria of capacity, access and cost. In addition, I address the limitations of the thesis, 
chief among them the fragmentation of data sources, and I explore policy and research 
implications of the findings.  
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2. “Truths” About Mental and Private Health Care in Africa and Kenya 
 
 
 
 
 
Figure 2-1: A man carrying home water in Nyeri 
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“My chief object is not to enter into controversial discussion 
with those who have attempted, or are attempting to describe the 
same things from outside observation, but to let the truth speak 
for itself.” – Jomo Kenyatta (Kenyatta 1961) 
 
 
2.1 Introduction 
The study of private health care in Africa is full of controversy. Should private care exist? Does it 
undermine public care? Does it exacerbate inequalities? The same is true of the field of global 
mental health. Does mental illness exist in low-income countries? Does promoting treatment 
advance the cause of the pharmaceutical industry? Following the lead of Kenya’s first president, 
Jomo Kenyatta, whose dissertation on the customs of the Kikuyu tribe under British 
colonization was no less controversial, “my chief object is not to enter into controversial 
discussion.”  
Instead, in this chapter I will look at the existing “truths,” in other words what is known 
from the literature about these topics, paving the way for a contribution to the knowledge 
through my empirical work. The chapter is divided in three sections. First, I will explore existing 
models of care for mental disorders in low-income countries. Next, I will review the evidence of 
what treatments are cost-effective. Finally, I will summarize the debate surrounding the role of 
non-state actors within African health care and provide facts and figures about their presence in 
Kenya. In each section, I will highlight gaps in the literature, where the “truth” has yet to be 
written. 
 
 
2.2 Models of mental health care in LAMIC 
 
2.2 - a) Specialized services 
As we have seen, specialized services for mental health care are relatively rare in Kenya. Hospital 
care includes residential services for acute patients in designated psychiatric units, and some 
outpatient care at designated district hospitals with a psychiatric nurse on staff. In the public 
sector in Kenya, specialized care is almost exclusively available in hospitals. Within the non-state 
sector, there was no evidence on the availability of specialized mental health care when I began 
research into this topic. Two models of exclusively specialized care are studied in this thesis: 1) 
residential care in a for-profit psychiatric hospital; and 2) outpatient care from private practice 
psychiatrists and psychiatric nurses. 
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2.2 - b) Integrated services 
Two of the main models for delivering mental health care in Africa are 1) through primary care 
and 2) through perinatal care. Proponents of primary care (Jenkins, Othieno, Okeyo, Aruwa, et 
al. 2013; Wright et al. 2013) note that this is the first resort for health care across all health 
systems, regardless of GDP, and that in a context of constrained specialised resources, it is all the 
more paramount. The rationale for focussing on perinatal care (Honikman et al. 2012; 
Nakigudde et al. 2013) is that childbirth is the single occasion when an woman is most likely to 
come in contact with the formal health system, and that it privileges access to care by women. A 
large-scale study funded by the UK Department for International Development is currently 
examining an intervention for mental health in both primary and maternal health care sites 
across five low-and-middle income countries including three in Africa: Ethiopia, Uganda and 
South Africa (Lund, Tomlinson, et al. 2012). Called the Programme for Improving Mental 
Health Care (PRIME), this study focuses on three priority conditions, namely depression, 
alcohol disorders and schizophrenia.  
In a similar vein to integrating mental health within primary care, there is also a move in 
Africa to integrate mental health within chronic disease care (de-Graft Aikins et al. 2010; de 
Menil et al. 2012), which includes the treatment of HIV. The rationale for integrating mental 
health within chronic disease care is multiple. First and foremost, mental disorders are in many 
cases a form of chronic disease. Disorders like schizophrenia are sometimes accompanied by 
ongoing symptoms, such as paranoia or disorganized thinking. Other disorders, such as 
depression, can be cyclical and recurring. Chronicity is not a characteristic of all mental disorders, 
however, as some people experience full recovery from a single illness episode.  
Another reason for integrating mental health within chronic disease care is because there 
can be a reciprocal relationship between mental disorders and chronic disease. The existence of a 
comorbid mental disorder tends to worsen the prognosis for chronic disease, and the existence 
of a comorbid chronic disease tends to aggravate symptoms of mental disorder. One example of 
this reciprocal association between mental health and chronic disease is that of comorbid 
depression and diabetes. A recent study by Leone and colleagues systematically mapped the 
evidence of associations between comorbid depression and diabetes with socio-economic status 
(Leone et al. 2012). Most of the 14 articles in the literature explored predictors of depression in 
people with diabetes. Some evidence was found to suggest that comorbid depression and 
diabetes were associated with lower socio-economic status, although the association was not 
found between comorbidity and education. 
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In response to the evidence on comorbidities, integrated treatments are being developed 
to address these illnesses more comprehensively. Integrated treatments can mean either 
established referral systems, or a combined treatment package delivered by a single provider. As 
one of the best-resourced illnesses, HIV has benefitted from the greatest amount of research 
into integrated care. As might be expected, treating HIV has been found to positively impact 
people’s mental health (Okeke and Wagner 2013). Less intuitively, treating mental health 
problems has been found to improve HIV outcomes, among those on anti-retroviral therapy 
(Joska and Sorsdahl 2012).  Mechanisms for this effect include improved medication adherence, 
and better access to and continuity of care. Specific mental health interventions have been 
developed for people with HIV, such as the “Friendship Bench” problem-solving approach, 
which has been shown to alleviate symptoms of common mental disorders in an HIV affected 
population in Zimbabwe (Chibanda et al. 2011). 
In light of the clinical benefits of integration, recent research has focused on its potential 
economic benefits. Again, HIV research is the source of most of the literature on this topic, 
which has not yet been analysed for mental health care. A systematic review of the efficiencies of 
integrating HIV treatment and care with other health services found 35 peer-reviewed articles 
and 11 grey-literature articles on this topic (Sweeney et al. 2012). Only one of the articles 
compared integrated care with a non-integrated control, so it was not possible to estimate the 
cost-effectiveness of integration. The literature did, however, suggest that integrating care 
improved technical efficiencies, as demonstrated by lower unit costs of care. Furthermore, a 
study called Integra is underway, led by some of the same authors as the systematic review, to fill 
the literature gap on the cost-effectiveness of integrated care, and Kenya is one of its sites 
(Warren et al. 2012).  
 
2.2 - c) Community-based interventions 
Also involving primary care, but not limited to it, are a broad range of strategies promoting 
“community mental health.” The precise meaning of this term varies depending on the context 
(Hanlon, Wondimagegn, and Alem 2010). In addition to outpatient treatment, it can also include 
care within the community itself, which is to say in village streets, homes, religious venues, and 
schools (Raja 2009). Community mental health also involves a host of different actors, typically 
less-specialized in health.  
In the context of increasing access to community mental health, considerable attention 
has been turned to the ability of lay-health workers to treat mental disorders, an approach 
referred to as “task-shifting.” Most of the task-shifting literature comes from Asia (Rahman et al. 
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2008; Patel et al. 2010; Chowdhary et al. 2014). A systematic review of task-shifting in mental 
health suggests that the outcomes of this approach are, as yet, inconclusive, though they have 
shown signs of promise in certain contexts (van Ginneken et al. 2013). The review uncovered 
seven studies of task-shifting from low-income countries and fifteen from middle-income 
countries. Most of the studies focused on the influence of task-shifting on recovery from 
common mental disorders, particularly depression, anxiety and post-traumatic stress disorder. 
The study found that at two-to-six months post intervention, task-shifting appeared to increase 
the recovery rates from depression and anxiety. One of the studies reviewed came from Uganda 
(Bolton et al. 2003). The authors of the Cochrane review noted, however, that the data were 
subject to selection bias, small samples and high drop-out rates, making the findings 
inconclusive. 
Another key type of community-based care takes the form of user-led, or “self-help” 
groups. Despite endorsement of service user involvement by global mental health policy makers 
(World Health Organization 2001, 2005), there is very limited research in this area from low- and 
middle-income countries. A trial from India demonstrated for the first time in a low-income 
setting that participation in user-groups (called self-help groups) was an independent determinant 
of good outcome for people with schizophrenia (Chatterjee et al. 2009). The groups constituted 
part of a community-based rehabilitation programme. In Africa, there is qualitative evidence of 
users forming networks at local, district and national levels in Ghana in order to influence health 
and development policies (Yaro and de Menil 2009). The work in Ghana was done with support 
of the NGO BasicNeeds, also active in Kenya. Papers have been written in Zambia (Katontoka 
2007) and South Africa (Kleintjes et al. 2010; Kleintjes, Lund, and Swartz 2013) articulating the 
potential effects of increasing service user involvement within mental health, but no quantitative 
evidence exists on their outcomes.  
In Kenya, a group calling itself Users and Survivors of Psychiatry Kenya (USP-Kenya), 
was established in 2007 to give voice to service users in policy debates and raise awareness 
among the general public about the nature of mental disorders. USP-Kenya was also supported 
with financing and infrastructure from BasicNeeds (USP-Kenya 2011). There appears to be a 
significant overlap, therefore, between the informal not-for-profit sector and the formal not-for-
profit sector.  
Among international NGOs working in mental health, there is a particular interest in 
displaced and brutalized communities as a consequence of humanitarian disaster (Betancourt et 
al. 2010). In Uganda, for example, the Peter Alderman Foundation set up training workshops 
and psycho-trauma centres to help overcome the effects of years of civil war between the Lord’s 
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Resistance Army, led by Joseph Kony, and the government of Yoweri Museveni (Nakimuli-
Mpungu et al. 2013). A number of organizations aim to provide mental health care to refugees, 
such as International Medical Corps, working with Somalis in Ethiopia. Kenya shelters the 
world’s largest refugee camp, Dadaab, which is home to some 500,000 mostly Somali refugees in 
the north-east of the country. Two international NGOS and a governmental organization – the 
International Rescue Committee, Médecins Sans Frontières and Gesellschaft für Internationale 
Zusammenarbeit (GIZ) – all have psychiatric nurses on-site providing mental health care to 
refugees. The effectiveness of these interventions is challenging to evaluate given the obvious 
constraints of conducting research in a context of acute insecurity. Some interventions for PTSD 
have shown benefit in adults, and group therapy and school-based supports have shown benefit 
for children with internalising symptoms, however the most commonly used humanitarian 
mental health interventions have not been subject to rigorous evaluation (Tol et al. 2011). 
Community-based interventions in their truest sense involve people outside of the health 
sector, such as village leaders, religious leaders, traditional healers, teachers, and community 
workers, sometimes known as volunteers (de Menil and Underhill 2010). Community-based 
mental health care is widely promoted as best-practice in international policy documents. For 
instance, one of the four objectives of the new flagship Mental Health Action Plan 2013-2020 
published by the World Health Organization is “to provide comprehensive, integrated and 
responsive mental health and social care services in community-based settings” (World Health 
Organization 2013). In middle-income countries, the emphasis of community mental health 
interventions is on de-institutionalizing existing mental health care, but in most of Africa, the 
emphasis is on creating new mental health services where there have been none. The leading 
providers of community-based care in Africa tend to be non-state actors rather than 
governments. Two models of community-based care stand out for having been most widely put 
into practice. These are the Mental Health and Development (MHD) model and the Community 
Based Rehabilitation (CBR) model.  
 
2.2.c.i Mental Health and Development (MHD) model 
The Model for Mental Health and Development was designed by Chris Underhill and field 
tested in India by DM Naidu and colleagues in 2000 (Underhill 2002). It is a rights-based 
intervention composed of five modules (figure 4-2): capacity building; community mental health; 
livelihoods; research and policy; and collaboration (formerly management). The MHD model, 
which is innovative for its inclusion of poverty-reduction strategies within a health care context, 
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was first described in detail within the handbook Mental Health and Development: A Model in Practice 
(BasicNeeds 2008). A synthesis of its five modules follows.  
 
Figure 2-2: Modules and activities of the MHD model  
 
 
Source: BasicNeeds Operations Manual, 2010 
 
Capacity building: Capacity building exists along three levels: users and carers, community leaders, 
and health and development workers (including community workers). The MHD model starts by 
consulting people with mental illness or epilepsy and their carers to assess their needs, as voiced 
by themselves. Listening to and sensitising key community leaders (village elders, police officers, 
government officials, religious leaders) takes place in parallel and is said to foster local ownership 
and adaptation of the intervention. Capacity building continues with health and development 
workers, who are trained in the aspects of mental health and development germane to their 
work. Emphasis is on diagnosis, treatment and prevention for health workers, and on 
recognizing mental illness or epilepsy and its links to poverty for development workers. One of 
the main outputs of the capacity building module is self-help groups of service users and carers, 
who are offered training in a number of topics, ranging from managing group dynamics and 
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techniques of self-advocacy to book keeping for income generation. The underlying principle of 
this module is to mobilize and empower communities to address the issues arising from or 
generating mental ill health. 
 
Community mental health: Medical treatment in community health care settings is an essential 
component of the MHD model. Community mental health care is delivered principally in 
partnership with the national health service of a given country, as well as with private providers, 
such as charitable clinics. BasicNeeds also engages with practitioners of traditional medicine, 
who are often the first port of call for people with mental disorders seeking care. The main focus 
of the community mental health module is making care accessible in community settings (figure 
4-1), as opposed to psychiatric hospitals, where it is typically found in low-income settings (Raja 
2009). In the first instance, this involves creating outreach clinics in primary care centres, where 
psychiatric nurses or psychiatrists are brought in on regular occasions to provide treatment. 
Later, general health workers are often trained in mental health using national curricula (as per 
the capacity building module), and mental health clinics become integrated into primary care – 
offered alongside other standard health treatments, as per WHO policy (World Health 
Organization and World Organization of Family Doctors 2008). Community workers also form 
an essential ingredient to the community mental health module, supporting service users in their 
homes and neighborhoods, outside of the clinic (de Menil and Underhill 2010). 
 
Livelihoods:  In calling the organization BasicNeeds, Underhill chose to emphasise not only that 
mental health care is a basic need, but also that people with mental illness or epilepsy have basic 
needs that go beyond health care. BasicNeeds argues that engaging in a livelihood is one of the 
best means for overcoming the stigma surrounding mental illness and epilepsy. Income 
generating activities are mostly carried out in the context of self-help groups, but can also be the 
work of individuals, depending on the development services available in a given community. 
Livelihoods are grouped in two categories: 1) income generation; and 2) unpaid productive work, 
such as tilling soil, feeding animals, fetching water or cleaning. 
 
Research and Policy: Including research within a community development model was a noteworthy 
decision on the part of those designing the MHD model, as community development workers 
sometimes resist data collection, arguing that it detracts time from important programme 
implementation. Research conducted in the context of the BasicNeeds model therefore has a 
clear practical application –  for example, looking at causes of drug shortages (Raja, Kippen, and 
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Reich in press), or the public funding available for mental health in a given country or district 
(Raja et al. 2010). Much of the research aims to gather evidence for promoting or implementing 
health and development policies and improving practice. A sample of people with mental illness 
or epilepsy also engage in participatory action research to inform field staff of what is working 
and what needs changing in the model’s application. 
 
Collaboration (formerly management): The MHD model is managed and delivered through a web of 
public and private partnerships, numbering 88 in 2010 (BasicNeeds 2011). As a rule, BasicNeeds 
employs locals in their country of origin, rather than bringing in experts from abroad. In order to 
implement the BasicNeeds model, there must first be a partnership with government, so that the 
work is locally authorised. Partners must also meet a set of due diligence criteria, and are chosen 
on the basis of their interest in mental health and development, their standing in the community, 
and their organizational capacity, particularly as regards community workers and livelihoods. The 
Model for Mental Health and Development has been manualised by BasicNeeds to increase its 
dissemination and ensure standards of practice. The Operations Manual, which is regularly 
updated, breaks down each module into its component activities (figure 1) and is available for 
use by interested organizations by means of a license agreement.  
 
2.2.c.ii Community Based Rehabilitation  
Within the field of disability the leading intervention model is Community Based Rehabilitation 
(CBR). The CBR model was developed in the 1980s by Swedish doctor Einar Helander, a 
specialist in rehabilitation medicine (Helander 1993). The model consists of five domains: health, 
education, livelihood, social, and empowerment, each further divided into five elements, as in the 
matrix above (figure 4-3). (World Health Organization 2010). 
CBR was standardized in a 1994 policy paper, jointly authored by the International 
Labour Office, UNESCO, and the World Health Organization (International Labour 
Organization, World Health Organization, and United Nations Educational 2004). In 2004, the 
same group of international agencies updated their thinking in a strategy paper celebrating the 
twentieth anniversary of CBR’s inception (International Labour Organization, World Health 
Organization, and United Nations Educational 2004). The paper defined essential elements for 
implementating CBR at national, district and community levels, and secured endorsements of the 
model from a panoply of sectors (social, health, education, employment, NGO, media and 
community).  
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Figure 2-3: Community Based Rehabilitation model 
 
 
In addressing the use of CBR for the treatment of mental disorders, a word is called for 
on the position of mental disorders within the field of disability. (The language preferred by the 
disability community is “psycho-social disabilities,” as opposed to mental disorders.) Many 
mental health activists have lobbied to include mental illness within the definition of disability. 
The passage in 2007 of the Convention on the Rights of Persons with Disabilities was hailed as a 
great step forward in this respect in that it acknowledged that disorders of the mind constitute a 
disabling condition. Specifically, the convention defines persons with disabilities as “those who 
have long-term physical, mental, intellectual or sensory impairments which, in interaction with 
various barriers, may hinder their full and effective participation in society on an equal basis with 
others.” (United Nations 2007). Not all mental health service users identify as disabled, however, 
particularly those from low-income countries (Lamichane 2014). The financial and resource 
benefit attached to this label in high-income countries is not present in low-income settings, and 
disability is typically viewed as a chronic condition from which there is no recovery. The term 
can therefore be seen by some as stigmatizing. 
 
2.2.c.iii MHD in comparison 
There is considerable overlap between MHD and CBR. Three of the five model areas show 
almost perfect overlap, namely health (CBR) and community mental health (MHD), education 
(CBR) and capacity building (MHD), and livelihoods (CBR and MHD). The two additional CBR 
branches, social wellbeing and empowerment, are also terms that cohere with MHD principles. 
Furthermore, preliminary research has shown signs of success for integrating mental health into 
CBR under certain conditions (Raja et al. 2008).  
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Some differences do stand out between these approaches, however. The main distinction 
between the three models is their genesis. Whereas CBR has its roots in the field of 
rehabilitation, the MHD model is the offspring of the field of development. BasicNeeds makes 
economic-based arguments – principally the reduction of poverty – for working in mental health 
(McDaid and al 2008). Indeed, BasicNeeds does not consider itself foremost as a health charity, 
but rather as a development organisation that happens to work with people with a health 
condition (Underhill 2011). 
The development orientation of BasicNeeds is reflected in a more collectivist approach 
to intervention – starting with the community rather than with the individual. As opposed to 
CBR, which works principally at the unit of the individual, the MHD model works principally at 
the unit of groups, particularly self-help groups. The stated purpose of these groups is to 
encourage and capacitate people with mental illness or epilepsy to take charge of their lives (Yaro 
and de Menil 2009).  
The development approach inherent in the MHD model is also reflected in the way that 
BasicNeeds engage in the discourse of human rights.  The MHD model principally promotes the 
right of people with mental illness or epilepsy to development (United Nations General 
Assembly 1986) as distinct from their right to health care (United Nations 2007; United Nations 
General Assembly 1991). Both rehabilitation and psychiatric care are also conceived as 
fundamental rights, but they are framed as means to an end, which is development, rather than 
as ends unto themselves (Underhill 2011).  
 
2.2 - d) Traditional and faith healing 
The informal sector for mental health care in Kenya is substantially larger than the formal sector, 
but less well documented. An estimated 80% of rural health care in Kenya is provided by 
traditional healers, and  that rate may be higher in cases of mental health problems (Ndetei 
2007). Healers come in many forms. Some healers are generalists, while others specialize in the 
treatment of certain disorders, including mental disorders (Okonji et al. 2008).  
Psychiatrist Marx Okonji and colleagues shed some light onto mental health coverage by 
healers in a report on a healer workshop in Meson Division, Kisumu District. The 70 healers 
identified for the study were presumed to represent almost the whole population of healers in 
the division (population 50,000), making the ratio of healers to general population 1:714. The 
most appropriate analogue to the majority of healers is neither psychiatrists nor psychiatric 
nurses, but primary care providers. Kenya has approximately 2,000 primary care centres (Okonji 
et al. 2008), putting the ratio of primary care centres to general population at 1: 19,000. Healers 
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are considerably more prevalent than all types of formal health care providers, and up to 25 
times more prevalent than primary care providers. Despite their pervasiveness, little is 
documented about the nature of care currently provided by healers to patients with mental 
disorders. 
 
2.2 - e) Literature gaps 
Despite the existence of several coherent models of care for mental disorders in low-income 
countries, evidence on their effectiveness is limited by the dearth of research in this area. Only 
1% of all clinical trials on the treatment and prevention of mental disorders is conducted in low- 
and middle-income countries (LAMIC), where 80% of the world’s population lives (Patel et al. 
2007). If the literature is thin from low-income countries in general, it is thinner still from Africa. 
A systematic review conducted by Vikram Patel and colleagues for the first of two Lancet series 
on global mental health (ibid) found fifty-one studies from sub-Saharan Africa, but the majority 
were of limited generalizability, because samples were so small. Three quarters of trials 
conducted from LAMIC had fewer than 100 participants.  
In 2010, the World Psychiatric Association commissioned a review of the literature on 
community-based mental health care in Africa and found “a conspicuous lack” of evidence 
(Hanlon, Wondimagegn, and Alem 2010). Of the 24 evaluations located in the published and 
grey literature, 70% were from South Africa, the only middle-income country in sub-Saharan 
Africa, and only five studies included any form of comparison (pre-post or comparison to 
another model). Not a single study evaluated clinical outcomes using standardised symptom 
scales. Equally, no evidence was found on the effectiveness of either traditional healing or user-
groups, though both were noted as potentially promising interventions. In the Kenyan context, 
the MHD model has been widely implemented for the treatment of mental disorders, whereas 
CBR has not, so I have chosen to evaluate the MHD model, which is the subject of chapter four 
of this thesis. 
 
2.3 Cost-effectiveness of mental health care in LAMIC 
The literature on models of care focus primarily on two dimensions of Tanihashi’s spectrum of 
coverage, namely availability and acceptability. However, in order for existing and emerging 
interventions to be implemented at scale in low-income settings and start redressing the 
treatment gap, they must be not only effective, but affordable. This is especially true in contexts 
of poverty, where, for example, running water is not the norm (figure 2-1). Two further 
dimensions that are critical to achieving full coverage, therefore, are economic accessibility and 
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effectiveness. Both dimensions can be addressed in combination through cost-effectiveness 
analysis.  
Cost-effectiveness analysis allows for comparison between two different types of health 
service, for example mental disorders and malaria. “Where is your bed-net?” was the question 
once posed to psychiatric epidemiologist Vikram Patel by development economist Jeffrey Sachs 
(Patel 2011). To justify investment, mental health services must be of comparable cost-
effectiveness to the leading alternative health interventions – such as bed-nets for malaria. Policy 
decisions require data on avertable disease burden, not attributable burden (Chisholm 2005), and 
economic evaluation is a leading way of measuring avertable disease burden.  
Ideally, economic evaluations of mental health care in LAMIC should be based in 
empirical data and tailored to a country or region of focus (Chisholm 2005). However, a 
systematic review of economic evaluations of mental health in LAMIC (Shah and Jenkins 2000) 
found only ten empirical studies reporting on cost-effectiveness, and only one from Africa, 
conducted in 1989. The study, from South Africa, sampled 51 people with mental disorders and 
interviewed them before and after the introduction of home visits by psychiatric nurses (Gillis, 
Koch, and Joyi 1990). Hospital days decreased by half following the home visits, which led to 
estimated savings of Rd 786 ($309) per patient per year: a promising result, but insufficient 
evidence for high-level policy making across the continent. 
In the intervening years since the review was published, one economic evaluation was 
published using patient-level data from India. The study compared the cost-effectiveness of a 
lay-health worker intervention for depression with treatment as usual in public and private 
primary care clinics. Interestingly, the task-shifting intervention, devised by Vikram Patel and 
colleagues, was found to be more effective than treatment as usual in public facilities, but not in 
private practice (Patel et al. 2010). Effect was measured using the revised Clinical Interview 
Schedule, and scores in the public sector intervention group were 4.8 points better (20% of the 
baseline score) at 6 month follow-up than in the control group. Scores improved markedly for 
both intervention and control groups, particularly among private providers, where scores had 
fallen by approximately 60% across both intervention and control groups at follow-up. The 
researchers noted that recovery rates among the control group of private GPs was high, and they 
speculated that this could be the result of selection bias: private GPs who are interested in 
participating in a clinical trial are likely to be more motivated than the norm.  
The cost-effectiveness results reflect these clinical findings (Buttorff et al. 2012). The 
intervention dominated in the public facilities – meaning it was lower-cost and had better effects 
– whereas costs and effects were almost equal between intervention and control in the private 
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facilities. The overall cost of the intervention was Int$ 177 per person, divided evenly between 
direct health system costs and indirect opportunity costs. Intervention costs were lower than 
control costs, driven by lower indirect costs, specifically lost wages from sick days (Int$ 108 in 
the control group vs Int$ 64 in the intervention).  
In the absence of patient-level data, the next-best alternative, which comes at little cost 
and can be performed rapidly, is economic modelling. Where possible, economic models are 
populated with data from a specific country, so as to more accurately reflect variation in costs 
relating to local context. The standard threshold for cost-effectiveness of an intervention is that 
it costs less than per capita GDP per Quality Adjusted Life Year gained (World Health 
Organization 2005).Two studies have used country-level data to design Markov models of 
mental health interventions: one from Chile and one from Uganda. Both studies estimate the 
cost-effectiveness of treatments for depression. The Ugandan model (Siskind, Baingana, and 
Kim 2008) used outcome data from a locally conducted study of interpersonal group therapy 
(Bolton et al. 2003; Bass et al. 2006), to which it added booster sessions. The primary outcome 
was number of episodes of depression, which were estimated to decrease by 16% with group 
therapy plus booster sessions. The incremental cost of this intervention was $1,150 per Quality 
Adjusted Life Year (QALY) gained – which falls below the standard threshold of per capita 
GDP. 
The Chilean model (Siskind, Araya, and Kim 2010) used outcome data from a stepped-
care intervention for women (Araya et al. 2003) and estimated intervention effects over the 
women’s lifetime. The incremental cost-effectiveness ratio (ICER) of stepped-care versus 
treatment-as-usual was less than per capita GDP ($9,900 at the time in Chile). The results were 
highly sensitive to the estimates of treatment coverage (relating to adherence), which ranged 
from 50% to 80%. Stepped-care became notably more cost-effective when modelled with higher 
adherence than usual care. 
Because of a scarcity of data, the bulk of literature on economic evaluation of mental 
health in LAMIC is produced through economic modelling. There is a widespread lack of 
evidence on the costs of basic health services, particularly those provided by non-state actors. 
The WHO have devised their own method for estimating cost effectiveness within a given 
country or region by drawing on data from across multiple countries.  The WHO CHOICE 
method for measuring cost-effectiveness (technically cost-utility) has two particularities: the 
comparison group is always ‘no treatment’ and outcome is measured in DALYs (World Health 
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Organization 2003).6 These characteristics enable comparisons across different health conditions, 
which is an invaluable tool for health policy planning. In the last ten years, the WHO CHOICE 
method has been used to calculate the cost-effectiveness of treatments for depression (Chisholm 
et al. 2004), bipolar disorder (Chisholm et al. 2005) and schizophrenia (Chisholm et al. 2008). 
According to a synthesis of cost-effectiveness analyses from WHO CHOICE publications 
(figure 2-2), interventions for schizophrenia appear relatively low-performing, while 
interventions for alcohol disorders perform better – on par with those for maternal and natal 
health. Interventions for malaria, however, outperform all mental health interventions in terms 
of cost-effectiveness. The field of mental health does not yet have a bednet. 
 
Figure 2-4: Cost-Effectiveness of Selected Health Interventions in African Sub-region E 
Source: Figure created by Daniel Chisholm and included with permission (April 2011) 
Treatments Legend: ALC = alcohol; DEP = depression; BRC = breast cancer; CVD = cardio-
vascular disease ; DIB = diabetes; IAP = indoor air pollution; INJ = injury; IRD = iron 
deficiency; MAL = malaria; MNH = maternal and natal health; SCZ = schizophrenia; TOB = 
tobacco dependence; UVF = under-nutrition 
 
Since the WHO CHOICE method is designed with the putative audience of policy 
planners, a sectoral approach is preferred to the analysis of a single intervention for a single 
disorder. A sectoral approach refers to an analysis of all treatments within a given sector of 
                                                 
6
 A DALY, or disability adjusted life year, is the sum of years of life lost and years lived with disability from a 
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health care, in this case mental and neurological disorders. Two papers have adopted a sectoral 
approach to model packages of care for priority mental health conditions (Chisholm 2005; 
Gureje et al. 2007). The first study of this kind by Dan Chisholm and colleagues modelled a 
package across the 14 WHO sub-regions, including Africa-E, which encompasses Kenya.  
The package included treatments for two severe mental disorders (schizophrenia and 
bipolar disorder) and two common mental disorders (depression and obsessive-compulsive 
disorder) with coverage rates of 50% for all disorders except schizophrenia, which it estimated at 
80% (Chisholm 2005). Chisholm concluded that, at a per capita cost of $3-4, a minimum of 
1,600 DALYs could be averted per million people living in sub-Saharan Africa. The 
interventions with the lowest cost-effectiveness in the package were for severe mental disorders, 
which amounted to two-thirds of the cost but only one-third of the gain. However, the author 
noted that other considerations than efficiency come into play in rational decision-making, in 
particular considerations of equity. (This point will be addressed in the following chapter on 
methods.)  
Also adopting a sectoral approach, Oye Gureje and colleagues (including Chisholm) 
modelled a package of care for mental disorders in Nigeria (Gureje et al. 2007). The Nigerian 
package covered a different set of conditions at slightly different rates of coverage than the 
WHO regional study. In addition to schizophrenia and depression, the Nigerian package covered 
care for epilepsy and alcohol disorders, instead of for bipolar disorder and OCD. The modelled 
rates of coverage ranged from 40% for depression to 80% for alcohol disorders. Gureje 
concluded that the cost of such an intervention would amount to US $0.77 per capita (80 Naira), 
which he deemed an affordable amount within the Nigerian context.  
In conclusion, evidence from economic modelling suggests that several mental health 
interventions could be cost-effective at scale in Africa. In practice, however, few interventions 
are actually being put in place. The public health sector is over-stretched in terms of skilled 
workers, medical supplies and financial resources. What room is there then for the private sector 
to fill some of this gap? 
 
1.2 Non-state health coverage in sub-Saharan Africa and Kenya 
 
1.2 - a) In sub-Saharan Africa 
Because of a shortage of public health resources across sub-Saharan Africa, attention is 
increasingly turning to harnessing the potential of the non-state sector (Smith, Brugha, and Zwi 
2001; Marek et al. 2005; International Finance Corporation 2007; Bennett 2005).  Discussions 
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around the role of non-state actors in global health often err towards principle rather than fact. 
The challenge of gathering evidence in this area is that its components are less well organised, 
and therefore harder to monitor. There is a lively debate is around whether the non-state sector 
is contributing positively or negatively to health care coverage.  
 
Positive contributions of non-state providers 
The strongest argument in favour of the non-state sector (both for-profit and not-for-profit) is 
practical (Smith, Brugha, and Zwi 2001; Harding 2009; Harding and Preker 2003): non-state 
providers are delivering health care at a large scale with or without the endorsement of policy 
makers. Non-state actors provide an estimated 50% of formal health care in sub-Saharan Africa 
(International Finance Corporation 2007). To ignore them and focus exclusively on 
improvements in the public sector amounts to ignoring half of health care provision. Moreover, 
there is considerable overlap between state and non-state actors, since many doctors and nurses 
work in the public sector part-time and in the private sector for the other part.  
An extension of the practicality argument is that non-state providers increase access to 
health care. A study by Joanne Yoong and colleagues made an effort to empirically measure this 
assumption by examining the association between private sector participation rates and health 
care consumption in 34 sub-Saharan countries (Yoong et al. 2010). Data were drawn from 
Demographic and Health Surveys in relation to two conditions: child birth and childhood 
respiratory diseases. Overall rates of medical service use were low (50% for people with health 
care needs), and a strong positive association was found between levels of private sector 
participation and use of health facilities: a 10% increase in private participation was associated 
with a 15% increase in use of health services. These results held when controlling for income 
and maternal education, two factors associated with higher levels of private participation. The 
main limitation of the study is that it is cross-sectional, so it is not possible to impute causality to 
the association. 
A systematic review of the literature questioning the impact of non-state service 
provision on access to and quality of services concluded that “there is a need for much stronger 
evidence” (Patouillard et al. 2007). The review, which focused on the for-profit sector only, 
found 52 articles evaluating impact on a range of different private sector interventions. Half the 
studies were evaluations of training for private providers, while a third focused on social 
marketing and franchising, suggesting that these are the leading areas of study, if not activity 
within for-profit private health care.  
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Arguments are also found in favour of non-state health care among supporters of 
regulated market forces, who argue that provider competition and choice are good for 
consumers, and that health care is a good investment (International Finance Corporation 2007; 
Zwi, Brugha, and Smith 2001). This is the stance of a report commissioned by the International 
Finance Corporation and researched by McKinsey, titled The business of health in Africa: Partnering 
with the private sector to improve people’s lives (International Finance Corporation 2007). Additional 
pro-market arguments include that the non-state sector is more innovative and that they can 
make available expensive services that wouldn’t otherwise be offered (e.g. MRI machines). More 
ethically-oriented pro-market arguments can be found among proponents of user empowerment, 
since evidence from Asia suggests that service users prefer non-state provision: they perceive the 
non-state sector as having more flexible access, shorter waiting times, greater confidentiality, and 
greater sensitivity to their needs (Zwi, Brugha, and Smith 2001).  
 
Negative contributions of non-state actors 
For each point in favour of the non-state sector, a counter-point has been made by opponents, 
which I have summarized in the table below (table 2-4) (Hanson et al. 2008). They argue that 
high user fees (particularly in the for-profit sector) cause the private sector to decrease rather 
than increase access to health care, particularly among the poor (Oxfam 2009). The pro-private 
retort is that wealthier patients receiving care from the private sector lightens the public sector 
burden, enabling them to focus on the neediest (Marek et al. 2005). However, the strongest 
critics contend that, rather than increasing coverage, non-state providers act as substitutes for 
public providers, thereby undermining the public health system for no gain in overall population 
health (Marek et al. 2005; Oxfam 2009). Little evidence exists at the moment to confirm or deny 
these conflicting positions.  
The most substantiated critique of the non-state sector is the uneven quality of services, 
resulting in part from a lack of appropriate regulation (Sauerborn 2001; Zwi, Brugha, and Smith 
2001). There is considerable evidence to back this critique from a range of specialties including 
malaria (Kamat 2001), TB (Uplekar, Pathania, and Raviglione 2001), respiratory illnesses 
(Chakraborty and Frick 2002) and leprosy (Uplekar and Cash 1991). A host of problems were 
found in these studies, including failure to use appropriate diagnostic tests, and provision of 
drugs for inadequate lengths of time. Despite these serious short-comings, some researchers 
argue that comparable quality short-comings can be found in the public sector, and that the 
drivers of quality care are management and incentives, rather than whether the provider is 
publicly or privately owned (Hanson et al. 2008).  
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Table 2-1: Key points in the debate around non-state health care in LAMIC 
 
Keep in private care Keep out private care 
1. It is being widely used, so better to 
monitor than exclude. 
2. It increases access to health care. 
3. Users like it. 
4. It provides products and services that 
might not otherwise be available. 
5. Introduces competition and choice 
6. It is more innovative. 
7. There’s overlap between the sectors.  
1. It is costly and user fees reduce 
access to services. 
2. It is low quality, because 
unregulated. 
3. It is unequitable – caters to the 
rich and urban. 
4. It undermines the public sector. 
 
Beyond questions of quality, private sector service distribution also raises questions about 
equity. It is often assumed that private care serves wealthier populations to the exclusion of 
poorer people, who cannot afford the fees. While it is true that a greater proportion of those 
using non-state care is wealthy, the evidence does not bear out the hypothesis of exclusion of the 
poorest (Gwatkin 1999; Marek et al. 2005). A further critique around equity contends that private 
care focuses on urban populations to the exclusion of rural populations. Geographic distribution 
is, indeed, uneven, however, it is less so than suggested by critics. (I will address both of these 
challenges to equity within the context of Kenya in the following section.) 
Thus, a more nuanced stance emerges placing emphasis on contextual factors in 
determining the strengths and weaknesses of non-state health provision in developing countries. 
This position, put forth by Kara Hanson and colleagues at the London School of Hygiene and 
Tropical Medicine (Hanson et al. 2008), notes great diversity among non-state actors, and 
contends that each should be examined separately, rather than conflating the performance of 
for-profit and non-profit, formal and informal actors alike.  
 
2.3 - a) In Kenya 
The relative shortfall of information about non-state mental health care in Kenya comes in stark 
contrast to the well-developed nature of Kenya’s private health care sector in general. In 2010 
the World Bank completed a rigorous Private Health Sector Assessment in Kenya, as part of the 
project Private Sector Partnerships-One (PSP-One) (Barnes et al. 2010). The assessment noted 
that Kenya’s private sector is unusually well organized relative to other developing countries, 
  
44 
 
particularly around professional associations and trade groups. Moreover, pharmaceuticals 
represent a smaller segment of private sector spending in Kenya than in most other LAMICs, 
suggesting either that drugs are less over-prescribed, or that there are more providers relative to 
the number of drugs. Overall, private sector participation in Kenya’s health system was noted to 
be large and growing.  
Indicators of the private sector’s size include the total market value, the number of 
providers, and the proportion of health visits made to those providers. According to the World 
Bank Assessment, the private health care market in Kenya is valued at Int$ 542 million (Ksh 20.7 
billion), two-thirds of which are spent on hospitals. As of the latest national health account data 
(Ministry of Medical Services and Ministry of Public Health and Sanitation 2011), nearly a 
quarter (22%) of total health expenditure goes to private facilities (figure 2-3), and half of that 
(46%) is spent on hospitals. Private hospital expenditure goes in majority (60%) to for-profit 
hospitals, in the form of out-of-pocket and insurance payments (figure 2-4).  
In terms of provider numbers, three-quarters of all doctors and two-thirds of nurses are 
estimated to work in the private sector – though not exclusively so (table 2-1). Furthermore, 59% 
of health facilities are privately owned, with faith-based organizations alone owning a quarter of 
hospitals and 15% of health facilities (table 2-2).  
 
Figure 2-5: Distribution of Kenya’s total health expenditure in 2009/2010 
 
Data source: National Health Accounts 2009/10 
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Figure 2-6: Distribution of Kenya’s health spending to private providers 
Data 
source: National Health Accounts 2009/107 
 
On the demand side, 55% of urban health visits and 41% of rural health visits in Kenya 
are made to private providers (table 2-3). This suggests that the geographical spread is more 
equitable than might be expected. That being said, the bulk of rural provision may be from not-
for-profit providers. Out-of-pocket (also called household) spending, which represents one third 
of health financing in Kenya, is split half and half between public and private providers. Data 
from 2005/6 national health accounts (figure 2-5) suggest that almost equal amounts of out-of-
pocket funds are going to for-profit and not-for-profit hospitals (14.8% vs 11.2%).  However, 
not-for-profit hospitals are likely to be seeing more patients, so this figure is potentially 
misleading.  
 
Table 2-2: Estimates of Kenya’s health personnel by sector, 2007-08 
 
 
Source: Barnes 20108 
                                                 
7
 CHWs only accounted for 2% of private spending in the 05/06 NHA, as compared to 30% here. While CHW 
numbers have doubtless increased with the advent of a new strategy and their involvement in HIV treatments, 
this dramatic increase could also reflect a change in the definition or reporting of community health workers 
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Table 2-3: Distribution of Health Facilities in Kenya by Type and Ownership, 2006 
 
 
Source: Barnes 2010 
MOH = Ministry of Health; FBO = Faith based organization; Private = for-profit 
 
 
Table 2-4: Visits to health providers in Kenya by sector, 2007 (%) 
 
 
Public 
 
For-profit 
 
FBO 
 
Chemist 
 
Other 
 
Total 
 
Urban 45.5 29 4.8 18.7 2 100 
Rural 59.5 16.8 6.8 14.3 2.7 100 
Source: Barnes 2010 
 
 
The World Bank assessment coincides with increasing interest by the Government of Kenya 
in private sector provision of health care. The policy document Vision 2030 (Government of 
Kenya 2007), which defines Kenya’s strategy for development over the next two decades, makes 
public-private partnerships one of the “key initiatives.” More broadly the policy states: “One of 
the basic strategies for achieving the health care goals of Vision 2030 is structural change. This 
will be achieved through an enhanced regulatory regime and the creation of an enabling 
environment to ensure increased private sector participation.” The World Bank report takes this 
further, arguing that “most government officials acknowledge that the public sector cannot 
provide for all of Kenya’s health needs, and recognize the importance of the private for-profit, 
not-for-profit and faith-based sectors” (Barnes et al. 2010). 
                                                                                                                                                        
8
 The World Bank report drew its data from the Ministry of Medical Services Strategic Plan, which is not 
publicly available. The Ministry of Public Health and Sanitation posted its plan online, however it does not 
contain data on human resources. I have therefore had to replicate tables 4-6 from the World Bank report. In 
addition, the 2009/10 national health accounts do not report on out of pocket spending, so I similarly had to 
replicate figure 7 from the World Bank report. 
  
47 
 
 
Figure 2-7: Out-of-pocket spending in Kenya by provider, 2005/06 
 
 
Source: Barnes 2010 
 
The distribution of non-state care between the poorer and wealthier segments of Kenyan 
society appears relatively even. Kenya’s 1999 Demographic and Health Survey (Measure DHS 
1999) reports that among the poorest quintile, 47% of health care for a sick child was received 
from a private provider, which was only somewhat lower than use by the wealthiest quintile 
(65%). The most recent DHS survey from Kenya unfortunately does not distinguish between 
public or private health care providers when examining rates of child health care attendance. It 
does, however, report on reproductive health. Over one third of contraceptives in Kenya are 
acquired from a private medical provider, plus an additional 6% from private non-medical 
sources, such as “shops” (unlicensed pharmacies) (Measure DHS 2009). Though high, this rate 
represents a decrease of 14% relative to 2003, when 41% of contraceptives were sourced from 
private medical providers.  
The recent DHS report further reveals that private care is not equally used for all types of 
health care. Antenatal care, for instance, is 83% government provided. Since a majority (56%) of 
births in Kenya take place at the home, it may be that antenatal care is viewed as more optional, 
and that private care is used less for health services deemed optional. 
The geographic distribution of private care between in Kenya appears slightly skewed 
towards urban care, but fairly even. According to the 1999 DHS data 49% of rural populations 
accessed health care through private providers as compared with 59% of urban populations 
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11.2% 
14.8% 
7.8% 
3.4% 
1.7% 
5.6% 
1.1% 4.1% 
Government hospitals
Not-for-profit hospitals
For-profit hospitals
Private clinics
Public health centres &
dispensaries
Not-for-profit health centres and
dispensaries
Private pharmacies
  
48 
 
(Measure DHS 1999). A more recent household survey conducted by the Ministry of Health and 
reported on in the World Bank assessment found similar numbers with 49% of rural health visits 
and 55% of urban visits being made to private providers in 2003 (Barnes et al. 2010). 
The quality of private health care has been evaluated in Kenya for reproductive health 
(Agha and Do 2008, 2009), malaria (Abuya et al. 2010), TB (Chakaya et al. 2008) HIV, and drug 
distribution (Liambila, Obare, and Keesbury 2010). In addition, some attention has been given to 
the use of franchises for malaria, reproductive health and primary care (Decker and Montagu 
2007; Chiguzo et al. 2008; Fertig and Tzaras 2005).  
Little evidence, however, exists for the use of private care for chronic diseases, such as 
cancer, cardiac disease and mental disorders. Indeed, the World Bank assessment notes the need 
to address this literature gap: “Analyzing the use of the private sector in the area of chronic 
illnesses was not part of this private health sector assessment’s original scope of work, but such 
an analysis would be an important contribution” (Barnes et al. 2010). 
 
2.4 Conclusion 
There is a growing literature on the effectiveness of mental health interventions in low-income 
countries and some evidence – mostly from economic modelling – on the cost-effectiveness of 
some approaches. The literature is all but absent, however, on the topic of non-state provision of 
mental health care in low-income countries. For-profit care is a particularly unpopular area of 
research within mental health care, and other than doing head-counts of private psychiatrists, 
almost nothing is documented about its nature or costs. The four empirical chapters of this 
thesis will therefore aim to fill the gap in the literature on mental health coverage by non-state 
providers, looking at four models of care provided by different provider types: 1) the MHD 
model provided by an NGO; 2) inpatient hospital care provided by a for-profit provider; 3) 
outpatient specialized care provided on a for-profit basis; and 4) traditional and faith healing. 
Further context surrounding these models will be provided within each empirical chapter 
that follows. But first, in the next chapter, I will explore three broad issues in methodology, 
namely concerns about the value of economic evaluation, the development of a new case study 
method for evaluating interventions in community mental health, and the cultural applicability of 
psychiatric diagnoses and research tools. 
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3. On Costs, Cases and Culture: An Overview of Methods 
 
 
 
 
Figure 3-1: A drawing from art therapy at Chiromo Lane 
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3.1 Introduction 
The leading methodological challenge to conducting research into mental health care in 
Kenya is accessing data. The choice of methods used for analysis in this thesis was driven in 
part by the nature of available data, which in turn was informed by my personal trajectory 
and connections in the field of global mental health.  
Prior to embarking on this thesis research, I worked for four years for the NGO 
BasicNeeds. BasicNeeds worked in four countries in Africa: Ghana, Uganda, Tanzania and 
Kenya. Ghana was the longest-standing programme, founded in 2002 and had the largest 
scale network of self-help groups. Uganda served for a time as the headquarters of the 
African Directorate, making it a center-point for the organization’s international policy.  
Tanzania had a unique programme focusing on child carers. However, I chose to work in 
Kenya for a number of reasons. 
Kenya is better resourced in mental health than its East African neighbours and the 
BasicNeeds programme there was the first I encountered.  I spent two weeks in 2007 for my 
induction into the organization, meeting staff and learning about the programme model. My 
contact with the BasicNeeds Kenya office grew with time into a rewarding professional 
relationship. In 2009, BasicNeeds Kenya undertook an “impact study” of their work, in 
partnership with a leading mental health researcher from the University of Cape Town. The 
organization saw this as an opportunity to evaluate not only the health, but also the economic 
impact of their intervention model, however they did not have a health economist available to 
conduct that analysis.  
I came to the LSE with the purpose of learning economic evaluation and with the 
BasicNeeds dataset more or less in hand. The data from the BasicNeeds impact study was not 
sufficient, however, to constitute a PhD dissertation. My broader interest was in the role of 
non-state actors within mental health care, and BasicNeeds had completed a study in 2008 on 
the role of traditional and faith healers in mental health service provision, together with their 
partner organization the Africa Mental Health Foundation. I therefore pursued contact with 
the Africa Mental Health Foundation, and entered into an agreement with them to analyse the 
data on healers.  
There remained, however, a key missing area in the landscape of non-state care, 
namely the for-profit formal sector. As I looked into the question and spoke with my 
contacts, the name of Dr. Frank Njenga came up repeatedly.  I contacted Dr. Njenga with no 
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previous ties to him and he kindly agreed to meet me. Over the course of a number of 
encounters, in which I described to him the case study method and the people supervising my 
work, he decided to open the doors of his hospital, the only private psychiatric hospital in 
Kenya.  
In addition, I was interested in whether there was any market for specialist private 
outpatient care, not only provided by psychiatrists, but also by psychiatric nurses. I hired the 
Research Assistant from BasicNeeds Kenya to interview private providers, and I arranged 
myself to attend the Annual General Meeting of psychiatric nurses. 
I have employed mixed methods of analysis, not only of necessity, but also of design. 
The qualitative data provide rich context and depth of understanding, while the quantitative 
data enable the measurement of scale, and offer potentially more objective measures of 
association, paving the way for causal analysis. Following the lead of Joanna Coast, I have 
combined qualitative and quantitative data in my approach to the economic evaluation of the 
BasicNeeds model for Mental Health and Development (Coast 1999). Chapter 4 approaches 
the evaluation qualitatively, while chapter 5 addresses it quantitatively, and each chapter 
provides different insights. In chapters 6 and 8, I weave qualitative and quantitative analysis 
together to examine for-profit hospital care and traditional and faith healing. Chapter 7 is the 
chapter with the most limited qualitative data. 
The aim of this chapter is to first give an over-arching account of my data sources, 
ethical considerations and methods of analysis and then to address three issues pertaining to 
methodology. The methodological points emerge from analysis conducted in chapters 5, 6 
and 8. First, I will explore the purpose, nature and ethics of cost-effectiveness analysis 
(chapter 5). Next, I will discuss my choice of the case study method and my contribution to 
its manualization (chapter 6). Finally, I will reflect on challenges posed to the validity of 
cross-cultural psychiatric epidemiology, particularly around the notion of “concept 
equivalence” and its absence, termed “category fallacy” (chapter 8). As this thesis uses mixed 
methods and analyses multiple datasets, the individual empirical chapters will provide more 
specific detail on the methods used therein. 
 
3.2 Sources of Data 
This thesis combines primary and secondary data. Thanks to pre-existing ties I had from 
working for the NGO BasicNeeds, I was able to access data from two studies collected by 
BasicNeeds and its partner, the Africa Mental Health Foundation, which I used for secondary 
data analysis. In addition, I collected primary data with the help of the BasicNeeds Research 
  
52 
 
Officer, a Kenyan woman of Luo origin with a master’s degree in public health, to collect 
primary data on private practice of mental health providers. Finally, I myself collected 
primary data from a private psychiatric hospital and from psychiatric nurses attending an 
annual general meeting of their professional association.  
The planning stage of my field-work was made possible thanks to a Mobility Bursary 
of £2,500 from the London School of Economics and Political Science for travel and study in 
Cape Town. Crick Lund, head of the Alan Flisher Centre for Public Mental Health at the 
University of Cape Town (UCT), and co-principle investigator on the BasicNeeds-UCT 
Impact Study in Kenya, supervised my research in Cape Town from September through 
November 2011.  
Looking across the empirical components, the thesis pieces together data from a 
complex web of sources (table 3-1). The data combine qualitative and quantitative material, 
synthesized in an inter-disciplinary approach for the purpose of greater comprehensiveness. 
Secondary data came from two sources: 1) the “MHD Impact Study” conducted jointly by 
BasicNeeds and the University of Cape Town, examining pre-post outcomes on 203 
consecutively enrolled adult participants in the Mental Health and Development model in the 
districts of Nyeri and Meru; and 2) the “Healer Study” conducted jointly by BasicNeeds and 
the Africa Mental Health Foundation, examining the diagnosis and treatment of mental 
disorders by 54 traditional and faith healers and 116 adult patients in Kangemi, an informal 
settlement of Nairobi. The data from the MHD Impact Study were predominantly 
quantitative; whereas the data from the Healer Study were predominantly qualitative. I 
supplemented the secondary data from the MHD Impact Study with my own primary 
collection of costing data from the NGO BasicNeeds and direct observation of a self-help 
group and a mental health clinic.  
In addition, I supplemented both the MHD Impact Study and the Healer Study with 
key informant interviews. I use the term key informant interviews in keeping with the 
definition of the United States Agency for International Development, namely “qualitative, 
in-depth interviews of people selected for their first-hand knowledge about a topic of interest. 
The interviews are loosely structured, relying on a list of issues to be discussed” (United 
States Agency for International Development 1996). Each key informant interview was 
conducted with a question guide, which I outlined ahead of the meeting. I took hand-written 
notes during the interviews and typed them up on the same day for electronic record keeping. 
On occasion, I noted verbatim speech. Some of the key informant interviews are referenced 
in the chapters of this thesis, whereas others informed the direction of my overall research 
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and research questions without eliciting specific citable references. Key informants provided 
oral consent to participate. They are referenced within the thesis as KI ## in chronological 
order of the interview. Key informant interviews were most central to the early stages of my 
research. 
In addition to key informant interviews with 22 informants, I elicited opinion from 17 
experts to assist with the analysis of data. Experts were approached from a range of 
disciplines including neurology, private health care, health policy, NGO management, 
nursing and research. Their information was used to guide specific methodological decisions 
within the chapters. 
Primary data were also gathered from three additional sources: 1) a case-study of a 
private for-profit psychiatric hospital, including data from accountancy records of 455 adult 
patients; 2) a self-report questionnaire that I designed and administered to 50 psychiatric 
nurses; and 3) a semi-structured interview that I designed and administered to 11 outpatient 
providers.  
The total number of people from whom or about whom quantitative data were 
collected is 944, including 774 people with mental disorders accessing services and 120 
mental health service providers. Sampling methods ranged from snowballing (chapter 7) and 
purposive sampling (chapter 8) to convenience sampling (chapter 7) to sequential enrollment 
(chapter 5). 
 All photographs contained in the thesis were taken by me with permission of those 
photographed, with one exception (in chapter 8), which was reprinted with permission. The 
primary purpose of the photographs is to contextualize the findings, and occasionally to serve 
as a visual metaphor, as in the concluding chapter. 
 
3.3 Site Selection 
Both urban and rural locations were included in this thesis. However, the population 
of Kenya is predominantly (76%) rural (Index Mundi 2011), whereas the sites in this thesis 
are predominantly urban, making the data not nationally representative. This is because site 
selection was based on the availability of data, and non-state providers are more present in 
urban areas. The sites represent three of the main Kenyan ethnicities: Kikuyu, Luhya and 
Luo. Data on the MHD model and on private practice were collected from the districts of 
Meru (figure 3-2) and neighbouring Nyeri, at the base of Mount Kenya – a traditionally 
Kikuyu land.  Data from psychiatric nurses were also collected in Kisumu, a lake-town in 
Nyanza Province, of predominantly Luo ethnicity with a Luhya minority. The population 
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Table 3-1: Sources of data for thesis 
SECONDARY DATA 
   Chapter Research method and tools Title Sample Ethical approval 
4 
Interview administered questionnaires:  
- General Health Questionnaire (GHQ-12) 
- WHO Quality of Life Questionnaire 
(WHOQOL Bref) 
- Economic Status Tool  
MHD Impact 
Study 
203 adult MHD 
participants 
University of Cape Town  (REC Ref: 098/2009) 
and Kenya Medical Research Institute 
(KEMRIRES 7/3/1).  
7 
Socio-demographic questionnaire  
In-depth Interview on Healing 
Healer Study 
54 healers 
116 adult patients 
Kenyatta National Hospital 
  
 
 
 
PRIMARY DATA 
   Chapter Research method and tools Title Sample Ethical approval 
4, 5, 6, 7, 8 Key informant interviews N/A 22 informants 
Kenyatta National Hospital (P450/10/2011) 
Meetings and correspondence with experts 17 experts 
5 
Case study of a private psychiatric hospital: 
- Staff interviews 
- Participant observation of clinical and non-
clinical encounters 
- Review of patient accounts 
Case study 1 hospital 
11 staff interviews 
 455 patient accounts 
6 
Self-report questionnaire administered to 
psychiatric nurses Outpatient 
study 
50 psychiatric nurses 
Semi-structured interview administered to 
private practice providers 
11 private practice 
providers 
4 
Focus group discussion with MHD participants 
MHD Impact 
Study 
1 focus group (8 
participants) 
Covered under the ethical clearance of MHD 
Impact Study above Participant observation of MHD model 
1 self-help group, 1 
clinic 
NGO costs and hidden costs of the MHD model N/A 
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Figure 3-2: Map of Kenya 
 
 
from the informal settlement of Kangemi, where the healer study was conducted, were 
largely Kikuyu and Luhya. Together, the Kikuyu, Luhya and Luo represent 41% of the 
Kenyan population, however Kenya’s census lists over thirty ethnic groups, many of which 
do not figure in this thesis (Ambetsa Oparanya 2010). Greater detail is provided within the 
empirical chapters on the rationale for site selection from secondary data sources. 
 
3.4 Ethics 
In order to access both primary and secondary data, I entered into three data-
sharing agreements with four organizations. The sometimes lengthy negotiations leading 
up to these agreements ensured that the interests of all parties were protected, including 
those of the research subjects. Contracts were agreed with BasicNeeds and the University 
of Cape Town (appendix 1), the Africa Mental Health Foundation (appendix 2) and 
Chiromo Lane Medical Centre (appendix 3). The data agreements outlined the conditions 
under which data would be analyzed, to what ends, and the parameters for their 
publication.  While in Nairobi, my work was supervised locally by Professor David Ndetei, 
director of the Africa Mental Health Foundation and member of the Research and Ethics 
Committee of Nairobi University. With guidance from Professor Ndetei, I obtained a local 
research permit (appendix 4) and my primary data collection received ethical approval 
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from the joint committee on research ethics of Nairobi University and Kenyatta National 
Hospital (appendix 5). 
The two secondary sources of data for this thesis were designed and collected by 
third parties, and came to me with existing ethical approvals. The BasicNeeds Impact 
Study design was approved by the Human Research Ethics Committee of the Faculty of 
Health Sciences (REC Ref: 098/2009) at the University of Cape Town (UCT) and by the 
National Ethics Review Committee at the Kenya Medical Research Institute (KEMRI/RES 
7/3/1). Participants provided informed consent, or assent and their caregiver consented. 
The healer study was granted ethical approval by the University of Nairobi and Kenyatta 
National Hospital joint Ethical Review Committee. Both studies provided written informed 
consent, or assent from patients and their care givers (appendix 6, Impact Study consent 
form). 
When I began field work for my primary data collection in November 2011, I was 
not planning on collecting any data from people with mental disorders. Instead, I intended 
to collect only data from hospital records. As a result, I read the LSE Research Ethics 
Policy and filled out the LSE Research Ethics Review Checklist (appendix 7) which 
formed part of my major review document, approved in September 2011. I did not proceed 
with a review from the LSE’s Research Ethics Committee. Once in Kenya, I submitted my 
research protocol to the University of Nairobi and Kenyatta National Hospital, and 
received approval in October 2011 (P450/10/2011).  In December, an opportunity arose for 
me to visit a private psychiatric hospital, and from there I was granted permission by the 
hospital board to study their practice. I therefore filed for an amendment to my original 
ethical clearance, which was granted in May 2012. 
Obvious ethical concerns emerge in collecting primary data from a vulnerable 
population. During the case study and my field visit of the BasicNeeds programme, I 
interacted with people with mental illness or epilepsy at various stages of recovery. The 
most severely ill patients were those I spoke with at the Chiromo Hospital Group.  
At Chiromo, I was introduced by a member of staff to those patients who attended 
a morning community meeting open to all patients. It was explained in English that I was a 
researcher trying to understand the model of care. A number of patients chose to approach 
me out of curiosity and with a desire to share their experience. Some patients, who did not 
attend the morning meeting, may have thought that I was associated with the staff and 
could affect change in their environment. For example, one woman led me to the washing 
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line, asking me where her clothes were. However, my inability to respond to queries like 
this made it quickly apparent that I did not play a role in treatment.  
At no point was any patient required to interact with me. I was conscious not to 
approach patients in visibly acute conditions, so as not to risk interfering with their 
recovery or becoming part of a paranoid delusion about being observed.  I mostly 
interacted with patients when they were at meals or in unstructured time outside in the 
courtyard. Some of my interactions were one-on-one, when a patient approached me, and 
others were collective, when I approached a group of patients talking amongst themselves. 
I did not ask to enter patients’ rooms out of concern for their privacy. At one point, I was 
given the occasion to observe a session of E.C.T, however I chose not to do so, out of 
concern that the patient was not able to refuse my presence, and thus was unable to provide 
consent.  
Ethical concerns also surrounded my collection of data from service providers at 
Chiromo. In the course of my field work, I held in-depth interviews with eleven members 
of the staff. Consent for these interviews was given orally. I explained the purpose of my 
research and noted that they were not required to answer any questions I asked. Preserving 
the confidentiality of the staff at Chiromo was essential. Any potentially negative 
information shared with me by staff could have put them at professional risk, as the 
findings were shared with the hospital board. To mitigate this risk, I interviewed and spoke 
with many members of staff and avoided including material that might be attributable to a 
specific individual.  
A further concern at Chiromo was for the reputation of the facility itself, since there 
was no way to de-identify Chiromo Lane, as it is the only private psychiatric hospital in 
Kenya. Indeed, the hospital would not have wanted the research to be de-identified, as they 
explicitly stated that they were interested in participating partly because it would serve 
their brand as a progressive facility engaging with scientific evidence. To address the 
concern of the hospital’s reputation, I asked the hospital director to review my analysis of 
the data, and made him a co-author on a paper I published based on this material. The 
director did not change any of the content, contributing only further insights about the reason for 
findings pertaining to low occupancy rates. 
For the study of the Mental Health and Development model, I collected some, 
though minimal, primary data from staff and patients. All patients with whom I spoke were 
consenting participants in the BasicNeeds and University of Cape Town study to which my 
research was an addendum. My verbal interactions with these patients were in two groups: 
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a focus-group of patients attending a clinic, and a self-help group meeting. The MHD 
patients were all in advanced stages of recovery. Our interactions were mediated by a 
translator. In addition, I held one-on-one in-depth interviews with seven members of staff 
implementing the MHD model. Consent for these interviews was given orally and 
confidentiality of staff has been preserved. 
Finally, I collected primary data from psychiatric nurses and psychiatrists using 
two tools: a semi-structured interview and a questionnaire. Respondents to the interview 
provided signed informed consent (appendix 8), while those completing the questionnaire 
were given both a written and oral explanation of its purpose, as well as the opportunity 
not to participate. In the case of psychiatric nurses, I was told they were not supposed to 
work in public and private simultaneously (KI 19, October 5, 2011). That rule appears to 
have been more enforced in Nairobi, however, than in rural areas where the shortage of 
health professionals encouraged a more practical approach. Nonetheless, disclosing 
information about their private practice could have put the nurses at some risk of 
chastisement, so maintaining confidentiality was essential. I did not record the names of 
the psychiatric nurses completing the questionnaire, and I de-identified the data from the 
interview respondents. 
 
3.5 Positionality and Influence of Gate-Keepers 
The choice of subjects for my research was largely influenced by gate-keepers. I 
borrow this term from Robert Burgess, among others, who uses it to describe a person, 
usually an authority, who has the ability to grant a researcher access to a subject or group 
of subjects (Burgess 1982). Recent discussion of gate-keepers has focused on their ability 
to control research subjects, and therefore impede true consent. Tina Miller, for example, 
notes that gate-keepers have the “power to sanction access to less powerful individuals,” 
and alludes to several forms of that power, including cultural, hierarchical, paternal and 
therapeutic (Miller and Bell 2002).  In my case, a number of powerful gate-keepers both 
threatened and ultimately enabled the progress of this PhD research. The gate-keepers took 
the form of both individuals and institutional structures, for example the senior 
management team at BasicNeeds, and the Board of Chiromo Lane Medical Center.  
My choice of the case study method for the study of Chiromo Lane was informed 
by my relationship with the lead author of that manual, Alex Cohen, who had supervised 
my master’s thesis at the Harvard School of Public Health. He co-authored the manual in 
2011, just as I was exploring the design for my thesis research. In December 2011, on 
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meeting the Director of Chiromo Medical Center, I first considered using his case study 
method within my thesis. Other methods were also available for learning about the extent 
of mental health coverage provided by Chiromo Lane. One alternative, for example, was to 
focus only on quantitative data drawn from medical records. To do so, however, would 
have required prior knowledge about how records were kept at Chiromo and what they 
contained. In addition, the medical record approach would have missed valuable pieces of 
context about the orientation, history and place of Chiromo within the wider system of 
private residential care for mental disorders. Another alternative method was to focus only 
on qualitative data from informant interviews with patients, their family, clinical and 
support staff. Qualitative research of this nature, however, was not an active interest of the 
hospital Director – a key gate-keeper – and the study had to be of mutual interest to me and 
him in order to be carried forward. The Director was foremost interested in questions of 
health economics, making a mixed methods approach more appropriate. Furthermore, the 
case study approach allowed for flexibility and an iterative approach to formulating 
questions in a context where very little was known ahead of the initial research. 
The impetus for conducting an economic evaluation of the model for Mental Health 
and Development came initially from the senior management team of the NGO 
BasicNeeds, who were eager to determine how their model compared to other health care 
interventions. I was employed by BasicNeeds for the four years prior to embarking on my 
thesis research, working in various capacities, including raising funds, supporting the 
senior management team to develop their strategic framework, and interviewing 
programme directors and implementing staff to draft their Operations Manual. This work 
gave me a unique insight into the nature of BasicNeeds’ work, and the principles and 
history underlying the Model, allowing me to delve into my PhD research with the benefit 
of what would ordinarily have required many months of observation and background 
reading. In addition, my previous employment earned me the trust of BasicNeeds staff, 
such that they spoke with me candidly, rather than measuring their words out of concern 
for what I might think. The quality of my data and my ability to analyze them were 
therefore considerably aided by my precedent with the organization.  
 BasicNeeds also played a role in introducing me to the director of the Africa 
Mental Health Foundation. The two organizations were joint principle investigators on the 
study of traditional and faith healers, which forms the basis of my data in chapter seven. 
Although the funding for that research came from a service delivery grant to BasicNeeds, 
the funding had expired by the time I researched the data – five years after the study’s 
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completion – and there were no constraints posed on me by the funders, nor by the two 
NGOs. 
In addition to collaborating with BasicNeeds to share data, I hired one of its 
employees, Milka Waruguru, to serve as a research assistant on my thesis. Milka 
interviewed the private practice mental health providers for the chapter on outpatient care, 
she set up my site visit to Nyeri and Meru, and she was in continual correspondence with 
me answering specific questions about the nature of the MHD intervention and of the 
Impact Study protocol. Milka’s involvement helped me clean the data from the Impact 
Study and improved my analysis. The choice of patients with whom I conducted a focus 
group in Meru was made by Milka and BasicNeeds partner staff, as a result of which it 
highlighted examples of successful outcomes. I did not, however, rely heavily on the focus 
group data, and the selection bias on that part of my data was offset by explicit effort to 
elicit feedback from staff on areas where the intervention and the research had been most 
challenging. Milka is likely to have shared a similar bias to me in favour of BasicNeeds. 
Her principal role on this thesis, however, was independent of BasicNeeds, in collecting 
data from private practice psychiatrists and psychiatric nurses (the subject of chapter 6). It 
is possible that some of the individuals approached to participate would have known of her 
affiliation with BasicNeeds and been influenced either to participate or not to participate 
on the basis of their opinion of the NGO. It is not possible, however, to verify this 
hypothesis. 
That being said, my previous employment with BasicNeeds also raised a question 
of conflict of interest in terms of evaluating their outcomes.  No doubt, I wanted their 
intervention to prove cost-effective. I did not, however alter the data in any way, and I 
subjected the analysis to review by my two supervisors, as well as presenting it on two 
occasions, once in a public conference on global mental health, and once in a workshop of 
health economists at the LSE. At no point were my methods called into question for being 
biased. Furthermore, the NGO placed no constraints on the independence of my research. 
They asked only to be included as co-authors on any publications that might emerge from 
this data in the scientific literature. The flip-side of conflict of interest is interest, and 
research into the area of global mental health cannot be done in the absence of interest. As 
it stands, interest in this field remains limited, and therefore community mental health 
interventions such as that of BasicNeeds are as yet under-researched. I believe the merit of 
undertaking this research, albeit cautiously, well outweighs the potential risk of conflict of 
interest. 
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3.6 Context-specific challenges 
Conducting research in a context of international war and domestic instability raises 
significant challenges, as demonstrated in Kenya. The relatively short duration of my field 
work and the absence of comparison data from the public sector were the result of the 
insecurity and a health sector scandal that took place as my research unfolded. 
On October 16 2011, the Kenyan military launched Operation Linda Nchi (Swahili 
for “Protect the Country) jointly with Ethiopia and the Transitional Federal Government of 
Somalia. The object of the offensive was to eliminate al-Shabaab, a Somali-based Islamic 
fundamentalist group with links to al-Qaeda. In the previous month, Shabaab had claimed 
responsibility for the kidnapping of two Medecins Sans Frontieres workers in the Dadaab 
refugee camp, and the kidnapping and killing of three tourists (a disabled French woman 
and a British couple) in the coastal resort towns of Lamu and Kiwayu. There ensued a war 
that continues to this day.  
On November 6th 2011, a month and ten days after Kenya declared war on 
Shabaab, I arrived in Nairobi to start my fieldwork. While I was conducting a case study of 
a private inpatient psychiatric facility, on May 28
th
 2012, an explosion wracked a popular 
shopping complex on Moi Avenue in the central business district of Nairobi, injuring 30 
and killing one. Almost weekly throughout this time, grenades were thrown into churches 
at Sunday worship.  
In July 2012, 5,000 troops from Kenya joined 12,000 troops from other parts of 
Africa to form the African Union Mission in Somalia (AMISOM). Together, they sought 
to overthrow the Shabaab-dominated port town of Kismayo, a mission that was 
accomplished in September 2012. A four-day siege of Nairobi’s Westgate shopping mall 
took place in September 2013, leaving 72 dead (including a young, female foreign health 
worker). The Westgate mall attack was reportedly a retaliation by Shabaab for the taking 
of Kismayo. Had I not felt at personal risk throughout this time, I might have extended my 
fieldwork in Kenya. Instead, I spent only three months there, predominantly in Nairobi, 
avoiding public transportation and public meeting places as much as possible. 
At the same time as international conflict was raising security threats, domestically 
health worker strikes and a scandal within the public health care system absorbed much of 
the attention of Ministry of Health. The scandal surrounded the National Health Insurance 
Fund (NHIF), an entity that came into being in 1966 offering coverage for inpatient health 
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care for all people working in the formal sector. At the end of April 2012, the 
Parliamentary Committee on Health blew the whistle on NHIF disbursements being made 
to “ghost clinics.”  They noted that the fund had paid half of their quarterly disbursements 
(USD 3.8 million) to only two companies, Clinix Healthcare Ltd and Meridian Healthcare 
Centres, both of which used the money for capital investment to expand their clinics, rather 
than to provide services (Mureithi 2012). Clinix Healthcare came under the closest 
scrutiny, as it was 99% owned by a foreign company, registered in the British Virgin 
Islands. Furthermore, it was discovered in late May that an unexplained transfer of Ksh 
900 million (USD 10.7 million) was made from the NHIF to the Isle of Jersey. Half of the 
quarterly budget was missing. 
There ensued a political drama. The head of Civil Service, Francis Kimemia, 
sacked the entire NHIF board on Saturday May 5th. At the opening of the work week on 
Monday May 7, the Minister of Medical Services, Anyang Nyong’o, reinstated the board. 
Later that same day, Prime Minister Raila Odinga overruled Nyong’o, sacking the board 
once again. The Parliamentary Health Committee issued a report, which the MPs tabled, 
and then a hearing was held with the Director of Pharma Investment Holdings. In mid-
June, Clinix and Meridian were removed from the NHIF roster of providers (Karongo 
2012).  
The Ministry of Health was so consumed by the drama unfolding with the NHIF 
that it had little space for external requests such as my own. In May 2012, I contacted the 
Ministry on a daily basis for a period of two weeks, trying to access data about 
hospitalization of people with mental disorders within public facilities. In the subsequent 
weeks I made multiple visits to the headquarters, met with members of the nursing staff 
and received oral agreements. But the data were never made available.  
In addition to the challenges of war and government corruption, the more mundane 
day-to-day challenges of conducting research in a low-income country are manifold. They 
include the absence of electronic medical records, slow or broken internet connections, 
which sometimes cause emails to disappear, power outages that make work come to a halt, 
old computers crashing and irretrievably loosing data, research assistants not fully trained 
in data entry using quantitative databases to enter qualitative data, key contacts changing 
mobile phone numbers, and people not showing up to meetings because of grid-lock traffic 
or road accidents. This is just a selection of the challenges, but lends some idea of why it is 
a great privilege to have had access to the data that I did for this thesis. 
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3.7 Methods of Analysis 
The empirical chapters of this thesis employ several different methods of analysis. Chapter 
4 renders a qualitative description of an intervention model for mental health care.  Chapter 
5 on non-profit care uses economic analysis. Chapter 6 on for-profit inpatient care 
combines case method with regression analysis. Chapter 7 on for-profit outpatient care 
employs descriptive statistics. And chapter 8 on traditional and faith healers uses 
framework analysis and simple quantitative tests of binary association (chi-square, logistic 
regression). I will enter into further detail on two of these methods – economic evaluation 
and case study – to explore their limitations and innovations. Then I will take a step back 
and question the validity of cross-cultural research into mental health care. 
 
3.7 - a) Economic Evaluation 
 
3.7.a.i Why undertake economic evaluation? 
A provocative series of tweets by of Richard Horton, editor of the Lancet, recently 
challenged the discipline of health economics at large, and the use of economic evaluation 
in particular (Parkin, Appleby, and Maynard 2013). In his first tweet, Horton lamented, 
“The promise economics offers is seductive: how to allocate scarce resources in society. 
It’s a false promise.” He went on to attack economic evaluation, observing, “Rationality, 
for the economist, means subjecting every thought/decision to a cost-benefit analysis. A 
wholly narrow view of humanity." And further, "The assumption is that human beings 
make cost-benefit decisions based only on self-interest. No."  
Horton’s Twitter manifesto against health economics reveals his misunderstandings 
of the field, but nonetheless highlights the “ethical minefield” (Williams 1992) in which 
this method sits and incites a justification of these methods. Economic evaluation is not 
appropriate for “every thought,” as it is itself a costly undertaking.  Indeed, the limitations 
in many studies – including in this thesis – relate to limitations in resources for research.  
Only interventions that may be rolled out widely or are particularly costly are worthy of 
economic analysis. More importantly, Horton’s observation that “self-interest” is the main 
(indeed “only”) guide to economic evaluation is mistaken. The purpose of economic 
evaluation within the context of health economics is to guide decisions for social, not 
individual benefit.   
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The “seductive” rationale for economic evaluation is to guide resource allocation in 
situations of scarcity. As a method, it therefore lies at the heart of debates around 
distributive justice. By enumerating costs and consequences, economic evaluation 
proposes to make more transparent the implicit trade-offs that individuals and societies 
often make blindly (Drummond, Sculpher, and Torrance 2005, chapter 2). As the costs of 
health care have been spiralling in industrialised economies, and as data collection and 
analysis methods become increasingly sophisticated, the supply and demand for economic 
evaluation have rapidly escalated.  In the early 1990s, the proportion of clinical trials 
incorporating economic analyses jumped from 2.5% to over 25% (Kim, Morris, and 
Schulman 2000), plateauing at that level in subsequent years (Glick, Polsky, and Schulman 
2001). 
Horton is not the first to raise riot at the idea of introducing cost as a criterion in 
decisions about medical practice.  In 1980, a scientist writing for the New England Journal 
of Medicine charged that “a physician who changes his or her way of practising medicine 
because of cost rather than purely medical considerations has indeed embarked on the 
“slippery slope” of compromised ethics and waffled priorities” (Loewy 1980). A 
prominent health economist from the University of York, Alan Williams, retorted years 
later that the alternative to economic evaluation is “the lottery.”  More specifically: 
“Judgments about the value of another person’s life … are 
inescapable in a system which is expected to behave in a non-
capricious manner in discriminating between the well and the ill, 
between the severely ill and the slightly ill, and between those 
likely to benefit from a particular treatment and those unlikely to do 
so, in order that some systematic priority-setting can take place. The 
supposedly more ethical alternative of making these decisions by 
lottery … seems to me quite inhuman and uncaring” (Williams 
1992) 
Moving beyond the question of whether economic evaluation is evidence of “compromised 
ethics” or of being “human and caring,” the next pertinent question becomes what methods 
of analysis are used. We move then from whether economic evaluation is worth 
undertaking to how to go about it.  
 
3.7.a.ii Types of economic evaluation 
Though employed in common parlance as a synonym for all economic evaluation, cost-
benefit analysis is but one of several types of economic evaluation. Three types of 
economic evaluation dominate the literature, namely cost-benefit analysis, cost-
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effectiveness analysis and cost-utility analysis. The definition of an economic evaluation 
used here, that of Michael Drummond, is “the comparative analysis of alternative courses 
of action in terms of costs and consequences” (Drummond, Sculpher, and Torrance 2005, 
chapter 2). The particularity of cost-benefit analysis, as the term is used in health 
economics, is to value consequences in terms of monetary benefit, which raises 
challenging ethical questions about how to value life, as well as practical questions about 
how to attach a monetary value to improvements in health.  
A more widely used evaluation method is cost-effectiveness analysis, which 
measures consequences using disease-specific outcomes, such as depression-free days. 
Cost-effectiveness is designed to answer the question, “Which of two treatments is 
preferred for the same condition?”  In economic rhetoric this is a question of technical 
efficiency (Dolan and Olsen 2002), meaning the transformation of inputs into outputs 
without waste. 
Health policy makers are often more interested, however, in allocative efficiency, 
meaning how to optimally distribute goods or services based on a population’s preferences. 
Allocative efficiency addresses the question: “Which of two treatments is preferred for 
different conditions?”  Answering that question quantitatively requires a means of 
comparing outcome across different health states. Broadly, the generic outcome of interest 
to economists is utility. Within the field of health care, however, utility is often assumed to 
be interchangeable with health, wellbeing, or quality of life (Dolan and Kahneman 2008). 
Some economists, such as Paul Dolan, have noted that this assumption could exaggerate 
the place that health actually occupies in a person’s individual utility function (ibid). In 
practice, the most common generic measures used in economic evaluations of health care 
are the Quality Adjusted Life Year (QALY) (Fanshel and Bush 1970; Williams 1996) and 
the Disability Adjusted Life Year (DALY) (Murray and Acharya 1997).  Together, these 
two measures form the basis of a third kind of economic evaluation, known as cost-utility 
analysis. 
Cost-utility analysis compares cost to the QALYs gained or DALYs averted by an 
intervention. A QALY is one year of perfect health, whereas a DALY is one year of life 
lost. The QALYs generated by a health care intervention are calculated by multiplying the 
number of years of life remaining (or time to follow-up in the study) by a utility weight 
associated with a given condition. Utility weights range from 0 for death to 1 for perfect 
health. DALYs are calculated by aggregating death and disability caused by an accident or 
illness, weighted by the estimated burden of that disability.  DALYs were first designed as 
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a measure of disease burden, but they have subsequently been used as an outcome 
measure.  
Much of the debate around QALYs and DALYs has pivoted on the methods used 
to value the utility of a given health state. The four most common methods for valuing 
health states are the visual analogue scale, standard gamble, time trade-off, and person 
trade-off (Drummond, Sculpher, and Torrance 2005, chapter 10). The time trade-off 
method was principally used to devise QALY utilities, whereas the person trade-off was 
used to devise DALY weights. The time trade-off method asks respondents to choose 
between a certain amount of time in good health versus a longer period of time unwell. The 
person trade-off method, instead, assumes the position of a public health planner, asking 
respondents to choose between saving a certain number of people with one health 
condition versus a smaller number of people with a worse health condition.  
Among the issues surrounding methods of valuation is whose utility is valued? 
QALY valuations were made by surveying thousands of individuals in the community for 
their perceptions (Billingham, Abrams, and Jones 1998). While democratic in approach, it 
tends to skew utility values in the direction of severity: people living with a disability often 
adapt to their condition and find it less problematic than imagined by those without the 
condition (Dolan and Kahneman 2008). DALY weights, not initially concerned with being 
democratic, were first calculated by a group of medical experts, who were forced to 
collectively arrive at a consensus (Arnesen and Nord 1999). In 2010, however, a new 
series of DALY weights was issued, which took account of responses from over 30,000 
members of the general population using online and household surveys across several 
countries, including Tanzania (Salomon et al. 2013). 
Another key methodological challenge surrounding DALYs and QALYs pertains to 
age-weighting (Barendregt, Bonneux, and Van der Maas 1996). Original DALYs use age 
discounting to reflect that a year lost to someone of working age is more economically 
costly than a year lost to a child or an elderly person. Subsequent attacks of this approach 
have led the Global Burden of Disease team, who make these DALY calculations for the 
World Health Organization, to offer several varieties of DALY, including one without age 
discounting. Finally, questions arise over whether health benefits, such as DALYs and 
QALYs, should be discounted at the same rate as capital (Claxton et al. 2011; Goodin 
1982). This debate is more relevant to long-term modelling projections, however, which 
are not within the scope of this thesis.  
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Despite the challenges levelled against the DALY and QALY methods, the 
advantage they procure of offering a single generic unit of outcome that allows comparison 
across a vast array of different conditions, is argued by proponents to outweigh their 
shortcomings, making them an attractive tool of economic analysis.  
I chose to use DALYs in my evaluation of the cost-effectiveness of the Model for Mental 
Health and Development (chapter 5), because it was not feasible to cross-over between the 
outcome measures used in my data and the QALY. Despite its name, the WHO Quality of Life 
instrument (WHOQOL Bref) is not convertible by any evident means to a QALY. The most 
common tool for measuring a QALY in Europe and some other countries is called the EuroQuol 
(EQ-5D), which scores quality of life along five dimensions: mobility; self-care; usual activities; 
pain/discomfort; anxiety/depression (EuroQol 1990). Two iterations exist, one with three levels of 
response (no problem, some problem, a lot of problem), and the other with five levels of response. 
The number of permutations of answers is therefore in the hundreds. Each permutation has been 
allocated a utility based on preferences stated by different populations predominantly in Europe, 
but also including some in Africa (Jelsma et al. 2001). The utility weight is then transformed into a 
QALY by means of a simple calculation, not dissimilar to that of the DALY, weighting the time 
spent in the health state with the utility associated with that health state. In the absence of the EQ-
5D or similar bespoke measure, however, it is challenging to calculate a QALY. By contrast, the 
General Health Questionnaire (GHQ-12) has established cut-off points for defining health states, 
which can be translated with relative publicly available disability weights used to calculate 
DALYs. 
 
3.7.a.iii Ethics and limits of cost-effectiveness analysis 
Although cost-effectiveness and cost-utility analyses increase the transparency of key 
factors involved in an intervention, they do not provide an automatic algorithm for 
decision-making. Some people have drawn up league tables of incremental cost-
effectiveness ratios (ICERs) in the effort to compare interventions (Gerard and Mooney 
1993). While such tables are useful at categorizing interventions into broad levels of 
efficiency, they cannot be used as a means of abdicating the process of prioritization.  In 
the words of Michael Drummond, “None of the approaches is intended to be a magic 
formula for the removal of judgment, responsibility or risk” (Drummond, Sculpher, and 
Torrance 2005, chapter 2). Or, to paraphrase the stance of Allan Williams, there is more to 
economic decision making than accountancy (Williams 1979). 
One of the chief limitations of economic evaluation is that it does not take into 
account how benefits are distributed, which is paramount to those concerned with equity. 
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In fact, economic evaluation is imbedded with implicit assumptions about equity. 
Principally, cost-utility analysis reflects egalitarian ethics, meaning that life has the same 
value for all people at all times, or “a QALY is a QALY is a QALY” (Williams 1992). 
While instinctively this notion rings true, there may be reasons to argue otherwise: 
“As a society, we may prefer to give a QALY to someone who is 
in very poor health, compared with someone who is close to full 
health, or to someone who has not experienced much good 
health during their lifetime, compared with someone who has 
experienced “fair innings” (Drummond, Sculpher, and Torrance 
2005) 
Building on this observation, Dolan and Olsen tease apart six factors influencing a 
person’s understanding of equity (table 3-2) (Dolan and Olsen 2002). In addition to illness 
severity and a person’s previous health profile – the two factors mentioned by Drummond 
– Dolan and Olsen introduce several new dimensions, touching on questions of personal 
responsibility and social knock-on effects. Many people intuitively believe that if a health 
condition stems from a lifestyle factor within their control, for example smoking or skiing, 
that said person should be held responsible and therefore less entitled to treatment than if 
he or she were an innocent victim, for example of a car accident (Williams 1992). In 
addition, Dolan and Olsen contend that some people, for example armed forces veterans or 
indigenous people, may be thought to have a claim on priority treatment. Finally, some 
illnesses, for example dementia, cause more impact on other members of a family or social 
network than others, such as hip replacement.  
 
Table 3-2:  Dolan’s six factors of equity  
 
1. Distribution of benefits 
2. Severity of illness 
3. Previous health profile 
4. Lifestyle 
5. Compensation or reward 
6. Impact on others 
 
Dolan and Olsen furthermore observe that a key dimension to assessing equity is 
age. In discussing the previous health profile of a hypothetical patient, they outline three 
types of “ageism”(Dolan and Olsen 2002). The first ageism is health-maximising, which 
tends to prioritize younger people. The second ageism is productivity maximizing and 
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tends to prioritize the working-aged. The third ageism revolves around the notion of “fair 
innings” (Williams 1997), which suggests that those who have lived a number of years in 
good health should allow priority to those who have not. The age-based dimensions of 
equity are even more relevant in a low-income country like Kenya, where approximately 
half of the population is under the age of twenty.  
Another limitation of economic evaluation – or perhaps more accurately of the role 
of economic evaluation in supporting decision-making – is that it is possible for an 
intervention to be cost-effective, but not affordable. Indeed, within an African context, 
where health budgets are squeezed dry, many interventions fall within this category. 
Defining affordability is challenging. The short-hand solution applied by many global 
health economists is to use per capita GDP as the ceiling for an affordable cost per DALY 
(Edejer et al. 2003).  This method, however, does not take into account that the 
affordability of an intervention depends on the prevalence of an illness or condition. 
Interventions such as vaccines, which must be delivered to entire populations, quickly 
become costly despite very high rates of efficiency. An economic evaluation should 
therefore be accompanied by an impact assessment, to determine, among other things, 
questions of affordability and acceptability.  
A final key limitation of economic evaluation is that it is based in utilitarian logic, 
and therefore subject to a non-consequentialist critique. Philosophically, the roots of non-
consequentialist thought, such as libertarianism, lie in the 18
th
 century writings of 
Immanuel Kant (Kant 1785) and his followers, including John Rawls (Rawls 2001) and 
Robert Nozick (Nozick 1981). Broadly summarized, the counterpoint to utilitarian thinking 
is that moral actions rely on a “categorical imperative”—an unconditional principle that is 
an end unto itself – rather than on ends justified by means. In application, this line of 
reasoning is found within the field of health and development predominantly among 
proponents of human rights. So, for example, interventions to reduce the chaining of 
individuals with mental illness may not be cost-effective (in practice, no such studies 
exist), but may be pertinent from a human rights perspective, which finds that chaining a 
human being defies a categorical imperative for treating people with dignity (United 
Nations General Assembly 1991).  
Discussion of economic evaluation would not be complete without considering the 
cost of conducting such an economic evaluation itself. Drummond et al quip, “Even 
economic evaluations should be subject to economic evaluation” (Drummond, Sculpher, 
and Torrance 2005, p. 355).  Again, this is especially true in the African context where 
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conducting a randomized controlled trial may mean diverting funds from needed 
treatments to research. Given the resource constraints, economic evaluations in an African 
setting must sometimes resort to imperfect study design, for example using observational 
studies rather than randomization, as is the case in the economic evaluation employed in 
this thesis. 
 
3.7 - b) Case Study Method 
In the context of limited resources for research, a pragmatic method of evaluation is the 
case study. I chose the case-study method as a principal means of gaining access to data on 
for-profit hospital care, because it is a practical and flexible method that accommodates the 
unpredictabilities of collecting data in East Africa. Prior to my initiating this thesis 
research, I did not have pre-existing ties with the for-profit mental health sector in Kenya, 
and the case study also enabled me to collect data without having a large pre-existing 
professional network. 
As defined by Robert Yin, case studies are a method of social inquiry that address 
contemporary phenomena and seek to answer the questions how and why (Yin 2014). Yin 
distinguishes case studies from ethnography, noting that they are conducted over shorter 
periods of time and do not necessarily involve participant observation. The case study is a 
useful technique within a context where little is known about the topic prior to its study, as 
is the case of private mental health care in Africa. Yin refers to this type as a “revelatory 
case”, as compared to other types, such as the common case, the unusual case, the 
longitudinal case or the critical case. 
Defining the case was more complex than I originally anticipated, because the 
psychiatric hospital in which I chose to conduct my work was part of a large and growing 
network. When I began the study, the network contained three mental health facilities in 
and around Nairobi. On my second visit, a fourth facility was being newly initiated. As I 
proceeded, a fifth institution was launched in Mombasa. Some of the facilities had closer 
links with one another than others. For example, two facilities shared a name and a board 
of directors, although they were located in different parts of Nairobi, while three other 
facilities had a slightly different ownership arrangement, although many of the directors 
were the same. Operationally, referrals between the five facilities were common. I chose to 
focus on one of the five facilities, as it was the oldest and had electronic records. However, 
I visited all four of the five facilities that were open to the public, all of which served as 
data points with which to contextualize my case. 
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While conducting the case study, I was also testing a case method manual (Cohen 
et al. 2012). The “Case Study Methodology to Monitor & Evaluate Community Mental 
Health Programs in Low-Income Countries” complements existing case study textbooks 
with specific questions important to consider when evaluating mental health programmes 
in resource-poor settings. It sets out seven domains of inquiry, namely: 1) context; 2) 
history; 3) programme model; 4) programme organization; 5) client population; 6) 
intervention; and 7) information systems. For each domain, the manual proposes a series of 
questions, some to be asked, and others simply to guide observation. My contributions to 
modifying these questions and updating the manual earned me a position as co-author on 
the second edition of the manual. The methodological contribution of the manual is modest 
and consists principally of formulating a set of domains of inquiry and articulating a series 
of question guides (appendix 9) specific to the practice of mental health care in low-
income settings. The authors of the manual did not ask me to use their method, however. It 
was I who approached them with the desire to test it, as the focus on mental health made it 
more relevant to my research than other case study manuals. 
I conducted a single case study, as opposed to multiple comparative cases, with the 
intent of using it as a method of evaluation.  Chief among the principles of data collection 
for case studies is the collection of multiple sources of data to triangulate findings. My 
case study drew on data from: 1) direct observation of therapeutic and non-therapeutic 
environments; 2) interviews and informal conversation with patients and staff; 3) physical 
and electronic archives; and 4) operational documents, such as pharmacy records and 
accounts. At the end of each day of visits, I compiled my direct observations and 
photographs electronically into field notes.  
As Yin observes in his methodology, at the outset “the specific information that 
may become relevant to a case study is not readily predictable.” In my case, I obtained 
access to a tremendous wealth of quantitative data from a newly implemented electronic 
accountancy system. These individual accounts became the basis for rigorous quantitative 
analysis with both a descriptive and an explanatory focus. The data provided information 
about length of stay, readmission and charge over the course of one year, as well as 
documenting the presence of third-party payers, namely private insurance. Ultimately, I 
conducted regression analysis to examine the relationship between who financed care and 
the quantity and price of that care. This level of quantitative analysis within a case study is 
unusual and constitutes a strength of this thesis. 
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3.7 - c) Cross-Cultural Epidemiology 
 
3.7.c.i Cultural equivalencies 
Taking a step back from the specifics of economic evaluation and the case study approach, 
a more fundamental question exists about the validity of any and all cross-cultural research 
by a European concerning mental health care in Africa. A key methodological concern 
surrounding health-related research in an African setting is that of cultural translation.  
Cultural translation can be particularly contentious in the area of mental health research, 
where categories of inquiry are arguably more socially constructed than other areas of 
health. In 1988, Joseph Flaherty and colleagues published a seminal article defining five 
key principles when adapting research instruments for cross-cultural use in psychiatry  
(Flaherty et al. 1988). The quality of cross-cultural adaptation was outlined in terms of five 
equivalencies: 1) semantic; 2) content; 3) technical; 4) criterion; and 5) conceptual. I will 
examine each in turn. 
Semantic equivalence is the most straightforward of Flaherty’s five, and it relates to 
the appropriate translation of idioms. Since mental health symptom checklists often use 
colloquial idioms of distress, such as “down in the dumps,” or “blue,” they can be easily 
mis-translated. The best practice method for avoiding mis-translation is that of back-
translation (World Health Organization 2014), which requires that a tool be translated into 
the local language and then translated back into the original language (often English), by a 
different set of translators, to see if the original meaning was preserved. This method is 
time-consuming and costly, however, as a result of which many studies do not employ 
best-practice (Prince 2013). 
In evaluating semantic equivalencies, I would stipulate that the data in this thesis 
are of average quality. The only symptom checklist used in my data was the Mini 
International Neuropsychiatric Interview  (Sheehan et al. 1998) used among patients of 
traditional healers. The tool was formally translated by researchers from the Africa Mental 
Health Foundation into two local languages (Kiswahili and Kikuyu) and it was spot-
translated into Luhya and Luo for a small number of patients who struggled to understand 
either of those two languages.  This does not represent best-practice in translation, as 
resources were not available for a more thorough process of back-translation. Nonetheless, 
the MINI has been widely used in East Africa, including by the researchers who designed 
the study and collected the data, so their familiarity with the tool may have improved the 
delivery of questions.  
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Content equivalence exists when each item on a questionnaire is relevant to the 
phenomenon of study. Existing research in cross-cultural mental health, for example, 
reveals that symptoms of guilt and worthlessness are rarely endorsed among people with 
depression in Asian cultures, particularly in China (Kleinman 1987). It could be argued, 
therefore, that a depression symptom check-list with an item for guilt or worthlessness 
would not meet content equivalence. I am not in a position to comment on the content 
equivalence of my data, as there are no comparable locally derived tools against which to 
measure it. 
Technical equivalence is achieved when the method of data collection does not 
distort the response. This is of particular concern in less literate societies, where filling out 
a questionnaire could lead to random responses, or to responding in a way deemed 
desirable, because it evokes a context of test-taking. In order to preserve technical 
equivalence in this thesis, two self-report checklists were interviewer-administered when 
evaluating the model for Mental Health and Development (chapter 5). Both tools were 
from the BasicNeeds Impact Study, namely: the General Health Questionnaire and WHO 
Quality of Life Questionnaire.   
The presence of an interviewer introduces another source of potential bias, namely 
social desirability. This is all the more true in that the interviewers were mostly the 
clinicians themselves, so participants may have wanted to demonstrate that they were 
improving to please the health care providers. There might equally, however, have been an 
incentive for participants to under-report their health, if they thought that doing so would 
lead to greater benefits. The social desirability bias was offset, however, by the fact that 
participants did not necessarily see the same clinician from one period to the next and 
therefore did not necessarily establish a significant therapeutic bond. Moreover, responses 
varied considerably between time two and time three, whereas if the responses were 
guided predominantly by social desirability, one would have expected them to improve 
after the first period of follow-up and then plateau. The main concern raised by the 
interviewers themselves was around the question about sexual wellbeing in the WHOQOL, 
to which a number of participants preferred not to answer. That question did not carry 
much weight, however, in the overall analysis. 
Determining criterion equivalence requires establishing the relationship of the tool 
with existing and established measurements of the same phenomenon. Within the context 
of psychiatric diagnosis, the gold standard tools are often clinician-administered (Prince 
2013), such as the Schedules for Clinical Assessment in Neuropsychiatry  (SCAN) (Wing 
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et al. 1990) or the Structured Clinical Interview for DSM Disorders (SCID) (First et al. 
1995). The General Health Questionnaire (used in chapter 5) has been validated in Africa 
using the DSM-IV as a gold standard (Chipimo and Fylkesnes 2010). The MINI diagnostic 
assessment (used in chapter 8), serves as a gold-standard measure against which to validate 
other tools, suggesting that meets standards for criterion equivalence (Breuer et al. 2014) 
As there are no gold-standard measures that have been locally developed, a higher level of 
criterion equivalence cannot be attained at present. However, both of these tools are based 
on biomedical (often considered Western) nosologies, raising concern over the fifth and 
last of Flaherty’s equivalencies. 
It is conceptual equivalence that has raised the greatest debate and fostered the 
most critique in relation to global mental health research. The question raised by 
conceptual equivalence is whether the tool is measuring the same theoretical construct in 
the new cultural environment as in the culture of origin. The most strident critique of 
conceptual equivalence is raised by Derek Summerfield (Summerfield 2012; Summerfield 
2008), though more moderate positions are also frequently expressed in the literature 
(White and Sashidharan 2014).  
Summerfield’s critique of the validity of cross-cultural mental health research 
centres around the process of identifying and diagnosing mental disorders. He attacks the 
very fundaments of what constitutes a mental disorder, labeling claims that half of people 
experience one in their lifetime as “disease mongering.”  
We face an epidemic of false positive diagnoses of mental 
disorder. […] There is now no more bloated category than 
“depression,” threatening to all but expunge the nuances of 
language denoted by “distress,” “sadness,” “despair,” 
“gloominess,” “pessimism.” (Summerfield 2012) 
Summerfield further notes that “Western psychiatry is but one among many ethno-
psychiatries” (Summerfield 2008) equating it to systems of traditional healing 
(Summerfield 2012) both in terms of the soundness of its diagnostic labels and the bravado 
of its treatment claims. Summerfield’s own bravado reveals itself, however, as he treads on 
uncertain ground suggesting that mental disorders in low-income settings are “normal 
responses to a social world that is no longer coherent or functional” (Summerfield 2008). 
Masking his opinion behind the work of Amartya Sen, he later notes: “It was only when 
people were more comfortably off, freed from the everyday imperatives of poverty and 
food insecurity that they acquired the “luxury” of generating concerns about their health” 
(Summerfield 2012). To suggest that mental disorders are a luxury flies in the face of 
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existing empirical data on the relationship between poverty and mental distress (Lund et al. 
2010; Lund et al. 2011). Nonetheless, Summerfield’s critique of validity raises a valid 
point, worthy of further exploration. 
 
3.7.c.ii Origins of cross-cultural psychiatry 
A more nuanced picture of the validity of mental health research can be found by 
contextualizing Summerfield’s arguments within a 100 year-old debate on the objectives of 
cross-cultural psychiatry. The debate has been framed in the literature in three phases: the 
old cross-cultural psychiatry; the new cross-cultural psychiatry (Kleinman 1977); and 
beyond to the age of global mental health (Kirmayer 2006). 
The positions of the old school of cross-cultural psychiatry – though they did not 
know themselves by that name – can be found in the writings of Emil Kraeplin (Engstrom 
1908) and K. Singer (Singer 1975). As described by its critics, the older generation viewed 
cultures as “closed, self-contained worlds in homeostasis or a steady state, with a 
substantial degree of homogeneiety across individuals” (Kirmayer 2006). Culture was 
understood to be the handmaiden of biology, a universal substratum that determined the 
expression and course of disease. Conceptually, biology was thought to give form to 
disease (pathogenesis), while culture merely shaped the content (pathoplasticity) 
(Littlewood 1991; Kleinman 1987). In the playful language of Geertz, quoted by 
Littlewood “culture is icing, biology cake […] difference is shallow, likeness deep” 
(Littlewood 1990).  
Concretely, the old generation of cross-cultural psychiatry scholars focused their 
attention on the research question, “What similarities exist in psychiatric diagnosis across 
cultures?” Thus, they set out with their diagnostic manuals in hand to find the prevalence 
of psychiatric disorders in other settings. Kraeplin was one of the first, venturing to Java in 
1904 to look for dementia praecox and manic-depressive illness – disease categories he 
had defined himself just a few years earlier in the first symptom-based classification of 
psychiatric disorders (Engstrom 1908).
9
 Kraeplin’s research launched a new line of study 
into cross-cultural epidemiology of mental health. On close examination of 100 patients in 
                                                 
9 Kraepelin’s legacy has been overcast by the eugenicist underpinnings to his concern with 
cross-cultural psychiatry. Underlying his desire to canvass the world and document the 
epidemiology of his newly coined disease categories, lay a concern that the German race was 
declining in quality – a problem that could be off-set with practices of “racial hygiene,” such 
as limiting alcohol consumption and preventing syphilis (Engstrom 1908). 
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a psychiatric asylum near present-day Jakarta, he found – through a process of multiple 
translations from Javanese to Dutch to German – that there was a specific condition in Java 
known as amok, characterised by an unexplained violent rampage, (Carr 1985) (which 
subsequently lent itself to the English expression “running amok”). Later critiques of 
Kraeplin note that the emphasis was on searching for universal symptoms or syndromes 
and translating them into familiar concepts. Thus, applying Western nosology to the 
Javanese context, the culture-bound syndrome amok would later be “translated” as brief 
reactive psychosis (Littlewood 1991).  
 
3.7.c.iii The “new” cross-cultural psychiatry 
Proponents of the “new cross-cultural psychiatry” argued that translations of disease 
categories from one language and culture to another constitute an error of “category 
fallacy” (Kleinman 1987; Kleinman 1977). Category fallacy can be understood as a form 
of selection bias, only the selection relates to symptoms rather than to individuals in a 
sample. The underlying observation, first articulated by Arthur Kleinman, is that a 
researcher tends to “find” or “see” what he or she is looking for, with disregard to whether 
what is found is meaningful (1977).  “A category fallacy is the reification of a nosological 
category developed for a particular cultural group that is then applied to members of 
another culture for whom it lacks coherence and its validity has not been established” 
(Kleinman 1987). The concept is most convincingly described when Kleinman inverts the 
direction of cross-cultural research. He imagines researchers from Latin America 
questioning New Yorkers to detect “soul-loss” (falta de animo), an illness category that is 
meaningful within certain Latin American cultural contexts, but has no referent in the 
streets of Manhattan (outside of Latin neighbourhoods).  
The direction of category fallacy is more commonly that Western researchers apply 
their (biomedical) illness categories onto other cultures. Some categories may have a broad 
application – this is particularly true of the so-called serious mental disorders, such as 
schizophrenia-spectrum and bipolar disorders. Others, however, may seem as irrelevant as 
soul-loss is to a New Yorker. Kleinman evokes dysthymia, characterized by chronic poor 
affect not severe enough to warrant a diagnosis of depression, as one example of a Western 
disorder without cross-cultural application.  
“Dysthymic disorder … may hold coherence in the more affluent 
West, but it represents the medicalization of social problems in 
much of the rest of the world (and perhaps the West as well), 
where severe economic, political and health constraints create 
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endemic feelings of hopelessness and helplessness, where 
demoralisation and despair are a response to real conditions of 
chronic deprivation and persistent loss, where powerlessness is 
not a cognitive distortion but an accurate mapping of one’s place 
in an oppressive social system.” (Kleinman 1987) 
Kleinman’s critique is not dissimilar to that of Summerfield; however he takes aim at a 
subset of the spectrum of depressive disorders rather than at the entire condition.  
The crux of the “new cross-cultural psychiatry” is the relationship between biology 
and culture, and which is determinant. In his defining article, Kleinman points to a key 
distinction between disease and illness (Kleinman 1977). The former is defined as 
biological, while the latter is a cultural construct. Kleinman, and his colleague Roland 
Littlewood, contest the notion that “disease is taken to be “real” and hidden by the illness” 
(Kleinman 1987). In their view, illness matters more than disease, as it shapes not only 
meaning, but also help-seeking behaviours and in turn the course of illness.  
“Depression experienced entirely as low back pain and 
depression experienced entirely as guilt-ridden existential 
despair are such substantially different forms of illness 
behaviour with different symptoms, patterns of help-seeking, 
course and treatment responses that, though the disease in each 
instance may be the same, the illness rather than the disease is 
the determinant factor.” (Kleinman 1977) 
The new cross-cultural psychiatry saw culture as open-ended and heterogeneous, focusing 
on “local worlds” rather than on national identities. It took active interest in individuals’ 
illness experiences and explanatory models.  By repositioning biology (disease) and culture 
(illness), the new cross-cultural psychiatry furthermore sought to contextualize medicine 
within politics. Thus, neurasthenia, for example, a condition characterized by chronic 
fatigue, was understood as an expression of demoralization in response to the Cultural 
Revolution in China (Kleinman 1982). The solution proposed by the new cross-cultural 
psychiatrists to the problem of validity was to start with local idioms of distress and work 
from the bottom up, rather than starting with biomedical categories and working down. 
 
3.7.c.iv Beyond the cross-cultural: global mental health? 
Thirty years after Kleinman’s launch of the new cross-cultural psychiatry, Lawrence 
Kirmeyer boldly sought to reappraise the field, ushering in the age “beyond the new cross-
cultural psychiatry” (Kirmayer 2006). This newest phase might better be dubbed the age of 
global mental health. The term global mental health is problematic, in that mental health is 
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inherently social and individual; however it extends from the popularly employed term 
global health, which replaced international health to convey that health and disease travel 
beyond national borders. In the last ten years, a Movement and a Centre were created in the 
name of global mental health.(Movement for Global Mental Health 2010; Centre for 
Global Mental Health 2008) 
Kirmeyer notes that the current age of global mental health has polarized the field of 
cross-cultural psychiatry. On the one hand lie clinicians and public health practitioners, 
who “assume the cross-cultural portability of psychiatric theory and practice in order to 
achieve practical outcomes,” with little self-reflection. On the other hand lie medical 
anthropologists, embarked on what “has seemed to be an exclusively critical enterprise that 
does not consider the exigencies of clinical practice and the legitimate efforts of patient and 
clinician to wrest something helpful from their encounter.” Indeed, the discussions between 
clinician-scholars and social scientists are too few, and often beleaguered (Summerfield et 
al. 2012). At the heart of the debate is the contention that “psychiatry itself is an agent of 
globalization” (Kirmayer 2006). 
The concept of category fallacy is now familiar to most researchers in global 
mental health; and a few studies have addressed this methodological challenge. In 
Zimbabwe, Vikram Patel conducted a free-listing exercise in the Shona language to arrive 
at locally appropriate descriptions of a depression-like condition known as kufungisisa, or 
thinking too much (Patel, Simunyu, and Gwanzura 1995). Theresa Bettancourt undertook a 
similar process to arrive at local idioms for depression-spectrum disorders among children 
surviving war in Uganda. One of the local idioms she found in Rwanda, two tam, 
interestingly, also translates as thinking too much (Betancourt et al. 2009). Professor 
Ndetei, who supervised this thesis in Kenya, contributed to the development of an East-
African symptom checklist for common mental disorders (Ndetei et al. 2006). Moving 
from diagnosis to measurements of outcome, Paul Bolton designed a symptom checklist to 
evaluate functionality in relation to the real tasks undertaken by people in rural Uganda 
(Bolton, Wilk, and Ndogoni 2004).  
For the most part, however, research has continued much as before in using tools 
designed in the West and attempting their translation into local language (semantic 
equivalence), without questioning the validity of the disease constructs (concept 
equivalence). As Kirmeyer laments: 
“To establish the cross-cultural validity of diagnostic constructs 
[…] demands […] detailed ethnography aimed at establishing 
  
79 
 
symptom, syndrome and illness meaning, as well as culturally 
valid indicators of sickness, disability and outcome. This 
methodological program has only been attempted in a few areas, 
yet one often hears psychiatrists doing international work 
confidently claim that many of the disorders in our nosology are 
universally valid.” (Kirmayer 2006) 
The main justification for not undertaking more of these ethnographies has been one of 
limited resources. Martin Prince observes, “If [the] resources are limited, then the local 
assessment may not live up to expectations, and adaptation of an existing measure from 
another culture may be more cost-effective” (Prince 2013). Indeed, poorly developed local 
measurements may be worse than carefully constructed foreign ones, which have 
benefitted from years of application and stood the trial of sophisticated statistical tests of 
reliability and internal consistency. 
The emphasis of this age of global mental health may be more on designing 
interventions and evaluating their outcomes than on scrutinizing the accuracy of diagnosis. 
A shift towards more practical and less theoretical arguments was first announced by 
proponents of the new cultural psychiatry. For example, Roland Littlewood observed: “As 
it is possible to employ a concept without having a term for it, we can, alternatively, pay 
greater attention to what people actually do pragmatically in cases of sickness. Illness 
categories are strategies as well as explanations” (Littlewood 1991). Diagnosis within a 
clinical context serves primarily as a first step in a strategy for treatment. Thus, researchers 
have tended to focus on large umbrella-categories of diagnosis, which are less contestable 
than more specific classifications. For example, the latest edition of the Diagnostic and 
Statistical Manual (American Psychiatric Association 2013) catalogues approximately 300 
illnesses, including “dependent personality disorder” and “intermittent explosive disorder,” 
whereas the World Health Organization’s flagship programme, the Mental Health Gap 
Action Programme (World Health Organization 2008) defines only eight priority 
conditions: 1) depression (which includes anxious depression); 2) schizophrenia; 3) bipolar 
disorder; 4) alcohol and substance abuse; 5) epilepsy; 6) suicide; 7) childhood disorders; 
and 8) dementia. 
The challenge posed by anthropologists to health services researchers, such as 
myself, resides as much in the appropriateness of interventions as in that of diagnosis. In 
particular, questions arise in relation to the extent to which medical solutions are offered to 
social problems. As Kirmeyer observes, “Psychiatry tends to have one answer for all these 
complex social ills – more mental health services” (Kirmayer 2006).  Kirmeyer’s chief 
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concern is the potential manipulation of research agendas by pharmaceutical companies, 
whose primary objective is to expand their market. If pill-popping becomes the globalized 
response to social suffering, then the field of global mental health must indeed question its 
legitimacy. Returning to Summerfield, there is “a question as to whether non-Western 
societies do need “mental health services” at all, as we understand them in the West, and if 
so, which bits?” (Summerfield 2012). 
The only international intervention studied in this thesis was the model for Mental 
Health and Development, by BasicNeeds. The singularity of this model is that it is 
implemented through local community structures and integrates social and economic 
activities in addition to psychiatric care. Thus it cannot be said of BasicNeeds that they are 
a conduit for pharmaceutical companies. 
 
3.7.c.v Relationship of this thesis to the cross-cultural debate 
Where does this debate about the validity of cross-cultural mental health research leave us 
in relation to the research undertaken in this thesis? The critiques levelled by medical 
anthropologists on the tools of health services research are relevant throughout this thesis 
and serve as a reminder to temper the conclusions drawn from the data. They are most 
relevant, however, in the chapter on traditional and faith healing (chapter 8), where the 
challenge of category fallacy holds the most ground. 
The first category that could be called into question by research into mental illness 
within Kenyan tribal cultures is that of illness. Traditional healing in Kenya does not only 
address illness, but also misfortune. According to Charles Good, problems of misfortune 
for which people in Kenya seek traditional and faith healing include “disaffection of a 
close relative, a broken marriage, loss of a job or lack of success in obtaining one. One 
woman asked a traditional medical practitioner to provide her with herbal medicine that 
would keep thieves away from her shop” (Good 1987). Jean Comaroff coined the term 
“affliction” to account for the combination of physical and non-physical complaints, illness 
and misfortune, addressed by healers (Comaroff 1980). 
The second category in question in the term mental illness is that of the mind. 
Existing literature on the cosmology of traditional healing in Kenya suggests that affliction 
is understood to stem from three broad causes. Within the Luhya cosmology, the causes of 
affliction are: 1) human (witches); 2) spiritual (especially ancestral spirits); and 3) 
environmental (air, water, food) (Wandibba 1995).  Luo cosmology adds to that trio 
affliction that is inherited and affliction resulting from breaking of social taboos (Sindiga 
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1995). In both Luhya and Luo cultures, mental affliction is not seen to sit only within the 
individual, but more broadly within the community and the environment. 
Yet another category in question is that of diagnosis. Anthropologists have 
observed that traditional African cosmology does not distinguish between cause and effect, 
etiology and symptom. In an often-cited passage from Jean Comaroff, describing the 
Tshidi tribe of South Africa and Botswana, she explains:  
“No fixed relationship exists between specific causes and 
symptoms. Particular causal metaphors (such as sorcery) can be 
applied to a wide range of sensations and, conversely, similar 
sensations may be associated with various etiologies. Indeed, 
symptoms and causes are not logically separated in Tshidi 
perceptions; the former are merely tangible expressions of the latter. 
… Thus, a broken leg is both fracture and sorcery.” (Comaroff 
1980) 
Diagnosis within a context of traditional and faith healing is not about labelling a 
condition, so much as it is about identifying the cause, which is inseparable from 
treatment. If all afflictions are either natural, human or spiritual, or some combination 
thereof, the question is less about which of those categories caused the affliction, but rather 
which human, or which spirit has intervened.  
Biomedical diagnosis may be less distinct from traditional diagnosis, however, than 
Comaroff would imply. Many disease labels, such as depression, are understood to have a 
heterogeneous origin, and its symptoms – fatigue, headache, sleeplessness or sleeping too 
much – are often non-specific. The biomedical diagnosis relies on a clustering of non-
specific symptoms into a category that becomes specific.  I will further address the specific 
tensions between emic and etic categories – those developed from within a given culture, 
and those imported from abroad – within the context of the chapter itself. However, if 
health services researchers were to surrender to the threat of category fallacy, nothing 
comparative could be said about traditional versus conventional medicine. It is therefore 
important to acknowledge this limitation, but not allow it to prevent thoughtful research.  
In conclusion, this thesis pulls together a considerable amount of data from multiple 
sources, presenting both strengths and weaknesses in research method. Although the 
samples and variables differ tremendously in size and scope, they are nonetheless unified 
by the overarching research question about the capacity, access and economic impact of 
non-state mental health care. Moreover, the six sources of data from rural and urban 
settings have unearthed rich new material on a topic that is little studied in a context of 
considerable challenge to research.  
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4. Evaluation of the Model for Mental Health and Development 
 
 
 
Figure 4-1 Photo of needs versus wants from a financial literacy training 
for BasicNeeds participants, provided by Financial Knowledge for Africa (FiKA) 
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4.1 Introduction 
An estimated 5,000 nongovernmental organizations (NGOs) in Kenya purport to work in the 
field of health. However, according to the umbrella organization Health NGOs Network 
(HENNET), only 250 of them are “viable,” meaning they have been operational for at least 3 
years, meet a minimum required annual budget, and have a reliable management structure, 
described as “a Board that is more than husband and wife” (KI 03, July 17 2011). Eighty five 
of these NGOs are members of HENNET, and a key informant from that organization 
speculated that a dozen of them do some work in mental health. However, most of the work 
that qualifies as mental health related is predominantly “psycho-social support,” or “life-
skills,” in other words prevention rather than treatment. The leading NGO provider of mental 
health treatment in Kenya is the HENNET member BasicNeeds. 
BasicNeeds, started operations in 2000 and has a mission “to enable people with 
mental illness or epilepsy to live and work successfully in their communities.” The NGO, 
which is headquartered in the UK, has delivered its intervention model in 14 countries – 4 
countries in Africa (Ghana, Tanzania, Uganda, Kenya), 7 in Asia (India, Pakistan, Sri Lanka, 
Lao PDR, Nepal, China, Vietnam), 1 in Latin America (Colombia), and 2 in high-income 
countries (Australia and the UK). The NGO targets both adults and children who self-identify 
as having a mental illness or epilepsy. The latest numbers published by BasicNeeds suggest 
that in 2013 their intervention reached close to 175,000 people, including through direct 
contact with services by 42,469 people with a mental disorder and 32,549 care-givers. The 
BasicNeeds intervention model, called the model for Mental Health and Development 
(MHD), stands out among mental health interventions in that it simultaneously addresses 
problems of ill-health and poverty through a user-based approach, involving multiple 
members of the community.  
With an annual turn-over of £2 million, funded largely by international aid, BasicNeeds 
makes a sizeable investment in mental health, but the social returns on that investment have 
not yet been evaluated in relation to the programme’s cost. Given that economic arguments 
are at the core of BasicNeeds’ rationale, it is particularly germane to subject their work to 
economic evaluation. At present, there is evidence that the MHD model is effective at 
improving the quality of life of people with mental disorders in Kenya (Lund, Waruguru, et al. 
2012), but the question remains how effective they are relative to treatment as usual and 
whether it is worth the additional investment. 
In 2009, researchers from the University of Cape Town (UCT) partnered in Kenya 
with the NGO BasicNeeds to evaluate MHD model in Nyeri North and Meru South. The 
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MHD model was funded in the two districts by two international funders:  the UK 
Department for International Development (DFID) and the European Commission (EC). 
The research was funded with residual money from DFID. Both donors funded BasicNeeds 
for three years, contributing approximately £500,000 each for the duration of the grant, 
though only a small fraction of that was allocated to research. The impetus for the impact 
evaluation came from BasicNeeds, as well as from the lead UCT researcher, Crick Lund, 
rather than from donors, who would have been satisfied with mid-term and end-of-project 
programme evaluations. At that time, no prior study of community mental health in Africa 
had ever used standardized outcome scales (Hanlon, Wondimagegn, and Alem 2010). The 
study employed a pre-post design and followed 203 consecutively enrolled participants in the 
MHD Model for 20 months. Measures of wellbeing, service use and economic impact were 
administered at baseline with two follow-up periods at 10 and 20 months. The descriptive 
outcomes of that study were published in 2012 (Lund, Waruguru, et al. 2012).  
In this chapter, I will evaluate the BasicNeeds model using a mixture of qualitative and 
quantitative data and methods. First, I will describe the MHD model in practice in Kenya, 
having outlined its broad principles in chapter two. Next, I will undertake an economic 
evaluation of the MHD model compared with treatment as usual, using one- and two-year 
time frames and adopting both societal and health systems perspectives. Finally, I will put 
those quantitative results in the context of qualitative findings about successes and challenges 
in delivering the model. This chapter primarily addresses two categories from within 
Tanahashi’s framework of coverage, namely accessibility (including affordability) and 
effectiveness. It does not seek to address the availability, acceptability or contact coverage of 
the MHD model.  
 
4.2 Methods 
This chapter combines primary and secondary data both qualitative and quantitative in 
kind, however it relies most heavily on quantitative data from a secondary source. The 
majority of the quantitative data come from a pre-post study with follow-up at 10 and 20 
months led jointly by the University of Cape Town and BasicNeeds. My principal role was in 
collecting supporting qualitative data and cost data, preparing the quantitative dataset for 
analysis, and analysing the data.  Participant outcomes from the UCT-BasicNeeds study have 
been analysed in a published paper (Lund, Waruguru, et al. 2012), but the data on user costs 
have not previously been analysed, nor has any attempt at a cost-effectiveness analysis been 
undertaken. As the study had no control group, I devised a method for estimating comparison 
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costs and outcomes from the literature for the purpose of cost-effectiveness analysis. In 
complement to the UCT-BasicNeeds secondary data, I collected primary data on NGO costs 
and estimated comparison group outcomes from the literature.  
With generous support of an LSE Mobility Bursary, I spent Michaelmas Term of 2011 
in Cape Town under supervision of Crick Lund, one of the principal investigators of the 
BasicNeeds-UCT Impact Study. Together, we addressed issues arising from cleaning the data 
(appendix 21). In addition, I worked closely with the director, research officer and accountant 
at BasicNeeds Kenya. Finally, I collected qualitative data during a site visit to Central Kenya in 
July 2011. I will first describe the methods used to collect and analyse qualitative data, then I 
will turn to the measurement and analysis of quantitative data on outcomes and costs.  
The study design was approved by the Research and Ethics Committee at the 
University of Cape Town and by the Ethical Review Committee at the Kenya Medical 
Research Institute (KEMRI). Participants provided informed consent (appendix 5), and if they 
were unable to do so their caregiver did. The right to refuse participation was clearly explained 
by the BasiscNeeds Research Officer and held no consequences. Data were shared with me 
according to a signed Memorandum of Understanding between the University of Cape Town, 
BasicNeeds and the LSE (see chapter three for further detail on ethics). All additional data 
that I collected were covered under the ethical clearance of the original study.  
 
4.2 - a) Location 
The BasicNeeds-UCT Impact Study was funded by a DFID project operating in Meru, 
Laikipia, Nyeri and Nyandarua counties. Laikipia was not selected as a research site, because 
the Ministry of Public Health declined to participate. Nyandarua and Nyeri have similar 
population characteristics, so the principal investigators felt they could be selected 
interchangeably, whereas Meru is slightly wealthier, making for a useful contrast. The principle 
investigators therefore chose Meru and Nyeri as the study sites. The European Commission 
also funded the work of BasicNeeds in these two counties, though they did not fund the 
research. 
Meru County has population of 1.4 million and an area of 7,000 km², while Nyeri 
County is about half the size of Meru with a population of 700,000 and covers an area of 
3,300 km² (Ambetsa Oparanya 2010). The 2009 Census (ibid) reports that in Central province, 
80% of people have primary or pre-primary education. In terms of household wealth, 40% 
have access to running water, 91% use pit latrine toilets, 85% own a radio and 75% own a 
mobile phone. The economies of Nyeri and Meru rely mostly on unmechanized farming, 
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produced largely for subsistence. The main cash-crops are coffee and tea, while maize, 
potatoes, beans, tomatoes and kale are produced for local consumption. The stimulant khat 
(known locally as miraa) is also a main product of the region. In addition, livestock rearing is 
common, particularly cattle, sheep, goats and chicken.  
Describing the programme location is complicated by the shifting boundaries of 
government districts in Kenya between 2007 and 2010. The number of districts escalated 
from 70 in 2006 to a peak of 256 in July 2009, and plummeted to 47 in September 2009 
(Nyasato 2010). Once the new constitution passed in 2010, districts were discarded in favour 
of counties. For the purpose of this study, the 2006 district unit approximates the coverage 
area better than the county unit; so I used the districts of Nyeri North and Meru South as the 
geographical boarders. The population and geography of these districts is approximately half 
that of the counties of Nyeri and Meru, however for fluency of reading, I refer to them in the 
chapter as Nyeri and Meru. 
 
4.2 - b) Qualitative Data 
The qualitative data are descriptive, arising from a number of conversations with BasicNeeds 
staff in Kenya and the UK, a two-day site visit to Nyeri and Meru counties on 19-20 July 
2011. On the site-visit (appendix 10), I interviewed seven members of the implementing staff: 
the lead representatives of two implementing partners; a psychiatric nurse; a clinical health 
officer; a community worker, and the BasicNeeds research and policy officer. In addition, in 
Meru I attended a mental health clinic in a primary care facility (Kajuli dispensary), where I 
held a focus-group discussion with service users (five men, two women), translated from 
Kitharaka by the community worker. Because of the issues of translation, I have paraphrased 
the responses from focus group participants rather than quoting them, as they are unlikely to 
represent verbatim speech. In Nyeri, I attended a self-help group meeting of the Mugunda 
group, which had 22 participants (14 women, 8 men). Discussion was conducted in Kikuyu 
and translated for me into English by the group treasurer. I chose not to record these 
sessions, out of concern that doing so would cause participants to be less forthcoming. 
Instead, I took detailed field notes, which I typed up at the end of each day. The main goal of 
this data was to better understand the challenges arising in the delivery of the MHD model 
and to witness examples of positive outcomes.  
In addition to this primary data, I also drew data from two unpublished external 
programme evaluations commissioned by donors (O’Connell, Musomi, and Mwangi 2011; 
Ntulo, Musomi, and Mwangi 2011). The authors of the DFID evaluation were Helen 
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O’Connell, Johnson Musomi and Judy Mwangi, each coming from differing areas of expertise, 
covering mental health, general health and programme evaluation. O’Connell is a PhD trained 
clinical psychologist specialized in early intervention and based in Ireland. She had previously 
evaluated the work of BasicNeeds in Tanzania. Musomi is a Kenyan medical doctor and 
Mwangi a Kenyan public health specialist, trained at the London School of Hygiene and 
Tropical Medicine. Both were employed by the NGO AMREF, the former as the Outreach 
Coordinator and the latter as a Regional Programme Officer in charge of Research, 
Monitoring and Evaluation. The European Commission evaluation was a mid-term 
evaluation, rather than an end-of-project evaluation, as a result of which one of the authors 
(Christina Ntulo) was an employee of BasicNeeds, though in Uganda rather than in Kenya. 
The other two authors were Musomi and Mwangi, the same evaluators who would see 
through the project’s completion in the DFID end-of-project evaluation. With backgrounds 
mostly in the NGO sector, these evaluators are likely to have been sensitive to the challenges 
of programme delivery in Kenya. I was given access to these evaluations thanks to my pre-
existing ties with the NGO. I know that they were not selected on the basis of being 
favourable evaluations, because I had access to all evaluations of the Kenya programme 
through an internal list-serve. These two evaluations were the most thorough and relevant to 
the research study in terms of timing and geographic coverage. 
Four years working with BasicNeeds provided me with a pre-existing depth of 
knowledge of their practice in Kenya. I first visited the BasicNeeds programme in Kenya in 
the spring of 2007, where I met the programme staff – most of whom continued to be 
employed in 2011 – and visited their programme in Nairobi. During that trip, I witnessed the 
opening of a new clinic in the informal settlement of Kangemi, and I observed the first 
meeting of a service user group with aspirations of national representation, called Users and 
Survivors of Psychiatry Kenya. Over several years working with the organization, I held 
numerous skype meetings and interviewed staff about their practices in view of writing them 
up into the organization’s Operation Manual. The knowledge I amassed of the organizational 
model, in rhetoric and practice, enabled me to evaluate its work in Kenya more expediently 
than would a newcomer and with greater access to people and supporting literature. At the 
same time, it made me less neutral to the outcomes of the data. I had reason to hope that the 
intervention would prove effective and cost-effective. To counter-act that bias, of which I was 
aware, I explicitly inquired about challenges to the model’s delivery and tried to reach beyond 
positive messages. 
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I used thematic analysis to analyse the qualitative data from Nyeri and Meru. The a 
priori themes were defined by the activities of the MHD Model. In the first round of analysis, 
I read through the field notes and grey literature and grouped comments according to MHD 
activities. Then I created new categories for observations that did not fit into an activity, 
which I later labelled overarching comments. 
 
4.2 - c) Scope of Outcomes and Costs 
 
4.2.c.i Outcomes Tools and Measures 
Since the MHD Model is holistic, and seeks to address not only health, but also social and 
economic outcomes, the principal investigators chose outcome tools that measured not only 
health, but also quality of life. The primary outcome measure was the General Health 
Questionnaire 12-question version (GHQ-12, appendix 11) and the secondary measure was 
the WHO Quality of Life Questionnaire, short-form (WHOQOL Bref, appendix 12). Clinical 
data were collected by three male health professionals: a psychiatric nurse, a clinical officer for 
health and an occupational therapist. Data were collected at three intervals: baseline (time 1), 
10 months (time 2), and 20 months (time 3). 
 
GHQ 12 
Despite its name, the General Health Questionnaire was designed as a screening tool for 
detecting mental distress in a general population. It has been widely used in international 
research, including in Africa (Gureje 1991; Abiodun 1993; Amoran, Lawoyin, and Lasebikan 
2007; Chipimo and Fylkesnes 2010). The tool exists in various formats, ranging from a long-
form of 60 questions to a short-form of 12 questions, which was used for this study. Usually, 
the GHQ is self-administered, but since the Impact Study population were not highly literate, 
the tool was interview administered. Respondents were asked to rate how they felt in relation 
to their “normal self,” and responses were coded on a 4-point Likert scale from “much less 
than usual” to “much more than usual.” There are two methods for scoring the GHQ-12: the 
Likert scoring method (0,1,2,3) gives rise to scores from 0-36, while the bi-modal scoring 
method (0,0,1,1) gives rise to scores of 0-12. Since most of the literature reports on the bi-
modal scores, we adopted that method. Higher scores indicated worse symptoms. 
The GHQ-12 has established cut-off points, which enable a continuous outcome 
measure to be converted into a binary outcome of sick or healthy, which is useful for 
economic evaluation. The thresholds differ, however, in different cultural contexts (Goldberg, 
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Oldehinkel, and Ormel 1998). Literature from Kenya (Njenga 2000) suggested using 2/3 as 
the cut-off point for sickness (ie scores lower than 3 were coded as healthy). This is more 
conservative than the literature from Nigeria (Gureje and Obikoya 1990), which uses a 1/2  
cut-off, but is consistent with the cut-off used in Zambia (Chipimo and Fylkesnes 2010). 
The GHQ has not widely been used for cost-effectiveness analysis. A number of 
studies calling themselves cost-effectiveness studies have used the GHQ, but they are not true 
cost-effectiveness analyses in the standard economic sense (Drummond, Sculpher, and 
Torrance 2005). Some studies (Aracena et al. 2009; Glass and Goldberg 1977) compare mean 
GHQ scores between intervention and control groups to determine which is more effective 
and then separately analyse costs; but they fail to bring the two measures together into an 
incremental cost-effectiveness ratio or net monetary benefit, and thus never define a unit of 
cost-effectiveness. Other studies are true cost-effectiveness analyses, however they either 
employ the GHQ as a secondary measure of outcome, unassociated with cost (McIntosh et al. 
2009; Woods et al. 2012), or they use it to screen study participants (Noordik et al. 2009), or as 
a predictor of outcome (Kendrick et al. 2006). I located a single cost-effectiveness study from 
1998 (Morriss et al. 1998), using the GHQ as a primary measure of effectiveness for an 
intervention training GPs to recognize mental disorders in somatising patients. The authors, 
Morriss and colleagues, used the same analytic approach as I have adopted, namely translating 
patients with scores of 2 or less on the GHQ as recovered, and calculating the cost per 
recovered patient. David Goldberg, who designed the tool, is a co-author on the outcome 
paper from that study (Morriss et al. 1999), suggesting he deems this an acceptable way to use 
the tool. 
 
WHOQOL Bref  
The 26-item WHOQOL Bref, a shortened form of the WHOQOL 100, measures quality of 
life along four domains: physical health, mental health, social relationships, and the 
environment. Questions are asked on a Likert scale of 1-5, resulting in a maximum total raw 
sore of 130 points. (Three questions are reverse coded.) Domains are built from a range of 3-7 
questions, and are scored by taking the mean of responses multiplied by 4 (World Health 
Organization 1996). The result is a score from 4-20, which can then be converted to a score 
out of 100, for ease of interpretation (Chou et al. 2013). Transformation to a score out of 100 
does not follow a simple multiplication by 5. According to the guidelines, the score out of 100 
is calculated as follows: 
 
  
90 
 
WHOQOL domain (100) = (WHOQOL domain (20) – 4) * (100/16) 
 
The WHOQOL scale also includes two general questions, one about quality of life in general 
(“How would you rate your quality of life?”) and one about health (“How satisfied are you 
with your health?”).  
Unfortunately, there is no agreed method for aggregating the four domains and two 
general questions into a single measure of quality of life. Drawing from the literature, I 
summed all items on the scale (reverse coding, where required) to create a continuous raw 
score, as done by Deribew and O’Connel and others (O’connel, Skevington, and Saxena 2003; 
Deribew et al. 2013; Gassmann et al. 2013, ). While it remains close to the data, the challenge 
with this approach is that it weighs more heavily the quality of life domains with more 
questions attached to them, and it is hard to interpret the meaning of a one point increase. 
Because of the challenges related to aggregating and interpreting WHOQOL scores, I did not 
use the WHOQOL for the cost-effectiveness analysis. Instead, I used it as a way of 
triangulating the GHQ outcome scores, to test the accuracy of that data. I therefore have 
analysed WHOQOL outcomes at 10 and 20 months without extrapolating the data to one and 
two years.  
 
Healthy days and DALYs 
Outcome tools were transformed in several ways. First, an analysis was done of the 
change in score on the WHOQOL and the GHQ. Next, the cut-off point for health in the 
GHQ enabled translating the outcomes into a binary outcome of sickness or health. Health 
was then further specified into a number of healthy days, based on a linear trend between the 
baseline and follow-up scores. Finally, healthy days were translated into an estimate of DALYs 
using disability weights. Death was also reported as an independent outcome. 
 
4.2.c.ii Scope of Costs 
Cost data were identified from multiple sources. NGO costs were assembled from 
expenditure data reported to grant donors (the European Commission and the UK 
Department for International Development). Government costs were drawn from World 
Health Organization unit cost estimates for Kenya. User costs were measured as part of the 
BasicNeeds-UCT Impact Study and comes from the Economic Status Tool, an adaptation of 
a tool by Murthy et al. (Murthy et al. 2005). Comparison group costs were held constant, using 
baseline data from before the intervention. 
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I used baseline data to estimate the costs of a no-treatment control. Follow-up data 
were designed to be collected at 9 and 18 months. In practice the mean time to follow-up was 
294 days (s.d. 36) and 593 days (s.d. 39) respectively, which amounts to approximately 10 and 
20 months of 30 days (9.8 and 19.8 precisely). I have reported the descriptive outcomes using 
the data as they were collected; however for the purpose of cost-effectiveness analysis, I 
extrapolated the data to estimate costs at 1 year and 2 years. 
Costs were calculated from two perspectives: societal and health system. The societal 
perspective, which includes indirect costs to society such as changes in productivity and 
unpaid labour, is the most commonly adopted in economic evaluation. However, the health 
system perspective, which reports on direct costs only, is more often the interest of policy 
makers.  Costs were calculated per person per year in keeping with the conventions of 
economic evaluation (Drummond, Sculpher, and Torrance 2005). Cost data were analysed in 
Kenyan shillings converted to international dollars using the 2011 IMF implied PPP 
conversion rate, equal to 42.479 Kenyan shillings per dollar (International Monetary Fund 
2013).  
A key methodological question around costing related to how to define the 
intervention being costed. Should I include the MHD Model as a whole, or only those 
activities that directly impacted on the measured outcomes? Including the whole Model has 
the advantage of preserving the intervention as BasicNeeds conceived of it and promoted it to 
the funders; however, it also runs the risk of inflating the cost per effect by incorporating 
elements of the model that do not influence the immediate measured outcome. I chose to 
include almost all costs, excluding only the costs of research studies, since they have no 
immediate measurable effect on the clinical outcomes of the intervention; however I included 
monitoring and evaluation, audits and participatory data analysis (which involves programme 
participants) as well as overhead costs associated with the office in the U.K. All other costs 
were included.  
 
4.2 - d) Measurement Issues around Outcomes 
 
4.2.d.i GHQ-12  
As GHQ outcomes were measured at approximately ten month intervals, they had to be 
annualized to match the comparison outcomes. For the first year of data, I took into account 
the outcomes at both 9 months and 18 months, adjusting for the exact number of days 
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between interviews. To annualize the GHQ at one and two years, I assumed the trend 
between time 2 and time 3 was linear (figure 4-2).  
Figure 4-2: Example of a line used to calculate healthy days 
 
I created linear equations for each person in the sample with x equal to days since 
baseline and y equal to GHQ score (figure 4-3). The linear assumption is supported by 
precedent from the literature (McCrone et al. 2004). Then I solved for the value of x = 365 
days, or at two years for x = 730 days. Since I did not know the y axis intercept value for the 
line between time 2 and time 3, I used the linear equation )( 11 xxmyy  which translates 
for one-year outcomes to: 
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For the 20 subjects lost at time 3 but with data at time 2, I used the same linear equation, but 
drew the line between baseline and time 2. There was no significant difference in mean GHQ 
score at baseline between those lost at time 3 and the rest of the sample ( 16.1201 t p=0.25), 
suggesting that the values imputed were missing at random.  
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Figure 4-3: Linear method for estimating 12 and 24 month GHQ outcomes 
 
 
To annualize the change in GHQ score, I used a slightly different equation, so as to 
take into account all three data points in a non-linear fashion. I added the first change in score 
by a fraction of the second change to arrive at an estimated change in 365 days. The equation 
at year one looks as follows: 
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The second half of the equation represents the number of missing days to complete the year 
)365( 2Tdays multiplied by the change per day (GHQ change divided by the number of days 
between time 2 and time 3). To estimate the two year outcomes, I multiplied the change in 
score from baseline to time 3 by a fraction of that same number, representing the change per 
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day for the number of missing days. The equation, a variant on the previous one, looks like 
this: 
 
3
3_1730
730
T
TT
days
GHQGHQ   
 
4.2.d.ii Healthy days 
I assumed the same linear trend between follow-up points to estimate the number of days 
spent in health. Figure 4-2 shows a sample linear equation using a baseline score of 5 and a 
follow-up score of 2. Time was mapped on the x axis in days and the GHQ score was mapped 
on the y axis. The number of days sick was defined as the x value when y equals three – the 
cut-off score for health. The number of healthy days in a year was therefore 365 minus the 
number of sick days. Since research interviews were not conducted exactly 365 days apart, the 
numbers were adjusted by 365 divided by the difference in time between interviews to 
estimate the number of days healthy per year. The number of healthy days between baseline 
and year one was determined by the following equation with x equal to sick days, baseline 
GHQ score equal to the y intercept, and the estimated 12-month GHQ score for the second 
value of y. 
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If y = 3, then the number of sick days x in the first year is: 
GHQ
days
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
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Next, I outlined four scenarios (figure 4-4): 
1. The person started and ended sick 
2. The person started and ended healthy. 
3. The person started sick and got better. 
4. The person started healthy and relapsed. 
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Figure 4-4: Scenarios for healthy day calculations  
 
 
In the first scenario, the number of healthy days in the first year were equal to 0. The 
second and fourth scenarios were excluded, since the cases that did not meet baseline criteria 
for illness were excluded from analysis. In the third scenario, where the person started sick, 
healthy days = 365 – x, using the equation above for x at y = 3.  
Two year outcomes relied as much as possible on raw data, rather than on 
extrapolation.The total number of healthy days in two years was calculated as the sum of 
healthy days in the first 10 month follow-up, plus the estimated healthy days in the remaining 
time.  To estimate the second part of the equation, a line was drawn between between time 2 
and the extrapolated 2 year GHQ score –an extension of the line between times 2 and 3 
(figure 4-3). The equation for this line was calculated as follows: 
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 Plugging in the values at time 2 for x 1 and y 1 we get: 
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Next, I used the same scenarios as for year one (figure 4-4). 
1. The person started and ended sick 
If GHQ2 and GHQ3A > 3   Healthy days = 0 
2. The person started and ended healthy. 
If GHQ2 and GHQ3A < 3Healthy days = 730 – days at time 2. 
3. The person started sick and got better. 
If GHQ 2   3 and GHQ3A < 3Healthy days = 730 – days at time 2 – x  
4. The person started healthy and relapsed. 
If GHQ 2 < 3 and GHQ3A   3  Healthy days = x when y =3. 
 
4.2.d.iii DALYs 
 
In order to increase the generalizability of the study results, I converted the GHQ outcomes 
into Disability Adjusted Life Years averted (DALYs). A DALY is defined as the sum of death 
and disability, referred to as Years of Life Lost (YLL) plus Years Lost to Disability (YLD). 
Typically, a DALY is measured over the lifetime of an individual, however I chose not to 
project my disability outcomes forward, as the long-term outcomes of mental health 
interventions are uncertain. I therefore calculated DALYs per year for the two years covered 
by the evaluation. The most basic equation for DALYs set out by Christopher Murray and 
colleagues (Murray and Lopez 1996) is: 
 
DALY = YLD + YLL 
 
YLL = N * L 
With N = number of deaths and L = age-specific life expectancy at death 
Life expectancy was time-discounted using the equation for present value of annuities: 
1 − (1 + 𝑟)−𝑡
𝑟
 
The discount rate r was set at 3% based on conventional DALY calculations, for the purpose 
of comparison with other studies. 10 
                                                 
10
 This is lower than the 7% discount rate than I adopted for unit costs, because there is precedent arguing for 
adopting a higher discount rate in a low-income African context. 
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YLD = P * DW * L 
With P = prevalence; DW = disability weight and L = duration of the illness in years 
As the sample was entirely sick, P was equal to 100%.  
 
Projecting the YLL outcomes to 24 months was challenging, because is not possible to 
predict death for a given individual. So rather than using N as the number of deaths, the data 
were aggregated into a single mortality rate for the sample. I used observed deaths (table 4-1) 
to calculate the 10-month mortality rate11 for the two follow-up periods, disaggregated by 
diagnosis (appendix 14). The mortality rates for SMD were 0.02 and 0.05 at 12 and 24 
months, while for epilepsy they were 0.00 and 0.02 and for CMD they were 0.04 in the first 
year. The age-specific life expectancy at death was calculated based on the observed deaths at 
20 months, using Kenyan life tables (Global Health Observatory 2011). I did not adopt age 
weighting, since that technique has been critiqued on grounds of equity. The mean years of 
life lost per person who died, using a 3% discount rate per year, was 16.47 years for the whole 
sample, but it was higher for epilepsy (25.95 years) than for schizophrenia (15.28 years), as 
epilepsy tends to affect people starting at a younger age. As there was only one death of a 
person with epilepsy, however, these numbers are far from certain.  
I calculated two-year DALYs for serious mental disorders and epilepsy, but not for 
common mental disorders, as there is insufficient literature with which to estimate two-year 
counter-factual outcomes. To calculate DALYs at two years, it is not possible to simply add 
the change in DALYs in year one to the change in DALYs in year two, because that would 
miss the DALYs averted from maintaining the good health of those who improved in the first 
year. Neither is it possible to subtract the year two DALYs from the baseline DALYs, because 
that would assume that no one would have spontaneously improved in the first year. So, I 
made the same assumption of spontaneous recovery in the first year as for the treatment as 
usual group. 
 
DALYs averted in the 1st year = DALYs at baseline – DALYs at 12 months 
 
DALYs averted in the 2nd year  =  DALYs at baseline – DALYs at 24 months - spontaneous 
recovery in year 2 
 
                                                 
11
 Mortality rate is defined as deaths divided by person years. 
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Table 4-1: Observed deaths and years of life lost at 20 months in the MHD sample 
 
SMD 
deaths 
CMD 
deaths 
epilepsy 
deaths 
Total 
deaths 
Age-
specific  
life exp. 
YLL 
 
M F M F M F M F M F Raw Discount 
15-19 0 0 0 0 1 0 1 0 51 53 51 25.95 
20-24 0 0 0 0 0 0 0 0 47 49     
25-29 1 0 0 0 0 0 1 0 43 45 43 23.98 
30-34 1 1 0 0 0 0 1 1 39 41 80 30.20 
35-39 0 0 0 0 0 0 0 0 35 37     
40-44 1 0 0 1 0 0 1 1 32 34 66 28.60 
45-49 0 0 0 0 0 0 0 0 28 30     
50-54 0 0 0 0 0 0 0 0 24 26     
55-59 0 0 0 0 0 0 0 0 20 22     
60-64 0 1 0 0 0 0 0 1 17 18 18 13.75 
65-69 0 0 0 0 0 0 0 0 13 15     
70-74 0 1 0 0 0 0 0 1 10 11 11 9.25 
75-79 0 0 0 0 0 0 0 0         
80-84 0 0 0 0 0 0 0 0         
Total 3 3 0 1 1 0 4 4     269 131.74 
Mean YLL 15.28 14.30 25.95         33.63 16.47 
 
 
I calculated disability (YLD) using recently published Global Burden of Disease 
(GBD) 2010 disability weights, which range from 0-1 for 230 health states (Institute of Health 
Metrics and Evaluation 2010). A challenge in DALY conversions was determining which of 
the 203 disability weights to apply to my sample (table 4-2).  
 
Table 4-2: Disability Weights used for DALY Conversions 
Health state 
GHQ-12 
score 
DALY 
weight 
Schizophrenia 3-12 0.689 
Bipolar disorder 3-12 0.480 
Common mental disorder, moderate 3-7 0.406 
Common mental disorder, severe 8-12 0.655 
Epilepsy, moderate (treated) 3-7 0.319 
Epilepsy, severe 8-12 0.657 
 
Two health states exist in the GBD study for schizophrenia: acute (0.756) and residual 
(0.576). Acute schizophrenia, as defined by GBD researchers (Ferrari et al. 2012), is associated 
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with positive symptoms (hallucinations, delusions) and applies to 63% of cases, while residual 
schizophrenia is associated with negative symptoms (catatonia, flat affect) and is found in 37% 
of cases. Since the two states are qualitatively different, rather than reflecting a difference in 
severity, it was not possible to estimate the proportion of the sample with acute versus 
residual schizophrenia. Instead, I calculated an average disability weight for schizophrenia by 
multiplying the weight for acute and residual schizophrenia by their respective prevalence, 
which amounts to a weight of 0.689 for all those with a GHQ score of 3 or more.   
 Two GBD health states exist explicitly for bipolar disorder – manic (0.480) and 
residual (0.035) – while bipolar depression falls into one of the three health states associated 
with depression: mild (0.159); moderate (0.406); and severe (0.655). The diagnosis of bipolar 
disorder was coded into the data with the additional information “manic disorder,” so I coded 
all those with bipolar disorder scoring above the case threshold with the disability weight for 
manic.  
Common mental disorders were rare in this sample, and consisted almost exclusively 
of depression. The GBD study divides depression into three different health states each with 
their own disability weight: mild (0.159); moderate (0.406) and severe (0.655). The 
BasicNeeds-UCT Impact Study did not contain a severity measure; however the distribution 
of GHQ scores for people with common mental disorders (appendix 17) is skewed towards 
the more sick end of the spectrum.  
Several possible methods exist for estimating illness severity of the sample. One 
approach is to look to the literature on severity cut-offs used for the GHQ-12, most of which 
comes from high-income countries. Researchers from New Zealand adopted a cut-off of 8 in 
the GHQ-12 to estimate severe depression (Bushnell et al. 2005), drawing on scoring 
guidelines provided by Goldberg, who designed the tool (Goldberg and Williams 1988).  
Another approach is to map the GHQ scores onto a comparable tool with defined 
severity parameters. The Patient Health Questionnaire nine items (PHQ-9) is a widely used 
screen for depression, including by the UK’s National Health Services (Spitzer, Kroenke, and 
Williams 1999). The PHQ-9 is scored on a scale of 0-27 with scores of 15 or higher indicating 
moderate-to-severe depression. Research from India demonstrates high correlation (r=0.72) 
between the PHQ-9 and the GHQ-12 (Patel et al. 2008), suggesting that a cross-over between 
the two scores may be possible. If correlation were perfect, then one unit on the GHQ-12 
would be equivalent to 2.25 units on the PHQ-9, resulting in a cut-off of 6/7 (15/2.25 = 6.67) 
for moderate-to-severe depression.  
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Yet another approach to coding severity is to isolate the top quartile or the population 
scoring one standard deviation above the sample mean. While this statistical approach offers a 
marker of severity relative to other cases within the sample, it does not account for the 
possibility that the entire sample is severely ill – a realistic possibility in Kenya where only the 
most ill reach treatment. The statistical cut-off is therefore a less attractive approach. I opted 
for the more conservative of the literature-based approaches, and coded as severe all those 
with a score of 8 or higher. 
For epilepsy, the GBD study allocated disability weights to four different health states: 
1) treated, seizure free (0.072); 2) treated with recent seizures (0.319); 3) untreated (0.420); and 
4) severe (0.657). This essentially breaks down into two levels of severity – moderate and 
severe – with a different weight for those on treatment as opposed to those not on treatment. 
The distribution of baseline GHQ scores for people with epilepsy in our sample appears 
bimodal (appendix 17), which supports the division of outcomes into moderate and severe. As 
with common mental disorders, I coded as severe those with a score of 8 or higher.   
In computing DALYs, those with a diagnosis of “other” (n=6) were excluded from 
the analysis, as there is no associated disability weight. Those with baseline GHQ scores below 
the cut-off for health (n=4) were also excluded from the analysis of DALYs, as there was no 
possible change in health status. 
 
4.2.d.iv Estimated comparison outcomes 
Comparison outcomes were estimated from the literature (tables 4-4 and 4-5), using a 
treatment as usual comparison. In the Kenyan context, for the majority of individuals with 
mental disorders, treatment as usual is equivalent to no treatment from conventional 
medicine.  Those few who do receive medical treatment receive limited hospital based care, 
while others receive traditional healing.  For common mental disorders data were only 
available from a multi-site study from mostly high-income countries, which employed a no-
treatment control.  
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Remission 
Common mental disorders –  A study by the researchers who designed the GHQ proved useful in 
estimating outcomes for a putative no-treatment control. Simon, Goldberg and colleagues 
analysed data from a WHO study (Simon et al. 1999) using the GHQ-28 across fifteen 
countries of varying income levels, including Nigeria. Out of 948 people diagnosed with 
depression, 545 had unrecognized – and therefore untreated – depression. The GHQ-28 
scores of these untreated depressed people dropped a mean of 7 points between baseline and 
one-year follow-up. The equivalent drop on a GHQ-12 score, assuming the two scales are 
proportionate, would be 3 points (7/28 = 3/12). I therefore estimated the GHQ-12 scores of 
the BasicNeeds depressed population, had they been untreated, by subtracting 3 from their 
baseline GHQ scores. I then transformed the continuous score into a binary outcome of 
sickness or health, based on the 2/3 cut-off point used in Kenya.  
Severe mental disorders – Several studies exist reflecting on the outcomes of untreated 
populations of people with schizophrenia in low-income countries and are reported in table 4-
4 (Haro et al. 2011; Kebede et al. 2003; Ran et al. 2001; Ran et al. 2007; Teferra et al. 2011; 
Thirthalli et al. 2009). The most culturally comparable population to our Kenyan sample was 
that of a study conducted in rural Ethiopia. Kebede and colleagues followed a cohort of 307 
individuals with schizophrenia over four years. They measured  natural course using, among 
other tools, the Short Form 36 (SF-36), a questionnaire with 36 items scored on a Likert scale 
across eight domains, including a mental health domain (Ware et al. 1993). 
At baseline, 89% of the sample were treatment naïve; however 28% of follow-up time 
was spent on treatment. The sample had 23% recent onset schizophrenia, while the remainder 
had long-standing disorder. The mean SF-36 mental health score increased in the first year by 
9.2% for those with long-standing schizophrenia and by 18.3% for those with recent onset 
schizophrenia. It increased from baseline to year two by 12.4% for those with long-standing 
disorder and by 20.3% for those with recent onset schizophrenia. The mean increase over the 
whole sample was therefore 11.3% in the first year and 14.2% in two years. 
The literature indicates that there is good correlation  between the SF-36 and the 
GHQ (Romppel et al. 2012; Failde, Ramos, and Fernandez-Palacin 2000), particularly in 
relation to the mental health subscale of the SF-36, which has a Spearman rank correlation of 
0.73 (McCabe et al. 1996; Kelly et al. 2008). An improvement of 11.3% and 14.2% on the SF-
36 mental health scale translates to a decrease in GHQ-12 of 1.4 and 1.7 points respectively. I 
then transformed the continuous score into a binary outcome of sickness or health, based on 
the 2/3 Kenyan cut-off point for the GHQ.  
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Epilepsy – The literature on the natural course of epilepsy offers widely diverging 
estimates of spontaneous remission, ranging from 20% to 57% (Hesdorffer 2010; Kwan and 
Sander 2004; Nicoletti et al. 2009; Placencia et al. 1992; Schmidt and Sillanpää 2012; Wang et 
al. 2003). I met with Ley Sanders, an expert on epilepsy research in low-income countries at 
the University College of London, who noted that the literature on natural remission of 
epilepsy has overlooked the high rates of mortality among those lost-to-follow-up. He believes 
that spontaneous remission rates are lower than previously estimated (including by himself), 
and that mortality from epilepsy-related accidents is higher. Recent data from Kenya, 
however, suggest that spontaneous remission rates from epilepsy are in fact much lower than 
previously estimated, ranging from 6-8% per year (Newton 2013). Since the Kenyan estimate 
is based on empirical data from the same place and time, as opposed to non-empirical 
estimates, I chose the rate of 7% spontaneous remission for my analysis. 
 
Mortality 
To estimate death in the comparison group, I used disease-specific standardized mortality 
ratios (SMR). The SMR is the ratio of deaths in a designated cohort, over that in the general 
population with the same age and sex distribution in a given year. It is more accurate to use 
the SMR than the simple mortality rate, because SMR is standardized to the age and sex of the 
population. For common mental disorders, I used a conservative estimate of 1.6 from a recent 
meta-analysis (Cuijpers et al. 2013). For severe mental disorders, I used an SMR of 5.98 from 
an Ethiopian study, which also formed the basis of estimates of remission (Teferra et al. 
2011).  
For untreated epilepsy, I used new data collected in Kenya between 2007 and 2008 
(Ngugi et al. 2014). The study draws on data from 754 individuals with active convulsive 
epilepsy and over 230,000 members of the general population to derive an SMR of 6.5 for 
active convulsive epilepsy. Those not taking anti-epileptic drugs (over half the sample) had a 
death rate of 48.8, as compared to a rate of 33.3 in the total sample. The implied SMR for 
untreated active convulsive epilepsy is therefore the all-epilepsy SMR times the  rate ratio of 
those untreated as compared to the whole sample: (48.8/33.3)*6.5 = 9.5. However, following 
communication with Charles Newton, I have chosen to use the more conservative SMR rate 
of 6.5, because of concerns he has about the accuracy of data on treatment adherence. This 
number may be subsequently modified when new biometrically verified adherence data is 
made public by Newton and his team at the Wellcome Trust centre in Kilifi Kenya. 
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Table 4-3: Expected deaths in a matched sample with untreated mental disorders  
General population SMD CMD Epilepsy All 
mortality rate male female male female male female   
Age Male Female N deaths N  deaths N deaths N deaths N deaths N deaths Total 
15-
19 0.002 0.003 
5 0.07 0 0.00 1 0.00 0 0.00 5 0.08 3 0.062 0.22 
20-
24 0.003 0.004 
5 0.10 2 0.05 0 0.00 1 0.01 4 0.09 4 0.106 0.35 
25-
29 0.005 0.005 
14 0.41 4 0.13 0 0.00 0 0.00 11 0.35 4 0.137 1.02 
30-
34 0.007 0.007 
15 0.60 7 0.28 2 0.02 1 0.01 3 0.13 3 0.130 1.17 
35-
39 0.010 0.009 
11 0.63 10 0.56 1 0.01 3 0.04 2 0.12 3 0.182 1.55 
40-
44 0.010 0.011 
7 0.41 7 0.47 0 0.00 2 0.03 2 0.13 0 0.000 1.03 
45-
49 0.011 0.013 
5 0.32 10 0.78 0 0.00 4 0.07 0 0.00 3 0.254 1.42 
50-
54 0.010 0.014 
1 0.06 3 0.25 0 0.00 1 0.02 0 0.00 1 0.090 0.42 
55-
59 0.012 0.019 
0 0.00 5 0.55 0 0.00 2 0.05 0 0.00 1 0.121 0.73 
60-
64 0.017 0.024 
2 0.21 2 0.29 0 0.00 0 0.00 2 0.23 2 0.315 1.04 
65-
69 0.030 0.037 
0 0.00 0 0.00 0 0.00 2 0.10 1 0.19 0 0.000 0.30 
70-
74 0.047 0.056 
0 0.00 2 0.67 0 0.00 3 0.24 0 0.00 0 0.000 0.91 
75-
79 0.074 0.085 
0 0.00 0 0.00 0 0.00 0 0.00 1 0.48 0 0.000 0.48 
80-
84 0.120 0.134 
0 0.00 0 0.00 0 0.00 1 0.19 0 0.00 1 0.869 1.06 
total deaths 65 2.81 52 4.02 4 0.04 20 0.76 31 1.80 25 2.265   
1 year 6.83 0.79 4.06 11.68 
2 years 13.66 1.59 8.12 23.37 
mortality rate 0.058 0.033 0.073 0.059 
 
To convert the disease-specific SMRs into a probability of death for the study sample, 
I multiplied the number of people in my sample (N) by the expected death rate for a normal 
population with the same age and sex distribution as mine, using Kenyan life tables (Global 
Health Observatory 2011). The equation for calculating years of life lost for a given age and 
sex cohort was:  YLL = mortality rate * N * SMR  
Next, I aggregated the total expected deaths by diagnosis and calculated a mortality 
rate (appendix 14), which I used to calculate a mean number of Years of Life Lost, as was 
done for the MHD group, described in the section on DALYs. The mortality rates thus 
calculated were 58 per 1000 for severe mental disorders, 33 per 1000 for common mental 
disorders and 73 per thousand for epilepsy (table 4-3). 
 
DALYs 
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Estimating DALY outcomes for the comparison group was done in different ways, depending 
on available data. DALYs for common and severe mental disorders were calculated in the 
same way as for the intervention group. YLDs for common mental disorders and epilepsy 
were calculated using GHQ scores, to determine the severity of disability weight, multiplied by 
time spent sick (1 – healthy days). A single mean YLL was calculated for the whole sample, by 
multiplying expected mortality by the estimated time spent dead, which was assumed to be 
50% of the year (the midpoint). Two-year DALYs were not calculated for common mental 
disorders as insufficient data were available in the literature on the natural course of these 
disorders beyond 12 months. 
Epilepsy outcomes had to be estimated at the aggregate, rather than by imputing 
patient level data, as there was no way to estimate GHQ outcomes. Untreated epilepsy has its 
own GBD disability weight of 0.42, regardless of severity, and seizure-free epilepsy caries a 
low-level disability weight of 0.072, presumably reflecting sequelae of the disease. Those 
estimated to be sick were presumed sick the whole year, and those in remission were 
presumed healthy the whole year – since the definition of remission was two years seizure 
free. As with the intervention group, DALYS averted in two-years were calculated by 
comparing the DALY state at year two with baseline. The mean DALYs for people with 
epilepsy were calculated as follows: 
 
DALY = YLD + YLL with: 
 
YLD    = (disability weight) * (% year sick) (population proportion sick)  
 
= (disability weight 1) * (% year sick) (1- remission rate – mortality rate) + (disability weight 2) 
*(% year sick)*(remission rate) 
 
YLL    = 1* (mortality rate) * (50% year dead) 
 
DALY epilepsy  = (0.42*1*(1 –0.3 –0.057)) + (0.0072*1*0.3) + (1*0.057*0.5) 
           
DALY epilepsy  = 0.301 
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Table 4-4: Literature on natural course of mental disorders in low-income settings 
Study Location Condition Sample Outcome measure Follow-
up 
Results 
Kebede 
2005 
Ethiopia schizophrenia N= 307 with follow-up 
data, age 15-49; 28% of 
follow-up time was spent 
on treatment as usual 
SF-36, SANS & SAPS 
(Scales for assessment 
of positive and 
negative symptoms) 
4 years SF-36 mental health score increased from a mean of 52.1 
to 61.3 at year 1 and 64.5 at year 2, ie an increase of 
9.2% in one year and of  12.4% in two years 
Alem 
2009 
Ethiopia schizophrenia N=307 (82% male) SF-36 5 years Throughout follow-up 30.8% of cases were continuously 
ill, while 5.7% enjoyed a near-continuous complete 
remission. In the final year, 54% were in psychotic 
episode, while 17.6% were in partial remission and 
27.4% were in complete remission. Odds of remission 
were 4.55 higher for those on antipsychotics than those 
not. 
Teferra 
2011 
Ethiopia schizophrenia N=307 (82% male) Standard Mortality 
Ratio (SMR) 
5 years SMR was 5.98. The mortality rate was 8,661/100,000 for 
men and 5,006/100,000 for women. 
Thirthalli 
2009 
India 
(Karnataka) 
schizophrenia N= 215, 33 untreated at 
follow-up, 58% untreated 
at baseline 
IDEAS (Indian 
Disability Evaluation 
and Assessment 
Scale), PANSS 
(Positive and Negative 
Symptoms Scale) 
1 year Mean score statistically unchanged in those untreated. 
IDEAS mean score at baseline and follow-up 8.9 (0.67) 
8.8 (0.58) 
PANSS mean score at baseline and follow-up 81.46 
(7.42) 78.18 (5.04) According to the 7-point cut-off used  
for the IDEAS, all of them remained disabled at one 
year follow-up 
Haro 2011 
(SOHO 
study) 
Algeria, 
Egypt, 
Saudi, 
Turkey 
schizophrenia N=701 from Africa & 
Middle-East, Only 8.9% 
never treated 
Clinical Global 
Impressions – 
Schizophrenia (CGI-
SCH) 
3 years In the Middle East & Africa, 17.8% achieved functional 
remission, while 79.6% achieved clinical remission over 
3 years 
Ran 2001 China 
(Sichuan) 
schizophrenia N=510 total, 367 active 
cases  
Social Disability 
Screening Schedule 
(SDSS) 
2 years 9.6% of those untreated achieved complete remission 
and 8.3% achieved partial remission 
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Ngugi 
2013 
Kenya epilepsy N=752 with epilepsy – all 
prescribed anti-epileptics, 
but not all adherent 
Clinical assessment by 
neurologist 
3 years Overall SMR was 6.5, mortality rate for those non-
adherent to anti-epileptic drugs was 48.8 vs 33.3 overall. 
Nicoletti 
2009 
Bolivia epilepsy N=103, 71 with data on 
seizures, only 10.5%  had 
taken an antiepileptic drug 
for more than 2 months 
Standardized 
questionnaire 
conducted by 
neurologists using 
ILAE definitions of 
seizure 
2 years  
5 years 
10 years 
10/103 had died in 10 years; 2-year remission for those 
not on treatment was 57.7% (30/52) 
5-year remission for those not on treatment was 44.2% 
(23/52), but if you include those who died and assume 
they were symptomatic, then the numbers drop to 48% 
and 37% respectively. 
Hesdorffer 
2010 
N/A epilepsy N/A – commentary N/A N/A A 1–2 year spontaneous remission occurs in 20% to 
44% of prevalent epilepsy 
 
Wang 2003 China   epilepsy N=387, 130 untreated N/A N/A 41% remission  
Placencia 
1992 
Ecuador epilepsy N=1020, 643 untreated Clinical assessment by 
doctors & a 
neurologist using 
ILAE definitions  
N/A 49% of those untreated and 31% of the whole 
population entered into spontaneous remission 
Kwan 2004 Lit review  epilepsy N/A  N/A N/A Spontaneous remission estimated at 30%. 
Simon 1999 Multi-site common 
mental 
disorders 
545 unrecognized 
(untreated) cases 
GHQ-28 1 year Mean score dropped 7 points from baseline. 
Whiteford 
2013 
Lit review common 
mental 
disorders 
adults in primary-care 
settings 
Multiple tools 1 year 53% remit spontaneously within 12 months. 
Cuijpers 
2013 
Lit review Common 
mental 
disorders 
22 studies Multiple tools Multiple 
years 
Relative risk of death for major depression is 1.58 
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Table 4-5: Parameters used to calculate DALY outcomes 
 
 
SMD CMD Epilepsy 
 
MHD Comparison MHD Comparison MHD Comparison 
Mean  
healthy days 
55 in 1 year 
456 in 2 years 
8 in 1 year 
33 in 2 years 
9 in 1 year 26 in 1 year 53 in 1 year 
436 in 2 years 
26 in 1 year 
77 in 2 years 
Source Impact study  
(GHQ-12) 
Kebede 2003 Impact study 
 (GHQ-12) 
Simon 1999 Impact study 
(GHQ-12) 
Newton 2013 
Mean duration 
of disability 
(years) 
0.849 in 1 year 
0.375 in 2 years 
0.978 in 1 year 
0.955 in 2 
years 
0.975 in 1 year 0.928 in 1 year 
0.855 in 1 year 
0.402 in 2 years 
0.929 in 1 year 
0.895 in 2 years 
DALY weight 
schizophrenia 0.689 
bipolar 0.480 
severe (GHQ>=8) 0.655 
moderate (GHQ<8)  0.406 
severe ((GHQ>=8) 0.657  
moderate (GHQ<8) 0.319 
Source Institute of Health Metrics and Evaluation 2010 
Mortality rate 0.02 at 10 months 
0.05 at 20 months 
0.058 per year 0.04 at 10 months 0.033 per year 0.00 at 10 months 
0.02 at 20 months 
0.059 per year 
Source Impact Study  
Teferra 2011 &  
Global Health 
Observatory 
2011 
Impact Study 
Cujpers 2013 &  
Global Health 
Observatory 
2011 
Impact Study  
Ngugi 2014 &  
Global Health 
Observatory 
2011 
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4.2 - e) Measurement Issues around Costs 
 
4.2.e.i Government costs  
The principal government inputs into the MHD Model in this setting were clinical health care 
in the form of inpatient and outpatient care. Government costs were valued using the WHO 
CHOICE unit cost estimates for a public outpatient health visit in rural Kenya and for a 
public hospital bed day (World Health Organization 2011). The cost of a single outpatient 
visit was valued at Ksh 84 (Int$ 2.42), which includes all costs (building, staff, operation costs) 
except medicines and diagnostics. There are typically no diagnostics associated with outpatient 
mental health visits in this setting, and medicine costs were entirely born by users, as measured 
by the EST. The EST questionnaire assessed the use of outpatient mental health services, but 
not of outpatient health care overall. Outpatient mental health services were only available at 
follow-up, so no costs are associated with the control.  The cost of a single inpatient bed day 
was valued at Ksh 375 (Int$ 10.7), covering the “hotel” costs, ie personnel, capital and food 
(World Health Organization 2011).  
 
4.2.e.ii NGO Costs 
NGO costs (table 4-6) were calculated top-down for the first year of the study from the 
expenditure records filed with the two donors funding the MHD model in these districts, 
using the costing methodology set out by Creese and Parker for the World Health 
Organization (Creese and Parker 1994). Donor financial reports had to be aligned to the 
research calendar and converted into the same currencies. The Impact Study research year 
started on July 31st 2009; whereas the DFID project reported on the UK fiscal year, starting 
April 6, and the EC project reported on the calendar year. In addition, EC expenditures were 
reported in Kenyan shillings, while DFID expenditures were reported in pounds sterling. I 
requested the monthly exchange rates that had been used for the DFID conversions and 
averaged them per twelve month period of study. The exchange rate used was 118.42 and 
124.46 per GBP in the first and second year. All cost calculations were done in Kenyan 
Shillings and converted after analysis into international dollars. All costs were calculated using 
2011 currency values. Inflation from December 2009 (midpoint of the first year of study) to 
December 2011 was 18.93%, and from December 2010 (second year) to 2011 it was 14.42% 
(Kenya National Bureau of Statistics 2012).   
It was not possible to derive unit costs from the NGO expenditure sheets. Spending 
was reported in some instances by activity and in some instances by output, but never by 
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quantity. So, for example “training of teachers for promotion of school mental health” was 
listed as an item on the EC expenditure, but it did not report on the number of trainings nor 
in which districts, nor was it possible to determine post-hoc from records.   
The most accurate way of calculating costs per person from grant expenditures was 
first to distribute them by district and then to divide them by the number of people seen in 
that district. This is because participants were tracked by location rather than by grant, since 
some locations were covered by several grants. So it was not possible to divide the total EC 
expenses, for example, by the number of participants in the EC project. The EC project 
operated in four districts of roughly equal size, only one of them (Nyeri) in the research area, 
so EC expenses were divided by four. The DFID project operated in seven districts, including 
the two study sites, so DFID expenses were multiplied by 2/7. Not all BasicNeeds 
participants within the districts of Nyeri North and Meru South participated in the study. A 
total of 429 individuals with mental disorders participated in the MHD in Nyeri North and 
Meru South during the first research year, so I further divided the combined EC and DFID 
expenses for the two districts by 429 to derive a mean cost per person. 
There were no hidden costs from volunteer work or use of donated items. In keeping 
with local rhetoric, the NGO called community workers “volunteers,” but they were in fact 
paid a per diem, which corresponds with a market value for their time, so no additional costs 
were associated with them. 
 
 
Table 4-6: Measurement of provider costs 
Unit Quantity 
 NGO Capital Costs 
 car 1 
motorbike 1 
computer 3 
desk & chair 3 
mobile phone 3 
camera 2 
  NGO Start-up Costs 
 Staff recruitment 5 BasicNeeds staff & 2 partner staff 
Signing partnership agreements 4 MOUs 
  NGO Recurring Costs 
 Personnel: 
 - BasicNeeds Programme Manager 1 person full-time 
- BasicNeeds Accountant 1 person full-time 
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- BasicNeeds Administrator 1 person full-time 
- BasicNeeds Community Animator 1 person full-time 
- BasicNeeds Research Officer 1 person half-time 
- Maendeleo & Caritas Coordinators 2 people full-time 
- Health workers 3 people, per diem 
- Community workers 77 people, per diem 
Supplies stationary and printing 
Building operation & maintenance 1 office in Nairobi Westlands 
Vehicle operation & maintenance 1 car & 1 motorbike 
Trainings: 
 - For health workers 1 five-day workshop, Kenya Medical Training Ctr 
- For SHGs 7 trainings offered to 32 groups in clusters 
- For partner staff 1 at start-up 
Social mobilization: 
 - Community consultation meetings 1 per village at start-up 
- Operating Mental Health Action Groups 1 group per district, quarterly  
- Meetings with District Health Coordinators N/A 
- Advocacy with local media N/A 
Monitoring & evaluation: 
 - External programme evaluations 2 
- Participatory data analysis Quarterly in each district 
- Partner review meetings Quarterly with each partner 
UK support costs N/A 
  Government Costs 
 Inpatient bed days variable 
Outpatient clinic visits 1/month 
 
N.B. The source of all NGO costs was grant expenditure sheets, and the source of 
government costs was WHO CHOICE 2011.  
 
Capital costs and were amortized over their useful life to determine their present value 
(in 2011), employing a linear discounting method, described by Damian Walker (Walker and 
Kumaranayake 2002, p. 60). The equation for amortization was: 
A = P * 
𝑟(1+𝑟)𝑛
1+𝑟𝑛−1
 
With A = cost per year 
P = initial investment (principal) 
r = interest rate 
n = number of years 
Start-up costs were similarly amortized. The capital goods purchased for or used by the 
project were: a used 4x4 car; a new motorbike; a laptop; a desktop computer; a printer; a desk; 
a chair; a camera and three mobile phones. December 2011 replacement values were located 
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for capital costs from website retailers and by phoning dealerships. The useful life of capital 
goods in the Kenyan context was deemed by the accountant at BasicNeeds Kenya to be 
considerably higher than in a standard European context. Whereas the conventional useful life 
of a computer and car are deemed 3 and 5 years respectively, he valued them at twice that rate 
– 6 and 10 years respectively, which is in keeping with other African analyses (Sinanovic et al. 
2003). Mobile phones were estimated to have 3 years, desk chairs 10 years, and cameras 5 
years of useful life. The Central Bank Rate of Kenya in December 2011 was 0.07 (Central 
Bank of Kenya 2011), which is about twice the conventional discount rate of 3% used in 
economic analyses (Sinanovic and Kumaranayake 2006), but less than the 8% rate that was 
recommended in South Africa in the 1990s (Sinanovic et al. 2003). 
 
4.2.e.iii User Costs 
User costs (table 4-7) were calculated from patient-level data collected in the BasicNeeds 
Impact Study, using the Economic Status Tool (EST, appendix 13). The EST is a 19-item 
multiple-choice and short-answer questionnaire, which is interview administered, with the aim 
of assessing health service use and costs to the service user and household. Mean values were 
were adjusted to a one year time-frame. Data were managed using SPSS 19. 
Cost data were cleaned by looking for outliers, by clarifying the terms of the questions 
asked, and by determining hidden costs where questions were not asked. In one instance, the 
costs recorded for medicines during hospitalization proved very high; but it was revealed that 
additional treatment costs, such as labs and scans, were included in the response, because they 
were not asked about elsewhere. I recoded the scans under hospital fees. User fees associated 
with mental health clinics were not recorded, but were added to the data post-hoc. 
The EST questionnaire asks about a range of time-frames, from one week to nine 
months. To calculate annual costs, I assumed a linear trend, for example multiplying 9 month 
costs by 4/3 to derive 12 month costs. This assumption is unlikely to be accurate on the level 
of the individual; but it may hold true on the aggregate level and is in keeping with costing 
conventions. When reporting descriptive results, the original time frame was preserved, and 
means were given only for those who responded positively to the question.  
 
Table 4-7: Measurement and valuation of user costs 
Direct costs Source Unit Value (Ksh) 
Hospital EST* 9f, 9g, 9j 
Hospital bed fee 
Doctor's consultation fee 
Travel cost 
variable 
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Medicines  EST 9i/18g 
Monthly expenditure on 
psychiatric medicines  
variable 
Healer EST 10d, 10f, 10g 
Healer fee 
Travel cost per session 
Number of sessions in 9 months 
variable 
Outpatient clinic visit Research Assistant 
Travel cost 
User fees  
50 first visit  
20 follow-up 
Indirect costs       
Change in patient 
productivity 
Kenya Ministry of 
Labour 2011 
One month minimum wage of 
unskilled agricultural worker 
3,765  
Patient days out of role  EST 8e, 9d, 9h One day out of role 162  
Carer days out of role EST 12e, 13b One day out of role  162  
 
* EST = Economic Status Tool 
 
 
Direct costs 
Direct, or out-of-pocket user fees included: 1) hospitalization; 2) outpatient treatment; 3) 
medicines; and 4) traditional healing. The assumption was made that doctor’s fees for 
hospitalization were one-off rather than daily recurring, based on information provided by my 
research assistant.  Transportation costs were included in each of the treatments and were 
doubled where the question asked about the cost getting to the clinic, to account for round-
trip. Money spent travelling to the hospital (EST 9f) was assumed to be round-trip and include 
the cost of travel of a carer. Economic evaluations in high-income countries often use running 
costs published by the Automobile Association to calculate the economic cost of vehicle 
travel, which includes wear and tear and servicing (Association 2013). In our study, travel by 
vehicle was rare. It was assumed on the basis of their income levels that those travelling by 
vehicle for treatment were using collective transportation and that none of the participants 
owned their own vehicle. Since collective transportation is a private for-profit service in 
Kenya, I used the price of travel as a proxy for the economic cost.  
Estimating the yearly cost of medicines was somewhat complex. Since baseline 
interviews were conducted from the clinic, just after the participant had enrolled in treatment, 
all participants were on medicines at baseline. The recorded data therefore did not reflect a 
treatment-as-usual control. I assumed that only participants who had been hospitalized in the 
months prior to baseline were on medicines at baseline.  
 
Indirect costs 
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Indirect costs for participants were calculated by aggregating time spent in hospital and in 
transportation to treatment. These were offset against the productivity gains resulting from 
return to work. Indirect costs for carers included days of work lost (EST 13) and hours spent 
care-giving (EST 12) within a normal day. Days of hospitalization were not counted as a loss 
to carers, since patients with mental disorders in Kenya do not require accompaniment by a 
carer, as is the case in some resource-poor settings. Nonetheless, the local researchers leading 
this study confirmed that it is customary for a carer to visit a patient once to twice a week in a 
district hospital and once a month in Mathare national hospital. Additional hidden costs to 
carers include making and bringing food, since hospital food is often insufficient. As data 
were not collected on these hidden costs to carers, I did not capture food costs and assumed 
weekly visits to district hospitals and monthly visits to Mathare, which I costed for travel 
expense and a day of lost productivity. 
A key methodological question is how to value carer and participant productivity in a 
largely non-wage economy. I chose to apply a flat rate, based on the current minimum wage 
rate, which is a variant of the human capital approach (Su, Sanon, and Flessa 2007), also 
referred to as an opportunity cost approach (Faria, Weatherly, and van den Berg 2012). 
Change in productivity among participants was determined from change in occupational 
status, and I valued paid and unpaid work equally. Examples of unpaid work include 
household work and subsistence farming. Two reasons for valuing unpaid work on par with 
paid work are: 1) that most activity in this poor, agricultural setting is unpaid subsistence work; 
and 2) this approach ensures gender equality, since more women in the sample worked in 
unpaid activities than men, especially in household work.  
The flat rate I chose for valuing carer and participant time is the monthly minimum 
wage of the lowest paid unskilled agricultural worker in Kenya. This flat wage rate was more 
appropriate than the patient-level data, because the sample of participants earning income was 
very small with a wide variance, and therefore potentially less accurate. I consulted with a 
health economist at UCT (Edina Sinanovic) to confirm the appropriateness of this method. 
The lowest agricultural wage in 2011, according to the Kenyan Ministry of Labour was valued 
at Int$ 98.0 (3,765 Ksh) per month (Kenya Ministry of Labour 2011), which amounts to a 
daily wage of Int$ 4.2 (162 Ksh), based on 23.3 work days per month. The following 
assumptions were made in calculating monthly income: a) a year was coded as 280 work days, 
equal to 52 weeks of 6 days, minus 21 days annual leave and 11 public holidays, as per Kenya’s 
labour law (ILO 2011); b) a month was coded as 23.3 work days, which equals the official 
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work year divided by 12; c) a season was considered four months, based on the usual farming 
seasons in Kenya: February-May; June-September; October – February. 
Change in productivity among MHD participants was measured using EST question 7. 
As there were no data on changes in productivity for a treatment as usual control, I held 
productivity constant at baseline levels for the control group. Those who moved from 
unemployment (codes 1 or 2) to full-time house work, unpaid work, or paid work (codes 4, 5, 
6) were valued at the minimum wage described above (Int$ 98.0/ 3,765 Ksh per month). Part-
time work, be it paid employment or household work (codes 3 and 7) was arbitrarily assumed 
to be 50% (the midpoint) of annual minimum wage. Thus, those moving from unemployment 
into full-time productivity were valued at 45,180 Ksh (the full annual wage rate) while those 
moving from unemployment to part-time, or from part-time to full-time productivity were 
valued at 22,590 Ksh. Students were valued as unemployed. Productivity loss from change in 
occupational status was calculated in the same manner as productivity gain. For the 20 cases 
lost to follow-up in year two, I used data from 10 month follow-up. Change in productivity 
was annualized to one and two years using the following equation with “days” referring to 
days until follow-up at time T: 
3
3_1730
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2
3_22_1365
730
)365(
T
TT
TT
T
TTTT
days
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days
days
prodprodprod



 
 
Kenya’s most recent data on employment and wages comes from the Kenya Integrated 
Household Budget Survey (KIHBS) of 2005/06. An analysis of that data (Pollin, wa Gĩthĩnji, 
and Heintz 2008) asserts that in the formal sector (where the most complete data was 
available), close to half of the working population earned beneath the statutory minimum 
wage. The minimum wage may, therefore, be an exaggeration of the actual average monthly 
income in the agricultural sector in the Central region.  
 
4.3 Results: Description of the MHD in Practice  
 
4.3 - a) Partners 
The main implementing partners of the MHD model in Nyeri and Meru were, respectively, 
the Catholic NGO Caritas and the local chapter of a national women’s organization, Maendeleo 
ya Wanawako, together with district departments of the Ministry of Health (figure 4-4). In 
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addition, BasicNeeds engaged several resource partners, which are organizations providing 
services or skills in support of the MHD model, but are not accountable for the model’s 
delivery. The resource partners in these two counties were the Ministry of Gender, Children 
and Social Development, who registered self-help groups, and the Ministry of Agriculture, 
who provided livelihood training to the groups. 
Maendeleo ya Wanawake (Women’s Development) is a volunteer-based community 
organization. BasicNeeds hired one person full-time to implement the MHD model, but prior 
to that the organization functioned without any revenue. The specialty of Maendeleo is to 
oversee self-help groups of women, and it has 400 such groups within its network in Meru. 
For the purpose of the MHD model, Maendeleo employed 25 part-time community workers: 16 
women and 10 men, reimbursed at a rate of Int$ 7.1 (Ksh 200) per activity. Each community 
worker devoted an estimated 5 full days a month on the intervention. 
Caritas is the department of social development within the Secretariat of the Catholic 
diocese of Nyeri. Each of the 45 Catholic diocese in Kenya has an independently financed and 
operated Caritas, and their directors meet annually to coordinate policy and practice. The 
Catholic diocese do not cover the same administrative boundaries as the Kenyan government, 
so Caritas Nyeri covers the counties of Nyeri and parts of Laikipia. Other departments of the 
Catholic Secretariat include education, youth, law and spirituality. Caritas Nyeri was founded 
in 1993 and currently runs 8 programmes: 1) mental health (since the partnering with 
BasicNeeds in 2007); 2) agriculture; 3) water and sanitation; 4) health (focusing on home-
based care for people with HIV and care for orphans and vulnerable children); 5) drought and 
famine relief; 6) governance; 7) peace-building; and 8) faith and empowerment (including 
training youth leaders). Each programme has an independent coordinator and staff, so 
BasicNeeds employed one full-time person at Caritas to lead the MHD model’s 
implementation in Nyeri. In addition, Caritas employed 52 of their 253 community workers 
on the MHD model. Community workers at Caritas were paid Int$ 10.8 (Ksh 300) per activity 
to work on mental health. 
The Ministry of Health supported the MHD model in Nyeri and Meru through the 
District Health Management Team by providing the services of psychiatric nurses and the 
venue of their health facilities free of charge. In exchange, BasicNeeds coordinated the clinics, 
ensured there were patients and medicines, and paid a per diem for the nurses’ time.   
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Figure 4-5: Organigram of BasicNeeds in Nyeri and Meru 
 
 
Legend: dotted ovals refer to resource partners, while solid black refers to implementing 
agencies. 
 
4.3 - b) Activities 
The activities involved in the MHD model often cross-over between different modules, so I 
will present them by activity rather than by module. 
Consultation meetings – These were meetings held for all community members to discuss 
mental health symptoms and to sensitize the public to mental illness. Community members, 
including people with mental disorders, discussed the experience of living with a mental 
disorder and facts about mental illness, prompted by the following questions, which are 
standard throughout all MHD programmes: 1. What is my/their life like?  2. What are 
my/their needs? 3. What can I do to meet my/their needs?  
Outpatient mental health clinics – Prior to the arrival of BasicNeeds, the only public 
outpatient mental health services in the area were found at Nyeri Provincial General Hospital 
and Nanyuki District Hospital. In Meru, the MHD model put into operation five outpatient 
mental health clinics: one open daily at Chuka District Hospital, and four outreach clinics 
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open once a month in Mukuni, Kajuki, Kaanwa and Mpukoni health centers or dispensaries – 
the lowest level public health facilities. In Nyeri, seven outpatient clinics were put into 
operation: in the towns of Endarasha, Naromoru, Gakawa, Mugunda, Karemeno, Bellevue 
and Warazo. Nurses drove to the clinics by motorbike at considerable personal risk: indeed 
one psychiatric nurse lost a finger in an accident driving to one of the outreach clinics. Public 
health clinics in Kenya are not free of charge, so users paid Int$ 0.5 (Ksh 20) per visit and Int$ 
1.3 (Ksh 5) on their first visit in keeping with general practice. 
Home visits – Home visits were made by community workers once a month in Nyeri 
and once a quarter in Meru. The purpose of home visits was to: a) check up on treatment 
adherence and medication side-effects; b) assess relationship dynamics within the family; c) 
discuss particular needs; and d) collect programme data. Patients with particular needs, for 
example a physical illness or experiencing particular distress, received additional visits, as 
needed. Research from India found that home-visits by community health workers were 
reported by service users to be stigmatizing in that context, because they were delivered by 
someone from outside the village, thereby calling attention to the fact that someone within the 
home was sick (Chatterjee et al. 2014). In the BasicNeeds, context, however, home-visits were 
delivered by community workers who lived within the villages they served.  
Self-help group formation and training – Self-help groups were established with the primary 
purpose of creating livelihood activities for participants, as well as offering psycho-social 
support and being vehicles for self-advocacy. Almost everyone in the study participated in a 
self-help group: the baseline rate of participation in self-help groups was only 7%, while by 
year one, it had grown to 94% (n=181). Maendeleo and Caritas oversaw 32 self-help groups 
between them (O’Connell, Musomi, and Mwangi 2011). Groups averaged 15-25 people in size 
(30 maximum), and they met once to twice a month and they contained both users and carers. 
Many groups had user fees of approximately 50 Ksh per month; however if a member could 
not pay they were nonetheless welcome to attend.  
In the set-up phase, a community worker (in some instance a recovered service user), 
referred to as a facilitator, supported the group activities, but this person had decreasing levels 
of involvement over time. Groups registered with the Department of Gender, Children and 
Social Development at a cost of Int$ 17.9 (Ksh 500), and several of them set up bank 
accounts. Twenty of the groups (63%) had received a loan or small grant of approximately 
Int$ 200-400 (Ksh 7,500 – 15,000) by the end of the project in 2011 (O’Connell, Musomi, and 
Mwangi 2011), but there are no data on loan repayments. Examples of livelihood activities 
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conducted by the groups in Nyeri and Meru include potato farming, soap making, and knitting 
and selling sweaters. 
The two partner organizations offered slightly different training to the self-help 
groups, depending on local resources and group demand. BasicNeeds and the partner staff 
collaborated to deliver  five core trainings, each lasting 1-2 days, as follows: 1) group 
formation and management; 2) book-keeping; 3) livelihoods training; 4) advocacy; and, 
optionally for groups having trouble cohering 5) group dynamics. In addition, the MHD 
model coordinators arranged for two external trainings: 1) financial skills, a one-day 
programme delivered by Equity Bank and Financial Knowledge for Africa (figure 4-1); and 2) 
livelihood skills training from a Ministry of Agriculture extension worker, in particular 
livestock rearing in Meru and soap-making in Nyeri. Groups received these trainings at 
different times in their development, according to their need – either expressed or observed. 
In addition, a support group was created for community workers in both Meru South and 
Nyeri as a strategy to ensure that they detach from the groups they were facilitating.  
Mental Health Action Groups – In each county the MHD model lead to the creation of a 
group of community leaders advocating for mental health, called a Mental Health Action 
Group. These groups had approximately 7-10 members including lawyers, priests, a user and 
carer, a youth representative and the MHD coordinator from the local partner organization. 
Groups met quarterly and addressed issues raised by the user and carer, or by the MHD 
partner. For example, a case was brought up in Nyeri about the rape of a woman with mental 
disorder; while in Meru the groups responded to problems of shortages in psychiatric 
medicines at the health centre and petitioned the clinic to waive user fees.  
 
4.4 Results: Analysis of Costs 
 
4.4 - a) Demographics 
The population at baseline consisted of 203 individuals: 104 from Meru and 99 from Nyeri. 
Median age at baseline was 35 years (range 18-81) with half the population 25–45 years old 
(interquartile range 19), and a quarter 18–25 years old. The population was evenly divided by 
sex (50.2% men). Half (53.7%) were never married. The mean household size was 6 people 
(range 1-17). Over half the sample (57.2%) were diagnosed with a severe mental disorder, and 
over a quarter (27.6%) had epilepsy (figure 4-6). Relatively few people (10.3%) had a common 
mental disorder. Half of participants (53.4%) were educated to less than a primary school 
level; a third (33.0%) had primary school education; and 20% had secondary education or 
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above. The education profile of the sample suggests a lower socio-economic status than the 
regional norm. According to the 2009 Census, only 14.7% of the population of Central 
province have pre-primary education and two-thirds (65.9%) have primary education 
(Ambetsa Oparanya 2010). Population demographics are reported by Lund et al in a table (4-
8) reproduced here (Lund, Waruguru, et al. 2012). 
 
Figure 4-6: Sample diagnoses at baseline 
 
 
 
 
 
Table 4-8: Population demographics of MHD participants 
(Reproduced from Lund et al 2012)  
 
Median age 35 
 % Male 103 50.7% 
Diagnosis 
  Epilepsy 56 27.6% 
Schizophrenia 67 33.0% 
Bipolar 32 15.8% 
Depression/anxiety 21 10.3% 
Psychosis 17 8.4% 
Other 10 4.9% 
Education 
  Never been to school 12 12.0% 
Some primary school 84 41.4% 
Completed primary school 67 33.0% 
Completed secondary school 28 13.8% 
College + 12 5.9% 
Marital status 
  Unmarried 109 53.7% 
Married 69 33.5% 
27.6% 
57.2% 
10.3% 
4.9% 
epilepsy (n=56)
severe mental disorder (n=116)
common mental disorder (n=21)
other (n=10)
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Divorced 13 6.4% 
Widowed 13 6.4% 
Prior work 
  No 125 61.6% 
Yes 78 38.4% 
Occupational status 
  None 111 54.7% 
Productive 69 34.0% 
Income generating  23 11.3% 
Household income source 
  Casual labour 62 30.5% 
Family farming  130 64.0% 
Salaried job 7 3.5% 
Business or other 4 2.0% 
 
4.4 - b) Change in productivity 
Household – The main source of household income for two-thirds (64.0%) of participants was 
farming, and for close to a third (30.5%) casual labour. Household income was understood as 
cash revenue. Since subsistence farming does not translate into cash, the income level 
reported per household was very low, at a median of Ksh 700 (Int$ 18.5) per month (mean 
Ksh 1,321, Int$ 35) for an average sample household size of 6 people.  
The average inflation rate over the study period, calculated from the monthly 
consumer price index (inflation = 100*2 baseCPICPI  ), was 3.4% for the first ten months 
of follow-up and 11.4% over 20 months. After adjusting for inflation, household income 
remained unchanged over the first ten months of intervention, but it almost doubled between 
baseline and 20 month follow up: the mean in Ksh at baseline, time 2 and time 3 was 1,321, 
1,374 and 2,517 (s.d. = 1,755, 1,387, 2,806, t 175 = 6.4; p<0.001). Nonetheless, the mean 
income at 20 months translates to Int$ 59.2, which is far beneath the agricultural minimum 
wage, and provides little on which to support a 6-person household. This potential 
intervention-related savings could not be included in the cost-effectiveness analysis, because 
there is no way to estimate the equivalent savings for the comparison group. 
Participants – Two thirds of participants had no prior work experience at baseline, and 
only 11.3% of participants were generating income. After ten months of intervention, 15.8% 
of the population were earning income (figure 4-7a), a significantly greater amount than at 
baseline (single sample two-tailed Z-test: Z=1.975, p=0.049). Those who were unemployed 
shifted from being disabled (decrease of 11.8% in 10 months) to being able to work (increase 
of 8.9%). In addition, the number of people in unpaid productive work slightly decreased, 
while those in earning income increased. 
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Figure 4-7: Change in occupational status after one year, overall and by gender 
 
a) Overall population 
 
 
b) By gender 
 
The association between occupational outcomes and the intervention appears to have 
been mediated by gender (figure 4-7b). The occupational status of men and women differed 
significantly at both baseline and follow-up (chi-square p=0.003 and p<0.001 respectively). 
Women tended to increase their engagement with unpaid productive work, while men did less 
unpaid work and generated more income after the intervention.  
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Few participants generated income (n=22 at baseline, 36 at 10 months), making 
statistical analysis of that variable challenging. The median income of those earning did not 
change from baseline to follow-up: it was 2,000 Ksh (Int $ 52.7) at both times.  
Gains and losses – In the course of 20 months, half of participants changed their 
productivity: 34.7% (n=61) experienced a gain and 13.6% (n=24) experienced a loss in 
productivity. It is possible that there is some measurement error in the estimation of 
productivity, since there is a subjective element to whether someone is coded as unemployed 
versus doing household work or working without monetary benefit. However, there is no 
reason to believe that the measurement error would be biased towards gains or losses in 
productivity, so it should cancel out on  aggregate. 
 
4.4 - c) Out of pocket expenses 
Hospitalization – The number of people hospitalized in the previous nine months dropped 
from 9 at baseline to 2 at ten-month follow-up. At baseline, the majority (n=5) attended the 
provincial general hospital; two attended the district hospital; and two attended the national 
referral hospital. The mean distance travelled to hospital was 99 km at a mean cost of Int$ 
12.3 (Ksh 467) per admission. All but one of those hospitalized were admitted once, and one 
was admitted twice. The average length of stay per admission was 26 days. Mean hospital fee 
was Intl $ 10.1 (Ksh 386) and mean doctor consultation fee was Int $ 15.2 (Ksh 575). 
Traditional Healing – At baseline, 7% of the sample (n=15) attended a traditional or 
faith healer, while at follow up only 1% (n=2) attended a healer. Those ever attending a healer 
(n=18) was used for analysis of descriptives, so as to increase the sample. More people (60%) 
attended faith healers than traditional healers (n=11 and 7 respectively). All traditional healers 
were herbalists, and one practiced a combination of herbs and prayer. Slightly more men than 
women attended healers (n=10 and 8 respectively), and their age distribution was comparable 
to that of the rest of the sample. The average number of sessions attended was 1.5 in the 
previous nine months and did not appear to differ in quantity by type of healer. 
One in five of those attending healers did so in Nairobi. None of them were attending 
hospital in Nairobi, so they may have travelled purposefully to attend a specialist healer. One 
third of those attending healers (n=5) walked to their appointment, taking 10-30 minutes, 
while the remainder were transported in a vehicle averaging three hours (127 minutes) one-
way. The mean round-trip transportation fee was Int $ 7.5 (Ksh 282, sd 306). 
None of the faith healers charged for their service, neither in cash nor in kind. The 
herbalists all charged cash on a fee for service basis, though none asked for in-kind payments. 
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The mean fee per session with a herbalist was Int $ 14.7 (Ksh 558, sd Ksh 356, range Ksh 60-
1,000) – the equivalent of three days of agricultural labour on minimum wage (Ministry of 
Labour Kenya 2012). Aggregating the consultation fees, transportation and opportunity cost 
of participant time, the mean cost of seeing a herbalist was Int $ 24.0 (Ksh 909) per session, or 
Int $ 53.3 (Ksh 2,021) per year. 
Community mental health clinic – No patient paid for community mental health services 
prior to the BasicNeeds intervention, as none existed outside of the hospital. BasicNeeds 
coordinated clinics cost Int$ 1.3 (Ksh 50) for the first visit, which went towards the purchase 
of a medical record book, and Int$ 0.5 (Ksh 20) on all subsequent visits, in accordance with 
standard public health fees in Kenya. Additional costs were associated with travel and time. 
The mean fee spent on travel to the community clinic per month was Int$ 1 (Ksh 37) and the 
mean amount of time was 40 minutes (0.67 hours). 
Sale or loan of property – At baseline one in five participants (n=40, 19.7%) reported 
having had to sell property or take out a loan in the previous nine months to cover treatment 
costs. At ten-month follow-up, the proportion of those needing loans or a sale dropped four 
fold to one in twenty (n=10, 5.2%). Moreover, the mean cost of the sale or loan dropped 
from Int $ 183.2 (Ksh 6,942) to Int $ 40.6 (Ksh 1,539). The largest reported sale or loan to 
cover treatment was Int $ 633.2 (Ksh 24,000) at baseline. 
 
4.4 - d) Unpaid care 
At baseline, just over a third (36.9%) of users reported receiving help from a carer, while after 
10 months of intervention only 8% received help from a carer. In addition, among those 
offering care, the mean time per week spent caring dropped from 14.7 hours at baseline to 7.5 
hours at 10 months. 
Out of concern that user self-report might not accurately reflect care-giver burden, in 
July 2012, three years after baseline, I collected additional data from 25 users and 25 carers 
with the help of the same research assistant who had overseen the original data collection. 
Users and carers were questioned independently of one another about whether they had 
received or given “help in performing any activity” (EST question 12a). There was perfect 
agreement between users and carers in terms of which users received help (n=12 or 42.9%), 
although users slightly under-estimated the number of hours of help they received relative to 
carers: the mean reported by users was 15.9 hours, whereas by carers it was 17.0 hours per 
week. For the purpose of costing, I preserved the original data unchanged.  
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Table 4-9: Costs before and after the MHD Model, all diagnoses  
 
Before After 1 Year After 2 Years 
 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
NGO Costs 1 0 0 0 0 0 1 22,941 22,941 22,941 0 540 1 23,708 23,708 23,708 0 558 
Capital 1 0 0 0 0 0 1 200 200 200 0 5 1 200 200 200 0 5 
Start-up 1 0 0 0 0 0 1 587 587 587 0 14 1 587 587 587 0 14 
Personnel 1 0 0 0 0 0 1 10,659 10,659 10,659 0 251 1 11,277 11,277 11,277 0 265 
Supplies 1 0 0 0 0 0 1 884 884 884 0 21 1 767 767 767 0 18 
Building & vehicle operation  1 0 0 0 0 0 1 2,078 2,078 2,078 0 49 1 2,441 2,441 2,441 0 57 
Training 1 0 0 0 0 0 1 999 999 999 0 24 1 1,063 1,063 1,063 0 25 
Social mobilization 1 0 0 0 0 0 1 1,060 1,060 1,060 0 25 1 1,003 1,003 1,003 0 24 
Clinic operation 1 0 0 0 0 0 1 878 878 878 0 21 1 883 883 883 0 21 
Monitoring and evaluation 1 0 0 0 0 0 1 764 764 764 0 18 1 1,552 1,552 1,552 0 37 
Sub-grants to partners & 
SHGS 
1 0 0 0 0 0 1 4,831 4,831 4,831 0 114 1 3,935 3,935 3,935 0 93 
Government Costs 203 0 45,000 550 3,683 13 193 1,010 10,010 1,071 674 25 173 2,021 58,271 2,565 4,839 61 
Inpatient bed days 203 0 45,000 550 3,683 13 193 0 9,000 60 674 1 173 0 56,250 544 4,839 13 
Outpatient clinic visits 203 0 0 0 0 0 193 1,010 1,010 1,010 0 24 173 2,021 2,021 2,021 0 48 
Direct user: 203 0 95,382 2,019 10,528 48 193 549 52,593 1,445 3,824 34 173 924 105,417 2,412 9,012 57 
medicines 203 0 42,815 1,035 5,934 24 193 0 8,135 624 827 15 203 0 15,961 1,224 1,623 29 
traditional healing 203 0 10,466 171 959 4 193 0 0 0 0 0 193 0 0 0 0 0 
outpatient clinic 203 0 0 0 0 0 193 549 549 549 0 13 193 1,078 1,078 1,078 0 25 
hospital 203 0 52,567 814 5,274 19 193 0 49,475 270 3,565 6 173 0 118,966 1,062 10,179 25 
Indirect user: 203 0 77,112 7,532 12,766 177 193 -58,271 52,021 215 22,027 5 172 -64,924 62,229 -12,492 35,671 -294 
change in productivity 203 0 0 0 0 0 193 -58,271 52,021 -410 21,766 -10 173 -69,581 62,229 -13,676 34,813 -322 
time sick  203 0 43,416 1,355 5,462 32 193 0 50,544 432 4,085 10 173 0 50,544 1,005 6,259 24 
informal care 203 0 52,650 6,177 10,506 145 193 0 8,424 190 1,155 4 173 0 676 7 68 0 
Total user 203 0 119,341 9,551 19,065 225 193 -57,008 53,855 1,664 21,999 39 172 -62,458 96,017 -10,072 36,394 -237 
Total cost 203 0 133,216 10,102 21,286 238 193 -33,057 77,806 25,676 22,021 604 172 -13,788 200,937 39,145 37,853 922 
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4.4 - e) Total costs 
Total costs of the MHD Model in the first year were higher than the treatment-as-usual costs 
recorded at baseline. From the societal perspective, the intervention cost Int$ 604 per person 
in the first year versus Int$ 238 for no intervention (as measured by baseline costs). At two 
years, the intervention cost Int$ 922, while the comparison is estimated to have cost Int$ 476 
per person (table 4-9). The relatively lower cost of MHD in the second year was largely the 
result of the savings from a return to productive work among those in the MHD Model.  
Not only did total costs change, but so too did their components, in other words who 
bore the costs (figure 4-8). Before the intervention, 94% of costs were born by the service 
user, whereas after two years of the MHD Model, the average user made savings of Int$ 237. 
The majority (85% in the first year) of intervention costs were born by the NGO. 
Government costs doubled over the course of the intervention, as increasing numbers of 
people accessed care in the community; however they remained modest throughout, 
amounting to only 6% of total costs before and in the first year after the intervention. 
The cost profile changed considerably by diagnosis (appendix 15). Severe mental 
disorders were associated with the lowest total costs before the MHD intervention amounting 
to Int$ 250 versus Int$388 for common mental disorders, primarily because people with 
common mental disorders received twice as much informal care as those with SMD (Int$251 
per year per person with CMD versus Int$ 101 per person with epilepsy) 
 
Figure 4-8: Who bears the costs before and after the MHD Model 
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After two years of intervention, epilepsy was the most costly illness at Int$ 995, as 
compared with Int$ 876 for SMD. This is largely because the savings from a return to 
productive work proved more modest for people with epilepsy than for those with severe 
mental disorders (Int$ 208 versus Int$ 398). 
 
4.5 Results: Analysis of Outcomes 
A preliminary analysis of outcomes has been published for this data (Lund, Waruguru, et al. 
2012), but this section expands on the published findings. The only repetition is the 
presentation of the population demographic profile. Outcomes are analysed in the following 
ways: 1) by change in absolute score on the GHQ and the WHOQOL; 2) by converting the 
GHQ score into an estimate of healthy days; and 3) by converting healthy days into DALYs 
averted. 
 
 
4.5 - a) Change in WHOQOL Scores 
The distribution of WHOQOL domain scores at baseline (appendix 19) appeared normal for 
physical, social and environmental domains, but were skewed toward the sick in the 
psychological domain, as might be expected in a population with mental disorders. 
WHOQOL domain scores showed a linear trend in improvement from baseline to twenty 
month follow-up (figure 4-9). Baseline scores were lowest for the environmental (mean 31.8) 
and highest for physical domains (mean 43.0).  
 
Figure 4-9: Mean WHOQOL domain scores over time, whole sample 
 
WHOQOL score 
 
 
43.0 
35.9 36.2 
31.8 
58.1 
47.9 47.8 
51.9 
65.4 
62.1 
65.0 65.3 
0
20
40
60
80
100
Physical Psychological Social Environmental
baseline
time 2
time 3
  
127 
 
The average change across WHOQOL domains (appendix 20) was an increase of 15% 
in 10 months and 28% in twenty months. The greatest change appears to have been in the 
environmental domain, which improved 20% in the first follow-up period and 34% in twenty 
months. The other domains performed comparably to one another, although the social 
domain appears to have improved more in the second year than in the first, jumping from an 
11% increase in the first year to a 29% increase in the second year. The difference in 
improvement between the environmental and all other domains was significant in both the 
first year and over two years, using one-way ANOVAs and the Tukey post-hoc test (
29.12748,3 F p < 0.001; 10.13688,3 F  p < 0.001). The change in domain scores were 
comparable across diagnoses (figure 4-10) with the exception of common mental disorders, 
which saw a greater increase in the social domain and less in the environmental domain.  
The change in total raw WHOQOL score (appendix 20) was 17 points out of 130 
(13%) in the first ten months and 28 points out of 130 (21.5%) over twenty months. The 
change appears relatively constant across diagnoses, but those with epilepsy appear to have 
benefitted more in the second year, as compared to those with other diagnoses: they had the 
smallest change in the first ten months (13 points) and the largest change by twenty month 
follow-up (30 points). 
 
4.5 - b) Change in GHQ-12 Scores 
Mean GHQ score decreased from 8.6 to 5.7 and finally 1.5 at baseline, ten months and twenty 
months. The distribution was heavily skewed to the right (sickness) at baseline and skewed to 
the left (health) at twenty months (figure 4-11), but developed a slight u-shape at ten months 
(appendix 16), indicating that some people were getting well, while others remained sick. The 
mean change in GHQ-12 score from baseline to ten months (appendix 16) was a decrease of 
2.9 points (24.0% of the 12 point GHQ score) whereas from baseline to 20 months it 
decreased 7.0 points (s.d 3.0) (58% of the GHQ) (figure 4-11).  
Despite the majority positive outcomes, the GHQ scores of 12.8% of participants 
(n=26) got worse between baseline and the first follow-up. The mean increase in score for 
those whose health got worse was 3.1 (s.d. 2.0), and one third of them (n=8) increased by only 
one point. In year two, the proportion of people whose scores worsened diminished to only 
3.4% (n=7). The counts were too small to analyse statistically, however it appears there was no 
apparent correlation between diagnosis and worsening scores (50% SMD, 15% CMD and 
35% epilepsy). 
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Comparing across diagnoses (appendix 18), there was no statistical difference in GHQ 
scores at baseline between those with serious mental disorders, common mental disorders or 
epilepsy (one-way ANOVA, 058.223,2 F  p= 0.15). There was also no significant difference 
in the change in GHQ scores by diagnosis in the first ten months, nor over twenty months 
(one-way ANOVA, 325.023,2 F  p=0.72 and 464.120,2 F  p = 0.26). Nonetheless, I have 
reported on outcomes by diagnosis, as the conditions described are clinically and biologically 
different and therefore do not warrant conflating. 
 
Figure 4-10: Mean change in WHOQOL domains by diagnosis at 20 months 
 
 
4.5 - c) Correlation between WHOQOL and GHQ-12 
There was considerable correlation between the WHOQOL and GHQ-12 scores at times 2 
and 3, but less so at baseline. The raw WHOQOL total had a Pearson’s correlation of -.669 at 
time 2 and -.606 at time 3. Correlation was also strong by domain at times 2 and 3, with the 
strongest correlations being with the environmental domain at time 2 (r= -.663) and with the 
physical domain at time 3 (r=-.690). The social domain showed higher levels of correlation at 
baseline (r=-.426) than other domains, but lower correlation at time 3 (r=-.356). These high 
levels of correlation support the validity of the GHQ as a measure of quality of life, or 
wellbeing in this population. On that basis, the subsequent analysis relies on the GHQ to 
estimate healthy days and DALYs averted. 
 
4.5 - d) Healthy days 
The health outcomes showed a positive, linear trend over the two years of study. After 
10 months of intervention, a third (34.0%) of participants were healthy, while after twenty 
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months three quarters (75.8%) of all participants were healthy, using the GHQ-12 cut-off of 3. 
Healthy day outcomes appear to have been better on average for those with severe mental 
disorders or epilepsy than for those with common mental disorders ( 85.1164 t  p=0.066). 
The difference in outcomes was not statistically significant at the alpha = 5% level, but it was 
significant at the alpha = 10% level ( 62.1182 t  p=0.10 at ten months and 65.1160 t  p=0.10 
at twenty months). No significant difference was found between outcomes of those with 
epilepsy and those with severe mental disorders. 
The annualized average number of healthy days gained in the first year of the MHD 
intervention was 50, but the benefits appear to have increased dramatically in the second year, 
bringing the two year average to 455 healthy days across all diagnoses (figure 4-13). The stark 
contrast between year one and two year outcomes (figure 4-12 b and c) is partly attributable to 
the method for measuring healthy days. Since a healthy day is determined by a threshold value 
(in this case 3), any improvements made above that threshold are not observed by this 
measure. Returning to the raw data of change in GHQ score, we observe that the increase in 
benefits in the second year were considerably less marked than they appear with the healthy 
day measure. The mean increase was 4.1 points in the second ten months, as compared to 2.9 
in the first ten months – using the projected data, this amounts to 3.9 points in the first year 
versus 4.5 in the the second year. It is also important to note the wide standard deviation of 
202 days around the two-year intervention outcomes. 
 
Figure 4-11: Mean change in GHQ score, whole sample, from baseline to 20 months 
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Figure 4-12: GHQ-12 distribution, whole sample 
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Figure 4-13: Mean annualized healthy days in MHD and comparison, by diagnosis 
 
 
4.5 - e) Change in DALYs 
The change in DALYs between baseline and follow-up was positive in the first year but 
negative in the second year (0.005 and -0.077 DALYs respectively) for those in the MHD 
group. This means that the health of the group as a whole deteriorated over time, despite the 
intervention. The driver of this result is death. Those who were alive improved markedly 
between year one and year two, as demonstrated by the mean change in GHQ score shifting 
from 4.2 to 8.4 points from one year to two years. The number of deaths also increased 
markedly, however, in the second round of follow-up: whereas only two people died in the 
first ten months of the study, six people died in the second ten months. The mortality rate in 
the first ten months of the study was significantly lower than standardized mortality rates for 
populations with these illness profiles (it was 2% for the MHD cohort as a whole, compared 
with figures from the literature of 6.3% for SMD and 5.98% for epilepsy). The mortality rate 
of 5% in months 10-20, however, though slightly lower than expected, nonetheless 
approximated the SMR from the literature, given the small sample size. As most of the deaths 
happened in the SMD diagnosis, their DALY outcomes are most affected, whereas the group 
with epilepsy experienced a positive change in DALYs in two years.  
 In the comparison group, health deteriorated more over two years, as reflected by a 
greater negative change in DALYs. The average change in DALYs was -1.052 in the first year 
and -2.250 in two years (table 4-10). The greater deterioration in health in the comparison 
group than in MHD implies that the MHD intervention is averting disability. 
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Table 4-10: Outcomes in MHD and comparison, by diagnosis 
 
SMD CMD epilepsy All 
GHQ N max mean sd N max mean sd N max mean sd N max mean sd 
MHD 1 111 5.6 -4.2 3 19 4.8 -2.8 4 49 3.7 -3.6 3 184 5.6 -3.9 3 
Comp 1 116 -1.1 -1.1 0 23 -3.0 -3.0 0 0 . . . 139 -1.1 -1.4 1 
MHD 2 104 2.6 -8.3 3 17 5.1 -9.4 4 44 1.2 -8.1 3 169 5.1 -8.4 3 
Comp 2 116 -1.5 -1.5 0 0 . . . 0 . . . 116 -1.5 -1.5 0 
Healthy 
days 
N max mean sd N max mean sd N max mean sd N max mean sd 
MHD 1 111 364 55 79.76 19 112 9 29.19 49 364 53 79.55 184 364 50 77.22 
Comp 1 116 365 8 48.06 23 243 26 63.08 56 26 26 .00 195 365 15 43.56 
MHD 2 104 729 456 201.67 19 721 474 213.48 46 634 436 208.30 173 729 455 202.26 
Comp 2 116 730 33 128.18 0 . . . 56 77 77 .00 172 730 47 107.08 
DALYs 
                MHD 1 111 .38 .002 .34 19 .08 -.464 .26 49 .60 .196 .19 179 .60 .005 .35 
Comp 1 116 -.20 -.839 .18 23 -.07 -.358 .17 54 -1.60 -1.805 .17 193 -.07 -1.052 .52 
MHD 2 108 .41 -.173 .47 16 .72 .107 .42 43 .51 .096 .29 167 .72 -.077 .45 
Comp 2 116 -.39 -1.653 .35 0 . . . 54 -3.14 -3.533 .33 170 -.39 -2.250 .94 
 
4.5 - f) Loss to follow-up and death 
Subjects lost to follow-up appear to have had a mix of both good and bad outcomes, 
comparable to the rest of the cohort. There was no statistical difference in age, sex, diagnosis 
or any other variables studied between those lost to follow up and those retained in the study. 
At 10 months, ten subjects (4.9%) were lost to follow-up, and at 20 months, 30 subjects 
(14.8%) were lost (table 4-12). The main reason for loss to follow-up after two years was 
moving (n=11, 36.7%), and whereabouts being unknown (n=8, 26.7%). Among those who 
moved and were traced, six moved for marriage, employment or both. Two of those lost to 
follow-up were found to have negative outcomes: one was arrested and the other had 
developed acute psychosis (though originally diagnosed with epilepsy). 
Eight people died in the course of the study (3.9% of the sample). Among those who 
died, causes of death were available for three cases and reflect a mix of natural causes and 
illness-related mortality: asthma attack, assault, and suicide. As stated previously, two of the 
deaths occurred in the first ten months of study and the remainder occurred between ten and 
twenty months. Projecting the data to two years, we would expect that 10 people might have 
died (table 4-3). The number of deaths observed and projected is markedly less than the 
expected deaths (table 4-1) in this population.  
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Table 4-11: Reasons for Loss to Follow-Up 
 
Reason Lost N 
Percent 
Sample 
Percent 
Lost 
Died 8 3.9 26.7 
Declined interview 1 0.5 3.3 
Moved 11 5.4 36.7 
Whereabouts unknown 8 3.9 26.7 
Defaulted on treatment 1 0.5 3.3 
Other 1 0.5 3.3 
Total 30 14.8 100 
 
The expected number of deaths in two years of a Kenyan population with the age, sex 
and disease profile of our sample was 23 – 14 with serious mental disorders, 1 to 2 with 
common mental disorders and 8 with epilepsy. The eight people who died in this study were 6 
with serious mental disorders, 1 with common mental disorders and 1 with epilepsy (table 4-
1). The deaths averted appear to have been greatest for those with epilepsy, however the small 
size of the sample and the rarity of death as an event make it challenging to test this 
association statistically. Nonetheless, the deaths in our sample exceeded the expected deaths 
among a comparable healthy sample of Kenyans, which would have been 4.6 in two years. 
The excess mortality may be linked to the relative poverty as well as to the illness of the 
population. 
 
 
4.6 Cost-Effectiveness and Cost-Utility Analysis 
 
4.6 - a) Incremental cost effectiveness ratios (ICERs) 
The incremental cost-effectiveness ratio of the MHD Model is defined as follows: 
ci
ci
EE
CC
ICER


  
With C = costs, E = effects, i = MHD intervention  and c = comparison.  
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Table 4-12: Costs, effects and incremental cost-effectiveness ratios, by diagnosis 
Diagnosis 
GHQ 
unit 
Healthy 
day 
change in 
DALY 
from 
baseline 
Total 
Cost  
(Ksh) 
Total 
Cost 
(Int$) 
Base Case 
Direct 
Cost 
(Int$) 
Sensitivity 
2 Direct 
Cost 
(Int$) 
SMD      
  MHD 1yr 4.2 55 0.002 25,217 594 602 649 
Comp 1yr 1.1 8 -0.839 9,360 220 80 80 
ICER 1yr (soc) 120.0 7.97 444   
  ICER 1yr (hs) 167.6 11.12 620   
  MHD 2 yr 8.3 456 -0.173 37,220 876 1,236 1,321 
Comp 2 yr 1.5 33 -1.653 18,719 441 161 161 
ICER 2 yr (soc) 64.4 1.03 294   
  ICER 2yr (hs) 64.4 2.54 726         
CMD      
  MHD 1yr 2.8 9 0.120 28,188 664 587 635 
Comp 1yr 3.0 26 0.137 14,285 336 77 77 
ICER 1yr (soc) -1681 -19.2 -18,987   
  ICER 1yr (hs) -2621 -29.9 -29,605         
Epilepsy        
MHD 1yr NA 53 0.196 25,152 592 602 649 
Comp 1yr NA 26 -1.805 10,312 243 19 19 
ICER 1yr (soc) NA 12.54 175     
ICER 1yr (hs) NA 20.92 291    
 MHD 2 yr NA 436 0.096 42,271 995 1,167 1,238 
Comp 2 yr NA 77 -3.533 20,625 486 37 37 
ICER 2 yr (soc) NA 1.42 140   
  ICER 2yr (hs) NA 3.15 311         
All dx      
  MHD 1yr 3.9 50 0.005 25,676 604 599 647 
Comp 1yr 1.4 15 -1.052 10,102 238 60 60 
ICER 1yr (soc) 145.4 10.55 347     
 ICER 1yr (hs) 213.7 15.5 510   
  MHD 2 yr 8.4 455 -0.077 39,145 922 1,216 1286 
Comp 2 yr 1.5 47 -2.250 20,203 476 121 121 
ICER 2 yr (soc) 64.8 1.09 205   
  ICER 2yr (hs) 159.1 2.69 504         
 
*soc = societal perspective; hs = health systems perspective; comp = comparison group; 
ICER = incremental cost-effectiveness ratio 
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The total costs were composed of the sum of provider costs (NGO and government) and user 
costs (direct and indirect). As described earlier (see “scope of costs”), for the counter-factual 
intervention I assumed that costs were held at the baseline values of the study population. 
Thus, the costs for “comparison, 1 year” refers to the baseline costs, while “comparison 2 
years” refers to the baseline costs times two. Effects were modified according to published 
rates of spontaneous remission and standardized mortality ratios described in the previous 
section on measurement of outcomes. Using this equation, I derived several ICERS, differing 
by unit of outcome and by diagnosis (table 4-12).   
The average cost per healthy day (figure 4-14) was Int$ 10.55 in the first year, but 
decreased to Int$ 1.09 in two years. From the societal perspective, across all diagnoses, the 
incremental cost of the MHD intervention was Int$ 347 per DALY averted in the first year, 
and Int$ 205 per DALY averted over two years. However, these averages mask considerable 
variation by diagnosis. 
The data suggest that common mental disorders were not cost-effective to treat using 
the MHD Model. This is partly because the natural course of untreated common mental 
disorders is very good, with roughly half of people with depression remitting spontaneously in 
a year (Whiteford, Harris, et al. 2013). That being said, the estimates of spontaneous remission 
are based on primary care samples, whereas one might assume that those entering treatment in 
Kenya would be suffering from more severe depression, so spontaneous remission in this 
group might have been lower than estimated. In addition, outcomes improved more in year 
two than in year one; however, since it was impossible to estimate control group outcomes in 
year two, it wasn’t possible to estimate cost-effectiveness for common mental disorders at 
two-years in this sample. Finally, the sample size was very small (n=24 at baseline), making 
analysis of this data more subject to error.  
Treating epilepsy with the MHD Model proved slightly more cost-effective in two 
years than in one, costing Int$ 140 vs. $175 per incremental DALY respectively (figure 4-15). 
The healthy day outcomes (figure 4-14), which do not carry disability weights, reflect much 
better outcomes over two years (Int$ 1.42 per day) than in the first year (Int$ 12.54 per day). 
The main driver of this finding is the reduced number of deaths of people with epilepsy 
relative to expectation. Only one person with epilepsy died in the 20 months of observation, 
whereas the expected number of deaths in a population with the same age distribution with 
epilepsy is greater than 5 in 20 months (appendix 14). The disability weights for epilepsy are 
lower than for severe mental disorders, thereby lending the changes in mortality more effect 
than the changes in disability with regard to DALY outcomes.  
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Figure 4-14: ICER per healthy day at one and two years, societal perspective 
 
 
Figure 4-15: ICER per DALY at one and two years, health systems perspective 
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By the end of two years, severe mental disorders appear to have been the most cost-
effective diagnostic group to treat using the MHD Model, although epilepsy was more cost-
effective in the first year. SMD cost Int$ 444 per DALY in one year and Int$ 294 per DALY 
in two years. The reason for the sharp increase in cost-effectiveness between the first and 
second year is that many people with SMD returned to productive work in the second year, 
having been previously disabled. The cost per incremental healthy day in year one was Int$ 
3.47, which is less than the minimum daily farming wage of Int$ 4.2 (162 Ksh), used to 
calculate indirect costs. Over the course of two years, the cost per incremental healthy day 
dropped to only Int$ 1.05. A dollar a day represents the living expense of an estimated half of 
Kenyans (UNICEF 2014). 
 
4.6 - b) Health systems perspective 
From the health system perspective, each healthy day cost Int$ 9.6 in the first year and Int$ 
1.65 in two years, all diagnoses combined. Severe mental disorders were the most cost-
effective to treat, costing Int$ 15.5 per incremental healthy day in the first year, and dropped to 
Int$ 2.69 over two years. Epilepsy cost Int$ 12.54 in the first year and Int$ 1.42 in two years. 
Common mental disorders did not appear cost-effective to treat, since they cost more and 
produced approximately the same effect as no treatment. 
The health system ICER per DALY averted was stable between the first and second 
year. Across all diagnoses, MHD cost Int$510 and Int$504 per DALY averted in one and two 
years. The treatment for severe mental disorders was less cost-effective than for epilepsy from 
the health systems perspective, because this perspective excludes the notable productivity gains 
made by people with SMD in the second year of MHD. SMD cost $620 per DALY in the first 
year and Int$726 per DALY in two years. The reason MHD appears less cost-effective in the 
second year is because the death rate increased among the population with SMD during that 
time. Epilepsy cost $291 and $311 per DALY averted in one and two years from the health 
system perspective. The conventional threshold for cost-effectiveness acceptability used in 
low-income settings is per capita GDP per DALY (Chisholm 2005). Kenya’s PPP adjusted 
gross national income in 2011 was Int$ 1,710 (World Bank 2011), making the MHD model 
appear cost-effective at one and two years for severe mental disorders and for epilepsy from 
the health system perspective.  
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4.6 - c) Sensitivity Analysis 
It is necessary to test the robustness of the findings relative to key assumptions included in the 
analysis. The most significant assumptions in this study are the values estimated for the 
treatment-as-usual comparison group, and the cut-off point used to convert the GHQ score 
into a healthy day. I therefore tested the ICER sensitivity using two alternative scenarios for 
measuring healthy days (table 4-13). Another source of uncertainty surrounds the 
measurements of cost, so I also altered the assumptions about costs. 
The greatest uncertainty around costs is the valuation of productivity, particularly the 
assumption that the productivity of a comparison group would have remained constant. The 
uncertainty in measuring productivity, however, is addressed through the health systems 
perspective analysis, which does not include any measure of productivity, and is discussed in 
the results section above. A further source of uncertainty around costs is in the WHO 
CHOICE unit costs for government inputs. An outpatient clinic visit is costed based on a 
primary health care visit, which typically lasts approximately 3 minutes. By contrast, a mental 
health visit is likely to last closer to ten to fifteen minutes for a visit (with first visits being the 
longest). I therefore tested the sensitivity of results to this cost by tripling the estimate for 
outpatient government-run clinics.12 
Scenario two, the worst-case scenario, adjusts assumptions by improving the 
comparison group outcomes and increasing government costs. It assumes that spontaneous 
remission from epilepsy is 20%, as previously published (Kwan and Sander 2004), and not 7% 
per year as indicated by as-yet unpublished data from Kenya (Newton 2013). In addition, it 
estimates comparison outcomes for severe mental disorders by using the published rate of 
5.7% for complete remission (Alem et al. 2009), instead of using the cross-walk technique 
previously described from the SF-36 to the GHQ-12. Furthermore, it increases the discount 
rate on DALYs from 3% to 7% to match the discount rate used for capital. Finally, it triples 
the government cost of outpatient clinics. 
Scenario two (figure 4-16) demonstrates that the findings for epilepsy are highly 
sensitive to the control group estimate in the first year, but considerably less so over two 
years. In the first year, treatment as usual appears better than the MHD Model (73 healthy days 
vs 53), while over two years, the MHD Model substantially outperforms treatment as usual 
(436 healthy days vs 146). The two-year ICER is $2.14 cents per healthy day as compared with 
Int$ 1.09 per healthy day in the base case. The shift in assumption for SMD control outcomes 
                                                 
12
 The clinician’s time is not the only input to the unit cost of a clinic, so tripling the cost is equivalent to 
more than tripling the clinician’s time. 
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leads to a three-fold improvement in those outcomes (from 6 healthy days per year to 21). 
Again, one-year outcomes are more sensitive than two-year outcomes. At one-year, the ICER 
for SMD increases to Int$ 16.70 per healthy day, up from Int$ 7.97 in the base case. Over 
two-years, however, the ICER decreases to Int$ 2.80 per healthy day as compared to $1.03 in 
the base case. For all diagnoses combined, the ICER is highly sensitive in the first year – 
jumping to a mean of Int$ 30.08 per healthy day, up from Int$ 10.55 – but much less sensitive 
over two years, shifting from Int$ 1.09 cents per incremental healthy day to Int$ 2.14 cents per 
day. 
 
Figure 4-16: Sensitivity Analysis, Case 2 (Worst Case) 
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a) ICER per DALY 
  
 
Figure 4-17: Sensitivity Analysis, Case 3 
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Scenario three (figure 4-17) adjusts assumptions for the GHQ cut-off. Since the GHQ 
measure relies on count data, the cut-off of 3 established in Kenya means a score of 2 
indicates health and 3 indicates sickness. However, my techniques for annualising outcomes 
required turning the GHQ into a continuous measure, including values between 2 and 3. In 
the base case scenario, scores of three or more indicated sickness, and anything less than 3 
indicated health. In scenario three, however, I tested using 2 as a cut-off, meaning anything 
greater than 2 indicated sickness and anything 2 or less indicated health. 
As with scenario 2, the results of scenario 3 proved sensitive in the first year, but less 
so over two years. The number of healthy days in the first year decreased across all diagnostic 
groups, including for control groups, where these outcomes were estimated using the GHQ 
(all cases except epilepsy). The number of healthy days among people in the MHD Model 
dropped by half in all three diagnostic groups in the first year: from 55 to 25 for SMD, from 9 
to 5 for CMD, and from 53 to 21 for epilepsy. Over two years, however, the results were fairly 
comparable, as a result of which the overall ICER remained unchanged at Int$ 1.12, just 3 
cents more than the base case per incremental healthy day. 
 The results set out above rely on mean values and do not account for variance around 
those means, which creates further uncertainty in the parameters. Drummond outlines several 
approaches to managing uncertainty in economic evaluation (Drummond, Sculpher, and 
Torrance 2005). The first is standard hypothesis testing, using t-tests. The challenge with this 
method is that the p-value does not reflect effect size, and moreover I cannot anticipate the 
desirable p-value for this context. The second method for managing uncertainty is to define a 
confidence region, creating a 95% confidence interval around costs and effects. The challenge 
with this method is that it assumes no association between costs and effects, which is rarely 
the case.  
 
A third method, which allows for the measurement of covariance is the incremental 
net benefit (INB) approach. Net benefit is defined as willingness to pay times the mean 
change in effects minus the mean change in costs (Nixon, Wonderling, and Grieve 2005): 
 
ceKKINB   )(  
 
where K = willingness to pay for 1 unit gain in health, c = costs and e = effects.  
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Table 4-13: Healthy days, scenarios 2 & 3 
 
 
 
SMD CMD Epilepsy All dx 
 N max mean s.d N max mean s.d N max mean s.d N max mean s.d 
 
Scenario 2 
 
epilepsy 20% and SMD 5.7% remission 
                         
MHD 1 111 364 55 80 19 112 9 29 49 364 53 80 184 364 50 77 
Comp 1 117 21 21 0 23 243 26 63 56 73 73 0 196 243 36 31 
MHD 2 104 729 456 202 19 721 474 213 46 634 436 208 173 729 455 202 
Comp 2 117 42 42 0 0 . . . 56 146 146 0 173 146 75 49 
Scenario 3 
 
GHQ cut-off of greater than 2 
  
   
  
   
  
   
  
MHD 1 111 243 25 46 19 62 5 16 49 122 21 37 184 243 22 42 
Comp 1 116 33 1 4 23 122 30 20 56 26 26 0 195 122 11 15 
MHD 2 103 701 404 219 16 638 469 191 42 666 427 184 165 701 419 205 
Comp 2 116 398 7 52 0 . . . 56 51 51 0 172 398 21 47 
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If the intervention is cost-effective, then INB > 0. Unlike with the ICER, which is a fraction, 
it is possible to run regressions using the INB as a dependent variable, and thereby to test for 
covariance. A standard way to display the results of these regressions is in a cost-effectiveness 
acceptability curve (CEAC), which plots the willingness to pay on the x-axis and the 
probability that INB(K) > 0 on the y-axis. Since the BasicNeeds-UCT study design is pre-post 
and control outcomes were estimated using the same sample as the intervention, analysis of 
variance and covariance is problematic. I therefore chose not to undertake a probabilistic 
analysis of uncertainty.  
 
4.7 Discussion and Limitations of the Quantitative Outcomes 
 
Compared with other health interventions modelled by the World Health Organization’s 
CHOosing Interventions that are Cost-Effective (WHO CHOICE) (Tan Torres Edejer et 
al. 2003), the MHD model appears an attractive choice for policy makers. As the WHO 
CHOICE costing method does not include valuations of productivity (Johns, Baltussen, 
and Hutubessy 2003), WHO CHOICE results are best compared with those of MHD 
from the health system perspective. Viewed thus, the MHD model performs in the same 
range of cost-effectiveness as HIV treatments. Highly active anti-retroviral therapy 
(HAART) combined with Directly Observed Treatment Short-Course (DOTS) for TB in 
the Africa E region costs Int$ 596 per DALY averted for simple HAART and Int$ 1,977 
for HAART Plus, while the MHD costs Int$ 503 over two years. Furthermore, the MHD 
substantially out-performs WHO CHOICE models for old mood stabilizers and 
psychosocial treatment for bipolar disorder (Int$ 2,165 per DALY)(Chisholm et al. 2005), 
and “first generation” antipsychotics with psychosocial treatment for schizophrenia (Int$ 
1,670 per DALY)(Chisholm et al. 2008).  
 Based on these results, there is an argument for scaling up the MHD model more 
broadly in Kenya. To do so, however, would require a significant investment of external 
funds, as the majority of direct costs are currently born by the NGO BasicNeeds, by way 
of international donors. In a country where per capita spending on health is Int$ 37 per 
year (World Health Organization 2012), an intervention costing Int$ 599 per person per 
year in direct costs to deliver is not readily affordable to the public sector. The returns on 
that investment are significant in terms of return to productive work; however they are 
not returns that would be monetized by the government. 
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 The quantitative data in this cost-effectiveness analysis are limited in their ability to 
inform about the challenges of programme delivery, as they reduce complex outcomes to a 
single number. The cohort in the BasicNeeds Kenya Impact Study consisted of a mixed 
diagnostic group, which constituted a challenge in the choice of an appropriate outcome 
measure. The GHQ, which was selected as the primary measure of outcome, is designed to 
assess psychiatric symptoms, rather than diagnosis, particularly symptoms of common mental 
disorders, but not psychoses or epilepsy.  
Very few studies (Caqueo and Lemos 2008; Wilkinson et al. 2000) have made use of 
the GHQ 12 in a population of people with severe mental disorders. In studies of severe 
mental disorders, the GHQ is more commonly used to measure the psychological strain on 
care-givers. One of the challenges in relation to the measurement of severe mental disorder is 
that the tool is designed to measure illness episodes, so it asks how a person is feeling in 
comparison to their “usual” self. In contexts of chronic disease, however, the usual self may 
be a sick self, which poses a risk to the validity of the responses. That being said, several items 
on the GHQ12 reflect symptoms of psychosis – in particular, items 1 (ability to concentrate), 
4 (decision making) and 6 (ability to perform daily activities). It may, therefore, be a 
meaningful measure of disease morbidity. 
The GHQ is also a poor measure of symptoms for epilepsy, as it does not ask about 
seizures. A study from Nigeria, however, found the GHQ-30 to be significantly correlated 
with a measure of quality of life among people with epilepsy (Mosaku et al. 2006). Indeed, the 
GHQ functions predominantly in this study as an indicator of quality of life rather than as a 
marker of symptom suppression: as such, the tool measures recovery in the broader sense 
than clinical symptom alleviation. The challenge remains, however, whether the cut-off used 
for common mental disorders is meaningful for severe mental disorders and epilepsy. Findings 
for SMD and epilepsy at two-years, however, proved relatively insensitive to the cut-off. 
Furthermore, a limitation of the data is the accuracy of self-report. Problems in self-
report can occur from recall bias – especially where periods of recall are long, such as nine 
months in many of the questions on the EST – or from a perceived desire to please the 
interviewer or provide socially acceptable answers, such as around income. For example, 
attendance of traditional healers may have gone under-reported, since the interviewers were 
clinicians with conventional medical backgrounds. 
In addition, converting to DALYs required making assumptions, which come with 
uncertainty. In particular, assumptions about the sample severity are potentially problematic. 
While it is customary to use cut-offs of the top quartile or one standard deviation above the 
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mean to measure extremes within a given distribution, which does not inform us about 
whether the entire sample is severe. It is possible that in a Kenyan context, those reaching 
treatment may all have severe symptoms. That being said, the GHQ is a continuous measure, 
and the distribution of GHQ scores did not all cluster at the extreme of sickness, so the data 
appear to support the notion that some patients were more severe than others. Nonetheless, 
the choice of cut-off for severity remains untested in a wider Kenyan cohort, creating some 
uncertainty about the DALY weights. 
Even at its best, DALY methodology has been subject to considerable criticism, 
particularly in relation to the selection of disability weights. The 2004 GBD study data used 
weights derived from a group of health experts, from mostly high-income countries, using a 
person trade-off method. That approach was deemed by many a poor indicator of actual 
disability weight, because it neither accounts for the preferences of the person in the 
condition, nor those of the general public, nor is it representative of expertise from low-
income countries. In response to this critique, the 2010 GBD update reassessed its disability 
weights, using two sources: a population-based survey conducted in Bangladesh, Indonesia, 
Peru, Tanzania and the USA; and an internet survey (Salomon et al. 2013). An ongoing 
critique of DALYs relative to the Kenyan context is that by weighting disability equally across 
all settings, DALYs undervalue the burden of disability in low-income settings, where the 
environment is less accommodating than in higher-income settings (Reidpath et al. 2003). The 
response to this claim is that weighting diseases uniformly is an expression of egalitarian 
values (Institute of Health Metrics and Evaluation 2010).  
Another potential weakness is that our study provides no measure of treatment 
adherence. An intervention check-list provided some indication of the degree to which people 
had participated in the programme, but it did not ask about medication adherence. It is 
possible that outcomes differed according to a person’s level of adherence to the MHD 
Model. That being said, the literature suggests that self-report of adherence is highly inaccurate 
(Mbuba et al. 2012), so the absence of this information may not be such a weakness. 
Moreover, since the cost-effectiveness analysis is interested in mean aggregate outcome, rather 
than in individual outcomes, the absence of adherence measure is less problematic in this 
context than it would be for an outcome study. 
Finally, and most importantly in the context of an economic evaluation, the absence of 
a control group is a severe limitation to this study, making it impossible to know what aspect 
of the changes observed are attributable to the intervention as opposed to external factors. 
For example, a part of the change in occupational status could simply be the result of the 
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ageing of the population – as participants get older, they are more likely to contribute to the 
workforce, especially since one quarter were 25 years old or younger. Inversely, loss of 
productivity could be the result of the economic down-turn, making part-time income 
generating jobs less available. 
The choice of literature for comparison group raised a number of challenges. The 
Ethiopian study consisted almost entirely of men, making it an imperfect predictor of 
outcomes for women. There was no literature on mortality rates of depression in a low-
income setting, so our data come from high-income countries where populations have better 
access to treatment, which could make the excess mortality an under-estimation of what it 
would be in a low-income setting. And estimated outcomes for untreated epilepsy vary 
tremendously, creating a substantial source of uncertainty. Nonetheless, the cost-effectiveness 
results remained robust over the course of two-years, despite sensitivity to individual 
assumptions in the first year. 
 
 
4.7 - a) Insights from the Qualitative Data 
 
Given the multiple limitations to the quantitative data, qualitative data offer a rich resource in 
unpacking some of the complexities underlying the MHD model’s outcomes. Discussions 
with patients and programme staff and review of documents by external evaluators revealed 
that delivering the MHD model was not without challenge. I will present two over-arching 
challenges, followed by specific challenges associated with certain activities, namely 
community consultation, outpatient clinics, home-visits and forming self-help groups. 
 
4.7.a.i Overarching issues 
A key over-arching concern was that of leadership, which powerfully affects the delivery of 
the MHD model. The model is only as good as the partners and people delivering it. Shortly 
before the onset of the evaluation research, BasicNeeds had to fire one of its implementing 
partners, because it was failing to adhere to its commitments. Furthermore, both the DFID 
and EC evaluators observed that the government authorities were not equally committed to 
the MHD project across all districts. EC evaluators remarked, “There was more suffering in 
the communities where the government entities are not delivering reasonable mental health 
services, (e.g. Laikipia North)” while DFID more discretely echoed, “In areas where 
government staff were not very involved or supportive, the delivery of programme outputs 
was very difficult and had limited impact.” Nyeri and Meru appear to have been areas where 
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the MHD model was functioning well, thanks to the engagement of partners and local 
government. However, it is apparent that the MHD model differs in content depending on 
the local partners. A greater adaptability to local contexts is the trade-off for potential 
inconsistencies from place to place. 
A further over-arching issue is that neither the EC nor the DFID grant was explicitly 
intended for the delivery of the MHD model. Instead, the EC grant supported democratic 
governance, while the DFID funding stream sought to promote human rights. Specifically, the 
EC funded BasicNeeds from the beginning of February 2009 through the end of January 2012 
in a project titled “Strengthening the capacity of people with mental disorders to hold 
government to account for mental health and development in Kenya” (contract DCI-
NSAPVD/2008/156-918). DFID funded BasicNeeds from the beginning of January 2008 
through the end of March 2011 in a project titled “Respecting the rights and needs of people 
with mental illness in Nyeri, Laikipia, Nyandarua and Meru South” (CSCF 450). BasicNeeds 
therefore sought to deliver their MHD model in such a way that emphasised the governance 
and rights focus of their donors. That meant emphasising user-based advocacy through self-
help groups instead of health care delivery. The donor evaluations reflect this emphasis, and 
raise the question of what is to be evaluated when evaluating a multi-dimensional intervention 
model. 
Further issues that emerged from the reports of patients, staff and evaluators relate to 
the capacity of the health-system and of service-users, coordination (particularly with HIV 
programmes) and resource constraint. These topics are most clearly addressed in describing 
the delivery of MHD activities. 
 
4.7.a.ii Issues by activity 
Community consultation – The chief challenge raised with regards to the community consultation 
meetings relates to the broader culture of NGOs and was variously dubbed by programme 
staff as an “issue of handouts,” or “dependency syndrome.” NGOs are known to hand out 
free goods to participants, and in some cases people come to depend on those hand-outs. The 
local HIV programmes, for example, offered samosas and tea when people attended their 
activities, while Caritas offered relief food through a different programme from the MHD 
intervention. A number of people would therefore come to the MHD consultation meeting in 
the words of one member of the programme staff primarily to “see what’s on offer.” In 
addition, MHD participants sometimes behaved with a sense of entitlement. The same staff 
member observed that when participants were receiving relief food from Caritas: “The food 
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was for all people in the locality, so they [MHD participants] had to queue with everyone else. 
They didn’t understand why they weren’t being given priority. They asked, “Why are you 
mixing us with them?”” MHD participants appear to have felt a sense of superiority over the 
other villagers because of their sense of belonging in the MHD programme run by the 
BasicNeeds partner, Caritas. 
The MHD model aspires to teach people to pro-actively address their needs, rather 
than passively receive benefits; however not all partner organisations appear to have 
assimilated that approach. The DFID evaluation noted: 
“The success of the programme … requires an ability [of programme 
staff] to have a clear understanding about rights-based approach vs. a 
service provision or a charity-based approach. While many 
organizations have adopted a rights-based approach, in reality the 
transition from service provision, particularly in the case of church-
based organisations, can be slow.” (O’Connell, Musomi, and Mwangi 
2011) 
The term “rights-based” is opposed to “charity”, implying that recipients of the MHD model 
should act as participants rather than as beneficiaries of the intervention. This distinction 
between charity and rights, or between passive and active participation also comes to play in 
the distinction made between “wants” and “needs,” illustrated on the flip-chart of a financial 
training session offered through the intervention (figure 1). Want implies personal 
involvement, whereas need implies an absence: “I will” versus “I lack.” Ironically, the name 
BasicNeeds evokes the language of passivity that the organization is trying to fight. As noted 
by the DFID evaluators, the spirit of dependency may be driven as much by partner agencies 
as by programme participants. 
Absence of coordination between different NGO programmes also raised an issue in 
organizing the community consultations. It sometimes happened that the community workers 
organized a consultation meeting on the same day as an activity of one of the local HIV 
programs, such as Afya+ or the International Centre for AIDS Care and Treatment Program 
(ICAP). In addition, NGOs competed amongst each other to hire the best community 
workers, but they did not have the same means. The HIV programmes were able to pay up to 
KSh 800 (Int$ 19) per activity, whereas BasicNeeds partners only paid a quarter of that (Ksh 
200, Int$ 5). While it was not possible to directly compare the amount of time required for an 
HIV activity as compared to an MHD activity, I was told that they were comparable. That 
being said, money was by no means the only incentive for community workers, who were 
referred to by the NGO as “volunteers.” Other incentives included: 1) not having to queue 
for treatment at the clinic; 2) receiving free drugs at the clinic; and 3) getting priority for casual 
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labour around the clinic, such as cleaning jobs. Social prestige was also cited as an incentive by 
partner staff. 
Outpatient clinics – Absence of coordination and the issue of hand-outs were similarly 
flagged as barriers to the delivery of the mental health outpatient clinics. Nyeri has a relatively 
high prevalence of HIV, and patients with both a mental disorder and HIV had to attend both 
the mental health clinic and a “comprehensive care centre” for HIV. Little communication 
existed between those two facilities. In relation to hand-outs, the same people who attended 
the consultation meetings to “see what’s on offer” would sometimes show-up at the clinic. As 
described by one health care provider, “Some clients were brought by a relative, because the 
relative wanted to see what assistance was available. But when they found it was only drugs, 
the person refused to take the drugs. Even the relative said ‘You are not sick, do not take.’” 
Fake patients were quickly routed out through the process of self-selection just described. 
As diagnosis and prescription were the main activities undertaken in the outpatient 
clinics, medication side-effects and shortages were the main source of challenge in this activity. 
Drowsiness was a common complaint from those taking medicines. A member of the 
programme staff recounted how a female patient had recovered and stopped taking her 
medicines after getting married. She reportedly said: “They make me sleep a lot, and now I am 
married, I need to get up, cook, clean…” A man in the focus-group echoed, “I used not to 
know myself, but now I do. The only problem is the drugs make me very sleepy.” Another 
member of the focus group noted frustration with the repetitive nature of maintenance drug 
treatment: “Will the drugs ever change? It’s always the same drugs.” The novelty appeal of the 
MHD intervention wore off over time. Finally, a key problem highlighted in relation to 
medicines is that they were supposed to be taken with food, and food was not always 
available, because of extreme poverty.  
Shortages of psychiatric medicines at the mental health clinics were equally cited as a 
problem. Since the clinics were government-run, they relied on government drug-supply 
systems. However, the drugs supplied to clinics were typically rationed on the basis of 
precedent, and in the past there had been no demand for psychiatric medicines. Clinics would 
often run-out of drugs, particularly carbamazepine for epilepsy. Some participants would be 
sent to the provincial general hospital, where supplies were better, but the distance and 
inconvenience reportedly led some participants to drop-out of the programme. BasicNeeds’ 
position was that they did not want to create a parallel system of health care, and that the 
demand for drugs should come from service users, rather than from their staff, otherwise they 
would fall into the trap of the dependency syndrome. 
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In addition to a shortage of medicines, the capacity of the public health system was 
stretched in terms of the ability of primary care providers to diagnose and treat mental 
disorders. As observed by the DFID evaluators:  
 “Primary care often struggles to deal with complex psychiatric cases.  
It deals with epilepsy very well but there may be a need for more 
specialized treatment at a district level for more complex cases. The 
balance between, on the one hand, increasing the local demand for 
local services and, on the other, working to ensure that such services 
are improving in their capacity to meet such demands, can be difficult. 
There is always a risk that the creation of demands, which cannot 
realistically be met, may have negative long-term consequences.” 
(O’Connell, Musomi, and Mwangi 2011) 
DFID’s observation was corroborated by a comment made to me that some health staff got 
“discouraged” because they found the mental health training inadequate. In particular, no 
treatment was available for the management of drug-abuse. One young-man with a drug-abuse 
problem in the MHD programme hanged himself. His suicide caused the programme staff to 
raise the need for specialist treatment of substance use disorders, but resources were lacking to 
pursue this need.   
Home-visits – The absence of psychological therapies within the MHD as practiced in 
Kenya was seen as a short-coming by both programme staff and the evaluators. Home-visits 
are conceived of as the primary means through which psychological support is given to MHD 
participants. They also serve as a form of follow-up for patients who have not shown up to 
their clinic appointment. Home visits do not, however, constitute formal counselling. As 
observed by DFID, “Research into brief psychological treatments, or group therapies should 
be explored.  … brief psychological interventions could reduce their reliance on medication 
and give them new skills for managing themselves” (O’Connell, Musomi, and Mwangi 2011). 
One of the health care providers noted that there was a perception that all that the clinics 
consisted of “Come, take your drugs and go.” The absence of psychological therapies is partly 
an issue of financial constraints but also of limited local capacity. There are not many trained 
therapists in Kenya, although there is a cadre of trained counsellors. Counsellors typically live 
and work in the cities, however, and hiring them can be costly.  
Self-help groups – One of the main challenges raised in relation to forming self-help 
groups was the slow pace with which people became interested. As described by one of the 
programme staff, “Groups are like Christianity: you preach, and preach, and preach, but when 
you ask who wants to join, only five people raise their hands. It takes time for the idea to 
catch on. Only once people see how it helps others, then they get interested.” In the context 
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of grants that last only three-years, it can be difficult to demonstrate the effects of self-help 
groups, which took about two-years to get running. 
The slow-pace of membership uptake was contrasted to an impatience among group 
members with the outcomes of their livelihoods projects. “People are not used to waiting for 
results from investments.” The example was given of a group that was given a grant of KSh 
10,000 (Int$ 235) that was invested on a group project between 10-15 members. In addition, 
the sense of entitlement observed during the community consultation also plays out in the 
livelihood activities. One of the programme staff observed, “Some people were given a small 
loan to make income, for example a plot of land to plant with potatoes. They would say, ‘It is 
too small what you give us.’” The grants and loans provided to self-help groups raised a 
further question of sustainability, as did the technical support provided to them from 
community workers and programme staff. The DFID evaluator commented “Self-help groups 
… will need ongoing support and advice for the foreseeable future, particularly in relation to 
advocacy and micro-finance” (O’Connell, Musomi, and Mwangi 2011) 
The verdict was mixed on the ability of self-help groups to serve as vehicles for 
advocacy. EC evaluators noted, “Caritas led meetings between users and government; [but] 
users did not have skills to use ongoing government projects, policies or even the new 
constitution as a basis for advocacy” (Ntulo, Musomi, and Mwangi 2011)At the same time, 
however, they reported that “the district health management team accused BasicNeeds Kenya 
and Caritas Nyeri of putting them on a collision course with people with mental illness, 
because of sensitization on their rights” (Ntulo, Musomi, and Mwangi 2011)Ibid). If district 
government officials were complaining of a “collision course,” then surely the user-led 
advocacy had some potency. Taking a step back, we can observe an inherent tension in the 
structure of the MHD model whereby the government serves both as a partner and as an 
adversary, or at the very least as a target of user-led advocacy. 
 These qualitative findings reveal uncertainties that cast into doubt the definitive nature 
of the quantitative results. The principle uncertainty is that Nyeri and Meru may not be 
representative of all MHD programmes, in that they appear to have been best-case scenarios. 
In addition, the programme delivery may have been positively influenced by the research 
process itself: the requirements of locating patients who had dropped-out in order to conduct 
research interviews, may have led to greater follow-up than in standard programme delivery. 
Finally, the fact that the activities of BasicNeeds were financed by donors interested in 
governance and human rights may have skewed the delivery of MHD in this setting less 
towards the health components and more towards advocacy. Nonetheless, the material 
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presented here reflects the reality of programme delivery through an NGO, where the 
“messiness” of resource constraints and donor demands inevitably shapes the practice of 
service delivery.  
The testimonies of the select group of patients participating in the focus-group 
illustrated ways in which the MHD model succeeded in bettering the lives of some Kenyan 
men and women. One man, observed his transformation from a perpetrator of domestic 
violence to a supportive father in the three years since he had begun participating in the MHD 
activities. He described having beaten his wife and chased his children under the influence of 
auditory hallucinations, and noted that he was no longer disturbed by voices. The only noises 
that continued to disturb him were those of motorbikes, and his main preoccupation had 
become the wellbeing of his wife and the education of his children. A man with epilepsy 
reported how prior to receiving treatment with anti-convulsants he needed to be accompanied 
at all times by a care-giver. He spoke with visible pride about his ability to walk on his own to 
the clinic, to wash his clothes, fetch water, and help out farming lentils and maize. His account 
revealed not only signs of his own recovery, but also the implicit relief on his care-giver, who 
no longer had to shadow his movements. 
Women in the programme reflected in their own way on how the intervention had 
helped them, emphasising their ability to participate once again in their family. A pregnant 
women, who had received treatment for psychosis, recounted that she used to wander around 
the village unclothed, as a result of which her family tied her up at home. Her experience of 
illness had been as a victim of abuse rather than a perpetrator, albeit from possibly well-
intentioned family members. Another woman told of how her children were taken from her 
by her parents, after she went wandering and slept in the forest. When asked how the 
intervention had changed her life for better or worse, her clear emphasis was on having her 
children back. Her experience of recovery emphasized the shift from a person being cared for 
to a care-giver, through mothering. The focus-group sample was skewed towards those who 
benefited most from the intervention; however the testimonies of those individuals are as 
relevant as the discussion of challenges in reflecting on the effectiveness of the MHD model 
in practice.  
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4.8 Conclusions 
 
In conclusion, based on a combination of the quantitative and qualitative data, the MHD 
model could arguably do more or do better, but it appears in its present form to be doing 
considerable good. The areas of greatest potential improvement are in the provision of 
psychological therapies, possibly through counsellors or by training lay-workers, as has been 
done successfully in Asia (Patel et al. 2010) and in working with service users to improve drug-
supply. The question of how to improve the sustainability of the livelihoods activities, which 
currently involve small grants, also merits further exploration. The strengths of the MHD 
model are the centrality of user-led advocacy, the equal emphasis on non-medical aspects of 
recovery (especially livelihoods), and partnership with local governments. The model offers 
specialised mental health care in a community setting, thus addressing a major gap in 
treatment for a vulnerable population.  
This study suggests that the MHD model is cost-effective and equitable. However, for 
this intervention to be affordable, international donors must continue to finance mental 
health. Moreover, at the country-level, the model’s sustainability requires dynamic, multi-
sectoral participation from government, civil society and local communities – taking the clinic 
into the community and the community into the clinic.  This robustness of findings from this 
study is limited by the absence of comparison group, and its generalizability outside of the 
setting of rural, Central Kenya has yet to be determined, making it difficult to infer 
conclusively the appropriateness of this model across the board. The results here would 
suggest that scaling up the MHD model might be worthwhile, starting by spreading to 
neighboring counties. Despite the limitations of this research, the study remains valuable in 
that it draws from patient-level data and provides rigorous economic analysis in a context 
(East Africa) and for a set of conditions (mental disorders) that are not typically subject to 
economic evaluation. 
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5. A Case Study of Mental Health Coverage in a For-Profit 
Psychiatric Hospital 
 
 
Figure 5-1 A session of art therapy at Chiromo Lane 
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5.1 Introduction 
 
One third (36.7%) of health expenditure in Kenya comes from out-of-pocket payments 
(World Health Organization 2012), and out-of-pocket expenditures goes predominantly 
(76.3%) to hospitals, including private for-profit hospitals, which consume 14.9% of them 
(Barnes et al. 2010). Understanding the drivers of private hospital expenditure is therefore key 
to containing health costs. Out-of-pocket expenditures are associated with catastrophic loss in 
low-income countries (McIntyre et al. 2006), so policy makers have been vying to create social 
health insurance in Kenya and elsewhere in sub-Saharan Africa (Hsiao, Shaw, and Fraker 
2007; World Health Organization 2010). 
In 2004, Kenya’s parliament passed a promising bill to create a National Social Health 
Insurance Fund, which would fund both outpatient and inpatient care for all Kenyans using a 
sliding scale of contributions (Hsiao, Shaw, and Fraker 2007). Disappointingly, the bill was not 
signed into law, because of concern over the feasibility of its financing. Now, the only 
operational social insurance is the National Hospital Insurance Fund (NHIF), which is under 
investigation by Kenya’s Ethics and Anti-Corruption Commission, and which allocates only 
22% of funds towards benefits (Hsiao, Shaw, and Fraker 2007). NHIF pays a flat-fee of Ksh 
800 (Int$ 20.8) for inpatient stays and enrolment is mandatory for all formal sector employees; 
but currently it covers only 5.5% of the population (Barnes et al. 2010).  
In this context of barriers to national insurance, private health insurance remains one 
alternative to user fees for financing health care, among those who can afford it. In Kenya, 
private health insurance is used by 2% of the population and accounts for 4% of total health 
expenditure (Barnes et al. 2010; Drechsler and Jütting 2007). Critics of private health 
insurance argue that it benefits only the rich and leads to spiralling use and costs of services, 
while proponents suggest that it provides financial protection, increases early access to 
services, and mitigates problems of wait-time and quality (Preker, Scheffler, and Bassett 2007). 
The debate remains largely theoretical in low-income settings in the absence of evidence. A 
systematic review of randomised controlled trials  and observational studies about the impact 
of health insurance in Africa and Asia found only one study of private health insurance, and it 
was from Asia (Spaan et al. 2012).  
Within the field of mental health, the main area in which private service provision 
dominates is in the treatment of substance abuse. Kenya’s National Authority for the 
Campaign against Alcohol and Drug and Abuse (NACADA) lists 59 accredited services for 
drug and alcohol abuse nationally, including 36 with residential facilities (NACADA 2014). 
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Information on the date of origin is available online for 37 services, and 75% of them were 
founded in the last ten years (figure 6-2). Only four of the services (7% of all services, 11% of 
residential services) are public, namely: 1) Mathare Hospital and 2) Kenyatta National Referral 
Hospital in Nairobi13; 3) Coast Provincial General Hospital in Mombassa; and 4) the newly 
opened rehabilitation at Moi Referral Hospital in Eldoret (Rift Valley).   
 
Figure 5-2: Growth in Kenyan Drug Treatment Centres, 1996-2012 
 
 
Figure 5-3: Residential Alcohol and Drug Rehabilitation Centres by Type 
 
 
 
Among the private services, it can be challenging to determine which are for-profit 
and which are not-for-profit, as a number of the services have not-for-profit status but 
function as self-financing entities. Most of the truly not-for-profit services are faith-based, and 
faith-based services accounted for 42% of services listed by NACADA, suggesting that the 
remaining half of all alcohol and drug abuse services in Kenya are for-profit entities (figure 6-
                                                 
13
 Kenyatta has a special para-statal status and controls its own budget; but functions as a public facility. 
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3). Based on online information, the mean number of beds in the twelve residential 
rehabilitation centres providing that information was 30 (s.d. 10), and the mean target length 
of stay in the sixteen facilities providing that information was 4 months (122 days). The 
standard deviation on target length of stay was large (99 days) because of a single outlier, 
which accommodated people for up to two years.  
Outside of alcohol and drug abuse treatment, inpatient non-state mental health care 
exists in two varieties: 1) in designated psychiatric wards of three private hospitals, all in 
Nairobi; or 2) in general wards or private rooms of general private hospitals, found all over the 
country. In both cases, psychiatrists, like other medical specialists, are not on the staff of the 
hospital; but pay visits to the patients they have admitted. Nurses on non-specialised wards 
may or may not have specialized psychiatric nursing training. Of the three private hospitals 
with psychiatric wards, two (Nairobi West and Avenue Hospital) are general hospitals with 
locked psychiatric wings; and only one – Chiromo Lane – is a designated psychiatric hospital. 
This chapter looks in detail at Chiromo Lane, a set of facilities to which I was granted 
rare access to conduct a case-study. The study comes at a pivotal time in the trajectory of the 
institution, as it is in the process of rapid expansion. The Chiromo Hospital Group now 
constitutes five facilities, with a total of 100 beds, making it the largest provider of private 
psychiatric services in Kenya and, to my knowledge, in East Africa. This chapter examines 
three types of mental health service coverage provided by Chiromo from Tanahashi’s 
framework: availability coverage; contact coverage and accessibility coverage with an emphasis 
on the latter. The chapter seeks to answer the following research questions: 
 
1. What health treatment is available to people with mental disorders at Chiromo? 
2. Who is contacting services at Chiromo? How many people and what are their 
characteristics? 
3. How financially accessible are these services? Does insurance increase access 
coverage? 
 
The chapter does not address the effectiveness of services at Chiromo, as no outcome data 
were available for analysis. 
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5.2 Methods 
 
5.2 - a) Case study method 
My fieldwork was guided by the Case Study Methodology to Monitor & Evaluate Community Mental 
Health Programs in Low-Income Countries  developed by Alex Cohen and colleagues (Cohen et al. 
2011). The case study method is a manualized mixed method drawing from the fields of 
medical anthropology and health services research, and incorporating participant observation 
with collection of basic quantitative data. The method is a practical means of describing 
programs that cannot readily be captured by randomized controlled trials (Cohen, Kleinman et 
al. 2002), and it emerged with an eye towards evaluating the work of non-state actors, 
especially NGOs. This is the first time the method is being put to use with a for-profit 
provider.  
Broadly, research using this method asks how well the programme responds to its local 
context, as defined by health policy, human and other resources, alternatives for care, and type 
of need. Data collection is conceptualized along seven topic areas: 1) context; 2) history; 3) 
programme model; 4) clients; 5) interventions; 6) organization and 7) information systems. In 
preparing the site visits and interviews, I revised the list of interview topic guides, which I 
submitted to the lead author of the case study manual together with comments on the 
contents of the manual. As a result of this contribution, I have been made a co-author on the 
second edition of the Case Study manual (Cohen et al. 2012).  
I chose the case method from among other available research methods for reasons of 
practicality. The case method allows for an iterative process of posing questions, getting 
answers and posing more questions, which is ideal in a context about which almost nothing is 
publically known. Furthermore, the case method made it possible to integrate both 
quantitative and qualitative inquiries and to do so in a way that was minimally threatening to 
the institution being studied. It allowed the institution to jointly define the area of research 
interest and for them to gradually gain trust through contact with me during my field work. 
The strength of the case study method for community mental health, as compared with other 
case study methods, is that the questions outlined in the question guide (appendix 9) were 
particularly germane to mental health care, for example addressing electro-convulsive therapy 
and self-help groups, thereby ensuring that I did not miss key areas of importance. 
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I made my first visit to Chiromo Lane on December 13, 2011 to assess the feasibility 
of the case method in that context. In May 2012, I received formal consent of Chiromo’s 
Board to conduct the research. Formal ethics approval for the research was granted by 
Kenyatta Hospital and the University of Nairobi joint Ethical Review Committee on May 18, 
2012 in an amendment to the original ethical approval of my PhD fieldwork, granted on 
November 14, 2011. 
 
5.2.a.i Qualitative Data 
Over the first two weeks of June 2012, I conducted daily visits to the four facilities in 
operation within the Chiromo Hospital Group so as to observe the environment and talk with 
patients and staff about their experiences. During that time, I conducted eleven interviews 
with members of staff: two directors, three nurses, four counsellors, the pharmacist, and the 
accountant. Interviewees were selected on the basis of who would be best equipped to answer 
the questions posed in the case manual question guide. The response rate to interviews was 
92% with one director refusing on the grounds that he had too many patients to see. He 
invited me, instead, to observe his patient sessions with permission from patients. Please see 
the section on ethics in chapter three for a review of the ethical considerations of this 
research. 
In addition to the formal interviews, I held informal conversations with a dozen 
patients, as well as with a nurse’s aid, the kitchen, maintenance and security staff, and I 
observed clinical practice during consultations of three psychiatrists (all directors), two group 
therapy sessions, and three community meetings. Finally, I held a key-informant interview 
with a person in charge of insurance for chronic disease at AAR, a health maintenance 
organization. It was not possible within the time constraints to interview an employer in 
charge of one of the employer-run insurance schemes.  
I took hand-written field notes throughout the course of the day, and at the end of 
each day, I typed them up. Much of the field notes consist of observations, but occasionally I 
recorded verbatim speech from my notes, when the language used seemed singular or  
noteworthy. The complete field notes constitute a 16,000 word record of my observations. I 
also took photos and collected supporting documents from the pharmacist, accountant and 
nurse in charge, as well as gathering publically available data from the internet on the 
landscape of providers of residential care. 
I used thematic analysis to analyse the qualitative data collected during my site visit. I 
started with an analytic framework using the domains defined by the case study (see appendix) 
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and I categorized my field notes according to those themes. Next, I sorted the themes 
according to what they revealed about my three research questions. The process of data 
collection and analysis were iterative in the first instance, as what I observed in the hospital 
helped to shape the set of questions I posed next.  
The purpose of the qualitative data analysis was to contextualize the quantitative data 
and to provide a depth of understanding and insights that could not be captured through the 
variables in the dataset. In addition, the qualitative observations helped guide what data I 
collected quantitatively. For example, I was not initially planning to find out rates of 
involuntary admission, until the question of patient rights emerged from observing the 
consequences of a patient refusing medication. Indeed, at the outset of the research, I did not 
anticipate having access to a relative abundance of quantitative data. It was only through the 
process of interviews and probing that the quantitative data were made available. The research 
question addressing availability coverage is better addressed by the qualitative data than by 
quantitative data, as these data provide insight into the inception of the service, and 
contextualize it within the wider landscape of services. 
 
  
5.2.a.ii Quantitative Data 
The primary quantitative dataset was compiled from detailed invoices from Chiromo Lane, 
which serve as a record of service use, cost of care, length of stay and readmission. These data 
were available thanks to a new hospital management information system, instituted in March 
2011. The accountant at Chiromo was forthcoming in sharing data, and went so far as to bring 
in the computer engineer who designed the HMIS in order to add the functionality of 
exporting data into Excel. Unfortunately, the Excel export function did not work for the 
detailed accounts, which were the main source of my quantitative data analysis. The 
accountant provided detailed invoices for all patients discharged from 28 March 2011 through 
27 March 2012. In addition, twelve months of follow-up data were made available for 317 
patients. Data were provided in Notepad (3,000 pages) and I re-entered selective components 
into SPSS 19. Data on medicine use were entered for a subset of the first 100 unique patients. 
I entered 33 variables from the detailed invoices (appendix 22), describing 
demographics (age, sex, religion, marital status, occupation, address) and costs of care (bed 
fee, counselling, group therapy, doctors’ fees, medicines, labs, ECT). In the raw data, each case 
was a discharge. I restructured the dataset from long to wide so that each case was a unique 
patient, thereby enabling analysis of follow-up data over 12 months. I also transformed the 
costs of care into binary variables to indicate whether different types of treatment had been 
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received. Finally, I computed additional variables of interest, such as length of stay per 
discharge, total length of stay, charge (per day, per stay, per year) and number of readmissions, 
(table 5-2) 
Quantitative data were also given to me from two other facilities within the Chiromo 
Hospital Group, called Bustani and the Retreat. These facilities provided patient admissions 
logs in Excel and Word, identifying all patients treated since they began operation (10 years 
and 2 years respectively), as well as their diagnosis, age and sex. Dates of admission and 
discharge were also recorded, so it was possible to calculate length of stay, however there was 
no documentation of readmission. In addition to these datasets, I collected my own data on 
involuntary admissions, reviewing the clinical records of the 50 most recent patients 
hospitalized at Bustani and Chiromo Lane.  
 
5.2 - b) Data cleaning 
I went to great lengths to verify the accuracy of the data, cross-referencing cases between 
datasets, and conversing on several occasions with the accountant, Musa Korir. I will describe 
the data cleaning methods I used on a variable by variable basis. 
 
5.2.b.i Editing 
I calculated length of stay in three ways: 1) by subtracting the date of arrival from the date of 
discharge; 2) by dividing the total cost of bed fees by the unit cost of bed fees; 3) where 
applicable, by dividing the total NHIF claim by the fixed daily claim amount of 800 Ksh. 
Where there were discrepancies, I relied on the total bed fee as the most accurate measure of 
length of stay, on advice from the accountant. I checked the variable for sex against patient 
names and found a number of discrepancies. So, I asked the accountant to re-enter all the data 
on sex and resolved all the ambiguities. I searched for duplicate names with different patient 
IDs and found three. In two cases, I determined from the address that the patients were the 
same and I merged the data, and in one case, I determined that the patients were distinct and 
kept them separate. 
 
5.2.b.ii Coding 
I transformed the string variable for primary diagnosis into a categorical variable testing 
multiple categorizations. Conversations from my site visit revealed that the term “mood 
disorder” refers to bipolar disorder, and MDP, short for “manic-depressive psychosis,” refers 
to schizo-affective disorder, so I recoded those conditions as such. I first categorized 
  
162 
 
diagnosis with as much specificity as possible. In keeping with Kenyan literature (Ndetei, 
Khasakhala, Ongecha, et al. 2008), I merged the diagnoses of  “psychosis,” “paranoid 
psychosis,” “psychotic” and “acute psychotic episode” with schizophrenia. Thus, the first 
categorization was in 8 parts: 1) alcohol disorder; 2) substance disorder; 3) bipolar disorder; 4) 
schizophrenia or non-affective psychosis; 5) schizo-affective disorder; 6) common mental 
disorder (depression/anxiety); 7) comorbid condition; 8) other. 
Using the categories from the WHO’s flagship Mental Health Gap Action Programme 
(mhGAP), I then reduced the number of diagnoses into six, five, four and three categories. 
The mhGAP defines eight priority conditions: 1) depression (and anxiety); 2) schizophrenia 
and other psychotic disorders; 3) alcohol disorders; 4) drug disorders; 5) childhood disorders; 
6) epilepsy; 7) dementia and 8) suicide (World Health Organization 2008). Suicide is a 
consequence rather than a disorder, and thus does not apply here; nor do childhood disorders, 
since Chiromo’s population is adult. Dementia was too rarely the primary diagnosis and 
epilepsy was never the primary diagnosis, so neither condition warranted a category of their 
own. That left the first four conditions, to which I added categories for comorbid conditions 
and other, to capture sleep disorders. The resulting classification had six categories. Next, I 
created a five-category model, which conflated alcohol with substance disorders. Then I 
created a four-category model, which conflated comorbid and other disorders. Finally, I 
created a three-category model: 1) substance use disorders; 2) severe mental disorders; 3) 
common mental disorders; comorbid conditions and other. In my regression analysis, I tested 
different diagnostic groupings, using three, four and five categories. The diagnostic grouping 
had no significant effect on outcomes. So, I chose the three category diagnosis, since it has the 
most statistical power.   
In addition to diagnosis, I explored various ways of transforming occupation from a 
string into a categorical variable. The Population Council, which conducts extensive research 
in Kenya on health and demographics, codes occupation into thirteen categories: 1) 
unemployed looking; 2) unemployed, not looking; 3) informal sector; 4) self-employed; 5) 
employed professional; 6) employed clerical; 7) employed manual, skilled; 8) employed 
manual, unskilled; 9) disabled; 10) casual skilled; 11) casual unskilled; 12) student;  13) other. 
The information in my dataset was not comprehensive enough, however, to be able to back-
code the data in that way. Next, I looked to the International Standard Classification of 
Occupation (ISCO), published by the International Labour Organization and widely used in 
economics (International Labour Organization 2012). This categorizes workers into ten major 
groups, each of which can be sub-divided into one of four skill levels. My data lacked 
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specificity on skill level, ruling-out the ISCO classification. Finally, I looked to an analysis of 
the 2006 Kenya Integrated Household Budget Survey (KIHBS) (Pollin 2009). This study 
divided occupation along three main lines 1) agricultural self-employed, 2) informal sector  
and 3) formal sector, each of which was associated with a mean income. I adopted this 
classification, adding categories for unemployed, student, and house-wife. 
 
5.2.b.iii Imputing 
A significant amount of data was missing on some of the key predictor variables, in particular 
doctors’ invoices, diagnosis and occupation. For diagnosis and occupation, I asked the 
accountant to return to the clinical files and locate the data on 133 missing cases. Occupation 
was not possible to retrieve, however, so it remained missing for 20% of cases (n=90). 
The invoice for doctors’ fees was missing from 30.7% of cases (n=182), three quarters 
of them (n=148) from patients with third party payers (chi square 1df p<0.001), so I imputed 
the missing data. The reason for much of the missing data is that invoicing for insured 
patients is often done directly to the insurer. Fees differed significantly by attending doctor, so 
I imputed values based on the attending doctor and whether the patient was insured. I 
imputed six different values, five for out-of-pocket patients according to their doctor and the 
sixth for patients with third party payers. There were not enough data points to vary the fee 
for insured patients by doctor. 
 
5.2 - c) Quantitative Analysis 
To explain variations between patients in amount and components of care, linear and binary 
logistic regressions were run in SPSS 19 on four dependent variables: 1) readmission; 2) 
cumulative annual length of stay; 3) charge per day; and 4) cumulative annual charge. 
Covariates examined were age, sex, diagnosis, insurance, attending doctor, and whether the 
patient was earning income prior to hospitalization. Since the distribution of total length of 
stay and total charge were highly skewed, I took the natural log of those variables and ran log-
linear regressions. Regressions were run on the 317 patients with 12 months of follow-up data. 
However, because of missing values, complete data were available for only 244 patients.  
For each of the regressions, I tested three models, using forward selection with four, 
five and six covariates. Model 1 used age, sex, diagnosis and insurance as covariates. Model 2 
added whether the patient was earning prior to hospitalization; and Model 3 added the 
attending doctor. Since 69 cases were missing data on occupation, the sample size for model 1 
was originally higher than models 2 and 3, so I reran the regressions with the same 244 cases 
as the other models, so as not to distort significance because of differing sample power. In the 
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following section, results of the qualitative and quantitative analysis are combined in order to 
answer the research questions.  
The terms cost and charge are used interchangeably at some points in the chapter for 
ease of reading, however it should be noted that the values reported are technically charges, 
not costs. Since bed fees changed during the period of study, the unit bed fee was held 
constant using March 2012 rates. Int$ were converted using the IMF rate of 38.4 Ksh to 1 
Int$.  
 
5.3 Results: Availability Coverage 
 
5.3 - a) Origins and Growth of the Institution 
Founded in 1996, Chiromo Lane offers acute private psychiatric care in a small-scale (30-bed), 
low-level hospital with comfortable accommodation, aspiring to the motto “recovery in 
dignity.” The founding staff are a social worker and three psychiatrists, the latter trained at the 
Maudsley hospital in London, UK, prior to establishment of psychiatric training in Kenya 
(1971). The impetus to its creation, as described by one of the founding directors, was 
demand.  
“I used to be the Medical Supervisor at Mathare and people would ask 
me, “Where else can we go?” because of the conditions there. First, I 
would send them to Aga Khan or Nairobi Hospital, where the general 
wards accept psychiatric patients. But the other patients couldn’t 
manage being next to psychiatric patients with erratic behaviour and 
the nurses were not trained in management of mental illness. So then 
we would send them to Avenue Hospital, which has a locked 
psychiatric ward with about 20 beds, but it became congested.”  
The founding directors put up their own money and took out loans to buy the land on which 
Chiromo sits.  
The building in which Chiromo is housed was a private home, not a purpose-built 
psychiatric hospital. Located in a former private home in the wealthy Westlands 
neighbourhood of Nairobi, it maintains the structure and feel of a home – with open doors, 
small rooms and a garden. Downstairs in the two-story building are five shared rooms for 
three to four people each, called “general wards.” Three of the general wards are designated 
for men and one for women.  Upstairs are seven additional rooms, five of which are private 
and often unoccupied. There is also a living room area with a television. Meals are served 
downstairs in an inner courtyard of the building, and the food is good local fare (ugali, 
sukumawiki, meat). 
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At any given time (other than meals) about half of patients can be found in the 
courtyard, sitting in chairs, reading the paper, or talking with one another. The garden area is 
closed off by a metal gate, guarded by an askari, a typical form of security for well-to-do 
Nairobi residents. The askari protect not only the patients from getting out, but also potential 
robbers from forcing their way in. 
Despite its convivial feel, signs of restriction are nonetheless present in Chiromo, as 
might be expected within a psychiatric hospital. As you enter the building, a sign reads in 
English, “Kindly hand over all your money and valuables to the nurse on duty for safe-
keeping.” On a bulletin board inside another sign reads “Notice to all: glass bottles not 
allowed. For safety reasons.” One room on the ground floor is reserved for solitary 
confinement of patients who become unmanageable. The staff refer to the room as “the obs 
room,” while patients call it “the cell.” One patient noted, “It’s not even a cell, it’s a 
mortuary.”  
Chiromo first expanded in 2001 (table 5-3), when the Board responded to a request 
from “stable” patients (non-violent, non-psychotic) to be separated from “unstable” patients. 
Bustani, meaning resting place, was created for that purpose with a focus on younger people. 
Though located in a different (equally wealthy) neighbourhood in Lavington, Bustani 
functions like a second 15-bed unit of a single hospital. Chiromo and Bustani are owned and 
managed by the same Board, medicines are supplied by the same source, nurses wear the same 
logo-ed uniforms, and patients are readily transferred between the two facilities, although they 
maintain separate patient identification numbers.  
A single story brick house, Bustani is surrounded by a large and well-tended garden. 
The living-dining room area is appointed with comfortable chairs and couches with plastic 
coverings and a large 8-seater dining table. Against the walls are two desks, one with a 
computer, although it is not working, and a very new-looking TV with satellite reception and a 
DVD player. The walls are hung with patient art as well as with supposedly calming images, 
such as flowers and swans. Bathrooms are the same for patients and staff and are clean. A 
water dispenser offers cold and hot water at all times.  
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Table 5-1: Chiromo Hospital Group Overview 
Facility Name 
 
Chiromo 
Lane 
 
Bustani 
 
The 
Retreat 
Havilah 
House 
Retreat 
Pwani 
Purpose Acute 
psychiatry 
("unstable" 
patients) & 
detox 
Acute 
psychiatry 
("stable" & 
younger 
patients) & 
detox 
Alcohol 
& drug 
rehab 
Alcohol & 
drug half-
way house 
Acute 
psychiatry
, detox & 
rehab 
Year established 1996 2001 2010 2012 2012 
Location 
Nairobi, 
Westlands 
Nairobi, 
Lavington Limuru 
Nairobi, 
Upper Hill Mombasa 
Beds 30 13 25 15 17 
Patients at time of 
visit 20 7 20 4 NA 
Target length of 
stay 2 weeks 2 weeks 6-8 weeks 3 months NA 
Average length of 
stay in days (s.d.) 11.8 (10) 15.9 (32) 52 (35) NA NA 
Average LOS per 
year 16.7 (18.5) NA  NA NA NA 
Admissions in last 
recorded year 450 129 91 NA NA 
Occupancy rate 56.6% 37.5% 51.9% NA NA 
Involuntary 
admissions 70% 22.9% 0% 0% NA 
% male 66.4% 63.8% 87% NA NA 
Mean age (s.d.) 36.3 (13.7) 30.7 (11.2) 
33.1 
(10.4) NA NA 
 
The environment at Bustani is much less restrictive than at Chiromo. Patients are 
allowed to keep their phones and belongings. Instead of the “Smoking highly prohibited” 
signs found around Chiromo, here a sticker on the bulletin board reads, “Hot chicks don’t 
smoke.” The bulletin contains other inspirational quotes, where Chiromo’s contains rules and 
public health messages. The four bed-rooms bear name plates over the doors with floral 
names: Mulberry (3 beds), Snow-drop (3 beds), Dahlia (2 beds), Balm (5 beds).  
The second expansion was from acute care to rehabilitation with the aim of improving 
continuity of care. In 2010, the Board of Chiromo (slightly modified) set-up The Retreat, a 
rehabilitation located in Limuru, one-hour’s drive from Nairobi. The Retreat is indeed 
physically a retreat: you approach the facility down four kilometers of “rough road” (dirt), 
passing a flower farm along the way. The facility was built from a stately home, so “huge,” in 
the words of one staff member, that “If I lived here, I would get myself five wives!” The 
spacious building is one story tall, and rooms are laid out in two gendered wings – four in the 
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male wing, two in the female wing, with up to six beds per room. The maximum capacity of 
the building is 25 “residents,” all recovering from alcohol or drug abuse. The shift in language 
used by programme staff from patients to residents reflects both the longer stays and also 
possibly a different concept they have of a person recovering from substance use problem, as 
compared with a person recovering from psychosis.  
Unlike Chiromo and Bustani, and despite being a converted home, The Retreat has a 
more institutional feel than the other two facilities. This is largely a result of the layout and 
decors. The walls are mostly hung with framed posters describing the mission, core values, 
philosophy and other key corporate or didactic principles. It has considerably less artwork or 
otherwise personal touches, and the large scale lends a feel of student hall to the living-room – 
which features a fish tank and a television with satellite reception. The bathrooms also have 
numerous stalls and showers side by side, unlike the other facilities, which have individual 
bathrooms. It is possible that the atmosphere of The Retreat reflects the influence of 
American rehabilitation clinics, as discussed below in the section on the programme model.  
In 2012, the year of my fieldwork, the Chiromo Group expanded in two more 
directions: functional and geographic. With a continuing emphasis on improving continuity of 
care in addiction treatment (figure 6-4), the Chiromo Board opened a half-way house in the 
centre of Nairobi, called Havilah House with a capacity of 13 people for expected stays of 
three months. The name Havilah refers to a biblical place, rich in gold and onyx, which may 
have been on the East African Coast. The house is rather more prosaicly located in the center 
of Nairobi’s Upper Hill neighbourhood on bustling Ngong Road, a major bus and matatu 
thoroughfare. It is also down the street from Dr. Njenga’s private outpatient practice (Upper 
Hill Medical Centre) and from Nairobi Hospital, one of the city’s pre-eminent private 
hospitals. The target population at Havilah House is people graduating from rehabilitation 
programmes, such as The Retreat, and re-integrating into work and life, but still wanting a 
structured environment that is substance-free. “Residents” meet as a “family” each evening 
for community meetings and can participate in two psycho-education groups on weekends. 
Random room checks ensure that the environment remains substance-free. 
The two-story building is converted from four private apartments, separated by two 
staircases in the front and back. Each apartment holds at least three rooms, a kitchen and a 
living room featuring wooden floors and big windows. They are comfortable without being 
luxurious. One apartment hosts the counsellor’s office and a large living-dining area with a 
television that is on at all times and a menu of meals posted at the entrance. Nonetheless, the 
environment bore physical signs of the distress that brings people to live at a place like 
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Havilah House. In the counsellor’s office, a broken window marred an otherwise scenic view 
of the courtyard. I was told that “a patient” had thrown a stone, because he was angry, 
without further explanation. Clients of Havilah House are typically referred to as “residents,” 
but the shift in language to “patient,” serves as a reminder that they remain in a treatment 
setting. 
Finally, June saw the opening in Mombasa of the newest member of the Chiromo 
Group, the Retreat Pwani, Swahili for Coastal Retreat. This 17-bed facility has a joint 
function of acute psychiatry and drug and alcohol rehabilitation, acting like a small-scale 
combination of Chiromo and The Retreat located on the coast, which is a main channel for 
the international drug trade. 
 
Figure 5-4: Care pathway for a person with substance use disorder in the Chiromo Group 
 
 
5.3 - b) Programme Model 
The programme model in the Chiromo Hospital Group combines bio-medicine with elements 
of the therapeutic community approach. In terms of the biomedicine, the programme 
distinguishes itself by specializing in comorbidity between substance use and other psychiatric 
disorders. In addition, the programme adopts a secular orientation, despite accommodating 
many religious patients. Until recently, the majority of rehabilitation centres in Kenya were 
faith-based, so facilities like The Retreat and Havilah House fit a niche market for secular care 
with an emphasis on psychiatric comorbidity. The Retreat, for example, offers daily visits by a 
psychiatrist, whereas most rehabilitation programmes in Kenya rely exclusively on non-
medical personnel. The secular care model, however, appears indissociable in this Kenyan 
context, from for-profit provision. 
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Figure 5-5: The “unwritten philosophy” at The Retreat 
 
Despite its secular approach, elements of Christian culture are nonetheless apparent 
throughout the Chiromo Hospital Group. In the Retreat, for example, an “unwritten 
philosophy” – which is in fact hand-written and posted on the wall (figure 6-6) – contains 19 
principles, some of them with Biblical overtones. The “philosophy” mixes idioms of common 
sense (“No free lunches,” “Count your blessings”), with Biblical phrases (“Honesty in word 
and deed,”), and apparent virtues (“Forgiveness,” “Humility”). The origins of the unwritten 
philosophy are unclear, although I was told they were compiled by staff. Rooms at the Retreat 
are named after parts of the unwritten philosophy, for example Forgiveness, which has six 
beds. Elements of the Christian prayer of St. Francis of Assisi is found both on the unwritten 
philosophy at the Retreat (“To understand rather than be understood,”) and also in Bustani, 
where “Lord make me an instrument of thy peace” appears on the bulletin board.  
The presence of religion at the core of treatment is evocative of the 12-steps approach 
to substance use care, popularized through alcoholics anonymous (AA) and narcotics 
anonymous (NA) (Ferri, Amato, and Davoli 2006). The second of the twelve steps, after 
admitting powerlessness over alcohol, is to acknowledge that there is “a higher power,” 
sometimes referred to as God. The schedule of AA and NA meetings is posted on the bulletin 
  
170 
 
board in Chiromo Lane, suggesting that the 12-step model forms part of the network of 
continuing care available to patients in the community. Religion is also a central part of life for 
most Kenyans, however, so even a secular approach to treatment might be expected to 
include allusions to religion if it is to be culturally grounded. So, for example, a group meeting 
at Chiromo Lane started with a prayer and a song (“This is the day that the Lord hath made”), 
but patients are not asked to make professions of faith, nor are they told that their recovery 
will depend on God. 
The therapeutic community (De Leon 2000) found in Chiromo is a peer-based 
approach to treating substance use disorders. Evidence of the therapeutic community 
approach was most visible throughout the hospital group in the form of daily community 
meetings in which patients were encouraged to voice “compliments and complaints.” These 
meetings were held in all facilities including Chiromo Lane, where they took place every other 
morning for about a half hour. The meeting I observed was attended by eight patients and 
three members of staff (two nurses, one counsellor), and it was not initially clear who were the 
patients and who were the staff. The meeting was run by a woman who turned out to be a 
patient and it opened with a prayer and a song. The list of compliments included that: the TV 
was on regularly; the food was delicious; the place was clean and didn’t smell; and some of the 
staff were good at listening. Complaints included that:  the hot water had run out; one of the 
nurses had been rude; the food was too salty; it was deemed excessive to put someone in the 
observation room because they smoked; and the bed sheets in the observation room needed 
changing. 
Chiromo’s therapeutic community or “TC” orientation was brought to the hospital 
group in the form of two large-scale trainings organized by NACADA and run by an 
American organization called Day Top. According to its website, Day Top has 13 residential 
centres in the United States, and has provided training overseas in Sri Lanka, Ecuador and 
Yunan, China. The first Day Top training in Nairobi took place in 2007 and lasted 6 weeks. It 
was open to all professionals with experience working with addiction, including psychologists, 
counsellors, and teachers. The second training, which took place in 2010, was more targeted, 
covering three core components of the TC approach: morning meetings, conflict resolution, 
and relapse prevention. The TC acronym suggests an intellectual product for sale and 
resonates with the more corporate approach of the Retreat, which was established the same 
year as the second training from Day Top. 
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5.3 - c) Psychological Therapies 
Patients were admitted to Chiromo by their psychiatrist. Fourteen psychiatrists admitted 
patients in 12 months; however 87% of patients were admitted by only four psychiatrists, 
three of them hospital directors. The range of interventions offered included visits with 
psychiatrists, group therapy, psychiatric medicines, labs and scans and electro-convulsive 
therapy (ECT) (table 5-4). The hospital staff operated three shifts, morning (7.30am-2.30pm), 
afternoon (1.30pm – 8.30pm) and evening (7.30pm-8.30am). At each shift there were two care 
assistants and one qualified nurse on duty. Status reports were written about patients 
throughout the course of the day, every 4 hours (10am, 2pm, 6pm, 10pm, 2am and 6am). Any 
member of staff could add to the patient notes, which were read aloud in morning rounds. 
In addition to daily consultations of approximately 15 minutes with a psychiatrist, two-
thirds of patients received either individual counselling (60.2%) or group therapy (36.9%). 
Counselling was given by one of four full-time counsellors, predominantly young university-
educated women. Patients receiving individual counselling averaged 1.2 sessions per week, 
each lasting up to an hour. Group therapy existed in various forms, including psycho-
education, art therapy and (rarely) family therapy. Patients receiving group therapy averaged 
1.4 sessions a week.  
Group therapy is eclectic in orientation. Counsellors asked selected patients to join 
the group, on the basis of whom they thought capable of group participation. Then they 
selected a group topic relating to the issues of the day, sometimes influenced by what has been 
voiced in the community meeting. On the day I attended, the topic was violence and fear, 
since a female patient raised a complaint during the community meeting about having been hit 
by another patient.  
Art therapy was held every other day at noon for one hour (figure 6-1), in alternation 
with group therapy. The session I attended was led by two counsellors and attended by ten 
patients (eight male, 2 female). The task at hand was to draw on an A4 paper in answer to the 
question “How are you feeling?” (chapter 3, figure 3-1). Patients each talked about their 
drawing and then counsellors elicited feedback from other patients. The discussion was lively 
and patients seemed engaged. 
Other potential non-therapeutic activities for patients included playing board games 
amongst themselves or with counsellors. However, games were not out in the open; they had 
to be requested by patients. Basketball was also an option in theory, although the ball was lost 
when I visited. On one occasion, I saw two patients playing badminton outside. But many of 
the patients were too ill to play games. 
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5.3 - d) Biomedical care 
One of the main forms of intervention at Chiromo, but by no means the only one, is 
medication. Patients are not allowed to refuse medication. In the words of one member of 
staff: 
“Sometimes we say, ‘If you refuse to swallow, we will give you an 
injection. Still, we have to make sure that they swallow and haven’t 
hidden the pill, so we sometimes open their mouth and check the 
tongue. If a person refuses medicines, you are wasting a whole day 
that is payable.” 
Staying in hospital without taking medicines is viewed as a “waste,” because medicines are 
understood as the primary means of treatment – the main thing being paid for. The focus on 
value for money expressed by this member of staff may partially be a response to her 
realization that I was interested in the economics of care, as much as a reflection of her own 
concern with cost-saving. Not surprisingly, some patients objected to forcible treatment. One 
of them observed:  
“In Europe they don’t inject you so much. Here it’s injections all the 
time. If they say, ‘Take this med,’ you must take it. If you refuse, they 
inject you with a ‘stopper.’ That’s what they call what they use to calm 
you down. It’s a thick white liquid.”  
During my visit I observed a man being forcibly sedated and put into the observation room. 
The origin of the episode that he refused to take his antipsychotic medication and became 
belligerent. He had a record of beating someone up so badly that the man was sent to hospital.  
At the site visit, 70% (n=14/20) of patients were admitted involuntarily, as compared 
to 23% (n=8/35) at Bustani, and therefore had limited choice in their treatment, including 
medication. (Kenya’s mental health law requires authorization from one doctor and one family 
member for involuntary admission.) Some said they received injectable medicines more than 
they would like. Indeed, three quarters (76.7%) receive an injection. Doctors and nurses 
preferred injection because it circumvents problems of adherence.  
From the HMIS data, I found that nearly all (91%) patients were prescribed a 
psychiatric medicine (mean 3.3 medicines). The rates of medicine consumption by category 
were: antipsychotics 81%; sedatives 70%; antidepressants 21%; anticonvulsants 17%; drug or 
alcohol medicine 9%; lithium 5%; and methylphenidate (Ritalin) 2%. A wide range of 
medicines was available, including six antidepressants (4 SSRIs, 2 SNRIs and an adrenergic 
receptor antagonist) and nine antipsychotics (4 typical, 5 atypical).  
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In general, doctors at Chiromo prescribed branded drugs, and the pharmacist was 
required to fill the prescription as written. Two thirds (n=6) of antipsychotics and five of six 
antidepressants were prescribed in only brand form. Among patients taking antipsychotics, 
half (50.6%, n=42) were given only branded medicines. For olanzapine, given in both forms, 
the brand cost 15 times the generic. Reasons for preferring brands included: 1) preferable 
means of administration (eg soluble drops for olanzapine); 2) some patients prefer brands; 3) 
greater quality assurance. In the words of one doctor, “The greater price than the branded 
medicine is the price of not getting better, which people don’t calculate. If you stay for an 
extra three days inpatient because your medicine didn’t work, that is expensive.” 
Chiromo’s pharmacy is a small room that is very well stocked. Eighty-seven medicines 
were prescribed to the patients in the HMIS sample, all of which were stocked locally. 
Chiromo even has a supply of some medicines that are not registered for use in Kenya 
(Ritalin, Naltrexone, Solian), having requested and been granted specific permissions to use 
them by the medical authorities. Most of the medicines (85%) come from a single local 
distributer called Krishna. Drugs that need to be imported are sourced directly from the 
manufacturer. Drug orders are placed once a week, on Wednesdays, and should supply run 
out, they can be restocked within the day. The only reason for shortage is when the suppliers 
run out, which happens rarely. The pharmacy tops up its wholesale prices by 33%, which is 
the maximum legal top-up controlled by a law on exploitation. It is not mandatory, however, 
for patients to buy their medicines from the Chiromo pharmacy. 
In addition to receiving medicines, over half of patients received a lab test (55.6%) or a 
scan (9.9%). The most common lab tests were blood tests, liver and thyroid functions, 
urinalysis, and diagnostics for infectious disease (e.g. HIV, malaria). Tests were also conducted 
to verify blood levels of medications, such as lithium. Scans included x-rays, 
electroencephalograms (EEG)s for epilepsy, computerised tomography (CT) head scans, 
magnetic resonance imaging (MRIs) and ultrasounds.  
 Lastly but significantly, sixteen per cent of patients (16.2% n=74) received electro-
convulsive therapy (ECT), averaging 4.9 sessions (max12, s.d. 1.8). E.C.T. was administered 
bilaterally and modified with the muscle relaxant suxamethonium. On one of the afternoons 
of my visit, E.C.T sessions were scheduled with three patients. They took place upstairs in one 
of the private rooms. I did not observe an E.C.T. session out of concern for the vulnerability 
of the patients and a difficulty they may have felt in declining my request. 
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5.4 Results: Contact Coverage 
455 unique patients were seen at Chiromo Lane in a period of 12 months from March 2011 to 
March 2012. Two thirds (66.4%) were male with a mean age of 36.3 years (range 14-82). The 
population was Christian (90.6%), Muslim (8.0%) and Hindu or undeclared (1.4%), in 
proportions reflecting the national population (Ambetsa Oparanya 2010).  Three-quarters 
(77.7%) lived in Nairobi; and during the site visit, 20% were foreign, from the Congo, Somalia 
and Sudan. It was not possible to get accurate data on addresses from the HMIS because the 
address noted was used for accountancy purposes so Kenyan addresses were preferred. Half 
(50.6%) were employed in the formal sector, a quarter (26.7%) were students, 13.5% 
unemployed or retired, 4.6% house-wives, and 4.6% farmers or informally employed.  
 
Figure 5-6: Patient diagnoses, Chiromo  
 
 
In 2010, 130 patients were seen at Bustani, two thirds (n=83) male, with an average 
age of 31 (sd 11). The mean length of stay was 15.9 days (sd 32.3, maximum 297). 
Readmissions were not recorded in this dataset. One third of patients in Bustani carried 
comorbid diagnoses. Over one half (n=66) were diagnosed with depression (with no sex 
differential). Just over a third (n=47) had a substance use disorder, the majority alcohol-based. 
In addition, just under a third of the population were diagnosed with ADHD (n=39), which 
was not found in Chiromo. Finally, a quarter (25%) of the population had a severe mental 
disorder, half of them (n=17) schizophrenia and the other half (n=16) bipolar disorder. 
The population of the Retreat was mostly male (87%), and alcohol dependence was 
the problem affecting most of the residents (59%), while the remainder were affected by drug 
dependency or alcohol-and-drug dependency. In 2011, 107 people were treated for a 
substance use disorder at The Retreat, staying an average of 52 days (range 1-198, sd 35).  
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The patients at Chiromo were well-educated and often well-travelled. Several of them 
spoke in fluent English of experiences in Canada, China, Dubai and beyond. On one occasion, 
a patient was looking for a word, and another one offered “egotistical.” Signs posted around 
the facility were also in English, the language of educated Kenyans and also an international 
language. The staff I met, however, were all fluent in Swahili, with one exception (a 
counsellor), and clinical encounters were often conducted in Swahili. 
Not all patients were articulate in English, however, nor were they all wealthy. I 
listened uncomprehendingly to a Somali man talk tearfully and imploringly, while holding my 
hand. And a woman, who appeared psychotic, spoke to me in agitated sentence fragments, 
mixing Swahili and English, about wanting to see her two children and asking where her 
underwear had gone. The lowest income patients appeared to be from among those whose 
care was paid for by an employer, as was the case, for example of a man who worked lifting 
cement bags. 
Two male patients on detox shared with me their observations about the quality of care. 
They started by saying it was good: “You eat well and sleep well here.” And then that it was 
“50/50 – neither so good, nor so bad.” One man complained that some nurses are less 
experienced than others and assume that all health problems relate to mental health.  
“I had an upset stomach because of some food that I ate and a bad 
smell was coming from my mouth. The nurse, he said it was the effect 
of the medicines I was taking, but me, I knew it wasn’t. Then I 
vomited a lot, and another nurse who was more experienced said that 
it could not be coming from those medicines, and he gave me a syrup 
and I felt better.” 
The distinction between health and mental health is of both clinical and personal significance: 
clinical, because people with mental disorders often receive worse physical health care than 
the general population, and personal because the man in question did not want all his 
behaviours to be explained by the single factor of his psychiatric diagnosis. A further 
distinction was noted by another patient, who wanted not to be identified with patients with 
different diagnoses. “Having a mental illness doesn’t mean you are mad. But they treat us all 
the same, like we are all mad.” Indeed, not all patients were “mad,” although approximately 
half were diagnosed with a psychotic disorder (figure 6-5). One third of patients had a primary 
diagnosis of alcohol (21.2%) or drug disorder (10.4%), and half had a psychotic disorder, 
namely schizophrenia or non-affective psychosis (38.4%), bipolar (11.4%) or schizo-affective 
disorder (2.7%). Only 7% had depression or anxiety; and a further 7% had comorbid 
psychiatric diagnoses.  
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Table 5-2: Population characteristics and services used at Chiromo Lane Medical Center 
March 2011-March 2012 
Source: patient accounts 
 
Demographics:    N 
Male 66.4% 302 
Mean age 36.3 (sd 13.6) N/A 
Nairobi address 77.7% 284/358 
Religion:   (Total N: 79) 
Christian 90.6% 74 
Muslim 8.0% 4 
Hindu or undeclared  1.4% 1 
Occupation:   
(total N: 
326) 
Formal sector employment 50.6% 165 
Students 26.7% 87 
Unemployed or retired 13.5% 59 
House-wives or unpaid work 4.6% 15 
Farmer or informally employed 4.6% 15 
Earning income 55.2% 180 
Financing:   
(total N: 
454) 
insurance (100% of fees) 15.8% 72 
employer (100% of fees) 12.7% 58 
out-of-pocket 71.5% 324 
NHIF (Int$20 co-pay) 29.0% 133 
Services:   
(total N: 
585) 
Individual counselling 60.2% 352 
group therapy 36.9% 216 
lab tests 55.6% 325 
scan 9.9% 58 
ECT 16.2% 91 
psychiatric medicine 91.0% 532 
Medicines   
(total N: 
101) 
antipsychotic 81.0% 83 
sedatives 73.3% 74 
antidepressants 21.0% 25 
anticonvulsants 17.0% 21 
alcohol or drug medicine 9.0% 9 
lithium 5.0% 5 
methylphenidate (Ritalin) 2.0% 2 
Received only branded 
antipsychotics 50.6% 42 
Received an injection 76.7% 77 
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5.5 Results: Accessibility Coverage 
 
5.5 - a) Insurance coverage 
One of the factors that stands out from the qualitative analysis of patients is that the services 
at Chiromo are reaching a predominantly wealthy population of sick people; and one of the 
primary means of broadening access to services across a wider population base is through 
health insurance. AAR, a health-maintenance organization chaired by Dr. Frank Njenga, one 
of Chiromo’s Directors, is reportedly the first insurance provider to cover mental health care 
in Kenya.  As described by one of the hospital Directors, Dr. Okonji, “It used to be that 
insurance wouldn’t pay for psychiatric services, period. It was an exclusion, despite the 1994 
Mental Health Act, which states that it is an offense to discriminate on insurance. I helped to 
write that Act, so I know.” 
An interview with a member of staff at AAR confirmed that they provide 100% 
coverage for inpatient mental health services up to a ceiling of Int$ 6,600 (Ksh 250,000). The 
ceiling had increased 2.5 fold in the past decade from a starting point of Int$ 2,600 (Ksh 
100,000). Suicidality and substance use disorders were excluded from all AAR coverage. 
However in cases of comorbidity, Chiromo sometimes submits the comorbid diagnosis to the 
insurer to obtain coverage. Pre-existing conditions were also excluded from individual plans, 
but not from corporate plans. The pre-existing condition policy had recently changed, 
however, to introduce limited coverage for people with chronic disease.  
Whereas inpatient hospital stays were well covered by insurance providers, I was told 
that none of them covers substance use rehabilitation. Only the National Hospital Insurance 
Fund contributes to rehabilitation costs, and its total contribution, making a flat payment of 
Ksh 3,000 (Int$ 70) – hardly enough to cover a single day of the two-month rehabilitation. 
AAR prided themselves on being an insurer aware of mental health problems. Every 
February, designated Mental Health Month, all patients who come into the clinic are screened 
with the Patient Health Questionnaire (PHQ-9).  Furthermore, throughout the year, anyone 
who makes more than four visits to the doctor within 12-months is given an evaluation, which 
includes the PHQ-9. The screening has been said to locate “hapa na hapa people” – literally 
“here and there people” – referring to people with unexplained medical conditions. I was told 
of one patient who had had seven stomach operations in the previous year, though nothing 
had been found. Treating mental health problems was justified economically by the insurer as 
a means of keeping down unneeded medical costs.  
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Many companies that don’t have a formal medical insurance scheme nonetheless have 
an ad hoc scheme. Companies view that they have a social responsibility to their employees, 
so they set aside a certain budget for medical expenses like any other company expense. 
Examples of companies that fall into this category are Kenya Power, KenGen and Portlands. 
Individual staff members do not usually contribute to the scheme. 
According to the HMIS data, a quarter of patients (28.5%, n=130) had their care paid 
in full by an insurance provider (n=72) or employer (n=58). Twenty-one insurers and 29 
companies provided coverage, in all cases without co-payment. There was no association 
between diagnosis and being insured (chi square p=0.54). The association between being 
insured and being employed was not significant at the 0.05 level (chi-square, p=0.08). In 
addition, NHIF partially reimbursed 29% of patients (n=133) with Int$ 20/day (Ksh 800). A 
third (36.8%) of those receiving NHIF paid for the rest of their care out of pocket. 
 
5.5 - b) Charges and components of care 
Chiromo charged fee-for-service with lower fees for patients paying out-of-pocket. Patients 
paid a flat “bed fee” per night for accommodation and hired staff, which amounted to nearly 
half (45.8%) the total charge (table 5-5). A minority (11.8%) had private rooms, while the 
remainder stayed in general rooms of 3-4 people. Those paying out-of-pocket paid an upfront 
deposit of Int$911 (Ksh 35,000) to cover approximately one week of “bed fees.” The second 
leading component of charges was psychiatric consultations, which represented one third 
(30.2%) of fees. Medications were the third highest expense, amounting to 10.0% of the 
invoice. The lowest-cost intervention was non-medical psychological therapies at only 1.6% of 
charges.  Mean charge per patient day in the general ward was Int$ 266 (Ksh 10,218). The 
distribution of total yearly charge was skewed with mean Int$ 4,262 (Ksh 163,648) and median 
Int$ 2,821 (Ksh 108,333).  
 
5.5 - c) Length of stay and readmission 
Mean length of stay (LOS) at Chiromo  was 11.8 days (max 93, s.d. 10.0). One quarter (22.2%) 
of patients were readmitted within 12 months (mean 1.4 readmissions).  Mean cumulative 
length of stay over 12 months (figure 6-7) was 16.7 days (median 10.6, max 153, s.d. 18.5).  
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Table 5-3: Component and aggregate charges 
 
Mean Component Charge Int$ Ksh % Total  
"Bed fee" (hotel fee) - out-of-pocket  117 4,500 45.8% 
"Bed fee" - third-party payer 130 5,000 
 Psychiatrist 78-104 3,000-4,000 30.2% 
Medication per day 32 1,220 10.0% 
E.C.T 299 11,500 7.9% 
Labs & scans 151 5,800 3.6% 
          MRI 234 9,000 
           x-ray 39 1,500 
 Talk therapy 
  
1.6% 
          art therapy 5 200 
           psycho-education groups 13 500 
           individual counselling 26 1,000 
 Other (eg external consults) 
  
0.9% 
Total   100.0% 
Aggregate Charge Int$ Ksh S.D. 
Mean charge per day 266 10,227 2,625 (Ksh) 
Mean charge per year 4,276 164,215 167,927 (Ksh) 
Median charge per year 2,821 108,317 71,622 (Ksh) 
    
 
Figure 5-7: Cumulative length of stay over 12 months 
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Mean Median S.D. N 
Annual LOS (days) 16.7 10.6 18.5 316 
LOS per stay (days) 11.8 9 10.0 585 
 
5.5 - d) Regression outcomes 
Readmission (table 5-7): All three models show having a third-party payer (insurance or 
employer-based) as a robust positive predictor of readmission, although the significance 
weakens to the 0.06 level in model three. Concretely, having a third-party payer increases the 
odds of readmission by 2-3 (the exponentiated betas of models 1-3). When model one was run 
on the larger sample (n=301), severe mental disorder also became significant. Severe mental 
disorder appears associated with risk of readmission, but complicated when employment is 
introduced. This may be because those with severe mental disorder are somewhat less likely to 
be earning income (although there is no significant association between these variables – see 
diagnostics below). The third model shows care by a particular doctor being preventative of 
readmission. It is possible, however, that the doctor  has a diagnostic speciality and therefore 
that this is an effect stemming from the influence of diagnosis. 
Annual length of stay (table 5-8): Model one shows both having a third party payer and a 
diagnosis of severe mental disorder (compared with substance use disorder) are both 
predictive of longer cumulative stays. When controlling for earning (model two), however, the 
effect of diagnosis disappears. Earning income becomes a significant predictor when 
controlling for doctors in model 3, with those earning income staying less long in hospital.  
Daily charge (table 5-9): The regression results confirmed that having a third-party payer 
predicted the daily charge, as was known from the two-tiered pricing system. What it revealed, 
however, is that patients with a severe mental disorder were also more likely to pay more per 
day than those with substance use disorders, controlling for insurance coverage, age, sex and 
the doctor. The effect size of this finding is quite small, however. Finally, the attending doctor 
was also found to predict charge in model 3.   
Annual charge (table 5-10): As for daily charge, annual charge was predicted by having a 
third-party payer and a diagnosis of severe mental disorder. When doctor was added into the 
equation (model three), all doctors appeared to have patients with higher charges than the 
reference doctor (not named here for confidentiality).  
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Table 5-4: Predictors of readmission  
 
Readmission 
Model 1 
(n=301) 
Model 2 
(n=244) 
Model 3 
(n=244) 
Predictor   Exp(B) S.E. Sig. Exp(B) S.E. Sig. Exp(B) S.E. Sig. 
Age 1.00 0.02 0.88 0.99 0.02 0.65 0.99 0.02 0.64 
Sex 1.00 0.45 0.99 1.14 0.46 0.78 1.30 0.48 0.64 
Payer 2.81 0.44 0.02 2.47 0.44 0.04 2.40 0.47 0.06 
Diagnosis 
         * severe mental disorder 1.97 0.52 0.19 1.98 0.52 0.19 1.53 0.54 0.32 
* common mental disorder & other 1.54 0.70 0.53 1.63 0.70 0.48 1.20 0.73 0.62 
earning income 
   
2.22 0.49 0.11 2.40 0.51 0.11 
doctor 
         doctor 1 
      
0.57 0.74 0.44 
doctor 2 
      
0.18 0.69 0.31 
other doctors             0.59 0.51 0.01 
Log likelihood ratio 158.70 155.90 148.20 
Reference group for diagnosis is substance use disorder,  for payee is out of pocket  
 
 
Table 5-5: Predictors of annual length of stay  
 
Cumulative LOS (ln) 
Model 1 
(n=244) 
Model 2  
(n=244) 
Model 3 
(n=244) 
Predictor   B S.E. Sig. B S.E. Sig. B S.E. Sig. 
Age 0.00 0.00 0.28 0.01 <0.01 0.11 0.01 0.00 0.10 
Sex -0.02 0.12 0.89 -0.05 0.12 0.67 -0.06 0.12 0.64 
Payer 0.27 0.12 0.03 0.31 0.12 0.01 0.34 0.13 0.01 
Diagnosis 
         * severe mental disorder -0.15 0.12 0.23 0.14 0.12 0.70 0.13 0.12 0.85 
* common mental disorder & other -0.07 0.15 0.66 0.06 0.16 0.24 0.03 0.16 0.31 
Earning income 
   
-0.21 0.11 0.06 -0.23 0.11 0.05 
doctor 
         doctor 1 
      
-0.04 0.20 0.85 
doctor 2 
      
-0.10 0.14 0.06 
other doctors 
      
-0.27 0.14 0.47 
R^2 0.03 0.04 0.06 
Reference group for diagnosis is substance use disorder,  for payee is out of pocket  
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Table 5-6: Predictors of charge per day  
 
Charge per day 
Model 1 
(n=242) 
Model 2 
(n= 242) 
Model 3 
(n=242) 
Predictor   B S.E. Sig. B S.E. Sig. B S.E. Sig. 
Age 0.00 0.00 0.95 0.00 0.00 0.73 0.00 0.00 0.93 
Sex -0.05 0.03 0.16 -0.05 0.03 0.13 -0.04 0.03 0.23 
Payer 0.22 0.03 <0.01 0.22 0.04 <0.01 0.19 0.03 <0.01 
Diagnosis 
         * severe mental disorder 0.07 0.03 0.04 0.07 0.03 0.04 0.08 0.03 0.02 
* common mental disorder & other 0.03 0.05 0.58 0.02 0.05 0.62 0.02 0.04 0.67 
earning income 
   
-0.03 0.03 0.37 -0.02 0.03 0.44 
Doctor 
         *doctor 1 
      
0.40 0.05 <0.01 
*doctor 2 
      
0.15 0.04 <0.01 
*other doctors             0.15 0.04 <0.01 
R^2 0.15 0.15 0.32 
Reference group for diagnosis is substance use disorder  
 
 
Table 5-7: Predictors of annual charge  
 
Total Charge (ln) Model 1 
(n=242) 
Model 2 
(n= 242) 
Model 3 
(n=242) 
Predictor   B S.E. Sig. B S.E. Sig. B S.E. Sig. 
Age 0.00 0.00 0.24 .007 .004 .073 0.01 .004 .074 
Sex -0.06 0.11 0.62 -.095 .115 .408 -0.09 .115 .459 
Payer 0.49 0.12 0.00 .537 .121 <0.001 0.53 .123 <0.001 
Diagnosis          
* severe mental disorder 0.21 0.12 0.07 .210 .119 .079 0.20 .119 .097 
* common mental disorder & other 0.11 0.16 0.48 .092 .160 0.56 0.06 .160 .718 
earning income    -.241 .111 .031 -0.25 .111 .025 
Doctor          
*doctor 1       0.36 .205 .078 
*doctor 2       0.05 .135 .697 
*other doctors             -0.12 .138 .393 
R^2 0.08 0.10 0.12 
Reference group for diagnosis is substance use disorder  
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Figure 5-8: Residuals for LOS regression, Model 1 
 
Figure 5-9: Residuals for Total Charge, Model 1 
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Figure 5-10: Residuals for Total Charge, Model 2 
 
 
Figure 5-11: Residuals for Total Charge, Model 3 
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Diagnostics: I tested the assumption of homoscedasticity (homogeneity of variance) by 
plotting studentised residuals. The residuals for the regression on total length of stay were 
clearly homogeneous (figure 6-8). For the regression of total charge, the residuals grew more 
homogeneous with each additional independent variable (figures 6-9 through 6-11), suggesting 
that the third model may be the best.  
I also tested the models for multicollinearity (table 5-6). In theory, having a third-party 
insurer and being in paid employment might be collinear, as insurance is often employer 
provided, but the chi square test of association was not significant at the 0.05 level (p=0.09). 
Indeed, since some insurance covers family members, the insured party is not necessarily 
employed. Next, I tested the association between diagnosis and payer, because most insurance 
companies explicitly do not cover substance use disorders; but the association was 
insignificant (chi square, p=0.36). In addition, I tested the association between diagnosis and 
employment, hypothesizing that people with severe mental disorders might be less likely to be 
in employment than those with substance use disorders. There was no association, however, 
between these two variables (chi square, p= 0.51). 
 
Table 5-8: Tests of collinearity (chi square) 
Variables p-value 
Diagnosis (3 categories) and payer 0.09 
Employment and payer 0.36 
Diagnosis (3 categories) and employment 0.51 
 
Finally, I examined the goodness of fit of the models, as suggested by the R squared 
statistic. The R squared figures were relatively low in all the regressions, as outcomes are likely 
to be driven largely by illness severity, a variable for which we had no measure. R squared was 
particularly low for length of stay (0.03-0.06), but the models were better at predicting daily 
charge (R squared 0.15-0.32). Annual charge was driven in part by length of stay, so its R 
squared falls between those for LOS and for daily charge (0.08-0.12). 
 
5.6 Discussion 
With eighteen psychiatrists admitting patients to the facility, Chiromo is a treatment facility for 
half of Kenya’s total population of psychiatrists. Moreover, given the small amounts of money 
invested into mental healthcare broadly in Kenya, the relatively large amount of spending in 
Chiromo makes it an important subject of study within Kenya’s mental healthcare system.  
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5.6 - a) Availability coverage  
The expansion of Chiromo over the past decade has largely served the purpose of improving 
continuity of care. The combination of facilities creates a single continuous service from 
hospital admission to home – but only for patients with substance use disorders at present. 
The conceived pathway of care for a patient with substance use disorder in the Chiromo 
Group in Nairobi is two weeks of acute care at Chiromo or Bustani, followed by six weeks of 
rehabilitation at The Retreat, then three months at Havilah halfway house, and finally a return 
home. The hospital group has yet to offer comparable continuous services for patients with 
non-substance related psychiatric disorders. Indeed, this appears to be a gap in service 
provision within both public and private mental health service provision in Kenya. The 
singularities of Chiromo within the larger context of residential services are its secular model, 
based on the therapeutic community approach, and the emphasis on comorbidity between 
substance use disorders and other psychiatric disorders.   
 
5.6 - b) Accessibility coverage 
The most salient finding from the regression analysis is the positive association between 
private health insurance and both quantity and cost of care. In terms of cost, it is possible that 
the higher cost of care to insured patients constitutes a mild form of cross-subsidy towards 
the out-of-pocket patients. That being said, out-of-pocket charge to the uninsured remains 
high, making this only a very partial cross-subsidy at best. In terms of quantity, in the absence 
of data on health outcomes, it cannot be rigorously determined whether additional days of 
hospitalization and readmission indicate moral hazard of insurance or greater access to needed 
treatments. However, the literature provides some benchmarks of quantity of care against 
which to begin to assess quality in this setting. 
Literature from other parts of the world on the effects of insurance on service use for 
chronic disease suggest that insurance may be associated with more care. On the side of 
quantity, a small study from Argentina found the odds of anti-depressant use were 7.2 times 
higher among the insured than the uninsured (Machnicki, Dillon, and Allegri 2011). A study 
examining insurance effects among 3,824 participants with common mental disorders in 
Santiago, Chile, found that half were privately insured, and they had 2.7 times higher odds of 
receiving a mental health consultation than those publicly insured, adjusting for the more 
severe symptoms found among the publicly insured (Araya et al. 2006). Health insurance was 
therefore associated with more coverage in a context of low overall coverage (20% of those 
with disorders received any consultation), but also with increased inequality. Health outcomes 
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for those on insurance may also be better, as suggested by findings from a large-scale study of 
a general population in China where having health insurance (of unspecified type) was 
associated with lower severity of depressive symptoms (Tian et al. 2012).  
In a higher-income context, the inverse relationship was found in relation to quantity 
of care and private insurance. A study from Israel observed that when insurance was 
associated with fee-for-service (i.e. a fee per inpatient day), it resulted in lower length of stay 
for mental disorders than in public health care, where provider payments were made based on 
an annual global budget (Bodner et al. 2010). The modality of provider payments may be as 
important as insurance in determining the quantity of care. 
In the African context, Chiromo has considerably shorter stays than most psychiatric 
hospitals, suggesting there is not an evident over-consumption of care. A general teaching 
hospital in Johannesburg has a mean psychiatric LOS of 15.4 days (van Rensburg 2011), 
which approximates the LOS in Chiromo. However, the Johannesburg hospital has a 
readmission rate of only 7.5%, suggesting better continuity of care after discharge (van 
Rensburg and Olorunju 2010). A  public general hospital in South Africa, found a mean LOS 
for psychotic men of 43.9 days (sd 39.4) (Niehaus et al. 2008). And a general public teaching 
hospital in Nigeria had a mean psychiatric LOS of 28.7 days (n=371) (Oladeji, Ogundele, and 
Dairo 2012).  
It is somewhat challenging to interpret Chiromo’s use of ECT in the absence of a 
severity marker for the population. Chiromo’s ECT rate, is high by global standards, but lower 
than among inpatient psychiatric populations elsewhere in Africa. According to a recent 
systematic review, African ECT rates range from 21-28% at hospitals in Malawi, Nigeria and 
South Africa (Leiknes, Schweder, and Høie 2012). It could be argued that a country with less 
accessible mental health treatment might have a more clinically severe population that 
warrants more ECT; however it could equally be argued that a country with a better health 
care system offering more community-based care would reserve hospital treatment for only 
the most severe.  
Beyond the question of its frequency is how ECT is administered. ECT in Africa is 
generally performed unmodified (without muscle relaxants) (James et al. 2010; Selis, Kauye, 
and Leentjens 2008), because of resource constraints, whereas Chiromo follows international 
guidelines, modifying ECT with a relaxant. The mean number of  sessions at Chiromo (5) 
approximates the 6 session dose recommended by the UK’s National Institute for Clinical 
Excellence (NICE) (National Institute for Clinical Excellence 2003). Patients receiving ECT at 
Chiromo are predominantly diagnosed with schizophrenia or bipolar disorder. NICE 
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guidelines do not recommend using ECT for schizophrenia; however, Royal College of 
Psychiatry guidelines specify cases where ECT is recommended, particularly for catatonic 
schizophrenia (Royal College of Psychiatrists 2005). On the basis of what can be measured, it 
appears Chiromo is performing ECT within the realms of appropriate use. 
 
5.6 - c) Contact coverage 
At 57.6%, occupancy rates at Chiromo were low at the time of study. I was told that one 
reason for keeping beds empty is that staffing capacity was not on par with infrastructural 
capacity, so that while the hospital could physically accommodate more patients, it could not 
do so to desired levels of quality. Another potential reason for low occupancy was the 
financial barrier to treatment. 
With a per-capita GDP of Int$ 1,015 (Ksh 38,970) (Kenya National Bureau of 
Statistics 2007), treatment at Chiromo lies well beyond the reach of most Kenyans, making 
charge the main barrier to access. By comparison, the World Health Organization’s method 
for Choosing Programmes that are Cost-Effective (WHO CHOICE) estimates the “hotel 
cost” (personnel, capital, food) of an inpatient bed/day in a public, urban hospital in Kenya at 
Int$ 14.49 (Ksh 505) (World Health Organization 2011). A comparable figure at Chiromo is 
the daily “bed fee” of Int $119 (Ksh 4500), considerably above the public sector estimate. 
Anecdotally, the lowest-income patients observed during the site-visit (eg someone employed 
lifting cement) were among those with employer-based insurance. Increasing insurance 
therefore may be a means of providing access to care from a broader population base. 
Despite being unaffordable to most Kenyans, Chiromo may be economically justified 
to the population it serves. With 50.6% of patients in formal employment, Chiromo’s 
occupational profile departs markedly from the national norm, in which only 9% of working 
age people (14% of those employed) work in the formal sector (Pollin 2009). The average 
yearly income in Kenya’s formal sector in 2011 (adjusted from 2007) ranged from Int$ 2,767 
(Ksh 9,000) for a private employee to Int$ 4,959 (Ksh 16,132) for a public employee (Pollin 
2009). If treatment were to enable people to return to employment, then the median cost of 
treatment at Chiromo would be cost-neutral for formally employed patients.  
Moreover, if Chiromo patients have better outcomes than those in the public sector, 
the additional cost of care could be justified for all patients from an economic perspective. 
There are insufficient outcome data to rigorously compare; however some process indicators 
provide insight into the relative quality of care. The diagnostic profile at Chiromo mirrors that 
in Kenya’s public psychiatric hospital, Mathare, where 34.4% have a substance use disorder; 
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and 51.0% have schizophrenia or psychosis (Ndetei, Khasakhala, Maru, et al. 2008). 
Chiromo’s readmission rate  of 22.2% is also in keeping with the that of 24.6% found in 
Mathare hospital (Ndetei, Khasakhala, Maru, et al. 2008); however comparison on readmission 
is limited by the absence of published data on length of stay at Mathare.  
  A more meaningful comparison may be along the lines of human rights. In February 
2011, CNN released a scathing documentary about Mathare (McKenzie and Formanek 2011) 
showing a dead body beside a live patient in an isolation cell. In response, the Kenya National 
Commission on Human Rights audited public mental health care, noting “systemic neglect” 
(Kenya National Commission on Human Rights 2011). The Commission inspected three 
public psychiatric inpatient units, finding staff-to-patient ratios of 1:80, and occupancy rates 
from a low of 105% to a high of 200%. Hygiene was poor, and hospitals lacked basic 
resources and equipment, like a functioning ECT machine. By comparison, Chiromo has a 
qualified nurse-to-patient ratio of 1:20, hygiene is good, the pharmacy is stocked without 
shortage, and the ECT functions.  
The patients at Chiromo tend to be wealthy and well-educated, although that was not 
true of all patients. Some patients expressed the desire to distinguish themselves from other 
patients on the basis of diagnosis – a request which was taken into account in the creation of 
Bustani for the treatment of people with non-psychotic disorders. In addition, patients wanted 
it to be recognized that not all their experiences were the result of their psychiatric condition. 
The majority of patients at Chiromo Lane were involuntarily admitted, whereas at Bustani 
most were voluntary, reflecting in part that there were more people with psychotic conditions 
at Chiromo Lane, who may have lacked insight into their condition, but also that Chiromo 
was viewed as the highest security treatment facility, and therefore also treated people with 
problems of anger control. 
Chiromo delivers acute psychiatric care each year to approximately 450 people, to 
quality and human rights standards higher than its public counterpart, but at considerably 
higher price. If there were more efficient (lower-cost) ways of delivering care, Chiromo might 
expand its services and increase its occupancy. Means of lowering inpatient costs include: 1) 
using more generics; 2) shifting the mix in staff to reduce reliance on psychiatrists; and 3) 
reducing readmissions, possibly through developing more outpatient psychosocial 
interventions and intermediary care, thus improving continuity of care. Incentives for cost-
cutting could be built into insurance, for example by mandating the use of generics. These 
lessons extend beyond the provision of mental healthcare specifically and are relevant to all 
inpatient care for chronic disease. Furthermore, if Chiromo wanted to make their services 
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available to a wider population in need, they could cross-subsidize care between their insured 
and uninsured patients to a far greater degree than is apparent.  
 
5.7 Limitations and Reflexivity 
My quantitative findings are limited by the absence of clinical outcome measures and of 
comparable data from the public sector. Comparison is also challenged by a lack of indicator 
of illness severity. Indeed, the regression analysis is subject to an omitted variable bias, as the 
model was driven by the available data. Illness severity is likely to be the largest predictor of 
length of stay, but there was no available measure to test that assumption. The low r-squared 
values of the regression results indicate that the variables in the model are not the primary 
factors that explain variance in outcomes.  
Furthermore, generalizations on the overall quality of private versus public care cannot 
be made on the basis of this single case. Indeed, the Chiromo model is not currently 
generalizable, because its concentration of qualified professionals would be unsustainable at 
scale in this low-income setting. Where it is more comparable is to the 36 other facilities in 
Kenya with residential care for substance abuse, although Chiromo offers hospital based care, 
whereas the others are residential facilities with little or no medical supports. It nonetheless 
represents one extreme of the continuum of care for mental disorders and substance abuse in 
Kenya (a continuum lacking in continuity), namely acute care. 
In exploring the limitations of the data, it is important to reflect on how my personal 
characteristics may have influenced my findings. My position as an unmarried, foreign white 
woman entering an African-populated hospital, dominated by male patients and female 
nursing staff is likely to have influenced the response I received. I might have been seen as a 
subject of interest in my own right, just as the patients and staff of Chiromo were subjects of 
interest to me. Having been invited to conduct the study by one of the hospital directors, I am 
likely to have been associated in the minds of patients with a member of staff, despite having 
presented myself as an independent researcher. Patients spoke to me openly, including voicing 
criticisms, but these criticisms may have been partially influenced by the impression that I 
could be instrumental in improving their situation, by reporting problems to staff. 
Nonetheless, having conducted a case study  of an Argentine inpatient facility for mental 
disorders (de Menil and Cohen 2009), I was attuned to the challenges of rendering oneself 
accessible to both staff and patients, and I actively elicited conversations with patients. 
Furthermore, having worked for four years with a not-for-profit mental health NGO, 
my bias is towards care that is affordable and serves all social groups, not only the wealthy. My 
implicit bias against expensive care may have led some members of staff to over-emphasise 
  
191 
 
efforts at cost-containment. That being said, the quantitative data, which are more objective in 
this respect, support the claims made by physicians, that if a patient was paying out of pocket 
and seemed to struggle financially, they would try to reduce the length of the inpatient stay.  
Being an outsider to Kenya served as both an advantage and a disadvantage in 
conducting this case study. As I did not master Swahili, the subtleties of what was said when 
discussions shifted into that and other East African languages were lost on me. However, were 
it not that I was an outsider, particularly from a well-reputed London university, I most likely 
would not have been given access to the hospital to conduct the study. A high degree of 
uncertainty surrounded my initial request, as the relationship between academia and the 
private sector in Kenya is sometimes fraught. This concern was ultimately resolved by drafting 
a non-disclosure agreement, a legally bounding document defining under what circumstances 
data could be shared and with whom.  
 The relationship of Chiromo’s director to the board of the AAR health management 
organisation constitutes an apparent conflict of interest insofar as he sits on the side of both 
provider and financer of his service. As the insurer, he would presumably want to contain 
consumption, whereas in the role of provider, he would want to increase it. When I posed this 
question to him directly, he refuted the conflict of interest, noting that from both perspectives 
the goal is to treat more people. From the insurance perspective he observed,  “It’s a numbers 
game,” meaning the more people who are covered, the cheaper it becomes to treat, whereas 
from the provider perspective, early detection and treatment are the way to lower the cost of 
care. He concluded, “I have said, and I will always say, that with mental disorders not to treat 
is more costly than to treat.” 
Despite its limitations, this study is notable as a first analysis of insurance effects on 
mental health care in Africa, and provides a useful benchmark of private inpatient practice 
against which to measure alternatives and future change. 
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6. Psychiatric Nurses and Outpatient Private Practice 
 
 
 
 
Figure 6-1: Private psychiatric outpatient clinic in Nyeri, 
Central Province, Kenya 
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6.1 Introduction 
Despite a growing interest in community mental health care in Africa (Hanlon, Wondimagegn, 
and Alem 2010), the literature is relatively silent on outpatient private practice. A systematic 
review of community mental health care on the continent found that “in the low-income 
countries of the Africa region, community mental health care is largely restricted to mental 
health care delivered by primary care workers, with specialist mental health workers (usually 
psychiatrists and psychiatric nurses) tending to provide care through hospital-based outpatient 
clinics” (Hanlon, Wondimagegn, and Alem 2010). 
Outside of Africa, in India, private outpatient psychiatry is known to be flourishing. 
The Indian Association of Private Psychiatry counts 1,890 members, a number deemed large 
and growing (Patil et al. 2011; Kala 2003). In Africa, however, private mental health care 
remains a hidden face in the landscape of literature on community care. The main discussion 
of private psychiatry in Africa comes from South Africa (Colin 2012), reflecting on changes 
since the introduction of managed care (Hanlon, Wondimagegn, and Alem 2010). What little 
the literature tells us about private psychiatric care in Africa is mostly limited to counting 
psychiatrists. Other cadres of private practitioners go un-enumerated, and the nature of their 
services is unexplored.  
In Kenya, 44% of psychiatrists work in private practice (Ndetei et al. 2007). Their 
geographic distribution is less equitable than that of public psychiatrists: one in nine private 
psychiatrists practices in rural areas, as compared with one in five public psychiatrists (ibid).  
In addition to psychiatrists, there are an estimated 30 practicing clinical psychologists, all of 
whom operate privately, as they are not part of a government service scheme (Khasakhala 
2011, October 5).  
The bulk of specialist psychiatric care in Kenya is delivered by psychiatric nurses. 
Psychiatric nurses in Kenya have prescribing rights, and thus can, and do, perform most of the 
functions of a doctor, as is done elsewhere in Africa (Chetty and Hoque 2013). There are two 
types of psychiatric nursing certification: certificate and diploma, requiring 1 and 1.5 year(s) of 
specialized training. General nurses in Kenya also receive some psychiatric training, but it is 
minimal. All nurses receive one unit in mental health, which translates to 60 hours of training. 
It used to be that all nurses would do a rotation in Mathare Hospital, the 600 bed public 
psychiatric hospital in Nairobi. More recently, however, some nurses rotate through the 
psychiatric units in the 13 provincial and district hospitals that have one. 
The shortage of psychiatric specialists in Africa is frequently attributed to outward 
migration to wealthier countries (Padmanathan and Newell 2012; Jenkins, Kydd, et al. 2010); 
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but less attention is turned to their migration internally to other fields of health. Kenya’s Chief 
Nursing Officer reports that, with a ratio of one nurse to 1,345 people, the country has a 
shortfall of 66,782 nurses to meet the norms recommended by its own Ministry of Health 
(Rakuom 2010). The Kenyan Ministry of Health estimates there to be 500 practicing 
psychiatric nurses (Kiima and Jenkins 2010); however, because of the general nursing 
shortage, not all of them work in mental health. Reliance on psychiatric nurses to deliver 
mental health care is greatest outside of Nairobi, especially in rural provinces, where there 
averages one psychiatrist per 3-5 million people (Kiima and Jenkins 2010).  
From a health systems perspective, it is essential to know the rate of participation of 
psychiatric nurses in mental health care in order to plan for appropriate levels of service 
coverage. This includes not only their participation in public health services, but also in private 
practice (figure 6-1), since two thirds (63%) of enrolled nurses are estimated to work in the 
private sector (Barnes et al. 2010). This chapter addresses three of Tanashi’s five types of 
coverage, namely availability, contact and (to a lesser degree) financial accessibility. 
Specifically, it addresses the questions:  
1) How many mental health specialists are available to offer mental health services? 
And what type of outpatient services are available in private practice? 
2) How many patients come into contact with mental health specialists and what are 
their characteristics? 
3) How financially accessible are outpatient services in private practice? 
Data are drawn from three sources: questionnaires; structured interviews; and key-informant 
interviews collected in Kisumu, Nyeri and Nairobi. 
  
 
6.2 Methods 
 
6.2 - a) Tools 
I designed two simple tools for this study: The Mental Health Nursing Questionnaire and the 
Private Psychiatric Practice Questionnaire. Prior to designing those tools, I intended to collect 
data on availability, accessibility and contact coverage by conducting a telephone interview 
with administrators at private hospitals. I designed a Hospital Questionnaire to that end, 
asking how many specialized mental health staff they employed, how many mental health 
patients were admitted in the previous month, whether they had psychiatric medicines in 
supply and a functional E.C.T machine and so forth. An experienced Kenyan researcher who 
piloted the initial questionnaire ruled out that method, saying that telephone interviews would 
  
195 
 
not be possible and that administrators would not answer such questions, even if they knew 
the answers, because they would need to receive personal authorization from someone in the 
hospital hierarchy. I concluded that personally administering questionnaires or interviews was 
a more promising approach in Kenya. 
 I chose to conduct interviews with nurses in private practice, because I was interested 
in learning in detail about the nature of their services, which have never before been 
researched. I chose questionnaires for the psychiatric nurses attending an annual general 
meeting because I wanted to maximize the number of respondents in limited time and was 
interested in relatively simple quantitative answers. 
The Mental Health Nursing Questionnaire  (appendix 23) is a 25-item multiple choice 
numerical answer survey (appendix 12), which was delivered to all psychiatric nurses attending 
the annual meeting of the mental health chapter of the National Nursing Alliance of Kenya 
(NNAK) in April 2012. The purpose of the tool was to determine 1) the proportion of 
psychiatric nurses working on mental health, and 2) the rate of participation of psychiatric 
nurses in the private sector. The membership in 2012 of the NNAK mental health nursing 
chapter stood at 53 nurses. Their annual general meeting was opened to both registered and 
non-registered nurses, however. A total of 50 nurses attended the meeting in Kisumu, and the 
response rate was 100% of attendees (n=50). 
The Private Psychiatric Practice Questionnaire (appendix 24) was developed to understand 
the nature of services offered by private practitioners and to estimate treatment coverage. It is 
a structured interview with sections on: a) patients (number, sex and diagnoses); b) treatment 
(duration, medicines prescribed); c) fees; and d) clinic operation (mental health vs general, 
hours, relation to public sector). The interview was delivered to psychiatrists and psychiatric 
nurses in person (with two exceptions) between July and September 2012 by my Kenyan 
research assistant, an employee of BasicNeeds with a master’s degree in public health. 
Both newly designed instruments were piloted in London and in Kenya. The Mental 
Health Nursing Questionnaire was piloted at London’s Institute of Psychiatry with an expert 
on Kenyan mental health and with a doctorate level Kenyan health researcher working in 
London. In Kenya, it was piloted with one clinical psychologist and one psychiatric nurse. 
Issues were raised in relation to the sensitivity of declaring locum work, and certain rephrasing 
was suggested.  
The Private Psychiatric Practice Questionnaire was piloted in Kenya with three private 
providers: a psychiatrist, a psychiatric nurse and a clinical psychologist. Concerns were raised 
about the length of the questionnaire, the formulation of questions regarding patient 
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characteristics, and the need for the questions about prescription practice. Adjustments were 
made and the revised questionnaire was re-reviewed by the same individuals. The sites selected 
were Nairobi and Nyeri – Nairobi because of the preponderance of private providers there, 
and Nyeri because the snowballing technique started with a contact there through the NGO 
BasicNeeds. 
Ethics approval for this data collection was granted by Kenyatta National Hospital and 
the University of Nairobi’s joint Ethical Review Committee (see appendix). Interview 
respondents signed informed consent (see appendix). Questionnaire respondents were given 
oral and written information about the purpose of the research and their right not to 
participate or to desist from participating. Names were not recorded and all responses were 
kept confidential. 
 
6.2 - b) Sampling 
I distributed the Mental Health Nursing Questionnaire on April 24, 2012 to all nurses 
attending the annual general meeting of the mental health nursing chapter of the National 
Nursing Alliance of Kenya (NNAK). Fifty people attended out of the 77 registered members, 
and all of them self-completed the survey. 
Sampling for the Private Psychiatric Practice Questionnaire was purposive, so as to 
acquire an equal number of respondents from Nairobi and the Central province. Psychiatrists 
were selected from the Kenya Medical Directory, which lists 39 professionals under the category 
“psychiatrists and psychologists” (Express Communications Ltd 2011).  Psychiatric nurses 
were identified using snowball sampling, where subjects refer other subjects. The response 
rate was 40%: 27 people were approached (22 psychiatrists, 5 psychiatric nurses, one third 
female), 11 responded (8 psychiatrists, 3 psychiatric nurses) and 16 refused. Reasons for 
refusal included: 1) absence of compensation, resulting in opportunity cost of income forgone 
from private practice; and 2) concern about confidentiality, particularly around earnings. There 
was no detectable bias in respondent uptake. Some respondents chose not to answer 
questions about prescription practice, but all other questions were completed. 
 
6.2 - c) Ethics 
Signed informed consent was received from all research subjects (appendix 11). The research 
methods were approved by the Kenyatta National Hospital’s Ethics and Research Committee. 
For further discussion of the ethics of this research, see chapter 3. 
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6.2 - d) Analysis 
Data were entered into two databases in SPSS 19 and analysed using simple frequencies and 
descriptive statistics. Data from psychiatric nurses in private practice were pooled across the 
two data sets to increase the sample size. There was no overlap in participants from the two 
studies, so no double-counting. 
 
6.3 Results: Availability of Psychiatric Nurses in Mental Healthcare 
Nurses were 54% female with a mean age of 46 years (sd 6.5), and 40% worked in Nairobi. 
Forty nurses had a psychiatric nursing degree (diploma n=33, certificate n=7), eight had none 
(general nursing only n=2, midwifery n=2) and two did not respond (figure 6-2). One quarter 
of those with a psychiatric nursing degree (n=10) had at least one other nursing degree: 12.5% 
(n=5) in community health, 7.5% (n=3) in midwifery, and 5.0% (n=2) in two or more 
specialties. 
 
Figure 6-2: Nursing degrees held by the sample 
 
 
Half (47.5%) of those with psychiatric nursing degrees (n=19), worked specifically as 
mental health nurses, while the other half were employed either as general nurses (20.0%, 
n=8), as other specialty nurses (15.0%, n=6), in administration (12.5%, n=5) or as nursing 
teachers (5.0%, n=2)  (figure 6-3). Among those employed as non-psychiatric clinical nurses, 
half (46%) their caseloads were mental health patients. The eight nurses without a psychiatric 
nursing degree worked mostly as general nurses (n=5), but also as administrators (n=2) or 
teachers (n=1). 
 
 
12.5% 
62.5% 
20.8% 
4.2% 
general nursing degree only (n=6)
psychiatric nursing degree only (n=30)
psychiatric nursing degree plus another specialty
(n=10)
general nursing degree plus another specialty (n=2)
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Figure 6-3: Employment functions of those with psychiatric nursing degrees 
 
 
Table 6-1: Employment of those with psychiatric nursing degrees 
 
 Psychiatric 
nurse 
Non-psychiatric, 
clinical 
Non-
clinical 
 
Total 
 
 
% N % N % N % N 
Sampled 100% 19 100% 14 100% 7 100% 40 
Employed by the 
public sector 40% 13 33% 12 17% 5 75% 30 
Employed by the 
public sector only 44% 
12 
37% 
10 
19% 5 68% 27 
Participating in the 
non-state sector 64% 
7 
36% 
4 
0% 0 28% 11 
Doing additional locum 
work 0% 
0 
100% 
6 
0% 0 15% 6 
Private practice, ever 50% 2 25% 1 25% 1 10% 4 
 
Among the 47 psychiatric nurses in clinical practice, all but one held a public sector 
job (table 6-1). Two thirds (66% n=33) worked exclusively in the public sector, while a quarter 
(28% n=14) worked partially in the non-state sector.  Those in non-state care worked for not-
for-profit hospitals (n=6), for-profit facilities (n=4) or a combination of providers (n=4).  
Ten per cent of nurses (n=5, including 4 with psychiatric nursing degrees) reported 
ever having managed a private clinic, and 6% (n=3) currently did so. All private practice 
nurses worked simultaneously in the public sector. Private clinics operated on average two 
days (14 hours) per week. The majority (n=4) operated general health clinics rather than 
mental health clinics. On average, five mental health patients were seen each week (range 3-
10), occupying one quarter of the patient caseload.  
20.0% 
47.5% 
15.0% 
12.5% 
5.0% 
general nurse (n=8)
psychiatric nurse (n=19)
other specialty nurse (n=6)
administration (n=5)
teacher (n=2)
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Outside of private clinics, psychiatric nurses also participated in private practice doing 
locum work at for-profit hospitals or NGOs. Fourteen per cent (n=7) reported doing private 
locum work in the previous month, largely (n=5) in for-profit hospitals. Only one locum was 
employed for mental health services. The amount of time spent in locum work differed widely 
across respondents from a minimum of a half day to a maximum of 9.5 days in the previous 
month. 
 
6.4 Results: Coverage of Private Outpatient Mental Health Services 
 
6.4 - a) Availability coverage 
Half of the eleven respondents (n=6) to the Private Psychiatric Practice Questionnaire were 
from Central province, but all the psychiatric nurses were from the province. A quarter of 
respondents (n=3) were women, and the average age was 46 years old (s.d. 9) (table 6-2). 
Respondents had worked on average 9 years (s.d. 5) in the private sector.  A quarter of 
respondents (1 psychiatrist and 2 psychiatric nurses) operated general clinics, serving physical 
and mental health needs jointly. All those operating general clinics were located in the 
province. The general clinics run by psychiatric nurses served on average only 5% patients 
with mental health problems, whereas the general health clinic run by a psychiatrist served 
65% patients with mental health problems. 
 A wide range of medications was prescribed. Three quarters of respondents offered 
atypical antipsychotics as their usual clinical response for psychosis. The two respondents 
offering only the older typical antipsychotics were both psychiatric nurses. One quarter of 
respondents sold medications at their clinic; while the remainder sent patients to local 
pharmacies. There appeared to be no association between the type of professional or their 
location and whether or not they sold medicines.  
Three quarters of private providers (n=8) split their time with the public sector. The 
preferred time for working in the private sector was weekday afternoons and Saturdays. 
Private clinics operated a mean of 24 hours per week (range 12-40, s.d. 7.8). Two respondents 
operated clinics at two different locations. Three quarters of those practicing in both public 
and private sectors (n=6/8) said the care they offered in a private clinic was different from 
what they offered in their public service. The main distinction was a greater choice of drugs, 
particularly the option of atypical antipsychotics in private practice. One respondent noted: 
“At the government clinics, prescriptions are dictated by the available psychotherapeutic 
medications.” Continuity of care was also highlighted as an area of difference. “I am able to 
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constantly follow the client,” in private practice, whereas follow-up was deemed poor in 
public practice. A psychiatrist from Nairobi, however, asserted that treatment in public and 
private was the same, saying, “All patients are equal.” 
 
Table 6-2: Private Outpatient Practice Descriptives 
 
Provider Profile Mean Range 
Age 46 34-65 
% female 27% 
 Time in private sector 9.2 years 4-19 
% also working in public 73% 
 Patient profile Mean S.D. 
% female 56% 
 common mental disorders 56% 0.18 
severe mental disorders 25% 0.16 
substance use disorders 15% 0.08 
epilepsy 2.5% 0.05 
childhood disorders 2.5% 0.03 
intellectual disability <1% 0.02 
Treatment Mean Range 
Duration of first visit 60 min 50-90 
Duration of standard visit 30 min 15-45 
Wait-time 20 min 3-60 
Use atypical antipsychotics 75% 
 Coverage 
  Active case load in 6 months 128 22-360 
Patients seen per clinic day 5 2-10 
Clinic operation per week 24 12-40 
Fees for standard visit Int$ Ksh 
Psychiatric nurse 13.0 500 
Psychiatrist 55.3 2,100 
–Nairobi psychiatrist      62.5 2,400 
–provincial psychiatrist 43.4 1,700 
   
6.4 - b) Contact coverage 
Respondents had an active case load of 128 mental health patients on average, but the 
number ranged widely from 22 – 360, depending on whether they were full-time or part-time 
in private practice and whether they operated a general or specialized clinic. (Active patients 
were defined as those seen in the past 6 months.) One quarter of patients seen each week were 
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new to the clinic. The mean number of mental health patients seen per clinic day was 5. 
Slightly over half of all patients (56%) were women. 
The majority of mental health patients (55%) were seen for common mental disorders. 
Another quarter (25%) were seen for severe mental disorders (schizophrenia, bipolar, 
psychosis). The third most frequent condition was alcohol and substance disorders, 
experienced by 15% of patients. Epilepsy (3%), childhood disorders (2%) and intellectual 
disability (less than 1%) were rare in private outpatient settings.  
Private practitioners saw their patients for an average of one hour on the first visit 
(range 50-90 minutes) and half an hour on follow-up visits (range 15-45 minutes). Psychiatrists 
reported seeing patients for 10 minutes longer than psychiatric nurses on both the initial and 
follow-up visit. All providers endorsed a typical wait time of 20 minutes (range 3-60 minutes). 
Patients were followed-up on average monthly (maximum, every 8 weeks). In the previous 
month, the professionals referred a mean of 12 patients (13% of their clients) to inpatient 
services. 
 
6.4 - c) Access coverage 
The mean fee of a standard consultation by a psychiatric nurse was Int$ 13 (Ksh 500), whereas 
for a psychiatrist it was four times that a Int$ 55.3 (Ksh 2,100). There was also an apparent 
difference in fees between doctors in Nairobi as compared with those in Central province. 
The mean follow-up fee for a Nairobi psychiatrist (n=5) was Int$ 62.5 (Ksh 2,400), while the 
provincial psychiatrists (n=3) charged Int$ 43.4 (Ksh 1,700) – a difference of Int$ 18.2 (Ksh 
700 Ksh). The duration of the consult was comparable across these two groups of 
respondents. Nearly two thirds of respondents (63%, n=7) modulated fees on the basis of a 
patient’s ability to pay, judged in part by their occupation. Fees also depended on the length of 
the session, which, for some, was flexible. 
 
6.5 Pooled Results 
By pooling the findings from psychiatric nurses in private practice in the two questionnaires, 
we increase the sample to eight individuals – five from the Mental Health Nursing 
Questionnaire and three from the Private Psychiatric Practice Questionnaire (table 6-3). Most 
psychiatric nurses in private practiece were male (88%), whereas overall psychiatric nurses 
were half (54%) women. Psychiatric nurses saw a mean of 2.6 patients per working hour and 
worked on average 12.6 hours in private practice.  
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The majority of patients seen by psychiatric nurses were not seen for mental health. 
On average two in every five patients (39%) were mental health patients. That being said, 
there was considerable variance in the extent to which these providers engaged in private 
practice. The number of hours in which their private clinics operated, for example, ranged 
from 2 to 28, resulting in a wide weekly range of patients seen. 
 
Table 6-3: Pooled results of coverage by psychiatric nurses in private practice 
 
N min max mean s.d 
age 8 39 55 46.5 6.6 
per cent male 8 0 1 87.5% 35.4% 
hours per week in private practice 7 2 28 12.6 10.0 
patients seen per week 8 5 40 19.8 13.2 
patients seen per working hour 7 0 6 2.6 1.8 
mental health patients seen per week 5 0 18 7.2 7.0 
per cent mental health patients 8 0 100 39.4 41.3 
 
6.6 Discussion 
 
6.6 - a) Availability coverage 
The data from the Mental Health Nursing Questionnaire demonstrates one way in which the 
mental health treatment gap in Kenya is adversely affected by the overall health treatment gap, 
as rare skilled labour is being drawn away from the practice of psychiatry to other areas of 
health. I found that half of those with psychiatric nursing degrees in Kenya are employed for 
functions other than delivery of mental health care. This finding is consistent with previous 
estimates,(Kiima and Jenkins 2010) but had never before been measured.  
A contributing factor to the “drain” of psychiatric nurses to other services is that one 
quarter of those with psychiatric nursing degrees also hold other specialty nursing degrees. 
Two specialties in particular – community health and midwifery – have particularly high 
overlap with psychiatric nursing. Inversely, however, it should also be noted that not all nurses 
who have worked in a mental health setting have psychiatric nursing degrees, as was the case 
of 17% of our sample. 
If the sample of nurses participating in this modest survey is representative, the results 
would imply that only 238 of the estimated 500 practicing psychiatric nurses in Kenya work 
specifically with mental health patients, which amounts to a ratio of 0.62 psychiatric nurses per 
100,000. Though low, this nonetheless amounts to higher than the average for low-income 
  
203 
 
countries, which are estimated to have an overall mean of 0.42 psychiatric nurses per 
100,000.(World Health Organization 2011) Moreover, in response to the demand for mental 
health services, roughly half of the people on the caseloads of psychiatric nurses in general 
practice are patients with mental health needs. The training of a nurse is often known by 
colleagues, as a result of which a psychiatric nurse will commonly be referred psychiatric cases, 
even when employed for other functions. 
Kakuma et al argue in The Lancet that the necessary ratio of specialist human resources 
to achieve desirable coverage for mental disorders in low-income countries is 22.3 health 
workers per 100,000 population: 6% psychiatrists, 54% nurses in mental health settings, and 
41% psychosocial care providers.(Kakuma et al. 2011) This works out to a ratio of 12 mental 
health nurses per 100,000. To achieve that ratio, Kenya would need 4,650 nurses working in 
mental health settings – 20 times the estimated number of psychiatric nurses currently 
practicing mental health care. Policy efforts to address this wide gap in human resources are 
focused on two strategies: 1) task-shifting counselling to lay health workers;(Kakuma et al. 
2011) and 2) integrating mental health into primary care by training clinical officers.(Jenkins, 
Kiima, et al. 2010; Jenkins, Othieno, Okeyo, Kaseje, et al. 2013) The latter strategy is also 
applied in settings with higher densities of specialised providers, such as the UK. 
The findings from this survey also point to a significant role played by psychiatric 
nurses in the private sector – through private outpatient practice, inpatient locum work, and 
with NGOs. One nurse noted that the Ministry of Health has a policy prohibiting 
simultaneous work in public and private facilities, out of concern that private work 
compromises public work: ‘If people work two jobs, they do it quietly.’  Nonetheless, 14% of nurses 
reported doing locum work.  A further 10% of psychiatric nurses have managed a private 
practice, and a quarter of their patients come seeking mental health services. Psychiatric nurse-
run clinics tend to operate outside of Nairobi, as the competition from private psychiatrists is 
high in the capital. Despite their significant involvement in private practice, the participation 
rate of psychiatric nurses in private practice was found to be lower than that of other types of 
nursing.(Barnes et al. 2010) 
 
6.6 - b) Contact coverage 
Data from the Private Psychiatric Practice Questionnaire provide insight into who is accessing 
private mental health care in Kenya. The leading diagnosis for which people attended private 
mental health clinics was common mental disorders, which is a departure from the clinical 
profile of patients in psychiatric hospitals. The majority of patients in both public and private 
hospitals in Kenya are affected by psychosis (Ndetei, Khasakhala, Maru, et al. 2008). In a 
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context where the term “mental” is associated with psychotic behaviour, a private clinic 
located in the community may offer a less stigmatizing option of care for non-psychotic 
patients. Privately owned clinics are more “private” to service users in that they are less visible 
and care can be sought with greater confidentiality. 
Another key factor that distinguishes patients accessing private outpatient care from 
those in public inpatient settings is that more of them are women. It is frequently found that 
women experience common mental disorders at higher rates than men (who are diagnosed 
more frequently with substance use disorders)(Whiteford, Degenhardt, et al. 2013), so the 
higher preponderance of women in these outpatient clinics is linked to the higher prevalence 
of common mental disorders in this setting. It is not possible to say from these data whether 
being female or having a common mental disorder is the driving factor in seeking care from a 
private provider. In theory, it would seem likely that having a common mental disorder might 
lead a person to seek care in a setting that is free of psychotic patients; however it is also true 
that women seek health care more than men. So either could be true. Regardless, the finding 
remains that outpatient private practice clinics increase access to mental health services by 
women. 
 
6.6 - c) Acccess coverage 
The fee of Int$ 13.0 (Ksh 500) charged by psychiatric nurses represents approximately two 
and a half days work by an unskilled agricultural labourer earning an average monthly income 
of 4,258 Ksh (Ministry of Labour Kenya 2012). This is a significant, but not unattainable sum. 
By comparison, the average fee of a psychiatrist (whose consultation runs on average 10 
minutes longer) represents half a month’s salary for the same agricultural worker, making it 
inaccessible to most.  
Higher costs among psychiatrists are driven not only by provider fees, but also by 
choice of medicines. Psychiatric nurses appear to adopt different prescription practices than 
psychiatrists, relying more on typical antipsychotics than on newer more expensive medicines. 
This may be the result of an effort to keep prices down, or a carry-over of practice from the 
public sector. The shortage of specialized human resources for mental health compounds the 
fee structure to make psychiatric nurses a more realistic means of expanding access to 
specialist mental health care than psychiatrists – as is also the case in the public sector.  
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6.7 Limitations & Conclusions 
 
6.7 - a) Limitations 
A limitation of the Mental Health Nursing data is the potential for sampling bias, as the 
sample represents only those attending the annual general conference on mental health in 
Kisumu. Residents of Western Kenya would have had an easier time attending the conference 
than those from other provinces. In addition, those with psychiatric nursing degrees who are 
no longer practicing mental health would probably be less inclined to attend such a meeting. It 
is also possible that those in private practice would be less likely to be members of the mental 
health nursing chapter. One reason for this is that there is a separate chapter of the NNAK 
for private practice nurses. The private nursing chapter of NNAK has 45 members, and when 
I met with the chair, she could not name any members who were psychiatric nurses (Sikobe 
2011, October 5), so I chose not to pursue that avenue of inquiry.  
A key informant interview with the chair of the mental health nursing chapter 
supports the idea that the sample may be skewed towards the public sector. She noted that 
seven years prior, when she became chair, “you couldn’t separate the mental health nurses chapter from 
Mathare Hospital” (KI 19, November 17, 2011). (Ngungiri 2011, November 17)All the 
members were from the national referral psychiatric hospital, the mainstay of public mental 
health care, and all their meetings took place in Nairobi. She herself worked full-time in a 
private hospital, and she managed to gradually shift the centre of focus of the professional 
association outside of Nairobi. Hosting the 2012 AGM in Kisumu, in the Rift Valley, was a 
testimony to that shift towards greater inclusiveness of psychiatric nurses outside of Mathare. 
The question is whether the bias towards Mathare Hospital reveals the actual nature of where 
psychiatric nurses practice in Kenya or a metropolitan-centred dynamic of the professional 
nursing association.  
Unfortunately, the registries of the Nursing Council of Kenya do not shed any light 
onto the matter, as they are not up to date: the national registries include all nurses ever 
registered, whether alive or dead, practicing or retired, thus inflating the figures for psychiatric 
nurses. The registries stated that there were 1,545 psychiatric nurses in July 2011 (KI 12, July 
22 2011), which is three times the number of practicing psychiatric nurses estimated by the 
Ministry of Health (Kiima and Jenkins 2010). In the absence of reliable figures on the number 
of practicing psychiatric nurses, it is not possible to say whether my sample was representative 
of the true number employed in the private sector. If it is the case that the mental health 
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nursing sample was biased towards public workers, then my estimate of the shortfall of 
psychiatric nurses is conservative, as is the estimate of their participation in private practice.  
A further limitation is that my nursing data do not address the treatment of mental 
disorders by non-specialist providers. One of the tasks of psychiatric nurses is to supervise 
primary care providers in questions relating to mental health treatment. The chair of the 
private nursing chapter noted that general nurses also see patients with mental disorders: “If a 
mental case walks in here, I’m not going to walk away and panic. I am calming the person down.” General 
nurses in Kenya have two and half to three and a half years of post-university training (for 
certificate and diploma levels respectively), which includes a unit of training on mental health.  
By limiting the study to specialist care, the present analysis misses a major component of the 
treatment of mental disorders; however time and resource constraints did not permit widening 
the inquiry.  
The Private Psychiatric Practice Questionnaire also has a potential for sampling bias in 
that individuals willing to respond to a research interview may be more likely to participate in 
the public sector than those who refuse to participate in research. Snowballing as a sampling 
method is also subject to sampling bias in that individuals refer others whom they know, 
making it more likely that they share similar characteristics. Snowballing, however, is an 
effective and low-cost strategy when the population being sampled is small and hard to reach, 
as is the case of private practice specialist mental health providers in Kenya.  
The greatest limitation faced by this chapter is that of data accessibility. Obtaining data 
from private health care providers is challenging in any setting, but even more so in a low-
income context. It is possible that my choice of research assistant, who is affiliated with the 
NGO BasicNeeds, may have dissuaded some private providers from participating, be it 
because they thought she was trying to influence them in some way, or because she might not 
approve of their for-profit work. On the other hand, she was local and had good connections 
in the area, making it possible for her to find potential subjects and persist in contacting them. 
The small sample sizes in this chapter limit the interpretability of the findings, as numbers are 
too small for statistical analysis of association. However, if the published number of 24 
psychiatrists working in the private sector is accurate (Kiima and Jenkins 2010), then by 
interviewing 8 private psychiatrists, I sampled one third of the national cadre.  
For future research, offering compensation for participation might lead to higher 
response among private providers. In addition, future research should seek the perspective of 
patients visiting private clinics to better understand their preferences. Finally, an additional 
source of private outpatient mental health care in Kenya comes from the growing cadre of 
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university graduates trained as counsellors, sometimes loosely referred to as “psychologists.” 
Counselling psychologists are employed by both the public and private sectors predominantly 
for HIV, substance use disorders, and non-pathological emotional strain; but they are rarely 
self-employed, working mostly within larger health care facilities. Further research would be 
useful on the capacity of counsellors to address the mental health treatment gap in outpatient 
settings. 
 
6.7 - b) Conclusions 
In conclusion, it appears that psychiatric nurses are migrating internally to nursing positions in 
other areas of health care, aggravating the existing “brain drain” on mental health. The 
specialized skills of psychiatric nurses are largely being used for general medical practice and 
other specialties, including midwifery and community health. The tendency of psychiatric 
nurses to work in general medicine applies to both public and private practice. At least ten per 
cent of psychiatric nurses have experience running a private practice, though the real number 
may be higher depending on the representativeness of the sampled population. 
The study of private practice providers demonstrated a large cross-over between 
private and public sectors. Three-quarters of private mental health providers split their time 
with the public sector. Private providers were often not a different category: they were the 
same people working in different settings. In fact, some private professionals asserted that the 
private sector pay helped them continue working in the public sector. In a context of under-
paying public health providers, private employment may be seen as a form of cross-subsidy 
for public health care.  
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7. Mental Health Coverage from Traditional and Faith Healers in a 
Nairobi Settlement 
 
 
 
 
Figure 7-1 Traditional healer demonstrating inhalation of herbs 
(source: BasicNeeds Kenya) 
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“In most developing countries […] the alternative to consulting traditional 
practitioners for mental health problems is not consulting anyone at all, as mental 
health professionals are not readily available.” (Jilek and Wolfgang 1993) 
 
“TM [traditional medicine] is sometimes also the only affordable source of health 
care — especially for the world’s poorest patients.”(World Health Organization 
2002) 
 
7.1 Introduction 
It has previously been said within health policy documents that traditional healing is the only 
accessible form of care for mental illness in many low-income settings (Jilek and Wolfgang 
1993; World Health Organization 2002). While true in some respects, this claim suggests there 
is no alternative to traditional care, or at best only a binary alternative between receiving care 
and receiving none. By extension, one is led to believe that Kenyans “take what they can get” 
when it comes to mental health care, without much in the way of choice. The reality in Kenya 
is that traditional practitioners come in many forms, and thus open the door to many 
alternatives from which an individual must choose. Furthermore, healers differ in type and 
denomination according to ethnic group. With over thirty ethnic groups recognized in 
Kenya’s census, this creates considerable variation in the notion of a healer. 
 
Table 7-1: Categories of traditional healer in Gusii 
Source: (Sindiga 1995) 
English translation Gusii 
1. herbalist omonyamete 
2. diviner omoragori 
3. “witch smeller” omoriori 
4. traditional birth attendant omorabi 
5. surgeon (includes dentist) omobari 
6. circumcisor omosari 
7. blood-letter omoromeki 
8. dealer in love-medicines omoebia 
9. undertaker of autopsies omwati 
10. rain maker omonyibi embura 
11. one who uses medicine to prevent disease & 
misfortune 
omokireki 
12. fortune teller omobani 
13. sorcerer omonyamosira 
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A book titled Traditional Medicine in Africa provides a useful anthropological overview 
of healing practices by tribe in Kenya (not, in fact, across Africa) (Sindiga, Nyaigotti-Chacha, 
and Kanunah 1995), and it underscores the heterogeneity of healers. Among the Gusii tribe of 
Western Kenya, the authors found as many as thirteen different terms for traditional healer 
(table 7-1).  These terms reflect specializations related not only to health, but also to general 
welfare, for example rain-making and fortune-telling. The catch-all term in Kiswahili for a 
traditional healer is mganga. Two of the most common specialties of healer that come in 
contact with people with mental illness are herbalists (mukimi wa miti) (figure 7-1) and diviners 
(mundu mue). Herbalists use plant remedies to heal sickness, while diviners reportedly have a 
supernatural power to see and heal (Jilek and Wolfgang 1993). A third category of healer that 
is popular among people with mental illness is a faith healer (muombaji, meaning person who 
prays). Faith healers are members of a religious congregation and use aspects of religious 
worship to heal.  
In practice, a considerable overlap has been observed between different types of 
healers. In his study of Luhya healing practices, Simiyu Wandibba contends, “Today 
traditional medicine has a new expert. This is a man or woman who combines the Bible and 
herbs to diagnose and treat a wide range of diseases” (Wandibba 1995). A recent case study of 
a Luhya faith healer in Western Kenya, who calls himself a mtumishi (servant of God) confirms 
this assertion. The healer held church services and used the Bible to heal, however the Bible 
served less as a text than as a piece of ritual paraphernalia. To diagnose problems of his 
clients, this healer placed a Bible on the floor and voices of witches were said to emerge from 
it. To rid the individual of the witches, the mtumishi later dramatically set the Bible alight with 
kerosene, while “The congregation listen[ed] to the voices of the witches crying and screaming 
that they [were] burning, and begging for mercy” (Okwaro 2010). The study’s author, 
Ferdinand Okwaro, observes the following:  
“For the Christianised Africans, the use of the Bible and the seemingly 
Christian procedures reassured them that they were participating in a 
Christian ritual although they might not agree with all aspects of the 
rituals, especially the burning of Bibles.” (Okwaro 2010) 
The key term in this description is “seemingly Christian.” Okwaro’s case study illustrates what 
he calls a “hybridization” and a “complex fusion of African and Christian cosmologies.” The 
Bible serves as a stand-in for what might formerly have been a more traditional tool of 
divining: “While his grandfather used a buffalo's switch to divine, he uses the Bible.” The 
focus of Okwaro’s article is on the relationship between faith healing and modernity, and he 
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denotes this practice as a “strategy,” which succeeds in “appealing to a wider clientele.” 
Christianity appears to be associated with modernity in this East-African setting, and 
modernity has wide appeal. The question is how representative this case is of the general 
practice of faith healing in Kenya. 
The religious profile of Kenya has changed substantially over the years, with the 
population becoming increasingly Protestant, especially evangelical Protestant. The 2009 
Census found that Nairobi was 74% Christian and 47% Protestant (Kenya National Bureau of 
Statistics 2009). The spread of evangelical churches is a trend noted across Africa, beginning 
in the 1980s (Teuton, Bentall, and Dowrick 2007). The evangelical church largely replaced in 
popularity the African Independent Churches (Zionist, Ethiopian, Apostolic for example), 
which formed a central research interest for anthropologists in the 1960s (Meyer 2004; Jilek 
and Wolfgang 1993). A syncretism between Christianity and traditional religion was 
established in Zionist and Apostolic churches in South Africa. Karl Peltzer described faith 
healing rituals involving tying wool around the wrist, applying ashes to the skin, and blood-
letting through the nose (Peltzer 1999). Little information exists, however, on the nature of 
faith healing within the more contemporary evangelical churches in East Africa. 
The leading piece of anthropological research on traditional medical practices in 
Kenya was conducted by Charles Good from 1977-1979 (Good 1987). The focus of Good’s 
work was the contrast between rural and urban practitioners of traditional healing and he 
placed a special emphasis on mental illness, which was one of the conditions most commonly 
addressed by the healers he observed. His urban population was drawn from the Mathare 
settlement, consisting of a predominantly Kikuyu population, but largely Kamba group of 
healers, while his rural site was southern Machakos, a Kamba dominated area. He carefully 
documented the symptoms, diagnostic categories and healing practices associated with mental 
illness, including a thorough description of the physical spaces in which healing took place – 
in keeping with his background in medical geography. Good’s rich description provides an 
invaluable benchmark for understanding traditional healing practices in Kenya. He notes of 
urban healers that they are entrepreneurs driven by “economic opportunity,” and that they 
adapt to changing circumstances. This suggests that the nature of urban healing practices is 
likely to have changed substantially in the three decades since Good’s study.  
Historically, research into traditional and faith healers has been highly politicized 
around the question of whether they are helpful contributors to the health system or harmful 
detractors. Early missionaries and colonists in Kenya, seeing traditional healing as a threat to 
the social order, labelled these practices as “witchcraft,” and banned them in the Witchcraft 
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Oridnance of 1925. In the 1950s, when Kikuyu armed forces, known as Mau-Mau, tried to 
overthrow the British colonial administration, the hunt against witchcraft became more acute, 
featuring ceremonies to burn healing paraphernalia. The Mau-Mau required their members to 
swear oaths as part of initiation into the group, and this oathing was associated in the mind of 
the British with sorcery. Women, however, were more often the targets of these witch-hunts 
than men. In 1955, 1,800 women and 150 men are reported to have had objects confiscated in 
three districts alone (Nottingham 1959 quoted in Good).  
In contrast to the colonial “civilizing” agenda, in the 1960s and 1970s, mostly Western 
medical anthropologists upheld the value of what they called traditional medical practice, or 
ethno-medicine, occasionally even romanticising it (Edgerton 1966; Peltzer 1999; Good 1987). 
Up into the 1990s, articles were written simply to note that “traditional medicine has much to 
offer” (Patel 1993). Over time, practitioners of conventional medicine have become more 
engaged with the idea of collaborating with traditional healers, spurred in part by an under-
supply of skilled medical professionals and also by the acknowledgement that the two systems 
of medicine have different things to offer. Nonetheless, current research suggests that a 
disciplinary divide remains alive today with anthropologists expressing openness towards the 
benefits of traditional healing, and biomedical practitioners more often remaining sceptical 
(with some exceptions) (Campbell-Hall et al. 2010; Asante 2012; Sorsdahl, Stein, and Flisher 
2010).  
As a result of this disciplinary divide, most of the research into traditional medical 
practice has been qualitative. A small exception exists around studies of help-seeking, where 
national household surveys have included quantitative questions about attending traditional 
care (Sorsdahl et al. 2009).  The distinctions between the categories of traditional and faith 
healer are nowhere clearly delineated. Researchers from Ghana, quoting other researchers and 
even drawing from the World Health Organization, offer this by way of definition: 
“Traditional healers (in Twi, okomfoo) are trained to administer locally 
prepared herbal medicine for the treatment of diseases (Crawford & 
Lipsege, 2004; WHO, 2002). Faith healers or pastors/imams are 
religious leaders who base their treatment on the powers of God to 
heal sickness (Kale, 1995).The major difference between traditional 
and faith healers in treatment practices is that the former pour libation 
(sacrifice to the gods) to the ‘small gods’ (obosom) at the shrines and 
also use herbs for treatment of mental disorders, whilst the latter 
employ prayers, fasting and the sprinkling of holy water as the major 
means of treating diseases (Puckree et al.,2002).”(Ae-Ngibise et al. 
2010) 
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What little quantitative evidence exists, suggests that faith healers are becoming more 
preponderant than traditional healers (Read and Doku 2013), particularly since the rise of 
Pentecostal churches (Ae-Ngibise et al. 2010). A recent study from Ghana, drawn from a 
sample of people attending a public mental health clinic, found that only 6% reported having 
previously attended a traditional healer for the problem, whereas 14% had consulted with a 
pastor (Appiah-Poku et al. 2004). Thirty years earlier in Ghana, a study of patients at the 
national psychiatric hospital found that 64% had consulted a herbalist and 26% had attended 
faith healing (Lamptey 1977).  
South Africans reporting using healers at the same rate as Ghanaians. According to a 
large-scale household survey, among those with a diagnosable psychiatric disorder, 9% 
attended traditional healers and 11% attended faith healers (Sorsdahl et al. 2009). Attendance 
of healers is not, however, equally distributed across the population. Peltzer found rates higher 
among Black South Africans, including a prevalence of up to 38% consultation with healers in 
one setting (Peltzer 2009). It is possible, moreover, that people under-report attendance with 
traditional practitioners when queried by health researchers, because it is frowned upon by 
many conventional medical providers. 
In 2007, nearly thirty years after Charles Good conducted his ethnography, the NGO 
BasicNeeds paired with the Africa Mental Health Foundation to update knowledge of 
traditional and faith healing practices for mental illness in Kenya. The study is based in an 
informal settlement of Nairobi, where alternatives for health care are relatively abundant. 
Starting from the observation that individuals living in Nairobi have a choice about what sort 
of informal care to seek, the study focused on two broad classes of provider: traditional 
healers (herbalists and diviners)  and faith healers (evangelical Protestants).  
Using their data for secondary analysis, I will address three of Tanahashi’s five types of 
coverage, namely availability, contact and acceptability. This is the only empirical chapter to 
address the question of acceptability coverage, thus touching on questions of culture that draw 
partially from the literature, if not the methodology, of medical anthropology. First, I will 
compare the socio-demographics of traditional and faith healers and the patients in contact 
with their services. Next, I will explore the nature of services made available by these two 
classes of healer, in particular diagnosis and treatment. Finally, I will examine the acceptability 
of conventional medicine to patients and providers of healing, as well as the acceptability of 
different healing types between one another. 
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7.2 Methods 
This chapter constitutes a secondary analysis of data collected in 2007 by researchers from the 
Africa Mental Health Foundation (David Ndetei and Lincoln Khasakhala) and from 
BasicNeeds Kenya (Allan Oginga). A small team of community health workers and research 
assistants affiliated with the Africa Mental Health Foundation supported them with the data 
collection, cleaning and management. Secondary analysis of qualitative data is problematic in 
that the person doing the analysis is divorced from the original context and relationship of the 
researcher to the subject of research (Parry and Mauthner 2005). This is particularly the case 
when a number of years have intervened between collection and analysis as was the case here. 
The principal arguments for conducting this re-analysis are: 1) that healers constitute an 
“elusive” population (Long-Sutehall, Sque, and Addington-Hall 2010), for which I could not 
collect data myself, given my parallel priorities and constraints, and 2) that the existing data 
had not been fully exploited and therefore warranted further analysis. In addition to examining 
the secondary data, I spoke with two of the co-investigators on the original study and 
conducted two key informant interviews to contextualize my understanding of healers. 
 
7.2 - a) Research questions 
The objective of the original study was to serve as a “benchmark of practice” of traditional 
and faith healing in relation to mental illness in Kenya. The study triangulated self-report from 
providers with that of service users. Five descriptive research questions were defined by the 
principle investigators: 
1. What are the socio-demographic characteristics of faith healers, traditional healers, 
mentally ill persons and their carers? 
2. What are the traditional names of the different types of mental illness that are 
managed by traditional and faith healers? 
3. What are the different symptoms of mental illness identified by traditional healers, 
faith healers, mentally ill persons and carers in the community? 
4. What are the procedures of identifying and treating different mental disorders by the 
traditional and faith healers? 
5. What are the clinical types of psychiatric disorders among the patients who are seen by 
faith and traditional healers? 
The study was written into a 72 page descriptive report by the three principle investigators and 
published in the grey literature by the NGO BasicNeeds (Ndetei, Khasakhala, and Oginga 
2008). The analysis on that report is not repeated by the contents of this chapter. 
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My own research objectives departed from those of the principle investigators. The chapter 
seeks to address the following research questions: 
1.  (Availability) Who are traditional and faith healers, and do they differ in terms of 
socio-demographics? What type of healing (diagnosis and treatment) do they offer 
people with mental disorders? 
2. (Contact) Who are the patients coming into contact with traditional and faith healers? 
Do they differ in terms of socio-demographics or illness profiles? 
3. (Acceptability) What is the relationship of healers and their clients to conventional 
medicine?  What do patients express about the acceptability of these different types of 
care? 
 
7.2 - b) Data collection and tools 
Qualitative and quantitative data were collected from providers and patients of traditional 
healing between July and August 2007. Data were collected by a small team of university 
educated research assistants, trained by the Africa Mental Health Foundation, as well as by the 
Research Officer at BasicNeeds. The interviews were predominantly held in Kiswahili. 
Research assistants also spoke Kikuyu, Luhya and Luo and could alternate with those 
languages as needed. 
A total of five instruments were used in the study (table 7-2), three were administered 
in slightly modified forms to patients and healers, and two additional instruments were 
administered to patients alone to measure diagnosis and stigma. Three of the tools were 
standardized, namely the Mini International Neuropsychiatric Interview (MINI) (Sheehan et 
al. 1998), The Stigma Scale, and the Systems of Belief Inventory (Sheehan et al. 1998; King et 
al. 2007; Kash et al. 1995). Two additional tools were designed and piloted by the Africa 
Mental Health Foundation and BasicNeeds for the purpose of the study: a structured 
interview, which I am calling the Healing Interview, and a socio-demographic questionnaire. 
To address my research questions, I have focussed on the data from three tools: the MINI; 
the Healing Interview and the socio-demographic questionnaire.  
The MINI Plus is a structured diagnostic interview designed by researchers in France 
and America (Lecrubier et al. 1997; Sheehan et al. 1998), which diagnoses conditions found in 
the Diagnostic and Statistical Manual (DSM IV) and the International Classification of 
Diseases (ICD 11). Screen questions detect symptoms, and follow-up questions are asked if 
the screen is endorsed. The tool has demonstrated validity and reliability on par with the 
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Structured Clinical Interview for DSM IV (SCID-R) and the World Health Organization’s 
Composite International Diagnostic Interview (CIDI) (Amorim et al. 1998), the two widest-
used diagnostic instruments, and it takes less time to administer (on average 22 minutes). The 
tool has been widely used in East African populations (Abbo et al. 2013; Ayazi et al. 2012; 
Rukundo, Musisi, and Nakasujja 2013; Warfa et al. 2012), and has been used as the referent 
against which to validate another diagnostic tool in Rwanda (Scorza et al. 2013). 
 
Table 7-2: Tools used in the original healer study 
 
Tool Respondent Author (Date) 
Mini-International Neuropsychiatric 
Interview (MINI Plus 5.0) 
patients Sheehan (1998) 
The Stigma Scale patients King (2007) 
Systems of Belief Inventory  patients & 
providers 
Kash (1995) 
Semi-Structured Healing Interview patients & 
providers 
Africa Mental Health Foundation  
Socio-demographic questionnaire patients & 
providers 
Africa Mental Health Foundation  
 
The current study used 12 out of 26 modules of the MINI, choosing to eliminate 
questions about disorders less commonly found in Kenya, such as anorexia, bulimia, and 
body-dysmorphic disorder, with the aim of reducing the research burden on subjects. The 
conditions screened for were: depression; dysthymia; suicidality; bipolar disorder; panic; 
agoraphobia; OCD; PTSD; alcohol and substance disorders;  schizophrenia and generalized 
anxiety. In addition, a diagnosis of epilepsy was coded by the research assistant based on 
information provided by the patient and carer. The MINI is designed to be clinician-
administered, but can also be administered by a lay-researcher with the benefit of additional 
training.  
The Semi-Structured Healing Interview asked 19 mostly open-ended questions about 
the nature of diagnosis, treatment and referral (appendix 25). The interview asked about types 
of treatment and elicited attitudes towards conventional medicine. It employed a free-listing 
technique that has been effectively used to elicit culturally sensitive data for the purpose of 
diagnosis of mental disorders in other parts of East Africa (Betancourt et al. 2009; Bolton and 
Tang 2002). The socio-demographic questionnaire (appendix 26) is a 13-item questionnaire 
with multiple choice answers about age, sex, marital status, education, religion, 
accommodation and employment. 
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7.2 - c) Location 
The study took place in Kangemi (figure 7-2), an informal settlement in the West of Nairobi 
with an estimated population of 64,000 (United Nations Habitat 2010). Kangemi is one of five 
wards in Nairobi Westlands, and its small area of 1.6 km2 is tucked between the wealthy 
neighbourhoods of Westlands, Lavington and Loresho. An estimated one in five people in the 
slum has access to running water (da Cruz, Sommer, and Tempra 2006). Kangemi was 
selected because BasicNeeds was running its MHD model there and had opened a clinic in 
one of the government health services. They chose Kangemi because it is one of the poorest 
of the informal settlements around Nairobi and they were able to access a space in which to 
open a mental health clinic. 
 
Figure 7-2: Map of the informal settlement of Kangemi 
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7.2 - d) Sampling 
Purposive sampling was used to select the 54 healers and 116 patients who were interviewed. 
First, the researchers paired with government administrators and local leaders to conduct a 
mapping of Kangemi. The settlement was divided into six divisions (Kichagi, Warugu, 
Kawangware, Marenga, Warugu, Kaptigat), and leaders associated with each division were 
asked to identify the traditional and faith healers within their community. Several group 
meetings were organised by community health workers with the local leaders and traditional 
and faith healers to explain the nature of the study and its objectives. In addition to healers 
identified by community leaders, others were located by research assistants by following up on 
advertisements for healing posted around the settlement area. To identify patients, the 
traditional and faith healers were each asked to propose three patients with a mental illness, 
whom they had seen on at least three occasions. 
The inclusion criteria for patients were that a) they self-identified as having a mental 
illness, b) sought care from a traditional or faith healer, and c) were willing to participate in the 
research. Inclusion criteria for providers were that a) they practice traditional or faith healing, 
b) they report to have treated mental illnesses, and c) they be willing to participate in the 
research. There were no exclusion criteria, though if an individual was not in a state of mind 
to be interviewed, it was agreed that the carer could respond to questions. Both children and 
adults were interviewed in the original study, but data in this chapter come exclusively from 
adults. In-depth interview data were missing from four patients, so the sample size for most of 
the patient analysis is 112. Descriptive data about healing procedures was available from 90 
patients and 50 healers. 
 
7.2 - e) Data cleaning and management 
Researchers from the Africa Mental Health Foundation and BasicNeeds cleaned and managed 
the data upon collection. Interview responses were documented on paper and tape-recorded. 
The interviews were then transcribed and translated from Kiswahili and other local languages 
by research assistants from the Africa Mental Health Foundation. Qualitative data were 
preliminarily analysed by a research assistant at the Africa Mental Health Foundation using 
Desk Smart software. He created codes using techniques informed by Grounded Theory 
(Corbin and Strauss 1990). Preliminary analysis consisted of open-coding, an inductive process 
by which categories emerged from the data, and selective coding, a deductive process by 
which material was selected and discarded in relation to the core variables of interest. The 
selective coding categories were guided by the initial research questions.  
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In November 2011, I signed a data sharing agreement with the Africa Mental Health 
Foundation, who are in possession of the data. The agreement gave me permission to analyse 
the data contained in two separate databases, one of providers and the second of patients. The 
databases were transferred to me in SPSS 14. A large number of variables contained extensive 
string data, however, so I extracted the string data into Word and then into NVivo, 
assembling all qualitative responses by individual and by theme.  
Original transcriptions were not available, as the computer containing them had 
crashed in the intervening five years between the study’s completion and my analysis. The 
resulting qualitative data is therefore a mix of coded categories (as evidenced by repetition of 
words and phrases) and pieces of transcription translated into English. The transcription often 
shifted from first-person into third-person narrative, presumably a license taken by the 
research assistants entering the data. There was approximately twice as much qualitative data 
from each provider as from each patient: the combined data from the 54 providers was of 
equivalent length to that from the 112 patients (approximately 5,000 words for each group). 
Though imperfect in form, the qualitative data are nonetheless rich in content. 
I cleaned the provider data by verifying the accuracy of key variables, such as the 
healer type. I checked healer type against the qualitative data provided and found two 
providers (H5 and H55) mis-coded as faith healers, who self-described as traditional healers, 
and one provider (H44) coded as a traditional healer, who self-described as a faith healer. I 
also checked sex against name. As the study IDs were not unique, I allocated a unique ID to 
each provider and patient. 
 
7.2 - f) Analysis 
In addition to cleaning the data, I also created a variable for ethnicity. Two Kenyan 
researchers, one Luo and one Luhya, separately coded the ethnicity of healers and patients 
based on their names. There were only two discrepancies and in both cases one of the 
ethnicities named was Luhya and none were Luo, so I chose the ethnicity given by the Luhya 
researcher, on the basis that he would know best what were Luhya names. Ethnicity was not 
attributable for five subjects out of the sample of 170. 
I calculated patient diagnoses using the algorithms provided in the MINI 
questionnaire. The data provided to me were raw, so diagnosis had not been analysed. 
Lifetime rather than current diagnosis was used in the analysis, as there was no information 
available on when in the course of treatment these interviews were held, and some patients 
may have recovered since commencing treatment.  
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I used thematic analysis to code qualitative data from respondents, in keeping with the 
techniques outlined by Bryman (Bryman and Teevan 2004). First, I restructured the qualitative 
data so that it was sorted by healer type and by broad theme – diagnosis, treatment, referral. 
Next, I discerned sub-themes from the data and grouped responses according to those sub-
themes. Finally, I wrote up the thematic analysis from those groupings. 
When referring to subjects in the thematic analysis, I have used the labelling H##T or 
H##F short for healer, ID number, and traditional or faith, and P##T, P##F and  P##B 
short for patient, ID number, and attending a traditional healer, faith healer or both. Five 
patients reported on visits to both traditional and faith healers. 
I coded the qualitative data numerically, so as to be able to perform simple tests of 
statistical association. I used the original codes handed to me by researchers from the Africa 
Mental Health Foundation as a starting point for quantitative analysis. For example, in 
response to questions about treatment, the following codes appeared in the original dataset: 
prayers; Bible-reading; counselling; fasting; herbs; drugs; medicines; advice; encouragement; 
food/money; therapeutic incision; witchcraft; body or anointing oil; sprinkling water; and 
blessings. Next, I combined some codes to create broader categories – for example herbs, 
drugs and medicines into one theme (coded herbs), counselling and advice into another theme 
(coded counsel). Each of these broader categories was made into a binary yes/no variable, 
which could be counted, and compared across healer types. Binary variables were also created 
for referral procedures (any referral, referral to conventional medicine, referral to faith healing, 
referral to traditional healing) and for symptoms (headache, talking a lot and so forth).  
Because of the small sample size, I started by looking at two-way associations (chi-
square and t-tests), using healer type as the dependent variable. I used the Fishers Exact 
statistic when the cell count was less than 5, for example when analysing diagnoses. If the two-
way association proved significant, I tested its correlation with other variables by way of a 
logistic regression. The 5 patients seeing more than one type of healer were excluded from 
these tests of association. 
 
7.2 - g) Ethics and funding 
Informed consent was sought from and signed by healers, patients and carers participating in 
the study.  Patients whose condition was such that they could not consent provided assent and 
a carer provided consent. The study was granted ethical approval by Kenyatta National 
Hospital Ethical Review Committee. The sample size was doubled in response to the ethical 
review by Kenyatta, so as to be able to run statistical tests of association.  
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The study was funded as part of a three-year (2005-2008) grant to BasicNeeds from 
the Department for International Development titled “Mainstreaming poor mentally ill people 
in the informal settlement of Kangemi in Nairobi Kenya.” The total grant amounted to 
approximately £400,000, but the research study constituted a small component of the larger 
project. 
 
 
7.3 Results: Availability and Contact Coverage 
For the sake of comparison, I will juxtapose responses from patients and providers, mixing 
the topics of availability and contact coverage, and structuring the results instead along the 
lines of socio-demographics, diagnosis and treatment. A separate section will be devoted to 
acceptability coverage. 
 
7.3 - a) Socio-demographics 
 
7.3.a.i Healers 
There was a preponderance of faith healers (n=31) over traditional healers (n=23) represented 
in the study, suggesting that faith healers may be more prevalent in Kangemi than traditional 
healers, since the sampling aimed to be comprehensive. Clear demographic distinctions 
appeared between the traditional and faith healers (table 7-3). With a mean age of 49 years, 
traditional healers were older on average than faith healers, who averaged 41 years (𝑡52 =
2.078, 𝑝 = 0.043). Faith healers were also more likely to be women (𝑋2(1, 𝑁 = 54) =
5.562, 𝑝 = 0.018): while only one in five traditional healers were women, faith healers were 
evenly divided between men and women (table 7-4).  In terms of religion, faith healers were 
exclusively Protestant, suggesting that they were Pentecostal healers, while a quarter (n=6) of 
traditional healers were Muslim, and 13% (n=3) were Catholic. 
In terms of ethnicity, the sample of providers were mostly Luhya (43%) and Kikuyu 
(31%), but there were also some Luo (12%), Kamba (6%) and Ugandans (8%). Faith healers 
were significantly more likely to be Kikuyu than traditional healers (𝑋2(1, 𝑁 = 51) =
5.653, 𝑝 = 0.017) with almost half (45%) of faith healers being Kikuyu, as compared to only 
14% of traditional healers. By contrast, one in five traditional healers was of Ugandan origin, 
whereas no faith healers were Ugandan. Luhyas constituted approximately half of both 
traditional and faith healers.  
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Economic distinctions were also apparent between the two healer types. Faith healers 
were more likely to have achieved more than primary education (𝑋2(1, 𝑁 = 54) =
5.468, 𝑝 = 0.019): two-thirds (n=19) of faith healers had more than primary education, 
whereas only 22% of traditional healers had gone beyond primary school and a further 22% 
had not completed primary school. Income levels also reflected a disparity between the two 
groups. Faith healers were more likely to be formally employed than traditional healers 
(𝑋2(1, 𝑁 = 54) = 5.332, 𝑝 = 0.032), and they were more likely to earn more than 5,000 
Ksh (Int$ 132) per month (𝑋2(1, 𝑁 = 50) = 7.484, 𝑝 = 0.006). Whereas 40% of faith 
healers earned more than 10,000 Ksh (Int$ 264) per month, only 10% of traditional healers 
earned a comparable amount, and 25% of healers earned less than 1,000 Ksh (Int$ 26) per 
month. Unfortunately, no information was available on the fee structures of these healers. The 
difference in income may partially account for a difference in housing between the two 
groups, with faith healers appearing slightly more likely to own a house than traditional 
healers, although the sample size is too low to confirm statistically. Using chi-square and 
logistic regression to test association between socio-demographics and provider type (table 7-
4), gender, income and employment were significant at the alpha 5% level, and education at 
the alpha 7% level. 
 
Table 7-3: Association between provider socio-demographics and healing type 
  X2 p-value β p-value 
Female 5.562 0.018 3.736 0.053 
More than primary education 5.468 0.019 3.311 0.069 
Income > 5,000 Ksh 7.484 0.006 7.484 0.006 
Employed 5.332 0.032 4.160 0.041 
Kikuyu 5.653 0.017 NA NA 
 
7.3.a.ii Patients  
One hundred twelve patients responded to the Structured Healing Interview. Three quarters 
of patients (73%, n=82) were attending faith healers and one quarter (27%, n=35) were 
attending traditional healers (table 7-5), including 4% (n=5) who were attending both types of 
healers simultaneously. In terms of religion, the patient sample were 100% Christian and 
predominantly Protestant (80%) with a mean age of 33 years. The majority (72%) were 
women. Half (47%) were cared for by a parent, spouse or child, while most of the remainder 
were cared for by other family members. Just over half were married and 70% were educated 
to primary level or less.  
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Table 7-4: Socio-demographic characteristics of traditional and faith healers 
 
 
 
Traditional 
 
Faith 
 
All 
 
23 
 
31 
 
54 
 N % 
 
N % 
 
N % 
Age 48.8 (sd 11.4) 
 
40.6 (sd 10.4) 
 
43.3 (sd 11.2) 
Female 4 17.4 
 
15 48.4 
 
19 35.2 
Married or cohabitating 17 73.9 
 
23 74.2 
 
40 74.1 
Ethnicity 
        Luhya 11 50.0 
 
11 37.9 
 
22 43.1 
Kikuyu 3 13.6 
 
13 44.8 
 
16 31.4 
Luo 2 9.1 
 
4 13.8 
 
6 11.8 
Kamba 2 9.1 
 
1 3.4 
 
3 5.9 
Ugandan 4 18.2 
 
0 0.0 
 
4 7.8 
Education 
        less than primary 5 21.7 
 
0 0.0 
 
5 9.3 
 primary 13 56.5 
 
12 38.7 
 
25 46.3 
more than primary 5 21.7 
 
19 61.3 
 
24 44.4 
Religion 
        Protestant  12 52.2 
 
0 0.0 
 
43 79.6 
Catholic 3 13.0 
 
0 0.0 
 
3 5.6 
Muslim 6 26.1 
 
31 100.0 
 
6 11.1 
Employment 
        None 22 95.7 
 
22 71.0 
 
44 81.5 
part-time 1 4.3 
 
1 3.2 
 
2 3.7 
full-time 0 0.0 
 
8 25.8 
 
8 14.8 
Income (monthly) 
        < 1,000 Ksh (Int$ 26) 4 20.0 
 
1 3.2 
 
5 10.0 
1,000-4,999 Ksh (Int$ 162) 12 60.0 
 
13 41.9 
 
25 50.0 
 5,000 -10,000 Ksh (Int$ 264) 1 5.0 
 
8 25.8 
 
9 18.0 
> 10,000 Ksh (Int$ 264) 2 10.0 
 
9 29.0 
 
11 22.0 
Rents house 22 95.7 
 
27 87.1 
 
49 90.7 
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Table 7-5: Socio-demographic characteristics of patients 
 
 
Traditional Faith All 
 
N=35 N=82 N=116 
 N % N % N % 
Age 31.7 (sd 9.0) 34.1 (sd 10.7) 33.4 (sd 10.2) 
Female 19 54% 65 79% 83 72% 
Married or 
cohabitating 24 71% 41 53% 63 57% 
Ethnicity 
      Luhya 23 79.3 26 34.7 51 44% 
Kikuyu 4 13.8 37 49.3 48 42% 
Luo 2 6.9 6 8.0 9 8% 
Kamba 0 0.0 3 4.0 4 3% 
Other   0 0.0 3 4.0 3 3% 
Education 
      less than primary 5 14% 10 12% 14 12% 
 primary 21 60% 50 62% 67 58% 
more than primary 9 26% 21 26% 34 30% 
Religion 
      Protestant  29 83% 63 79% 90 80% 
Catholic 6 17% 17 21% 23 20% 
Employment 
      None 18 53% 53 69% 70 64% 
part-time 12 35% 19 25% 30 28% 
full-time 4 12% 5 6% 9 8% 
Income (monthly) 
      <1,000 Ksh (Int$ 26) 10 48% 33 51% 41 48% 
1,000-5,000 Ksh 9 43% 31 48% 41 48% 
> 5,000 Ksh (Int$ 
132) 2 10% 1 2% 3 4% 
Living in rented 
house 33 94% 73 89% 106 91% 
Carer's relation 
      Spouse 3 16% 13 21% 16 22% 
Parent 4 21% 14 22% 18 25% 
Child 1 5% 5 8% 6 8% 
Other relative 11 58% 25 40% 36 49% 
Friend or neighbour 0 0% 3 5% 3 4% 
No carer 0 0% 3 5% 3 4% 
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Indicating low socio-economic status, most respondents (91%) rented rather than 
owned their home, and two-thirds (64%) were unemployed. The remainder were mostly 
employed part-time.  Half of patients reported earning less than Ksh 1,000 (Int$ 26) per 
month, while approximately another half earned between Ksh 1,000 and 5,000 (Int$ 132). 
However, the response-rate to questions about income was relatively low (72%), making this 
data potentially less accurate. Indeed, there was poor correlation between responses to the 
questions about employment and income: 29% of those unemployed (n=20) responded that 
they were earning more than 1,000 Ksh per month. It is possible that they earned money 
through casual labour rather than through formal employment, but nonetheless the responses 
around income and employment merit further attention. 
The ethnicities of patients matched those of healers almost identically. The patient 
population were almost evenly split between Luhya and Kikuyu (44% and 42% respectively), 
with a remainder of Luo (8%), Kamba (3%) and a scattering of other tribes. Patients of faith 
healers were considerably more likely to be Kikuyu (49%) than patients of traditional healers 
(14%), suggesting that ethnicity may play a role in their choice of provider. 
The patients of traditional and faith healers appeared relatively similar in socio-
demographic profile (table 7-6) with two exceptions: patients of faith healers were more likely 
to be women (𝑋2(1, 𝑁 = 112) = 7.032, 𝑝 = 0.008) and they appeared more likely to be 
employed (𝑋2(1, 𝑁 = 112) = 2.672, 𝑝 = 0.102), though the latter was only significant at 
alpha 10%. Since being female and employed are often negatively correlated, I ran a logistic 
regression using those two variables as covariates of treatment type. Being female remained 
significant (β=1.213, p=.014), but employment became insignificant (p=.214) as predictors of 
attending a faith healer.  
 
Table 7-6: Test of association between patient socio-demographics and healer type 
 
 
𝑋2 p-value 
Female 7.032 .008 
Married or cohabitating 2.007 .157 
More than primary education 0.042 .838 
Protestant 0.105 .293 
Employed 2.672 .102 
Income > 1,000 Ksh 4.153 .125 
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7.3 - b) Diagnosis 
 
7.3.b.i Healer Perspective  
When asked what types of mental illness (akili isiyo timamu) they treat, healers responded with a 
wide spectrum of answers (table 7-7). Because the data were coded in English by Kenyan 
research assistants with backgrounds in public health, the diagnostic labels applied were 
mostly drawn from conventional medicine, though it is unlikely that the healers would have 
used those words in many cases. For example, healers are reported to have said they treat 
epilepsy, depression, anxiety, schizophrenia, psychosis, bipolar (and “manic”), addiction, 
autism and cerebral palsy. Epilepsy was the most common condition cited by traditional 
healers (76%), while depression was the most common condition cited by faith healers (72%). 
In addition, the healers enumerated medical diseases not traditionally associated with mental 
illness, in particular HIV, cerebral malaria, sexual dysfunction and infertility. 
Despite the intrusion of researcher bias with regards to diagnosis, the data nonetheless 
preserved several local idioms of distress. Both traditional and faith healers alike used local 
terms meaning “demon-possessed”: 29% of traditional healers and 38% of faith healers used 
this term (table 7-8). A person possessed by demons was described as “talking to oneself, 
being sometimes sad and other times jovial, feeling as if being followed by unseen beings, 
sleeplessness” (h9f), as well as by being “irritable [and] fighting” (h39t) or “violent” (h49t) and 
“very afraid of people” (h43t). These descriptions evoke common symptoms of what 
conventional medicine might call psychosis, but they could equally be related to acute mood 
disorders or anxiety. In the absence of comparative data between diagnostic systems, it is 
impossible to say whether demon-possession maps onto a single conventional medical 
diagnosis. 
The term “madness” (madmen are wazimu in Kiswahili) was also loosely used by 
traditional and faith healers alike in association with severe psychosis mixed with destitution. 
For example, a faith healer described a madman as “walking aimlessly… eating his stool… 
eating anything in sight… very rough and dirty” (h01f). A Luhya traditional healer echoed 
elements of this description, noting that a madman is “poorly groomed, wears dirty clothes 
and runs around all day along the road, making incomprehensible speech and thoughts” 
(h35t). A distinction was drawn by a Kamba traditional healer between “a disease you are born 
with” and “demon-possessed” (kupagwa), which is acquired, with the former characterized by 
the affected people “at times [being] very good people, until a given season or time” (h49t).  
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A lesser used but nonetheless prevalent diagnosis was “bewitched”: 10% (n=3) of 
faith healers and 5% (n=1) of traditional healers used the term. This diagnosis appears to be 
associated with a wide range of complaints, including, but not always, being demon-possessed. 
Other local idioms of distress included “feeling tired in the head” (h35t) and suffering from 
“emptiness” (h34t), or “being quiet and over-thinking” (h17f), which are suggestive of the 
spectrum of anxiety and depression within conventional medical nosology. Finally the term 
“delayed milestones” was commonly used to refer to a developmental delay, not only in the 
form of mental retardation, but also a delay of life-events, such as marriage or child-bearing. 
 
 Table 7-7: Kiswahili words for mental illness and traditional practitioners 
 
English Kiswahili 
Illnesses 
 Mentally ill akili isiyo timamu 
Mad person mwenda wazimu 
Demon-possessed kupagawa 
Bewitched kurogwa 
Epilepsy kifafa 
 
Traditional practitioners  
Traditional healer mganga 
Faith healer muombaji 
Herbalist akimi wa miti 
Diviner mundu mue 
 
 
The process of arriving at a diagnosis was similar in some respects between faith and 
traditional healers. Both categories of provider based their assessments largely around direct 
observation, questioning, and listening. “They tell me their problems” (h43t) “I ask the 
history” (h17f). Experience was noted as an important element contributing to the skill of 
diagnosis. “I identify the problem by observation, through experience, as taught by my 
grandfather” explained a traditional healer (h49t), while a faith healer asserted, “I am able to 
know by seeing them, due to experience” (h1f).  
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Table 7-8: Mental illnesses treated by traditional and faith healers 
 
Diagnosis Traditional Faith 
  N % N % 
epilepsy 16 76.2% 17 58.6% 
depression 8 38.1% 21 72.4% 
“demon possession” 6 28.6% 11 37.9% 
mania 3 14.3% 7 24.1% 
schizophrenia 3 14.3% 5 17.2% 
“madness” or psychosis 3 14.3% 2 6.9% 
suicidality 1 4.8% 4 13.8% 
“bewitched” 1 4.8% 3 10.3% 
thinking too much 1 4.8% 0 0.0% 
stress or anxiety 0 0.0% 3 10.3% 
 
In addition to these factors, which also shape the diagnostic practices of conventional 
medical providers, traditional and faith healers both observed that they were helped by an 
additional super-natural force. For faith healers, the added power took the form of “God’s 
guidance” (h28f). A Luo faith healer observed “Through the holy spirits, I receive guidance on 
the type of person before me. After prayer, the demons in a possessed person start talking” 
(h1f). The plural of “spirits” is significant here, in that typically Christian doctrine refers to a 
single Holy Spirit. The plural suggests a synchronism between Christian and traditional 
cosmologies, since Luos traditionally believe in multiple ancestral spirits (Sindiga 1995). Also 
of note is that the external force assisting in diagnosis is not only that of the “holy spirits,” but 
also that of “the demons.” The agency of demons in diagnosis is echoed by another faith 
healer, who asserted: “Demons are manifested through a strong prayer and worship, and the 
patient starts to jump and talk non-stop” (h9f). Not all faith healers invoked demons, 
however. A number (n=5) of them noted instead that diagnosis was made through a process 
of repentance. Implicit in this approach is that the cause of mental illness is not demons but 
sin. 
Reference to a super-natural power distinguished two types of traditional healer from 
one another, namely herbalists and diviners. Whereas a pure herbalist relies on symptoms that 
can be directly observed or recounted, the diviner (or herbalist-diviner) connects with an 
external force – be it a divinity or ancestral spirits – and receives a revelation. One traditional 
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healer described having “powers to see and identify” (h39t), and several others explained that 
burning herbs helped them to connect with the spirits (h34t, h47t, h49t).  “I light herbs mixed 
in a pot – different herbs are crushed and mixed with some ash and a fire is lit – and I ask the 
patient to sit next to it, and the demon starts to talk, identifying himself” (h49t). A shared 
imagery of talking demons is evident between this traditional healer and the faith healers 
quoted previously. Some diagnostic codes, however, are specific to traditional healers. For 
example, after lighting herbs on fire, one healer noted: “The smoke must be vertical. If it goes 
horizontal, it means bad luck and the patient must make an offering” (h34t). In another case, 
also without a Christian analogy, diagnosis was made by communicating with spirits through a 
mirror.  
“I use a traditional way of looking into the mirror to see the 
problem and the causative agent. The client comes to my work 
place and I ask him how he feels. Using the mirror, I hold his right 
hand and I am able to translate the message I receive” (h33t). 
On the basis of these descriptions, we can deduce that at least seven of the traditional healers, 
about a third of the sample (30%), were diviners. Over half (56%) were herbalists, and the 
specialty of the remainder (n=2) could not be determined. 
 
7.3.b.ii Patient Perspective 
Data on symptoms were available from 76 patients. Unfortunately, patients were not asked to 
list their own symptoms, but rather general symptoms of mental illness (akili isiyo timamu), so it 
was not possible to associate idioms of distress with diagnosis. As with healers, the term 
“demon possession” was used by patients, though much less frequently (n=2, 3%). 
“Witchcraft” (or being bewitched) was only reported by one patient.  
Patients also enumerated many common symptoms of psychosis and depression. 
Symptoms of psychosis included “talking to self,” “laughing to self,” “walking aimlessly,” 
“talking without meaning,” “being unkempt,” as well as more unusual symptoms like being 
“naked,” “garbage collecting,” and “eating from garbage.” Recognized symptoms of 
depression described by the patients included “crying,” “feeling low,” “quarrelling,” “losing 
sleep” and “no appetite,” and wanting to end one’s life. In addition, two non-descript 
symptoms appeared commonly in patient descriptions, namely “headaches” (14%) and 
“thinking a lot” (11%).  
 
Table 7-9: Patient diagnoses, using the MINI, by healer type 
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Traditional 
 
Faith 
 
All 
 
35 
 
82 
 
112 
Diagnosis N %   N %  N % 
Any diagnosis 30 86% 
 
67 82% 
 
92 82% 
Mood disorder 24 69% 
 
50 61% 
 
74 66% 
Anxiety disorder 3 9% 
 
7 9% 
 
10 9% 
Bipolar disorder 1 3% 
 
15 18% 
 
16 14% 
Schizophrenia 1 3% 
 
0 0% 
 
1 1% 
Alcohol disorder 1 3% 
 
2 2% 
 
3 3% 
Epilepsy 6 17% 
 
2 2% 
 
8 7% 
Suicide attempt 7 20% 
 
11 13% 
 
18 16% 
No diagnosis 5 14% 
 
15 18% 
 
20 18% 
 
Note that the five patients of both traditional and faith healers are counted in both the 
traditional and faith columns, but only once in the “all” column. 
 
 
Table 7-10: Tests of association between patient diagnosis and healer type 
 
 
Chi square statistic p-value df 
Common mental disorder 0.748 0.387 1 
Suicide attempt 1.263 0.261 1 
Serious mental disorder 2.653 0.143 1 
Alcohol disorder 0.043 1.00 1 
Epilepsy 9.451 0.006* 1 
No diagnosis 1.022 0.312 1 
    
Turning to the biomedical diagnoses resulting from the MINI assessment (table 7-9), I 
found that diagnostic profiles were somewhat similar between patients of traditional and faith 
healers. Eighty two per cent (n=92) of those identified by healers as having a mental illness 
had a disorder diagnosable by the MINI. Among those with a diagnosable mental disorder, 
80% (n=72) had a common mental disorder. All of the ten cases diagnosed with anxiety had 
comorbid depression. A further 17% (n=16) of those with a diagnosable disorder met criteria 
for bipolar disorder, while only a single patient of one traditional healer was diagnosed with 
schizophrenia. Alcohol dependence was also rare with only 3% of patients (n=3) meeting 
criteria, while epilepsy was present among 7% of the patient population (n=8). As alcohol 
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disorders are more prevalent than epilepsy in the general population, we can observe that 
individuals with an alcohol problem are seeking care from healers with considerable less 
frequency than those with epilepsy.  Interestingly, one in five patients (18%) did not meet 
criteria for any mental illness using biomedical categories, though they were presumably 
experiencing distress. 
A relatively large number of patients (n=18, 16%) had a history of attempted suicide. 
There was an association between having attempted suicide and attending a traditional healer, 
significant at the alpha 10% level though not at the alpha 5% (p = 0.069) (table 7-10). If a past 
suicide attempt indicates illness severity, then it is possible that patients attending traditional 
healers may be on average slightly more ill than those attending faith healers. This hypothesis 
is supported by the greater proportion of patients with no diagnosable illness found among 
faith healers, although the latter association is not statistically significant. 
 
7.3 - c) Treatment   
Treatment did not vary systematically by diagnosis, although some healers reported having a 
system of treatment connected with diagnosis.  
 
7.3.c.i Faith Healing 
Faith healing existed in different forms, the greatest distinctions being whether it was 
individual or collective and whether it took place in the patient’s home, the healer’s space, or 
in the church. Half the patients of faith healers acknowledged receiving home visits. In 
general, when healing took place in the church it was collective, but in some instances, one-to-
one counsel was given in the church (p102f). Healing was sometimes performed by the pastor 
or priest, but also by self-appointed members of the congregation believed to have special 
healing powers (p77f); however data were not collected on the healer’s role within the church, 
so that wasn’t possible to quantify. Further differences existed in terms of the combination of 
different procedures undertaken. Several different procedures were described by providers and 
patients of faith healing, namely: 1) prayer; 2) Bible-reading; 3) counselling or encouragement; 
4) cleansing; 5) anointment and 6) offerings.  
 Prayer was the most ubiquitous component of all faith-healing, endorsed by 100% of 
providers and patients alike. Prayer took place in different ways, sometimes with the patient 
kneeling (p37f, p96f), sometimes with the healer laying hands on the head (p29f, p37f), often 
with the person prayed for closing their eyes (p8f). Usually the healer would utter the prayer 
and the person being healed would repeat the words (p93f). Prayer took place most commonly 
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in the church or home, however one Luo healer noted: “We pray for them at the church and 
in their homes and even at their birth places” (h1f). Going to the birth place to pray is 
suggestive of a traditional practice, which gives weight to the homeland because it is the 
resting place of ancestral spirits (Sindiga 1995). 
A number of patients healed in church noted that at the “praise and worship” part of 
the service, people were called forward to the altar to be prayed for collectively (p23f, p29f, 
p74f, p92f, p95f). One person mentioned that the church ran collective support-groups “to 
encourage each other” (p102f). As part of the collective nature of healing, patients were often 
asked to announce their problem publicly (p37f, p77f). Sometimes prayer was preceded or 
followed by singing (p78f).  
In other instances, however, prayer was viewed as a more individual act. Several 
respondents remarked that they were asked to pray for themselves “severally” (p24f) or “pray 
at home ‘til next meeting” (P37f). And in one case, the healer noted that he was “praying for 
strength” (h32f), possibly strength for himself to heal, as well as strength for the patient to 
endure. 
The second most common component of faith healing was counselling or 
encouragement, described by 59% of providers and 31% of faith patients. The most frequent 
emphasis of the counselling was providers telling faith patients to “trust [they] are healed” 
(p74f), “believe the demon has been cast out” (p92f), “have faith that God will heal” (p78f), 
or “believe God will answer the prayers” (p37f) – 22% of patients reported this emphasis on 
belief in a cure as part of the healing process. Providers confirmed the centrality of belief in 
the healing process. In the words of one faith healer, part of his technique is to “make the 
person believe in the Bible and the Holy Spirit” (h2f), while another healer described it as a 
“boosting of faith” (h7f). A smaller number of patients (n=3) observed that they were asked 
to repent their sins (p36f, p106f, p116f). One patient noted that she was “advised not to feel 
guilty” (p95f). Another reflected that she and the healer were “talking about the homestead” 
(p86f). And a healer stated that in his counselling, “the patient is encouraged morally and 
taught to accept” (h9f). 
Use of the Bible was the third most frequently noted component of faith healing, 
mentioned by 38% of healers and 11% of patients. It is possible that some patients view Bible 
reading as part of praying and therefore did not mention it separately. Neither patients nor 
providers elaborated on which passages of the Bible were read. The Bible was not only used 
for reading, however. A Luo faith healer observed “I make them kneel down and bang them 
with the Bible as I sprinkle water on the head” (h17f).  
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Though less frequently noted, faith healing was also accompanied by a process of 
cleansing. A Luo healer observed, “I cleanse the patient, the inhabitants and the whole house 
by spraying holy water” (h1f). A Luhya healer echoed this practice and described purifying the 
water first by boiling it and adding salt (h18f). Water was not the only form of cleansing. 
Fasting was also mentioned by four faith healers (14%) as part of their instructions to patients 
for ritual healing. There was a discrepancy, however, between healers and patients in his 
regard, since no patients reported having fasted.  
The most dramatic form of cleansing was “casting out of demons,” also described as 
“driving away” and “chasing” demons. This form of exorcism was reported by one Luo healer 
(h4f) and four patients (p36f, p71f, p92f, p96f), which represents about 5% of respondents in 
each group. Unfortunately, no further detail was provided in our data about this procedure.  
After cleansing, several healers and patients mentioned anointment with oil (described 
in one instance as olive oil). Four patients and four providers reported use of oil. One patient 
explained that she was asked to buy anointing oil costing 100 shillings (Int$ 2.6) and told to 
“put it in some water and let the oil stay for 7 days before use” (p23f). Though less explicitly 
monetary, the language of “offerings” was used by six patients, who noted that gifts of food 
or money constituted part of the proceedings. By contrast, none of the faith healers alluded to 
offerings. One healer noted, inversely, that she “provides for the [patient’s] need with food or 
money” (h21f). 
 
7.3.c.ii Traditional Healing 
The most common component of healing provided by both herbalists and diviners was herbs. 
(The term herbs refers here to all plant remedies, including roots and tree bark.) All of the 
traditional healers reported administering herbs, and all of their patients reported receiving 
them. Herbs existed in many varieties, the details of which exceed the scope of this study. A 
number of healers noted that the purpose of the herbs was to expulse material from within the 
body, be it through sneezing and salivating, or vomiting and diarrhoea (h38t). As described by 
one healer, “Those who appear mad are given a herb through the nose, and the patient drinks 
and then sneezes while drooling saliva and mucus, then calms down” (h49t). 
Herbs were given in many forms (table 7-11). The most common form of 
administration (reported by 67% of providers) was to serve a drink with crushed or powdered 
herbs. Usually the base of the drink was water, sometimes boiled to extract the substance, for 
example with tree bark (p11t). One patient described that the water was brought all the way 
from the East Coast of Kenya, “maji ya Mombasa” (water from Mombasa) (p12t). For bitter 
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herbs, the substrate was sometimes soda, for example Coke (p113t) or Fanta orange (h50t). 
Another means of ingesting herbs was to mix it in food, for example in mutton (h39t) or in 
the liver of a young dog (h50t).  
A second mode of administering herbs was air-born, through the nose or mouth. This 
included sniffing herbs, inhaling their smoke (h35t, h53t) or breathing in their vapour with a 
steam bath. One healer described that for psychosis, “the patient is put in a blanket with 
steam” (h35t). Patients were also covered when inhaling smoke, according to one healer 
(h53t).  
Still another means of administering herbs involved placing them on or in proximity to 
the body. Sometimes (n=4 providers, 1 patient) herbs would be mixed into oil and massaged 
into the body. At other times (n=3 providers, 2 patients), the herbs would be steeped into a 
bath in which the patient soaked (h38t, h47t, h53t, p9t, p65t). As described by one patient, 
“You remove clothes and enter into water. Then you are covered with a blanket and sufuria 
[cooking pot]” (p9t). Finally, some healers advise putting herbs and roots in contact or near 
the body while sleeping. A healer remarked, “a special concoction is tied on the patient’s head 
as he or she sleeps” (h35t). While a patient confirmed that she was “given some roots to put 
under the pillow” (p65t), and another remembered that herbs were placed “under the head at 
night” (p62f). 
A form of treatment practiced exclusively by diviners involved making small incisions 
across the body. One in three of the traditional healers interviewed (n=7) noted that they used 
incisions among their array of remedies. The process, according to one healer, is intended to 
produce bleeding and pain. “For persistent headaches, I make skin cuts on the temporal and 
frontal areas of the head until one bleeds. Then I apply traditional medicines on and in the 
wounds until the patient feels pain” (h35t). Another healer suggested that the incisions are a 
means of administering protective herbs. “Using a blade, I cut part of the body and insert the 
herbs in the body” (h55t). 
 
Table 7-11: Traditional and faith healing procedures 
 
 
TRADITIONAL 
 
FAITH 
 
Provider Patient 
 
Provider Patient 
 
21 26 
 
29 64 
 N % N %   N % N % 
Prayer 2 10% 4 16% 
 
29 100% 64 100% 
Counselling or  encouragement 1 5% 1 4% 
 
17 59% 20 31% 
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Asked to believe he/she is cured 0 0% 0 0% 
 
0 0% 15 23% 
Asked to repent 0 0% 0 0% 
 
2 7% 2 3% 
Use of the Bible 0 0% 1 4% 
 
11 38% 7 11% 
Fasting 0 0% 0 0% 
 
4 14% 0 0% 
Cleansing with water 0 0% 0 0% 
 
4 14% 1 2% 
Anointment with oil 2 10% 2 8% 
 
4 14% 4 6% 
Offering (food, drink, money) 0 0% 1 4% 
 
0 0% 6 9% 
Casting out demons 0 0% 0 0% 
 
1 4% 4 6% 
Herbs, roots or medicines 21 100% 26 100% 
 
0 0% 0 0% 
Data on mode of herb delivery 16 100% 
       Drink 10 67% 
       Rub in (incisions) 7 44% 
       Sniff or inhale 6 38% 
       Apply externally (oil, bath) 5 31% 
    
 
  Chew, lick or eat 4 25% 
       Incisions 7 33% 5 19% 
 
0 0% 0 0% 
Massage 4 19% 1 4% 
 
0 0% 0 0% 
Chains 1 5% 0 0% 
 
0 0% 0 0% 
Home-visits 18 86% 13 50% 
 
27 93% 25 45% 
One in five patients of traditional healers (n=5) reported receiving incisions. The 
proportion of patients who reported receiving incisions was lower than that of the healers 
who performed it, so it appears not to be a treatment of first resort for the most prevalent 
conditions. One patient described the procedure as follows. “He cut parts of the body then 
smeared with ashes in these parts. […] Then he mixed boiled water from barks of trees with 
crushed leaves and then poured it into the cuts” (p11t). A second patient reported that the 
healer “put the ashes where they act with a razor blade” (p100t). Another patient noted, “You 
are cut with a blade all over the body and they apply the herbs. Then they give you herbs to 
swallow and shower with” (p62t). For another patient, the cuts were focused on the stomach. 
She was “locked up in the house with the traditional healer. He poured out some liquid and 
grains as an offering to the ancestors and prayed to drive away demons. Then he cut my 
stomach and poured some liquid drugs” (p71t). The purpose of the cuts as described here is 
to “drive away demons” is is therefore presumably a treatment for the diagnosis of “demon 
possessed” (kupagwa) and possibly also “bewitched” (kurogwa). 
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The patients receiving incisions were predominantly male (n=4/5). There was no clear 
pattern of biomedical diagnosis visible in terms of who received incisions, however epilepsy 
predominated. Those receiving incisions had the following biomedical diagnoses: mood 
disorder (n=3); epilepsy (n=2); comorbid alcohol dependence (n=1). Since epilepsy was less 
prevalent than mood disorders among traditional healers, the rate of incisions amongst people 
with epilepsy was considerably higher than for mood disorders: one-third of patients with 
epilepsy received incisions as compared to 1/8th of those with mood disorders. One of those 
receiving incisions had previously attempted suicide, which is in keeping with the 20% 
prevalence of suicide attempt among those attending traditional healers. All of those receiving 
incisions had a diagnosable disorder, suggesting they may be more severely ill on average than 
other patients. 
In addition to the use of herbs and incisions, some traditional healers used prayer. 
Four patients of traditional healers (16%) described prayer being part of their treatment. 
Several healers prayed over the herbs rather than over the patient, with the aim of helping 
them to be more potent: one patient described that the healer “prayed over some herbs and 
asked me to drink it” (p89t), another that the healer said a “prayer for the herbs to be blessed” 
(p115t). One patient noted that she was “prayed for in language [she] did not understand” 
(p82t), but that appears to have been rare. Another healer “prayed to drive away demons” 
(p71t), as part of the act of making incisions. Two healers reported praying as part of their 
practice (h33t, h34t), one of them in combination with use of a mirror, arguably as much for 
diagnosis as for treatment. 
A final and highly contentious technique for managing mental disorders was the use of 
chains. One traditional healer noted that if a person exhibited aliyetumi wa majini (possession by 
Djinns), “The patient is violent, and at times they are chained, when seen for the first time” 
(h49t). Djinns are an evil spirit that form part of a Muslim belief system, and they play a role 
not dissimilar to demons within a Christian context. This traditional healer was Muslim, and 
blended elements of that system of faith into his practice. No patients reported having been 
chained. However, as chaining appears to be reserved for patients who are psychotic and only 
one patient in our sample had a history of psychosis, our data may not be a good source for 
testing the prevalence of this practice.  
 
7.3 - d) Follow-up care 
Follow-up procedures varied a great deal from healer to healer, though not ostensibly between 
traditional and faith healers. Traditional healers often gave their patients herbs to take for a 
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certain duration of time, ranging from two days (p46t) to two-months (p21t) and even up to 
three years (p60t). The majority of traditional healers reported following up after one or two 
weeks on the progress of herbal remedies (h41t, h42t, h54t). In rare instances, however, for 
both traditional and faith healing, treatment was viewed as one-off: “they just give the 
medication once,” reported a patient of a traditional healer (p33t), while a patient of a faith 
healer noted, “after prayers, that’s the end of everything” (p14f). A number of healers 
performed home-visits to check on the progress of healing. Since half of patients are seen in 
their homes for the initial treatment, this is a natural form of follow-up. 
Faith healers also performed frequent home-visits for follow-up care, according to 
their patients (p29f, p31f, p84f). One patient reported that the faith healer visited her home 
“every three days in the beginning, then every one week, when [I got] stronger” (p64f). A 
week seemed to be the standard period of follow-up, as reported by the healers themselves 
(h13f, h9f, h17f), which corresponds with the frequency of standard church services. Some 
patients, however, noted that there was no follow-up (p8f, p35f). Several faith healers noted 
that it was the choice of the individual being healed whether or not to return (h16f, h22f, 
h28f). Patient choice did not figure among the factors mentioned by traditional healers. 
 
7.4 Results: Acceptability Coverage 
 
7.4 - a) Referral 
Although traditional and faith healers tended to be accepting of conventional 
medicine, they were not equally accepting of one another. Several providers of faith healing 
expressed distrust of traditional healers, although the reverse was not overtly expressed. 
“There is need for linkage with hospitals, but not with the traditional healers, because they are 
not honest” (h32f), claimed one faith healer. Another stated more diplomatically, “people 
should only use prayers and hospital medicine” (h14f). 
Responses about referral practices (table 7-12) differed notably between providers and 
patients, however the low response rate from patients (26%, n=33) makes their data less 
robust on this question than on other topics. The majority (three-quarters) of providers, both 
faith and traditional, reported coordinating care with other providers, however a minority of 
patients (one-third) reported having been referred for care, or been the recipient of 
coordinated care.  
 
Table 7-12: Referral practices according to providers and patients 
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TRADITIONAL 
 
FAITH 
 
Providers 
 
Patients 
 
Providers 
 
Patients 
 
21 
 
13 
 
28 
 
20 
 
N %   N %   N %   N % 
Refers to other providers 16 76% 
 
4 31% 
 
22 79% 
 
7 35% 
Refers to conventional 
medicine 15 75% 
 
3 23% 
 
21 75% 
 
7 35% 
Refers to faith healers 4 20% 
 
2 15% 
 
6 21% 
 
0 0% 
Refers to traditional healers 3 15% 
 
0 0% 
 
1 4% 
 
0 0% 
 
The most common referral, reported by providers and patients alike, was in the 
direction of conventional medicine. A quarter to a third of patients reported being referred to 
conventional medicine, with referral rates slightly higher among patients of faith healers (35% 
versus 23%). It was rare that a traditional healer referred to a faith healer (n=4 providers, 
20%), and it was even more rare that a faith healer referred to a traditional healer (n=1 
provider, 4%). Faith healers more commonly reported referring to other healers of the same 
type, whereas traditional healers appeared as likely (relatively unlikely) to refer to a faith healer 
as to another traditional healer. A few healers noted that referral should be the initiative of the 
patient. “Linkages are not necessary. Let the patient decide on his own” (h29f), noted one 
provider, while another advised, “Let patients choose where to go” (h53t). 
 
7.4.a.i From the perspective of faith healing 
Faith healers saw an intrinsic connection between their work and the work of conventional 
medical providers, because both were perceived to be doing the work of God (table 7-13). “It 
is God who gives doctors wisdom, […] both doctors and patients need God” (h3f), said one 
provider, while another echoed, “God gave men the ability to know medicine; but we should 
also believe that God will heal us when prayer is involved” (h9f). Another faith provider noted 
that conventional medicine and healing are two means to a similar end: “Both prayer and 
medicines are powerful. God works in many ways” (h17f).  
Patients raised the same arguments as faith healers for the overlap between faith 
healing and  conventional medicine: “Conventional medicine is very important, but God has 
to be involved for it to work” (p1f), stated one patient, while another noted the dictum: 
“Doctors treat, but God heals” (p57f). Implicit in the idea that God heals is the supposition 
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for some that conventional medicine addresses symptoms, whereas faith healing provides a 
cure. As voiced by one patient, “prayers only can heal completely” (p4f).  
Some providers and patients alike noted that faith healing served a different, yet 
complementary, function to conventional medicine. Doctors and faith healers were seen as 
two parts of a whole: “They work hand in hand,” (p6f) observed one patient. Another patient 
noted a synergy between the two types of care: “Prayers can heal alone, but when combined 
with medical treatment they do better” (p37). A faith healer understood the specificity of her 
work as providing interpretation and meaning to the illness experience: “It is good to take 
drugs and also be taught about God's purpose for life” (h9f). Several patients noted that faith 
healing provided an element of encouragement or “uplift” that was absent from conventional 
medicine. One patient observed that she “prefers hospital medication, but combines with 
prayers for uplifting” (p3f), while another mentioned that “the hospital can provide drugs but 
the church is better at counselling and encouragement. Both work in their own ways” (p103f). 
Still another patient observed that faith healing, delivered through the community of the 
church, had the appeal of a more holistic approach: “I need the community support… [faith 
healing] looks at the individual as a whole” (p41f). 
Despite the widespread view that faith healing and conventional medicine are 
complementary, a number of faith healing patients did not hesitate to state a need for hospital-
based care for acute episodes of psychiatric illness. “If you are sick, go to Mathare Hospital” 
(p10f) said one patient, while another person responded to the question of how mental illness 
should be treated, “they should be institutionalized, then revealed [sic], when they are better, 
back into society” (p27f). Another patient noted the financial obstacle to hospital-based care, 
arguing “They should have some funds with which they can send one to hospital” (p80f). 
Hospital-based care was not seen as distinct from faith care, however. One patient 
recommended, “pastors should be going to the hospitals of mentally ill and pray for the 
patient” (p36f). 
A practical argument made by providers in favour of medical pluralism was that not 
everyone believes in God, or not with equal fervour. “There’s a need for both faith healing 
and hospital drugs – for those who don’t believe” (h15f). And again, “medical treatment 
works well for those with little faith; prayers work for believers” (h28f). Or, “It all depends on 
the individual's faith” (h29f). A patient added to this conviction that without faith even 
conventional medicine is ineffective. In her words: “you can take drugs, but because of lack of 
faith you don’t get well” (p5f).  
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A number of healers and patients felt that faith healing was more effective than 
conventional medicine, and some even thought conventional medicine was best avoided. 
Patients expressed the view that there is an order of operations and prayer should come first: 
“Both are good, but prayer should come before hospitals” (h10f). Or, “Prayers are supreme, 
but they may be combined with conventional medication” (p31f). Explanations for the 
superiority of faith healing differed. One patient commented that prayers are better because 
they offer a single solution for all problems, whereas medicine is different for each illness: 
“The same medicine can’t heal all diseases, but prayer can heal all the diseases. It doesn’t work 
always, unlike prayers, which work always” (p24f). Another patient thought faith healing had 
longer-lasting effects: “after prayer it takes [more] time before a relapse” (p113f). Whereas 
another person noted that the effects were more immediate: “It lifts my spirit and I feel the 
burden has reduced even before healing” (p32f). A healer concurred, arguing “faith healing 
works faster than drugs” (h26f). 
A few patients (7%, n=5) of faith healers stated that prayer had replaced medication: 
“I don’t even use drugs, prayers are more powerful” (p19f), and “I stopped taking drugs 
because I believe more in prayers” (p69f). One person asserted that “conventional medicine 
made me to be worse than I was” (p115f) – possibly the result of medication side-effects. Two 
individuals explained that the reason for stopping conventional medicine was the cost. “I 
prefer prayers as they are not requiring money, but with modern medicine I require medicine” 
(p26f), stated one patient. While another person resigned from future use of medication, 
declaring, “This is the last time I will use medication, I believe so. So I won’t buy more” 
(p118f). 
A single patient of a faith healer expressed a distaste for faith healing, saying “I prefer 
medical treatment, because in faith healing you can be misled and gotten into things you don’t 
want to be in” (p28f). Money was not mentioned by any of the patients of faith healers, 
neither as part of their care nor as an obstacle to it. 
 
Table 7-13: Patient preferences for care 
 
Traditional Faith 
  
 
28 71 
  
 
N % N % X2 p-value 
Healing and conventional medicine are equal 4 14% 30 42% 6.966 0.008 
Faith healing is better 5 18% 33 46% 
  Traditional healing is better 3 11% 0 0% 
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Conventional medicine is better 15 54% 7 10% 22.20 <.001 
It depends on the condition 1 4% 1 1% 
  Conventional medicine is bad 1 4% 1 1% 
  Traditional healing is bad 5 18% 1 1% 
  Faith healing is bad 0 0% 1 1% 
   
7.4.a.ii From the perspective of traditional healing 
As with faith healers, some traditional healers saw their work as the other face of conventional 
medicine. “All drugs are from herbs, it’s only that they make them into tablets and injectable” 
(h37f), noted one healer. Another observed, “After all, conventional medicine came from 
traditional medicine” (h49f).  
A pragmatic concern, expressed by a traditional healer, but not by faith healers, was 
the need to maintain clients. “People have left traditional treatment. We need to act also with 
the western convention and assist one another” (h34t). Money was also a factor in the 
preferences of patients of traditional healers. One person complained, “When there’s no 
response after a long time, it’s good to be told to go to hospital instead of wasting money 
when you can’t be cured” (p21t). Another patient, however, took an opposite stance, stating 
that traditional healing was the economical option: “Conventional medicine is better, but it is 
expensive” (p59t). 
Not surprisingly, several providers of traditional medicine felt their services were more 
effective than conventional medicine. In one case, efficacy was attributed to the potency of 
the remedy: “herbs are stronger than traditional medicine” (h38t) – note that “traditional” 
here refers to conventional. One respondent argued that the higher quality of traditional herbs 
was due to their being natural rather than artificially engineered: “Traditional herbs are good 
since they have not been mixed with some chemicals that may destroy body tissues. They are 
natural products” (h54t). One traditional healer made the caveat, however, that “conventional 
medical treatment to clients has a faster positive response, while mine takes a bit some time” 
(h33t). A different explanation for preferring alternative medicine (also found among faith 
healers) was that conventional medicine only suppresses symptoms: “Hospital drugs only 
reduce pain but don’t cure” (h50t).  
A few patients (n=3) also took a stance in favour of traditional healing compared with 
conventional medicine, though they were fewer in number than those espousing faith healing 
alone. One person stated, “You can’t mix traditional medicine with medical treatment” (p107) 
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without offering an explanation. Another patient argued that traditional remedy “is far much 
better, because it has no side effects” (P65). 
Some patients (n=5, 18% of those attending traditional healers), however, turned 
against traditional healing. One respondent based his opinion on outcomes, “I have been well 
since stopping herbal medicine and starting conventional medicine” (p12t). Two patients 
expressed concern about the quality of the herbs: “herbal drugs may be any fake leaves” 
(p39t), cautioned one, while another advised to “avoid traditional healers, since some of them 
fake medication” (p81t). Another patient distrusted healers more broadly than for the quality 
of their herbs: “I prefer doctors, because they tell the truth. Traditional healers may lie 
sometimes” (p60t). Several patients preferred conventional medicine, because they felt it was 
more systematic: “They assess you to confirm the illness, before treatment is given, unlike 
traditional medicine” (p21t), stated one patient, while another concurred “They [doctors] 
know how to recognize the illness, but the traditional healers just try [things] out” (p33t). One 
patient resolved “never [to] go back to traditional medicine” (p52t). 
 
7.4.a.iii Specificity of mental illness 
There was a perception amongst a number of traditional and faith healers alike that some 
conditions are better treated by conventional medicine – especially HIV, malaria and cancer – 
and others are better treated by traditional or faith healers. “There are problems that can only 
be taken care of by drugs, and others only by prayer” (h18f), stated a faith healer. A traditional 
healer said it differently: “Each day has its own disease to cure. Herbs treat demon-possessed 
people well, and malaria can be cured by hospital pills.” (h42t).  
Mental illnesses fell into the category that many healers thought were better treated 
outside of conventional medicine. One faith healer stated “conventional medicine doesn’t 
work for disturbances of the mind.” (h4f). Similarly, a traditional healer asserted, “for mental 
illness, we should try herbal medicine, where conventional medicine has failed” (h36t). 
Interestingly, a traditional healer, also observed that “some conditions are spiritual” (h5t) 
explaining that he refers patients to faith healers for that reason. That attitude did not apply to 
the majority of healers, however. 
Patients shared the notion that certain illnesses responded better to certain types of 
care. One faith patient remembered, “When I had cerebral malaria, the drugs really helped; but 
now I am leaning towards prayers” (p68f). Another faith patient noted, “Some [conditions] 
can only be cured by prayers and some by medicines. From hospital, you should be taken to a 
faith healer, because some illness might require faith, for example [being] demon-possessed” 
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(p106f). A herbalist patient echoed, “Sometimes medicine works and the traditional treatment 
doesn’t” (p16t). While another herbalist patient stated, “medical treatment reduced the pain, 
but traditional healers made the wounds and swellings go away” (p46t). 
For a number of patients, their view of conventional versus traditional healing was 
shaped by the concrete outcomes of care – both positive and negative. Stated succinctly, “All 
of them [types of healing] are good as long as they help” (p116f). This was particularly evident 
in patients with epilepsy. One patient asserted, “I think drugs are not as potent as prayers, 
because when I sought medical intervention for my problem it worked through prayers: I no 
longer have seizures” (p18f). For a second patient the absence of effect of conventional 
medicine was enough to promote faith healing, although the latter appears not to have had 
better effect: “Prayers are better, as I have seen them function in my life. I have been on 
medication, but there has been no difference – without fail I still have the seizures” (p30f). 
Inversely, a third patient with epilepsy pronounced himself in favour of conventional 
medicine: “medication is better since it has stopped all the episodes of convulsion” (p61f). 
 
7.5 Discussion 
 
7.5 - a) Different categories of illness 
The study confirms that traditional and faith healing remain widely used services for 
addressing common mental disorders. The forms of traditional healing represented by our 
sample were herbalists (akimi wa miti) and diviners (mundu mue). The labels used to diagnose 
patients differed from Western biomedical categories. In particular the terms “demon 
possessed” (kupagwa) and “bewitched” (kurogwa) were common across both traditional and 
faith healers. Birgit Meyer offers some insight into the significance of the devil or demon 
within Christian and traditional religion in Ghana. Studying the conversion to Protestantism of 
members of the Ewe tribe in the early 20th century, Meyer asserts: “The Ewe were classified as 
belonging to the general category of “heathens” [meaning devil-worshippers]… It was the task 
of the mission to lead them away from Satan back to the Christian God” (Meyer 1996). The 
devil became a cross-over symbol between Christianity and their traditional religion, another 
term for the spirits they worshipped. The traditional African religious structure, or cosmology, 
was therefore preserved within the Protestant church in Ghana. It is possible that a similar 
process took place in Kenya. The fact that the term “demon possessed” is equally shared by 
traditional and faith healers suggests that underlying concepts may be shared about the origins 
of illness. 
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The notion of “witchcraft” or “bewitching” appears to remain active in Kenya, despite 
the Witchcraft Ordinance of 1925 banning the practice, which was renewed and updated in 
1961 and 1977. Charles Good describes the belief clearly:  
“Belief in witchcraft and sorcery was and is an inseparable element of 
virtually all African systems of disease etiology… Acting from 
jealousy, greed, or a desire for vengeance, the perpetrators are believed 
to call on evil powers to bring misfortune and harmful agents that 
induce mental distress and physical harm to the victim.” (Good 1987) 
The idea of witches was explicitly captured in our sample in the term “bewitched,” but the 
term “demon” was more popular, and appears to encompass a similar idea. Demons were said 
to be “cast-out” by faith healers and their patients in the same way that witches and their 
curses or hidden charms were traditionally driven out of people’s body’s by diviners and other 
healers specialized in that area. 
In addition to these two terms, the language used by patients and providers to describe 
symptoms on the spectrum of depression and anxiety was in keeping with findings from 
neighbouring countries in Africa. In Rwanda, “having lots of thoughts” was also a common 
trope for a form of depression, known in the local language as two tam (Betancourt et al. 2009), 
and in Zimbabwe “thinking too much,” or kufungisisa, was equally associated with a depressive 
state (Patel, Simunyu, and Gwanzura 1995). 
Shifting from an emic to an etic perspective, based on the biomedical diagnoses 
contained in the MINI assessment, the large majority of patients (66% of the sample, 80% of 
those with a diagnosable disorder) attended healers for common mental disorders. The 
patients appeared relatively severe, as indicated by the fact that 16% had previously tried to 
end their lives. No comparable data is available from Kenya on the prevalence of attempted 
suicide in a clinical setting. Bipolar disorder was more commonly found among faith healers, 
while people with epilepsy appeared more likely to attend traditional healers. It is possible that 
patients with epilepsy attending faith healing would be referred to conventional medicine, or 
alternatively that patients perceive traditional healing as more effective than faith healing in 
addressing epilepsy.  
The notable under-representation among patients of both types of healers was from 
individuals with alcohol problems. Although less prevalent on the whole in Kenya than in 
many industrialized countries, alcohol disorders are widespread, particularly among men. 
While a large portion of the Kenyan population abstains from alcohol altogether, among those 
who drink, problem drinking is prevalent. The best data on alcohol consumption come from 
Western Kenya. In a study of over 4,000 people using demographic and health surveillance 
  
245 
 
data, 60% of men and 80% of women reported lifetime abstinence from alcohol, but 30% of 
men were using actively in the prior month (Bloomfield et al. 2013). A second study attempted 
to capture problem drinking using census data from over 72,000 individuals and found that 
only 7.2% of people (male and female combined) reported drinking in the prior month, but 
60% of them did so to drunkenness on half or more occasions (Lo et al. 2013). Combining 
these numbers, the census data would suggest that 4.4% of the general population may engage 
in problem drinking. Actual numbers could be higher than reported to census officials, 
because of reluctance to admit to problem drinking.  
Moreover, the prevalence of alcohol problems is typically higher in clinical settings 
than in the general population.  Ndetei and colleagues found a prevalence of problem drinking 
of 25% among 2,770 patients across ten general medical facilities (Ndetei, Khasakhala, 
Ongecha-Owuor, et al. 2009). By comparison, in the Kangemi healer sample – a treatment 
setting – only 3% had an alcohol disorder. This suggests that many low-income individuals 
with an alcohol problem in Nairobi are not seeking care from traditional or faith healers, 
which leads one to ask whether they are receiving any form of care. 
 
7.5 - b) Hybridization of treatments 
Despite a heterogeneity of treatment practices, patterns of care were readily visible between 
faith healers and traditional healers. The principal difference in treatment procedures between 
faith and traditional healers appeared to be that traditional healing was more biological in 
origin, focusing on the body – vomiting, diarrhoea, sneezing, drooling, eating, drinking, 
massaging, bathing – whereas faith healing was less material, focusing instead on the spirit  
through prayer, reading, talking, singing and sprinkling with water or anointing with oil. There 
was particular emphasis in faith healing on verbal counselling. Examples of faith counselling 
included advising an individual not to feel guilty, talking about the “homestead,” and speaking 
optimistically about the future and possibilities of recovery. Patients responded to these 
procedures expressing feelings of “uplift,” hope and encouragement. In some instances the 
church offered support groups and even professional counselling, thus filling a similar role to 
a conventional mental health care provider. 
Despite these differences, some aspects of treatment were shared across traditional 
and faith healers. Prayer was the most commonly shared technique, used universally by faith 
healers, but also employed by traditional healers. One faith healer even alluded to praying “at 
the birth place,” a practice suggestive of deference to ancestral spirits. More broadly, some 
traditional and faith healers in this study showed evidence of a shared cosmology, or 
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understanding of causality. Indeed, several descriptions of faith healing were evocative of 
traditional practice, suggesting that the hybridization observed by Okwaro in his single case-
study in Western Kenya is not idiosyncratic. For example, faith healers using the Bible to 
“bang” on people’s heads is more suggestive of a traditional practice that transforms the Bible 
into a ritual object, rather than a typically Christian practice of using the Bible principally as a 
source of text. Similarly, practices such as “chasing out of demons” are evocative of expulsing 
witches, underscored by references to plural “holy spirits.” Witchcraft and its treatment have 
long been a cornerstone of one branch of traditional African medicine. 
This cross-over between traditional and faith healing practices reflects a shift in 
healing techniques since the time when Charles Good first described them. An illustration of 
divination as it was practiced in 1979 can be found in the case of Kamau and his healer “K.” 
“K. revealed correctly and to Kamau’s amazement that he was 
involved in a land dispute that included his sister and two unrelated 
parties. Following the divination, which K accomplished by playing 
the “magic bow” (ota) and making numerous counts of small colored 
pebbles shaken from her special divining gourds (ketti), K. instructed 
Kamau to write down the names of all people who might bewitch 
him. […] K’s diagnosis also determined that Kamau was suffering 
from a nearly fatal illness caused by the witchcraft. To symbolize the 
seriousness of his illness, Kamau had to be ritually “resurrected” from 
his graveside. […] K revealed that Kamau had not had sexual relations 
for the past 5 months, and he agreed. K said this was a further sign of 
[the evil neighbour’s] nefarious deeds. Ceremonies included the use of 
a baby chick “less than 10 days old! Whose blood, drawn from a small 
cut made on its crest, was rubbed into small cuts K had made on 
Kamau’s back with a razor blade. The chick was also made to ingest 
some of Kamau’s blood, thus transferring the evil power of the 
witchcraft from Kamau to itself.” (Good 1987) 
Chicken blood and ritual resurrections are far from the descriptions provided by the 
respondents in this study. The practices enumerated by this sample often mimicked biomedical 
practice – with herbs administered like medicines. Although incisions continue to be made to 
“transfer the evil power of witchcraft,” the procedure has been somewhat “sanitized” by 
eliminating the chicken.  
Thus traditional practice in urban Kenya appears to have shifted in two main ways, 
first by a cross-over of some practitioners from mganga to mtumishi (traditional to faith healer) 
and secondly from a change in ritual objects of the farm (a chicken, for example) to objects 
drawn from biomedical or religious practice (herbs, the Bible). These changes may have been 
influenced by the Witchcraft Ordinance, which was updated in 1977, just two years before 
Charles Good conducted his research. Good noted the pragmatism of healers, stating: “urban 
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traditional medical practitioners adapt by diagnosing and treating problems in terms of causes 
and methods that are possible and credible for them to manage in the urban setting”. The 
symbols of biomedicine and the Bible appear to have become more “credible” to the Nairobi 
clientele than the previous language of mock-resurrection and chicken blood. Thus traditional 
healing has “modernized” by fusing cultural trends into a new, but related web of ritual and 
meaning. 
 
7.5 - c) Potentially negative practices 
A few procedures documented by traditional healers and their patients raise concern in terms 
of patient rights. Cutting the skin with a razor to pull out demons or spirits and deliver 
protective herbs (often in the form of ash) was a particularly prevalent practice, and one 
associated with pain. One patient observed that he had been locked up when the procedure 
took place, suggesting limited choice. One in three traditional healers mentioned using 
incisions among their healing procedures, while one in five patients of healers had experienced 
it. The highest prevalence of incisions was for patients with epilepsy (one in three); and all 
patients receiving incisions were male. However, the small sample (n=6) creates uncertainty 
around these figures. Though not widely documented, the literature on incisions suggests that 
this practice is also not uncommon in other parts of Africa. Articles from Nigeria (Adelekan, 
Makanjuola, and Ndom 2001) and South Africa (Peltzer 1999) refer to practices of 
“scarification” and “protective incisions,” however it is unclear whether these practices are 
seen to serve the same purpose as skin cutting in Kenya.  
A second alarming practice associated with traditional healing was chaining. It was 
mentioned by only one traditional healer, however, who noted it as a form of containing 
psychosis. Since psychosis was rare in our patient population, it was not possible to estimate 
the frequency of this practice. Chaining and binding with ropes, however, are known to be 
relatively common practice for containing acute psychosis across Africa. They are viewed as 
an intervention of last resort in contexts where sedatives and appropriate medication are not 
available. Chaining is not only practiced by healers, but also by family members. Ndetei (2010) 
notes the poignant case of a young man who was chained on both hands and both legs by his 
mother, while in the psychiatric facility in Puntland State, Somalia. The literature also 
documents cases from Sudan (Ndetei David and Mbwayo 2010), Ghana (Roberts 2001), and 
South Africa (Peltzer 1999). In Kenya, the practice of physical restraint is long-standing: a 
study conducted in the 1960s notes that 121 out of 126 (96%) Kamba people interviewed in 
south-central Kenya responded to the question "what should be done with a psychotic 
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person”, by saying "tie them, then have a doctor treat them" (Edgerton 1966). The practice 
has raised concern of human rights agencies in many parts of the world, including recently in 
Ghana (Human Rights Watch 2012).  
It is notable, however, that certain alarming practices that have been documented in 
relation to healing of mental illness in other parts of Africa were not found in this urban 
population from Nairobi. In particular, beating or whipping patients, including with palm 
fronds (Agara, Makanjuola, and Morakinyo 2008), is a well-documented intervention in 
Nigeria (Adelekan, Makanjuola, and Ndom 2001) and in Ghana (Roberts 2001; Ae-Ngibise et 
al. 2010). Flagellation is delivered by traditional and faith healers alike in these West African 
contexts, but was not found in our Kenyan sample. 
 Possible negative effects were also apparent in descriptions of faith healing. The idea 
that mental illness is caused by sin is particularly problematic, especially for those who do not 
recover, because it implies that they continue to be at fault. In addition, there are potentially 
stigmatizing consequences to the idea that the outcomes of healing depend on one’s degree of 
faith. By extension, those who do not improve are implicitly lacking in faith – again, a case of 
blaming the victim. Poor health outcomes become doubled with poor spiritual outcomes. 
Only one patient spoke negatively about faith healing, saying that “you can be misled and 
gotten into things you don’t want to be in” (p28f), so this observation of potential stigma is 
not borne out by this data, but it deserves to be tested in future studies. 
 
7.5 - d) Acceptability 
The outcomes of care and its costs were the principle factors influencing patient preference. 
Where patients improved, they preferred the type of care associated with that improvement, 
and when possible they sought to reduce costs. Literature from South Africa suggests that the 
cost of a consultation with a traditional healer is the same as for a conventional primary care 
provider (Sorsdahl 2009) with the average cost of traditional healing amounting to Int$ 72 
(R321) at the 2008 PPP conversion rate. Another study from South Africa, using data from a 
national household survey, found a median cost of care for a traditional healing consultation 
of Int$ 33.7 (R150) (Nxumalo et al. 2011). A study on a much smaller sample of 51 patients 
from Nigeria calculated that traditional healing cost three times as much as conventional 
medicine, although the author expressed a clear bias in favour of conventional medicine 
(Makanjuola 2003).  
Mbwayo and colleagues in Kenya, also researching in Nairobi informal settlements, 
observed that the economics of traditional healing are not only a question of cost, but also of 
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how payments are made. They noted that some healers accept in-kind payments, payments by 
instalment, and even deferred payments based on treatment outcome (Mbwayo et al. 2013).  
Patient satisfaction appeared lower for traditional healers than for faith healers. A 
number of patients (18%, n=5) expressed discontent with traditional healing, some of them 
because it came at significant cost with no perceived benefit. Some faith healers and patients 
perceived traditional healers to be “fakes” or “liars,” however the majority of patients did not 
speak poorly of traditional healers. One patient spoke ill of faith healers. 
Both providers and patients of faith and traditional healing adopted a widely accepting 
stance towards conventional medicine. From a principled argument, faith healers and their 
patients observed that God governs doctors and healers alike, whereas traditional healers 
observed that herbs form the basis of both conventional and traditional medicine. More 
practical arguments for adopting a pluralist approach from the perspective of providers 
included that some people have less faith, and the providers’ need to maintain a client base.  
This relatively accepting stance on behalf of healers aligns with the literature on 
referral between traditional and conventional medicine, which suggests that traditional medical 
practitioners are more likely to be accepting of conventional medicine than vice-versa 
(Campbell-Hall et al. 2010; Asante 2012). One study from South Africa, however, found that 
within the field of psychiatry conventional practitioners were more open to traditional healing 
than in other areas of medicine (Mokgobi 2013). Another study from South Africa suggests 
that traditional healers turn to conventional medicine only as a last resort and for temporary 
measures, such as tranquilizing injections, which they view as a physical rather than psychiatric 
intervention (Sorsdahl, Stein, and Flisher 2010).  
 
7.6 Limitations 
The principle limitation of this study is the use of secondary qualitative data that could 
only partially be reconstituted. The partial coding of the qualitative data made rigorous 
qualitative analysis challenging. Furthermore, as the data were not designed with the purpose 
of answering my research questions, they did not permit me, for example, to answer questions 
about the economic accessibility of healing or to estimate the proportion of patients seen for 
mental health reasons. Some data on the cost of healing, however, can be found in chapter 
four in the section documenting direct costs of care. 
Not only were the data partial, but the initial process of data collection may have been 
influenced by the mission of the NGO BasicNeeds, who were co-investigators on the study 
and who were responsible for distributing the funds that paid for the research. As seen in 
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chapter four, the MHD model involves community mobilization, including through 
involvement of traditional and faith healers. The main intent of BasicNeeds’ engagement with 
healers has tended to be ensuring that the rights of people with mental disorders are respected, 
and encouraging referral to conventional medicine when traditional remedies are not 
demonstrating an effect. This background agenda may have influenced the responses given 
about referral, particularly on the part of providers. That being said, the research assistants 
doing most of the data collection were employed by the Africa Mental Health Foundation 
rather than by BasicNeeds, and did not necessarily share the same purpose. Moreover, 
research is understood to be a separate activity from the service delivery modules of the MHD 
model, such as community mental health, capacity building and livelihoods. Nonetheless, the 
results must be read with an awareness of the potential hidden influences resulting from the 
funding and implementation of the research. 
The generalizability of these findings is constrained by the specificity of healing 
practices to a given ethnic group. It was clear that ethnicity was of importance in the choice of 
healer by patients in that the ethnic composition of the two samples was closely matched. The 
informal settlement of Kangemi represented Luyha and Kikuyu most prominently, making 
this study most relevant to healing practices within that group. Nonetheless, the urbanicity of 
these healers may have a somewhat homogenizing effect on their traditional practices. 
Moreover, some healers may have idiosyncratic practices that have no bearing on their ethnic 
traditions. 
A further limitation to the quantitative analysis of this data is that the questions elicited 
free-listed responses. Rather than asking a person whether they had received a certain kind of 
treatment, for example, the question asked what types of treatment they had received. This 
technique allows for unpredicted responses, but it is likely to be less accurate in terms of 
enumeration. In addition, because of the purposive sampling strategy, it is unclear whether the 
sample is representative of the actual patient population attending healers. Nonetheless, the 
quantitative data are more accurate than no numbers. Moreover, from a qualitative 
perspective, free-listing is preferable in that it does not guide respondents towards pre-elicited 
responses. 
A more substantial limitation to this research is the risk of category fallacy, as 
described in chapter three. By applying biomedical diagnoses from the MINI assessment to a 
context of traditional healing, the research stands the risk of finding what it is looking for 
while missing the point. The concept of a mental illness does not neatly map onto the 
diagnostic system – referred to by anthropologists as “cosmology” – of traditional healing. 
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Against this backdrop, asking traditional and faith healers to enumerate the mental illnesses 
they treat, and furthermore inquiring how they diagnose them could seem absurd.  
Countless articles have set about similarly problematic tasks, trying to translate 
traditional practices into the language of Western medicine.  Speaking of traditional healing in 
East Africa, David Ndetei noted in 2007: 
 “Of course, they do not call it psychotherapy, but in practice it is 
psychotherapy as we psychiatrists understand it today. … Compare 
this with Freud’s and others’ psychodynamic procedures at the end of 
1800s and early 1900s and ask yourself who really invented 
psychotherapy and when!” (Ndetei 2007) 
Other scholars are more nuanced in their assertions, such as Marian Tankink who states about 
born-again churches in Western Uganda, “Many aspects of the churches' activities can also be 
found in western trauma therapies”(Tankink 2007). Joanna Teuton, researching healers in 
Uganda, notes that faith healers are more inclined to use Western psychiatric terminology than 
traditional healers, especially the term “counselling,” suggesting “greater exposure to a 
biomedical concept of mental health” (Teuton, Bentall, and Dowrick 2007).  
James Dow responds to the epistemological challenge of claims of equivalency 
between traditional medical practice and conventional mental health care. As if in response to 
Ndetei (though written well before), he jibes:  
“Can we really accept the idea that a shaman, chanting and singing 
over a prostrate patient, is analogous to Sigmund Freud sitting back in 
his chair and musing over a patient recounting her dreams? ... 
Shamanism and faith healing are types of magical healing, a type of 
symbolic healing that involves the ritual manipulation of super-human 
forces. Its contrasts with psychoanalysis are dramatic enough to 
illustrate that psychoanalysis does not provide a universal 
model.”(Dow 1986) 
While Dow speaks against using psychoanalysis or Western biomedicine more broadly as the 
“model” on which to map traditional practice, he does not shy away from drawing parallels 
between the different medical systems. Indeed, Dow sets out to establish a “universal 
structure” of healing. Central to his thesis is that all healing involves a “cultural myth,” used to 
define the problem, and “transactional symbols” that are attached to emotions.  
Without delving further into the complexity of Dow’s tenets, we can simply observe 
that cross-cultural parallels are not anathema to anthropology, and that traditional and 
biomedical practices can be compared. Furthermore, the healers were able to identify people 
who were “mentally ill” (akili isiyo timamu). Eighty per cent of the sample purposively chosen 
by the healers had a diagnosable biomedical mental disorder, suggesting a good rate of 
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correspondence between their categories and those of biomedicine at the broadest level of 
diagnosis.  
In addition to the challenge of category fallacy, this study faces numerous limitations 
in relation to the quality of data. Most significantly the absence of full transcriptions is a great 
short-coming. As a result, the qualitative analysis had to rely on fragments of transcription and 
pre-coded material. Nonetheless, these fragments lent a greater richness to the analysis than 
purely quantitative analysis of this data would allow.  
The study’s strengths balance its limitations. In particular, the triangulation of data 
between patients and healers allows for a more accurate depiction of practices than studies 
engaging with only providers or only patients. In addition, bringing quantitative analytic skills 
to bear on the topic of traditional and faith healing, as I have done here, is a relatively rare 
undertaking. Finally, given the difficulty of obtaining access to this understudied group of 
providers and patients, the data available for analysis were quite rich. 
Looking forward, if traditional and faith healing are to be conceived of on the same 
plane as Western medicine, then they ought to be evaluated along the same principles. In order 
for this to be acceptable to healers and biomedical practitioners alike, it would be desirable that 
diagnostic tools be developed that reflect local understandings of illness, as has been done in a 
elsewhere in Africa (Patel and Mann 1997). No studies exist at present evaluating the effects of 
traditional or faith healing on mental health outcomes in Africa. Further research is essential in 
this area to move discussion forward from whether to how to invest in collaboration between 
these two systems of care.  
 
  
  
253 
 
 
 
 
8. Conclusion: Where to From Here? 
 
 
 
 
 
Figure 8-1 Woman herding goats, Chuka, Meru district 
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8.1 Introduction 
In this thesis I set out to establish what contribution non-state actors make to coverage for 
mental disorders in Kenya. Drawing on the theoretical framework of Tanahashi to define 
health care coverage, I posed the following questions: 
 What is the availability of non-state mental health services? 
 How economically accessible are non-state services? 
 How culturally acceptable are non-state services? 
 How many and which patients are in contact with non-state services? 
 How effective are non-state services? 
The dissertation was structured according to different types of actors working outside of the 
public sector – in the formal and informal sectors, on a for-profit and not-for-profit basis. 
Overall, I hypothesized that the non-state sector was playing a significant role in providing 
health care in Kenya, despite not being appropriately recognized by the literature, but I 
imagined that the distribution of non-state care might not be equitable in terms of geography 
and income status. 
Using mixed methods allowed me to address these questions from multiple angles and 
gave greater depth to my findings. In chapter four qualitative data from interviews with 
programme staff and patients unearthed some of the complexities in delivering the MHD 
model, which could not be detected from the quantitative measures used in the cost-
effectiveness analysis. Inversely, the quantitative measures were more impervious to claims of 
anecdotal evidence, which could be made of qualitative data. In chapter five on Chiromo 
Lane, the qualitative data provided a rich description of the services available and the patients 
coming into contact with them, as well as shaping the questions to be asked of the quantitative 
data. In the first instance, the quantitative data from the hospital were to be descriptive, 
providing a measure of the amount and costs of services provided, but through discussion and 
observation, the question emerged about the effects of insurance on those costs and quantities 
of care. In chapter six different sampling strategies – snowballing and convenience sampling – 
offered different approaches to answering questions about outpatient care: in the former, 
providing access to a small and elusive population and in the latter providing access to a 
greater number of respondents. Finally, re-analysing qualitative data on healing in chapter 
seven allowed me to call into question existing categories of traditional and faith healer, while 
triangulating between patient and provider perspectives and challenging the strength of 
findings through simple tests of statistical association. The many methods and sources of data 
in this thesis make the exercise of synthesising the findings more complex – comparable to 
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herding goats (figure 1) – however, jointly they provide a more complete picture of a topic 
that rarely comes to light. 
I will shape my research conclusions around for-profit versus not-for-profit care. First I 
will present a summary of the findings by chapter, and then I will group the findings 
thematically according to the five types of coverage in Tanahashi’s framework, namely: 
availability, contact, accessibility (including affordability) acceptability and effectiveness. Next, 
I will discuss the limitations of these findings, and finally I will explore their implications on 
future policy and research. 
 
8.2 Main Findings 
 
8.2 - a) Summary of findings 
In chapter 4, examining the cost-effectiveness of the MHD model, results were most 
definitive for people with schizophrenia-spectrum or bipolar disorders (the majority of the 
sample). MHD cost Int$ 594 per person in the first year and Int$ 875 over two years from the 
societal perspective. The difference in the second year was largely the result of savings from a 
return to productive work among those in the MHD model. The two year cost per healthy day 
gained was and Int$ 1.09 and Int$ 2.69 from the societal perspective – less than agricultural 
minimum wage. The cost per DALY averted over two years was Int$ 205 and Int$504 from 
the societal and health system perspectives – on par with antiretrovirals for HIV. Findings 
proved sensitive at one-year follow-up, but robust over two years to two alternative scenarios 
investigated. MHD achieved increasing returns over time. The model appears cost-effective 
and equitable, especially over two-years, though its affordability relies on multi-sectoral 
participation locally and internationally. The qualitative data called attention to challenges in 
delivery of the model, particularly in coordination with other NGOs, capacity of health care 
providers to diagnose and treat, variations in leadership from place to place, and the influence 
of funders on the content of the model. Overall, the MHD model appears to be improving 
the quality of life of the majority of its participants, though it could arguably be improved by 
offering psychological therapies and improving medication supply. 
Patients at Chiromo Lane (chapter 5) were 66.4% male with a mean age of 36.8 years. 
They were diagnosed with substance use disorder (31.6%), schizophrenia-spectrum and 
bipolar disorder (49.5%), common mental disorders (7%); comorbid disorders (7%), and other 
diagnoses (4.9%). In addition to daily psychiatric consultations, two-thirds received individual 
counselling or group therapy; half received lab tests or scans; and 16.2% received ECT. Most 
took a psychiatric medicine. Half of those on antipsychotics were given only brands. 
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Insurance paid in full for 28.8% of patients. The mean length of stay was 11.8 days per 
admission and, in 12 months, 16.7 days (median 10.6). 22.2% were readmitted within 12 
months. Patients with PHI stayed 36% longer than those paying out-of-pocket and had 2.5 
times higher odds of readmission. The mean annual charge per patient was Int$ 4,262 (median 
Int$ 2,821). Insurers were charged 71% more than those paying out-of-pocket - driven by 
higher fees and longer stays.  
The qualitative data depicted a facility with a relatively non-restrictive and welcoming 
physical environment, employing a therapeutic community approach to treatment in which 
patients were given a voice. Nonetheless, the majority of patients (70%) were involuntarily 
admitted and did not have a choice about whether or not to take the medicines prescribed. 
The preferred method of medication administration, to avoid problems of adherence, was 
injection. Mandating medications was justified as a cost-saving procedure. The human rights 
standards at Chiromo were visibly higher than in its public counter-part, Mathare National 
Referral Hospital. In 2011, Chiromo delivered acute psychiatric services to approximately 450 
people, to quality and human rights standards higher than Mathare, but at considerably higher 
cost. With more efficient delivery and wider insurance coverage, Chiromo might expand from 
its occupancy of 56.6% to reach a larger population in need. 
The chapter on formal outpatient services (chapter 6) revealed that only half (47.5%) 
those with psychiatric nursing degrees worked specifically as psychiatric nurses. Those 
employed as general nurses nonetheless saw on average half (46%) mental health cases. Ten 
per cent of psychiatric nurses had run a private clinic (75% of them general clinics), and 15% 
were doing private locum work alongside salaried employment. Kenya would need to increase 
the number of psychiatric nurses 20 times in order to achieve the internationally 
recommended ratio of 12 psychiatric nurses per 100,000 in low-income countries. It appears 
psychiatric nurses are migrating internally to nursing positions in other areas of health care, 
aggravating the existing “brain drain” on mental health. 
Among psychiatrists and psychiatric nurses running private clinics, a quarter ran 
general health clinics, while the remainder focused on mental health. Respondents had a mean 
active case load of 128 mental health patients. The majority of patients (55%) were seen for 
common mental disorders; 25% for severe mental disorders; and 15% for substance use 
disorders. Three quarters of providers split their time between public and private practice. Use 
of atypical antipsychotics and better follow-up were reported in private practice. Wait-times in 
private outpatient clinics were relatively short, estimated by providers to be 20 minutes. The 
mean fee for a standard consultation by a psychiatric nurse was Int$ 13 (Ksh 500) and by a 
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psychiatrist Int$ 55.3 (Ksh 2,100) – equivalent to 2.5 days and half a month respectively of a 
typical agricultural worker’s income. In a context where mental is associated with psychotic 
behaviour, a private clinic in the community may offer a less stigmatizing, more “private” (in 
the sense of confidential) option than hospital-based care, to those who can afford it. In 
addition, where public health providers are underpaid, private employment may act as a cross-
subsidy for public health care. 
Finally, the chapter on healers (chapter 7) found socio-demographic differences 
between traditional and faith healers, but considerable overlap in their interpretations of the 
cause of illness. Faith healers (all Protestant) were better educated and had higher incomes 
than traditional healers. They were also more likely to be women than traditional healers, as 
were their patients.  The mean age of healers was 43 years, while for patients it was 33 years. 
Traditional and faith healers alike diagnosed patients as “bewitched” or “demon-possessed”; 
however their patients were less likely to use those terms. According to biomedical diagnoses, 
75% of patients had a common mental disorder and 7% had epilepsy, while 18% did not meet 
biomedical criteria for a mental disorder. Patients with epilepsy appeared to attend traditional 
healers more than faith healers, while those with bipolar disorder were more likely to attend 
faith healers. There was a notable under-representation of individuals with alcohol problems 
among patients of healers (3%). 
The practice of traditional healing (herbalism and divining) was more biological than 
faith healing. Traditional healers focused on the body – vomiting, diarrhoea, sneezing, 
drooling, drinking, bathing – whereas faith healing was less material, and focused on the spirit 
through prayer, reading, talking, singing. Some aspects of treatment, particularly prayer, were 
shared across traditional and faith healers. A few procedures raise alarm in terms of patient 
rights, most notably a practice common among herbalists of cutting the skin with a razor to 
free demons. Faith healing also presented potentially stigmatizing principles in the idea that 
illness results from sin and that the outcome of healing depends on one’s faith. Both of these 
principles imply that those who do not improve are either sinful or lack faith – both cases of 
blaming the victim. Providers and patients of faith and traditional healing adopted a widely 
accepting stance towards conventional medicine. The outcomes of care and its costs appeared 
to be the principal factors influencing patient acceptance of a given model of care.  
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8.3 Thematic Findings 
 
8.3 - a) Availability Coverage 
How do these findings address the over-arching theme of coverage raised by my thesis? To 
address this question, first I will first look at coverage in terms of service availability, followed 
by accessibility and contact coverage, and finishing with acceptability and effectiveness 
coverage. In measuring the availability of mental health services provided by non-state actors, 
I will look at the number of human resources to estimate the number of patients treated.  
 
8.3.a.i For-profit care 
Outpatient care – My research revealed a hidden face of community mental health care 
in the form of private practice specialists providing outpatient care (de Menil et al. 2014). In 
Nairobi, the private practice market for mental health care appears to be cornered by 
psychiatrists, whereas outside of the capital, there are a significant number of psychiatric 
nurses running private clinics. Nurse-run clinics tend to be for general health care, but they 
include mental health and a quarter of patients are seen for mental health reasons. My sample 
of nurses attending the annual general meeting of the mental health chapter of the National 
Nursing Alliance of Kenya revealed that 10% had experience running a private practice. All of 
them also worked in the public sector. In addition, 14% of the nurses were working in part at 
other for for-profit health facilities. 
Inpatient care – Private hospital care for mental health is mostly centred around Nairobi. 
In Nairobi, three hospitals provide inpatient psychiatric care in specialized units: Nairobi 
West, Avenue Hospital and the Chiromo Lane Hospital Group. Collectively, these three 
hospitals offer approximately 100 psychiatric inpatient beds, which is one sixth of the number 
of beds in the public national referral hospital, Mathare. Outside of Nairobi, there are no 
psychiatric units on any hospitals in the non-state sector. 
In addition to these hospital beds on specialized mental health units, many general 
private hospitals offer inpatient psychiatric services in non-specialized units. Psychiatric 
patients in general hospitals can be seen either in general wards or in private rooms. According 
to Kenya’s Private Sector Health Assessment, there are 259 private hospitals in Kenya (Barnes 
et al. 2010). A further form of residential care provided on a for-profit basis is found in 
substance use rehabilitation centres. Data from NACADA suggest that there are 16 such 
facilities operating on a for-profit basis throughout Kenya. 
Because of the scarcity of health specialists in Kenya, psychiatrists (and other health 
specialists) are not salaried hospital employees on private hospitals. Instead, they operate as 
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consultants, who are given admitting rights at various hospitals.  Private hospitals themselves 
do not track the number of psychiatric patients seen within their facilities. Instead, these 
patients are tracked and followed-up by their psychiatrist. The best way to estimate the 
number of mental health patients seen on an inpatient basis in the non-state sector is therefore 
to interview psychiatrists. This is what I did, and on average private specialists (who numbered 
24 in 2010 (Kiima and Jenkins 2010)) referred 12 patients per month to inpatient care.  
Aggregating data from the chapters on outpatient and inpatient care, and combining it 
with pre-existing numbers from other sources, we can start to estimate the number of patients 
receiving specialized mental health care from private for-profit providers. Using the 
occupancy rates from Chiromo Lane and The Retreat rehabilitation centre, together with data 
on target length of stay from the websites of NACADA accredited facilities, I estimated the 
number of patients treated in specialized inpatient facilities. By combining the number of 
patients referred per psychiatrist with the number of private hospitals, published in the World 
Bank Private Sector Health Assessment (Barnes et al. 2010), we can estimate the number of 
patients seen in general hospitals.  
 
Patients treated in specialist facilities = N(facilities) * µ(beds) * occupancy * (1 year/LOS) 
Patients treated in general facilities = N(referrals/year) * N(private psychiatrists) 
         
The most complete information available is on for-profit inpatient care, which is treating 
an estimated 5,721 people with mental and substance used disorders each year – 3,456 in 
general hospitals and 1,517 in specialized psychiatric units (table 8-1).  For rehabilitation 
centres, which have an estimated occupancy of 52% and a target length of stay of 4 months, 
the predicted number of patients seen per year is 750. The data from this thesis do not enable 
us to estimate the coverage of traditional healers in the treatment of mental disorders. It is, 
however, apparent that many people with mental disorders attend traditional and faith healers, 
especially women with common mental disorders. 
 
8.3.a.ii Not-for-profit care 
Outpatient care – It is harder to quantify the coverage of not-for-profit mental health care by the 
non-state sector. According to my findings from the annual general meeting of psychiatric 
nurses, 20% of Kenyan psychiatric nurses work in part for not-for-profit facilities. Combining 
that with for-profit participation, we find that 28% of psychiatric nurses work part-time or 
more in the non-state sector. This number is markedly lower than the statistic cited in the 
World Bank’s “Private Health Sector Assessment for Kenya,” which found that 67% of 
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enrolled nurses work for the non-state sector. It is possible that my sample was skewed 
towards the public sector, because private sector providers may have more barriers or less 
incentive to attend an annual general meeting of a professional association. It is equally 
possible, and indeed likely, however, that the field of mental health is less privatised than other 
areas of health care. One reason for this could be that the private mental health market 
remains dominated by traditional and faith healing.  
Outpatient specialist mental health services are offered in selected areas of Kenya by 
NGOs. Only three of the fifty nurses questioned (6%) worked on an outpatient basis for not-
for-profit agencies. Unfortunately, the umbrella organization for health-related NGOs, 
HENNET, does not track which of its 85 members work in mental health. The NGO 
BasicNeeds is the leading mental health provider in Kenya and it organizes service delivery 
jointly with the state sector. BasicNeeds estimates that it enabled outpatient treatment for 
1,770 people with mental illness through their programme in 2010 (BasicNeeds 2011). Other 
NGOs also operate within the field of mental health in Kenya, in particular providing 
counselling to refugees. Such is the case of the International Refugee Committee, and MSF. 
Data on the number of people treated are unfortunately not publically available for these and 
other small-scale mental health programmes.  
 
Inpatient care – At the inpatient level, the only specialist not-for-profit mental health 
services are rehabilitation centres for alcohol and drug abuse. No not-for-profit hospitals were 
found with a specialized psychiatric unit. Indeed, the non-state sector dominates treatment for 
alcohol and drug abuse; without this sector, there would be almost no services available for 
people with these disorders. Ninety per cent of residential rehabilitation centres are privately 
run, and approximately half of them (16 facilities) are not-for-profit, faith-based organizations. 
Collectively, these not-for-profit rehabilitation centres treat an estimated 750 individuals with 
substance use disorders each year (table 1). 
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Table 8-1: Estimated national coverage of non-state specialist mental health care 
 
 
 
 
For-profit Not-for-profit 
Inpatient care (hospitals) Facilities Psych Beds Patients/yr Facilities Psych Beds Patients/yr 
General inpatient facilities 259 0 3,456 74 0 NA 
Psychiatric inpatient facilities 3 100 1,517 0 0 0 
Alcohol and drug rehabilitation centres 16 480 749 16 480 749 
Total inpatient 
  
5,721 
   Outpatient care (human resources) Providers Caseload/yr Patients Providers Caseload/yr Patients 
Psychiatrists 24 298 7,152 0 0 0 
Psychiatric nurses 30 144 4,320 30 NA NA 
Psychologists 30 NA NA 0 0 0 
Counsellors NA NA NA NA NA NA 
   
11,472 
   Total 
  
16,445 
  
NA 
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1.2 - b) Contact Coverage 
 
8.3.a.iii Treatment gap 
What percentage of the Kenyan population in need are in contact with mental health services? 
Measuring treatment coverage requires knowledge about prevalence rates of mental disorders 
in the community. The most complete data available are on the treatment of substance use 
disorders. There are no community-based prevalence data from Kenya on these disorders; the 
only community-based evidence is on substance use – pathological or otherwise (Atwoli et al. 
2011). Data on misuse (abuse, dependence) come from a clinic-based convenience sample 
(Ndetei, Khasakhala, Ongecha-Owuor, et al. 2009). The best available community-based 
prevalence data are from Nigeria (collected as part of the World Mental Health Survey): the 
12-month prevalence of substance use disorders was 0.8% (0.6% alcohol-related, 0.2% drug-
related) (Gureje et al. 2006). Applying this prevalence to the Kenyan population of 38 million, 
we would estimate that 304,000 people experience a substance use disorder in a given year. 
The prevalence of substance dependence, as opposed to abuse, was found to be only 0.1% in 
Nigeria, which would translate to 38,000 people in Kenya. By that measure, the 1,500 people 
receiving substance use treatment from non-state actors represents only 4% of the population 
in need.  
Although the non-state sector is meeting only a small fraction of the treatment gap for 
substance use disorders, it nonetheless is providing markedly more treatment than the public 
sector for these same disorders. If we assumed that the four public facilities operated at 100% 
occupancy with the same number of beds as the average non-state facility and that the average 
length of stay were 25% shorter than in the non-state sector, we would arrive at an estimate of 
approximately 500 people with substance use disorders being treated per year by public 
facilities – only 1.3% of the population in need. By this count, the non-state sector would be 
treating an estimated three times as many people with substance use disorders as the public 
sector.  
These estimates of public sector coverage are purely speculative, however. While the 
report of Kenya’s National Commission on Human Rights suggests that 100% occupancy is a 
reasonable estimate (Kenya National Commission on Human Rights 2011), no data exist on 
length of stay from a public mental health facility in Kenya. One might expect that longer-
term stays, such as those found at substance use rehabilitation clinics, would be shorter in the 
public sector, because of financial constraints to the state provider. Inversely, one might 
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expect that inpatient hospital stays (which tend to be shorter-term than rehabilitation centres) 
would be somewhat longer in the public sector than those found in Chiromo Lane, because 
patients are not paying for their own care, and the cost per day is considerably lower (based on 
WHO unit cost estimates). But it is not possible to put hard numbers to these estimates based 
on currently available data. 
Calculations of treatment coverage are equally, if not more, challenging for other 
mental disorders. If we assume that the prevalence of schizophrenia-spectrum and bipolar 
disorders corresponds to the estimate of 0.6% by the first community-based study of 
psychosis in Kenya (Jenkins et al. 2012) then 228,000 people in Kenya are affected by these 
illnesses. Using data from Chiromo Lane, we can postulate that people with schizophrenia-
spectrum or bipolar disorder represent two-thirds of inpatients at private for-profit facilities, 
which amounts to 3,332 patients a year. If these numbers are accurate, then only 1.5% of the 
population with these disorders is receiving inpatient care from a private provider. In the 
public sector, we know the number of inpatient psychiatric beds (1,114) (Kiima and Jenkins 
2010), but there are no data on average length of stay or admissions, so we cannot estimate 
the treatment coverage. The treatment coverage for depression and anxiety-related disorders 
(the common mental disorders) is particularly difficult to measure, because these disorders are 
largely treated on an outpatient basis, including through primary care, and no data exist on the 
coverage of public outpatient mental health care. 
 
8.3.a.iv Equity of contact 
The question of who is in contact with non-state mental health care raises concerns about 
equity, in particular around illness and gender. In terms of illness, different patients attended 
different providers. The most striking finding was that people with alcohol and substance use 
disorders are almost exclusively receiving care through the non-state sector, as discussed in the 
section on coverage of care above. In addition, common mental disorders were found more 
commonly in outpatient private practice than in inpatient settings – as might be expected. 
Over half of patients at private practices were seen for common mental disorders, while they 
represented only 10-20% of the inpatients at Chiromo Lane.  
Variation in illnesses creates a resulting variation in patient gender. Since, across multi-
national epidemiological studies women experience common mental disorders with greater 
frequency than men (Steel et al. 2014), the greater representation of common mental disorders 
in outpatient private practice means that women are accessing care more through these 
services. Over half (56%) of mental health patients in private practice were women. Women 
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were also in the majority at traditional and faith healers, constituting 72% of the sample. Faith 
healers were significantly more likely to have female patients than traditional healers. This is 
likely because faith healers themselves were more often women (48% vs. 17%). The diagnoses 
appeared relatively similar between these two patient groups, though the small sample sizes 
made comparison challenging. 
Though women sought care from outpatient services more commonly than men, data 
from the economic evaluation of the MHD model suggest that women do not differ from 
men in their response to treatment. Health outcomes were not statistically different between 
men and women. That being said, the benefits of the MHD intervention were not only on 
service users, but also on their carers, who were predominantly (72%) women. The average 
time spent care-giving was halved from 15 hours at baseline to 8 hours at follow-up, and the 
number of people who reported being assisted by a carer dropped from 37% to only 8%. The 
economic and psychological benefits of the intervention to carers thus disproportionately 
affected women. 
 
8.3 - b) Accessibility Coverage (Affordability) 
Limited data were available on income or wealth-levels of the patients studied, however proxy 
variables provided some insight. Using education level as a proxy for socio-economic status, 
the patients of the MHD model were among the poorest members of society, as demonstrated 
by their having attained lower than average levels of primary education (15% vs. 32% in the 
general population of Central province). By contrast, patients at Chiromo Lane were in the 
highest socio-economic bracket, as suggested by high levels of formal employment (50.6% as 
compared to a national average of 9%). We can conclude, predictably, that not-for-profit care 
targets the lowest socio-economic groups, while for-profit care caters to the wealthier.  
That being said, there is considerable grey area around private outpatient services, 
which appear to serve not only the rich, but also the “middle-class.” It is notable that 
traditional healers cost approximately the same amount per session as psychiatric nurses in 
private practice. It would appear mistaken, therefore, to assume that traditional healing is the 
form of care most financially accessible to the least well-off. Traditional practitioners are, 
however, more physically accessible in that their numbers are far greater than private 
practitioners – although the prevalence of non-specialist private practitioners was not 
examined in this thesis.  
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8.3.b.i Outpatient care 
Much as there is variation in capacity between the different cadres of non-state providers, so 
too is there variation in their costs and charge. Data on outpatient mental health care from 
private specialist providers suggest that the cost of a visit to a private psychiatric nurse is 
equivalent to 2.5 days of a farmer’s wage, while a visit to a psychiatrist costs two weeks of 
wages, making the latter unaffordable to most. These costs represent the price rather than the 
economic cost of care, which was not possible to calculate with the available data.  
Data on the economic costs of traditional healing were available from the economic 
evaluation of the MHD model. Faith healers did not charge for their services, whereas 
herbalists charged in cash on a fee-for-service basis. Neither faith nor traditional healers in this 
setting asked for in-kind payments. The mean fee per session with a herbalist was Int $ 14.7 – 
equivalent to three days of a farmer’s wage. This puts the cost of traditional healing on par 
with that of seeing a psychiatric nurse in private practice. When taking account of 
transportation and the opportunity costs of time or lost productivity (and perhaps earnings), 
the economic cost of seeing a traditional healer came to Int $ 24.0 per session and Int $ 53.3 
per year – equivalent to three weeks of a farmer’s wage. 
Findings on the MHD model suggest that it is equitable, favouring  poorer segments 
of the population and shifting the cost burden from them to other payers. Before the 
intervention, 92% of costs were borne by the service user, whereas after two years, the average 
user made savings of Int$ 289. The majority (86% in the first year) of direct costs were born 
by the NGO. Government costs doubled over the course of the intervention, as care shifted 
from hospitals to the community; however they remained modest throughout and decreased 
proportionally, amounting to only 6%-8% of total costs before and in the first year after the 
intervention.  The affordability of this model relies on multi-sectoral participation locally and 
internationally.  
 
8.3.b.ii Inpatient care 
Inpatient care at Chiromo Lane was the most costly of the interventions examined.  The 
average cost per inpatient day was Int$ 266, amounting to a yearly cost of Int$ 4,262. 
However, average costs were skewed by a few patients who required longer stays, so the 
median cost was considerably lower at Int$ 2,821. This is more than per capita Kenyan GDP 
(Int$ 1,015), but on par with the average salary of an employee in the formal sector (Pollin 
2009).  
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One way to offset the financial burden of treatment was through private health 
insurance. A quarter of patients at Chiromo had their care paid in-full either by an insurance 
provider or by their employer. Those with a third-party payer were 2.5 times more likely to be 
readmitted than those paying out-of-pocket, controlling for diagnosis, age, sex, and 
employment. They also stayed a third longer, and paid 25% more per day than those paying 
out-of-pocket. The combination of longer stays and higher prices led the overall annual charge 
to be 71% higher for those with a third-party payer than those paying out-of-pocket. It is 
impossible to say for sure whether more care reflects the moral hazard of insurance, or 
increased access to needed services, or both. However, there was no evident over-
consumption of care, when benchmarking the findings (on length of stay and ECT use) 
against other inpatient psychiatric units in Africa. This finding suggests that insurance may be 
enabling access to needed mental health services. 
 
8.3 - c) Acceptability Coverage 
The cultural acceptability of mental health care was addressed exclusively in chapter 
seven on healers in the informal settlement of Kangemi. One of the assets highlighted by 
patients about traditional and faith healing is that it offers an explanation and meaning to 
people’s experience of illness – teaching “God’s purpose,” or addressing the underlying causes 
and not just the symptoms to produce a “cure.” This vehicle of meaning appears to be at the 
heart of what renders healing not only acceptable but desirable to many individuals. 
Traditional and faith healers alike saw their practice as largely complementary to conventional 
medicine, either because conventional and traditional medicine are both based in herbs, or 
because God governs both patients and doctors. By and large, patients were pleased with their 
experience of traditional and faith healing (albeit more so by faith healing because it was not 
associated with costly herbs and treatment expenses), and often traditional healing and 
conventional medicine are used pluralistically in tandem with one another. 
 
8.3 - d) Effectiveness coverage 
The question of effectiveness of available mental health care in Kenya is vast and can only 
partially be addressed by the available data. The data from Chiromo Lane shed some light 
onto the quality of care in a for-profit inpatient facility, although there are no outcome 
measures and it is of limited generalizability. The patient-to-staff ratio at the facility was three 
times higher than that found in the public sector, medicines were available in wide variety and 
without shortage, electro-convulsive therapy was administered at doses in keeping with NICE 
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guidelines, and the facilities were clean and hygienic. By contrast, conditions at Mathare 
Hospital were so poor that 40 male patients escaped in a dramatic episode that took place in 
May 2012, while this research was being conducted (de Menil 2013). This episode followed on 
the heels of a report by the Kenya National Commission on Human Rights, which pointed a 
finger at the “systemic neglect” in effect throughout the public mental health system (Kenya 
National Commission on Human Rights 2011). 
The only true outcome data within the dissertation were found in the evaluation of the 
model for Mental Health and Development, a product of the NGO BasicNeeds. The MHD 
model appeared cost-effective from both societal and health systems perspectives, with the 
most conclusive data for those with schizophrenia spectrum and bipolar disorders over two 
years. Its cost-effectiveness as estimated by my data in comparison with the literature is in the 
same order of magnitude as that of anti-retroviral treatments for HIV. The model did not, 
however, appear cost-effective for common mental disorders in the first year, though the 
small size of that sample (n=21) makes this finding uncertain. Overall, the data suggest that 
mental disorders, including schizophrenia spectrum and bipolar disorders, can be effectively 
treated within the community, using a combination of outpatient mental health visits and 
social and economic supports in the form of community health workers and self-help groups. 
 
8.4 Limitations 
The findings in this thesis are limited by a number of constraints of the data. Chief among 
them is the highly fragmented nature of the datasets. As data on mental health care in Kenya 
are scarce, and more so still on non-state mental health care, the dissertation pulls together 
information from a diverse range of sources, both primary and secondary. The sources 
included computer archives, structured interviews, open-ended interviews, a questionnaire, key 
informants, the internet and the grey literature. The multitude of sources and types of data 
make the dissertation inevitably uneven from chapter to chapter. 
As such, the data in this thesis do not offer a comprehensive map of non-state mental 
health services, and gaps remain in the evidence. Geographically, the data come largely from 
Nairobi, Nyeri and Meru counties, which do not represent the country as a whole. This is 
particularly true of chapter five on for-profit hospital care, which is largely inaccessible to the 
country’s rural population, as well as to the majority of its urban population for reasons of 
cost. 
In addition, the data do not address mental health care provided by private non-
specialist providers, be they lay workers or primary care providers. Collecting non-specialist 
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data would have been too costly and time-consuming to include in this dissertation. In 
addition, no quantitative data were analysed on counsellors, a cadre of university-trained 
specialists who provide psycho-social interventions. Counsellors were only captured in the 
case study of Chiromo Lane. Indeed, counsellors appear to provide limited treatment for 
pathological distress – mostly substance use support – tending to focus more on non-
pathological distress, such as support for victims of domestic violence and people living with 
HIV. Closer examination of this cadre of workers would shed light onto not only treatment 
but also on prevention of mental disorders. 
Limitations differed according to the datasets. The data on outpatient care were 
limited by the small sample size (11). The reason for this, in part, may have been that no 
financial compensation was offered for participating in research, and the opportunity cost of 
participating was perceived to be significant for private sector providers. Were I to conduct 
further research on for-profit providers, I would challenge the prevailing norm among those 
advising my research in Kenya that views remuneration for participating in research as 
exploitative. 
The data on cost-effectiveness had a relatively large sample (203), but the sample size 
dropped significantly when looking at individual diagnostic groups, as was necessary when 
analysing outcomes. The main limitation of that data was the absence of control group – a 
design choice made for reasons of practicality. The NGO could not afford to identify cases 
and conduct research on a wait-listed control, as it was funded from intervention money 
rather than from a research grant. That being said, existence of standardized pre-post outcome 
measures on an NGO population in Africa is itself a rarity, especially within mental health 
services, so having any economic data to analyse was exceptional. I addressed the absence of 
control group by finding data in the literature from neighbouring Ethiopia, which faces similar 
resource constraints to Kenya, particularly rural Kenya.  
Data from Chiromo Lane were limited by the absence of outcome measures, as well as 
by the dearth of comparison indicators from the public sector. However, it is a rare luxury to 
have data of this richness, itemizing mental health services and costs, from sub-Saharan 
Africa, and it is unprecedented to have such data from a private facility. Furthermore, no 
quantitative data were initially anticipated from the case study of Chiromo. Rather, 
quantitative data were expected from the Ministry of Health, which – despite many requests – 
never produced any material. The lesson from that experience is that it would have been more 
practical to obtain data directly from the major public psychiatric hospital, rather than 
approaching the Ministry of Health.  
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The healer dataset was imperfect because of the missing transcripts and the inability to 
associate patients with specific healers. As a subject of secondary analysis, it also failed to 
answer some of my research questions, specifically on economic access. Nonetheless, the 
triangulation of data between providers and patients was a great strength of this dataset. 
Furthermore, it is challenging to obtain sufficient trust from healers to engage them in 
research, and as a European researcher, I would have been unlikely to obtain this data were I 
conducting primary data collection.  
 
8.5 Policy Implications 
Private health care in Africa has been the topic of growing interest for several years. One key 
informant noted, “Governments [in Africa] fall into two categories in their approach to the 
private sector: either they view it as a necessary evil, or as a reliable partner” (Gitonga 2011, 7 
October). Kenya falls clearly into the latter category. A national commitment to working 
jointly with the private sector has just been reiterated in the new health strategy, reinforcing its 
prominence in the previous strategy. The current strategy states: 
“This Policy recognizes the important role and participation of the 
private sector in all areas of health delivery… Drawing from past 
experiences, the private sector can be expected to contribute 
substantially to the urban primary and tertiary levels. … The 
government sees the private sector as a crucial partner, both as a 
source of financial resources for the health sector and in ensuring 
program delivery competencies.” (Government of Kenya 2012) 
The pro-private tone of Kenya’s health sector finds an echo in the mental health sector. The 
draft national mental health policy voices equal enthusiasm for private sector involvement. 
The word “private” is mentioned no fewer than 26 times in the 34 page document, including 
in the following enthusiastic terms: 
“As envisaged in the Kenya Vision 2030 and in this policy, the 
provision of mental health services will also entail partnership with the 
private and voluntary sector. The government will encourage and 
promote the development of the private sector in provision of mental 
health services. This will enhance the financial and human resource 
base for provision of mental health services.” (Government of Kenya 
2012) 
Both of these documents cite comparative advantages of private care. The national health 
strategy points to the provision of services at primary and tertiary levels in urban settings, 
while the national mental health strategy points to the private sector as a means of increasing 
human and financial resources – a “cash cow” of sorts. 
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What lessons does my research offer to proponents and detractors of private mental health 
care in Kenya and elsewhere in Africa? Kenya’s health strategy was the product of two 
separate health ministries – the Ministry of Medical Services and the Ministry of Public Health 
and Sanitation – a division resulting from the coalition government following the election 
violence in 2007-2008. My findings are more relevant to the former than the latter agency, as 
they address treatment more than prevention, and they are equally relevant to international 
donors. Four key policy lessons emerge in line with the sub-themes of my research. 
 
8.5 - a) Availability coverage 
Moving beyond the question of whether non-state care is desirable, from a policy 
perspective the question at play is how the state should engage with non-state actors. Several 
models of engagement exist. As outlined by Patouillard, models of engagement include: 
training, social marketing and vouchers, contracting, franchising, regulation and accreditation 
(Patouillard et al. 2007). These different forms of engagement work to different ends, some 
(training, regulation, franchising) to improve quality, others (vouchers) to increase access, and 
others (contracting) to increase scale, and many forms of engagement address multiple aims 
simultaneously. The research in this thesis suggests that availability coverage could be 
increased through more training and possibly contracting out services within certain counties. 
Kenya needs to train more nurses in both mental health and general nursing, so as to 
reduce the internal brain drain of psychiatric nurses to other specialties, and to address the 
system wide shortfall of nurses. General nurses should also be offered opportunities to 
increase their training in mental health, since they provide some of these services.  
Another way of increasing the scale of services provided would be for the government 
to contract out services that it is not equipped to provide. The model for Mental Health and 
Development offers a holistic intervention combining medical, social and economic activities, 
and appears to be delivered effectively at the community-level through a public-private 
partnership. It is especially effective for populations with severe mental disorders and epilepsy, 
while its efficacy in treating common mental disorders remains unproven. Further expanding 
this model beyond the handful of counties where it is currently implemented could 
complement existing efforts at integrating mental health into primary care, as well as providing 
livelihood opportunities to the poorest segments of society.  
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8.5 - b) Contact coverage 
It is evident that there is a substantial treatment gap across multiple levels of mental 
health care, which warrants action. The treatment gap for substance use disorders is 
particularly wide. The for-profit sector is currently providing an estimated three quarters of 
inpatient services for these disorders. For people with severe mental disorders, there is a great 
gap in services for supportive residential care, post hospitalization. At present, almost no 
services exist between the hospital and the home for this population. Finally, for those with 
common mental disorders, the efforts to address mental health needs through non-specialist 
primary care providers do not meet the estimated needs, and traditional and faith healers 
continue to be a first port of call. Making specialist services available in primary care facilities 
is possible, as demonstrated by the model for Mental Health and Development.  
Psychiatric nurses cannot, however, work simultaneously in hospitals and community 
facilities, so there may be a trade-off in these two forms of care so as to reach larger numbers 
of people and intervene earlier in the course of illness. For acute care, there is scope for 
government or other payers to make more use of private hospitals, which are currently 
running at low levels of occupancy. 
In order to reach more women with mental health needs, it is advisable to increase the 
amount of outpatient services. This can be done in part by explicitly allowing nurses to work 
in both public and private sectors, a practice that is implicitly prohibited, though often 
undertaken. Making cross-sectoral work explicitly legal would clarify roles for nurses and 
might encourage the participation of some nurses otherwise hesitant to engage in this work.  
 
8.5 - c) Access coverage 
In relation to socio-economic inequities, private mental health care appears to reach the 
poorer segments of society predominantly through traditional and faith healing. Private 
outpatient clinics run by psychiatric nurses cost the same as a visit to a traditional healer, 
however they are less prevalent. Private hospital care is priced far outside of what is affordable 
to most Kenyans. The primary means by which care can be made more accessible is by 
lowering costs (through use of generics and less reliance on psychiatrists in the first instance) 
and by increasing insurance coverage. This lesson applies not only to mental health, but to any 
chronic, non-communicable disease. Similarly efforts at improving access to public mental 
health care facilities could help reduce the disparity between the two sectors. 
Quality mental health care is not cheap, but it can be cost-effective at ratios equivalent 
to a comparatively much better funded area, namely HIV. For mental health to be affordable 
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at scale, plans must be made for its adequate financing. Ultimately more money is needed, 
given the size of the gap. From the demand side, one way to offer financial protection is by 
including mental health within insurance schemes and expanding insurance coverage.  
From the supply side, a means of potentially increasing funds to mental health would 
be to include it within budgets and service plans for non-communicable diseases. In addition, 
mental health interventions should be jointly assessed for their economic benefits in returning 
people to productive work. Development funders might therefore take interest in 
opportunities for investing in mental health interventions that promote economic 
empowerment. 
 
8.6 Research Implications 
Reaching beyond policy to research, this dissertation offers a few key insights on how to 
improve the state of knowledge about non-state mental health care. 
1. The private sector is providing a significant amount of mental health care and needs to 
be tracked by newly developing health information systems. 
2. Basic data are needed across all sectors of the health system (public, private, informal) 
on mental health service use and outcomes – for example, length of stay, number of 
admissions and readmissions, as well as (ideally) health outcomes.  
3. Data on costs need to be more tailored to mental health services. 
4. The quality of non-state mental health provision needs to be monitored, particularly 
that of mushrooming rehabilitation centres. 
5. Future research should give a voice to service users with which they can co-produced 
research. 
The WHO’s new Mental Health Action Plan underscores the first point about improving 
health information systems.  The Plan defines four key objectives: 1) to strengthen effective 
leadership and governance for mental health; 2) to provide comprehensive, integrated and 
responsive mental health and social care services in community-based settings; 3) to 
implement strategies for promotion and prevention in mental health; and 4) to strengthen 
information systems, evidence and research for mental health (Organization 2013). The fourth 
objective is followed by a target of 80% of countries “routinely collecting and reporting at 
least a core set of mental health indicators every two years through their national health and 
social information systems by the year 2020.” No information is collected by the health 
ministries on mental health from the private sector, other than a license to operate. If this 
continues, then Kenyan authorities will be missing a large part of the picture of mental health 
  
273 
 
services on offer in their country. Their health information systems need to catch up with 
their policy rhetoric to integrate private health care within the data they track.  
The absence of any published data on mental health service use in the public sector is 
more surprising and constitutes an ostensible gap in the knowledge about the national health 
system. The scientific literature has published statistics on the numbers of public providers 
(Kiima and Jenkins 2010) and the diagnostic profiles of patients (Ndetei, Khasakhala, Maru, et 
al. 2008), but no information is available on length of stay or readmission rates in public 
hospitals. Nor is there systematic tracking of the number of outpatient mental health visits at 
the primary care level.  
Outcomes of care from both conventional medicine and traditional and faith healers 
are necessary to evaluate their effectiveness. There is a particular need for greater ease of 
cross-over between measures of preference-based health-related quality of life and disease-
specific outcome measures for the purpose of cost-effectiveness analysis within mental health. 
This would enable more often use of the QALY as an alternative to the DALY, which is 
designed to account for disease burden rather than an intervention effect. Research into this 
area is well underway (Mihalopoulos et al. 2014) and promises to create more options for 
measuring outcomes relevant to mental health in the future. 
Research into traditional and faith healing needs to take account of differing 
understandings of disease causality, and diagnosis, so as to measure efficacy in a way that is 
meaningful to the patients and providers of these services. Appropriate research in this area 
might succeed in differentiating between practices that are helpful and harmful within this 
treatment class, and furthermore whether there are patient- specific factors that influence the 
benefits of treatment. 
Better measuring the costs of mental health care also presents an area of potential 
improvement for further research. The WHO unit costs for public outpatient services are 
likely to under-estimate the amount of time needed for a mental health consultation. 
Furthermore, when costing mental health services, as with any service for chronic disease, the 
choice of how to measure unpaid care is fundamental to the evaluations of cost-effectiveness. 
The concept alone of unpaid care raises questions in a cultural context where a family member 
may consider it part of their natural role to care for a disabled relative.  
With regards to quality of care, this thesis can only comment on the facilities for which 
data were obtainable and which may not be representative of the norm. The National 
Authority on drug and alcohol abuse (NACADA) have developed a new instrument for 
measuring the standards of rehabilitation centres, called the “National Standards for 
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Treatment and Rehabilitation of Persons with Substance Use Disorders” (Government of 
Kenya 2010). This very thorough set of standards covers four levels of care, starting from 
prevention to follow-up: community outreach, non-residential treatment, residential treatment, 
and continuing care. In addition, it takes into account family supports, levels of 
documentation, treatments for special populations, the therapeutic environment, and 
management procedures. A potential concern is that the standards are in fact so thorough 
(with 97 separate standards) that they may be challenging to implement within the resource 
constraints. Nonetheless, they form a promising basis on which to begin benchmarking 
service quality. 
Last but certainly not least, to the point about service user involvement, the research 
on mental health care in Kenya hardly ever involves users other than as research subjects. 
They are all but absent from research design or implementation. Service users and ex-users 
could be particularly well-placed to explore questions of quality within mental health treatment 
settings. 
 
8.7 Conclusion 
In conclusion, the treatment gap for mental disorders in Kenya is large, although it is slightly 
less large than it appears when looking only at public provision. Kenya’s private health sector 
is quite developed relative to its East African neighbours, and is responsible for approximately 
half of all general health care visits. Mental health care provision – both for-profit and not-for-
profit – is an active component of private health care, although apparently less so than in 
other areas of health care, such as reproductive health. While private for-profit (or self-
financing) care is more costly than public care, it appears also to be of higher quality in some 
instances. Moreover, it provides access to services to a different population, including people 
with substance use disorders and women. Finally, it is possible that private provision cross-
subsidizes public care by providers working in both sectors. It is important that future policy 
efforts build on private sector strengths (quality of care) and work on its weaknesses (cost of 
care). In future service expansion efforts, policy planners should be conscious of the possible 
flow-on effects of reforms from the public sector to the private sector and vice-versa. The two 
sectors, public and private, need not be viewed antagonistically, but rather as partners in a 
joint battle to fill a gaping hole in much-needed mental health services. 
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10.1 Data sharing agreement with BasicNeeds and the UCT 
 
 
 
 
 
 
 
 
 
 
 
Memorandum of Understanding 
 
Between BasicNeeds, the University of Cape Town 
And 
Victoria de Menil, London School of Economics 
 
 
 
This Memorandum of Understanding establishes the conditions under which the BasicNeeds-
University of Cape Town collaborative Impact Study data, collected from BasicNeeds’ 
programme site in Kenya, will be shared with Victoria de Menil. This MOU is in response to 
her request to use the data in her PhD research at the London School of Economics, under 
the supervision of Martin Knapp. Victoria will utilize the Impact Study data within the context 
of examining access to and the economic impact of BasicNeeds’ mental health and 
development interventions in Kenya.  
 
This Memorandum of Understanding will remain in effect until July 1, 2012. 
  
In specific, we agree that: 
 
1. Access 
Upon signing of this agreement, Victoria will be granted access to raw data from the 
BasicNeeds-UCT Impact study in STATA format.  She will analyse data at baseline, one year 
and two years follow-up from the following tools: 
 The Economic Status Instrument, adapted from India and translated specifically for 
the BN-UCT study 
 The General Health Questionnaire 
 The WHOQOL Bref 
 
In addition, Victoria will access data from BasicNeeds Kenya on their intervention costs in 
Nyeri and Meru during the time-period of the research. 
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2. Analysis 
Victoria will use the BN-UCT Study data for analysis in the following ways:  
 
Analysis of Access to Services 
Victoria will compare data from the Economic Assessment Tool in the Impact Study with 
data she plans to collect separately on service users in other clinical settings. In particular, she 
will compare the characteristics of patients attending non-state facilities with those of patients 
attending state-facilities, and will also compare non-state patients between themselves, looking 
at the difference between those attending for-profit and those attending not-for-profit 
facilities, and urban vs rural patients. In all cases, simple statistical tests of association will be 
used (eg. t-tests and chi-squared). The independent variables of analysis will be as follows: 
 
 Diagnosis 
 Age 
 Sex 
 Household income 
 Employment status 
 
Economic Analysis 
Victoria plans to undertake three types of economic evaluation for her thesis, which will 
involve the BasicNeeds-UCT impact data to varying degrees: 
 
Cost of illness: This will estimate the lost productivity from illness and the treatment costs of 
those in treatment for those with common and severe mental disorders and epilepsy. 
Prevalence data will come from a soon-to-be released study by Rachel Jenkins and colleagues 
which is the first community-based sampling of mental disorders to be done in Kenya. Cost of 
illness studies rely on the whole population in an area – in this case Kenya – so the 
BasicNeeds-UCT Impact data is not sufficient to run this analysis. She will therefore repeat 
the Economic Status Tool with 155 patients from rural and urban clinics in the public and 
private sectors.  
 
Cost-offset: This analysis calculates the costs of MHD treatment in Nyeri and Meru and the 
direct savings that offset those costs as a result of the intervention. Savings will be calculated 
based on gains in productivity of users and carers, and reduction in health care costs. 
 
Cost-effectiveness: Using two of the Impact Study’s outcome measures (General Health 
Questionnaire and the WHO-QOL), this analysis will examine the cost of the MHD 
intervention in relation to its effectiveness. Cost-effectiveness will be modelled using decision 
analysis, and the choice of comparison will be made based on responses to the question about 
prior treatment in the Patient Questionnaire. Her working assumption, which is in keeping 
with WHO CHOICE methodology, is that the best comparison group may be no treatment. 
Data on the outcomes of a no-treatment control can be imputed from the literature on the 
natural course of common and severe mental disorders and from interviews with experts.  
 
Victoria will take a social perspective on the economic evaluation. In essence, this means she 
is looking not only at health costs, but also at productivity effects.  Victoria will run the 
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analysis looking at the effectiveness at both 12 months and 24 months of intervention as 
compared to baseline. 
 
Variables of interest will come from the Economic Assessment Tool, including: household 
income level, cost of conventional health care before and after the intervention, cost of 
traditional healing before and after the intervention, and opportunity cost of lost productive 
days. Victoria will supplement these variables with additional data that she is obtaining 
separately on hidden costs, namely: costs of the BasicNeeds intervention in Kenya, costs of 
government clinics, costs of caring.  
 
 
3. Authorship 
Victoria will use the analyzed data for producing a peer-reviewed journal article on the theme 
of economic evaluation of BasicNeeds’ Mental Health and Development model.  
 
The Co-Authors for this paper will be:  
BasicNeeds: Joyce Kingori, Milka Waruguru, Sarah Kippen Wood, Saju Mannarath,  Shoba 
Raja 
UCT: Crick Lund 
 
The estimated timeline for this paper is six months from access to data until first submission. 
Victoria will show drafts of the papers to the co-authors and to her supervisors at the LSE. If 
further advice is needed, then Victoria will request agreement of the co-authors before sharing 
any drafts. 
 
Any additional publications generated with this data will recognize the original study 
researchers according to their level of participation in making the publication. Decisions on 
authorship will be made with reference to the International Committee of Medical Journal 
Editors guidelines, Ethical Consideration in the Conduct and Reporting of Research: Authorship and 
Contributorship.14 
 
 
4. Dissemination 
Victoria will disseminate her findings within Kenya jointly with BasicNeeds Kenya, as far as 
possible, selecting platforms that would be of strategic significance to BasicNeeds Kenya. In 
the event she has opportunities to present the findings outside Kenya she will do this after 
getting a written agreement from the head of BasicNeeds Kenya.  
 
 
5. Confidentiality 
At all times Victoria will ensure safeguards to protect the confidentiality of the data and to 
prevent unauthorized use or access to it. At no time will the raw data be shared with a third 
party other than Victoria, unless agreed separately in writing by the Principle Investigators. 
 
 
  
                                                 
14
 http://www.icmje.org/ethical_1author.html 
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10.2 MOU with the Africa Mental Health Foundation  
 
 
 
 
 
 
 
 
 
Memorandum of Understanding (MOU) between 
the Africa Mental Health Foundation 
and Victoria de Menil 
 
 
Stakeholders 
The Africa Mental Health Foundation (AMHF) is an organization dedicated to the research 
and practice of community mental health in Kenya and the surrounding region. It was 
registered in 2004 by Professor David Ndetei, an eminent psychiatrist, and is staffed by three 
clinical psychologists, two administrators, and a wide network of research assistants. In 
addition, AMHF hosts visiting overseas researchers studying mental health in Kenya. 
 
Victoria de Menil is a PhD student in the Department of Social Policy at the London School 
of Economics. She enrolled in 2010 under the supervision of Martin Knapp and David 
McDaid researching the question: What is the capacity and economic impact of non-state actors to 
address Kenya’s mental health treatment gap?  
 
Victoria first encountered the AMHF in 2007 while working at BasicNeeds, an NGO that has 
partnered with AMHF on past research. In July 2011, at the invitation of Prof. Ndetei, 
Victoria attended the Alderman Foundation Conference, where she met the AMHF team and 
the idea for the present collaboration emerged. 
 
 
Background 
In 2008, the Africa Mental Health Foundation (AMHF) and BasicNeeds Kenya (BNK) jointly 
completed data collection on the study Traditional and faith healers' practices in Kangemi informal 
settlement, Nairobi Kenya. The study collected qualitative and quantitative data on the socio-
demographic characteristics, practices and experiences of 54 traditional and faith healers, 79 
mental health service users and 44 carers. The study was analysed in a 72 page report 
published in hard-copy jointly by AMHF and BNK, under supervision of David Ndetei, 
Director of the Africa Mental Health Foundation. The two research officers were Lincoln 
Khasakhala of AMHF and Allan Oginga of BNK. 
 
The report highlighted several important distinctions between faith and traditional healers, 
however it did not test these distinctions using statistical tests of association. Moreover, the 
report has a limited readership, as it is not published online, nor by a peer-reviewed journal, 
and is not indexed by any academic database (eg. PubMed, PsycInfo, Google Scholar). Further 
analysis of this data could therefore generate more rigorous knowledge and better 
dissemination of the study findings. 
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In October 2010, Victoria de Menil began work on a PhD at the London School of 
Economics researching the question: What is the capacity and economic impact of non-state actors to 
address Kenya’s mental health treatment gap? Traditional healers form one important category of 
non-state actor within the purview of her thesis. Two sub-questions that the thesis seeks to 
answer in relation to traditional healers are: 
 What is their capacity to provide mental health care? 
 Who is accessing their care? 
The AMHF-BNK study could provide evidence with which to answer these questions. In 
addition, the expertise of the AMHF on research practices in Kenya could benefit Victoria’s 
work. 
 
 
Purpose 
The purpose of the present MOU is to mutually benefit the AMHF and Victoria de Menil in 
the following ways:  
1. By hosting Victoria’s PhD research under the aegis of the AMHF 
2. By engaging in a secondary analysis of the AMHF-BNK data with the aim of 
publishing these findings in a peer-review journal and in Victoria’s PhD thesis.  
 
 
Procedures 
 
The AMHF agrees to the following: 
Re purpose 1: 
 To provide expertise and guidance on the logistics of Victoria’s research 
implementation. 
 Where needed, to provide access to their network of research assistants, at Victoria’s 
expense. 
Re purpose 2: 
 To enter into a data sharing agreement regarding the data from the 2008 Kangemi 
healer study, with the option of other datasets in the future. 
 To allow Victoria to use the data within her PhD dissertation. 
 To discuss this and other relevant data – including a second study of healers 
undertaken more recently by Anne Mbayo – so as to give depth to the analysis and 
ensure consensus. 
 
Victoria agrees to the following: 
Re purpose 1: 
 To credit the AMHF as technical advisors in her research 
 To consult with the AMHF regarding methodological issues and to share findings with 
AMHF staff. 
 Where needed, to pay for research assistance from AMHF’s network 
Re purpose 2: 
 To treat the data confidentially and not to share it with third parties, other than for the 
explicit purpose of assistance with data analysis. 
 To discuss all findings – quantitative and qualitative – with Lincoln Khasakhala and 
Prof. Ndetei to arrive at consensus on their analysis. 
 To write up the findings for submission to a peer-review journal, such as Transcultural 
Psychiatry or the African Journal of Psychiatry. Victoria will write a first draft, which she 
will submit to the co-authors for comment and revision. 
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 To write up the findings as part of her PhD dissertation at the LSE, citing the source 
of the data. 
 
There will be no financial exchange as part of this memorandum. 
 
 
Oversight 
Compliance with this MOU will be the responsibility of each signatory. Any complaints 
should first be discussed with the other signatories. If any grievance is found in the conduct of 
Victoria de Menil, it can be taken up with her supervisors: 
 Martin Knapp: m.knapp@lse.ac.uk 
 David McDaid: d.mcdaid@lse.ac.uk 
 
 
Timeline and Renewal 
The agreement is valid from the date of signature through the completion of Victoria de 
Menil’s thesis, or the publication of findings relating to the AMHF-BNK data, whichever 
comes later. The estimated dates of application are October 2011 – October 2013. The MOU 
may be updated at any point during this time to reflect a change in the procedures, on 
condition of agreement by both parties. 
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Data Sharing Agreement 1 
 
 
 
Today’s Date 23 November 2011 
Working Title of Proposed 
Research 
Non state actors in Kenya’s mental health care: capacity, access and 
economic impact 
Name of related AMHF 
study 
Traditional and faith healers' practices in Kangemi informal 
settlement, Nairobi Kenya 
 
Date of AMHF data 
collection 
2007 
Authors for publication 
(First and Last Names and 
Institution) 
de Menil, Victoria – London School of Economics 
Khasakhala, Lincoln – Africa Mental Health Foundation 
Kingori, Joyce – BasicNeeds Kenya 
Oginga, Allan – BasicNeeds Kenya 
Ndetei, David – Africa Mental Health Foundation 
Estimated date of paper 
submission 
31 May 2012 
Paper 1 
Research question(s)/ 
hypothese(s) 
 
 
 
 
Research Question: 
What are the similarities and differences between traditional 
and faith healers with regards to socio-demographics and 
treatment practices? 
 
Hypotheses: 
Re treatment practices: I hypothesize that traditional healers 
perform fewer home-visits, and are use herbs and cutting 
with greater frequency than faith healers. I also hypothesize 
that traditional healers refer patients less frequently to 
conventional medical systems than faith healers. 
 
Re demographics: I hypothesize that faith healers are 
statistically younger than traditional healers and that their 
income level and educational attainment are higher. I further 
hypothesize that the sex distribution and geographic origins 
are the same between the two groups. 
 
Name of requested data set Traditional Data.sav 
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Outcome Variable 
(Dependent Variable)  
Healer type (traditional or faith) 
Predictor Variables 
(Independent Variables)  
Demographics: Healer age; sex; education; religion; 
employment; income; place of origin 
 
Treatment: type of treatment provided; home-visits; referral; 
follow-up 
 
 
Requested Variables  
(We do not send full datasets. Please list only those variables you will need for your 
analyses from the requested dataset.) 
 
province Province of birth of healer 
other Other province of birth: country 
age Age 
gender Gender 
educatio Level of education 
religion Religion 
r.others Other religion 
type Faith healer/ traditional healer 
employm Employment 
why If none, why? 
sacked sacked due to… 
retired retired due to… 
w.others Other cause of unemployment (specify) 
time If no employment, for how long? 
hseowner Who owns the house that you live in? 
income Estimated income per month 
i.other Other estimated income per month 
tfh2i If yes, what are the mental disorders that you see or get involved in? 
tfh3i What treatment/care do you provide for the mental disorders mentioned 
above? 
tfh4a Do you go to the homes of mentally affected persons? 
tfh4i If yes, what treatments do you offer as you visit them? 
tfhiq9 Do you carry out any procedures before starting the care? If yes, what 
procedures do they carry out? 
tfhiq10 How do you carry these procedures you have mentioned above? 
tf11a The treatments you have mentioned in 3 above; how do you carry them 
out? (elaborate each treatment procedure) 
tfhiq11a What drugs (herbal) do you use for conditions named above? (name the 
condition matching it with drug used) 
tfhiq12b Do you coordinate these services with other people? (health workers, 
traditional healers or faith healers)? If yes which organizations/persons do 
coordinate with? 
tfhiq13a The organizations/persons you coordinate with mentioned in 12 above, 
When do you refer the patients to them? 
  
309 
 
tfhiq14 The organizations/persons you coordinate with mentioned in 12 above, do 
they refer the patients back to you? If yes, when/under what 
circumstances? 
tfhiq16 The persons you see with mental disoders, how do you follow them up; for 
them to get further treatment/to complete treatment? 
tfhiq17 How do you view the conventional medical treatment as compared to your 
mode of treatment(s) 
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Africa Mental Health Foundation  
 
Data Sharing Agreement 2 
 
Today’s Date 23 November 2011 
Working Title of Proposed 
Research 
Non state actors in Kenya’s mental health care: capacity, access and 
economic impact 
Name of related AMHF 
study 
Traditional and faith healers' practices in Kangemi informal 
settlement, Nairobi Kenya 
 
Date of AMHF data 
collection 
2007 
Authors for publication 
(First and Last Names and 
Institution) 
de Menil, Victoria – London School of Economics 
Khasakhala, Lincoln – Africa Mental Health Foundation 
Kingori, Joyce – BasicNeeds Kenya 
Oginga, Allan – BasicNeeds Kenya 
Ndetei, David – Africa Mental Health Foundation 
Estimated date of 
completion 
31 June 2012 
Paper 2 
Research question(s)/ 
hypothese(s) 
 
 
 
 
Research Question: 
Is there a statistical difference between patients of 
traditional healers and those of faith healers with regards to 
diagnosis, and demographics? 
 
Hypothesis : 
I hypothesize that patients of faith healers are more likely to 
have a diagnosis of common mental disorder than patients 
of traditional healers, as well as being on average younger. I 
also hypothesize that the socio-economic status and gender 
distribution of both types of patients are comparable in this 
sample. 
Name of requested data set Adults data - Kangemi working file August.sav 
Outcome Variable 
(Dependent Variable) for 
Research Question 2 
Attending a traditional or faith healer – I will impute this 
variable from variables secb2i – secb4vii 
Predictor Variables 
(Independent Variables) for 
Research Question 2 
Diagnosis of mental disorders from the MINI, patient age; 
sex; education; religion; employment; income 
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Requested Variables  
(We do not send full datasets. Please list only those variables you will need for your 
analyses from the requested dataset.) 
 
serino serial number 
age1 age of patient 
age2 age of caregiver 
gender1 gender of patient 
gender2 gender of caregiver 
edu1 education of patient 
relig1 religion of patient 
emplo1 employment of patient 
emplo2 employment of caregiver 
inw1 if none, why? (patient) 
inwo1 Other 
inw2 if none, why? (caregiver) 
inwo2 Other 
infhl1 if none for how long?(patient) 
infhl2 if none for how long? (caregiver) 
wothyli1 who ownes the house that you live in? (patient) 
wothyli2 who ownes the house that you live in? (caregiver) 
eipm1 estimated patient income per month 
eother1 Other 
eipm2 estimated caregiver income per month 
eother2 Other 
rbtpatc1 Relationship between the patient and the caregivers ( patient) 
rother1 Other 
secb2i If yes, what treatment do you receive? 
secb3 What treatment/care do they provide for the mental disorders mentioned 
above? 
secb8i What procedures? 
secb9 How they you carry out these procedures you have mentioned above? 
secb10i Procedure 
secb11 What drugs (herbal) do they use for conditions named above?   (Name the 
condition matching it with drug used) 
secb15 Do you feel/ think there is need to form a linkage with the 
persons/organization mentioned in 12 above? 
secb15i If yes what kind of linkages? 
secb17 How do you view the conventional medical treatment as compared to the 
traditional/faith healers treatment? 
a8 Current major depressive episode 
a9 Current mood disorder due to general medical condition 
a10 Current substance induced mood disorder 
b5b Current dysthymia 
csumm Suicidality 
d6 Hypomanic episode 
d7 Manic episode 
e8 Current panic disorder 
e9 Current anxiety disorder with panic attacks due to general medical condition 
e10 Substance induced anxiety disorder with panic attacks 
f3 Current agoraphobia 
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g4 Current social phobia 
i10  How old were you when you first began having symptoms of OCD? 
j6 Current PTSD 
k1 In the past 12 months, have you had 3 or more alcoholic drinks within a 3 
hour period on 3 or more occasions? 
k2summ Alcohol dependence 
k3summ Alcohol abuse 
m11b Current psychotic disorder NOS 
m11c Current schizophrenia 
m13a Current psychotic disorder due to a general medical condition 
m13b Current substance induced psychotic disorder 
p5sum Current generalized anxiety disorder 
p6 Current generalized anxiety due to a medical condition 
p7 Current substance induced generalized anxiety 
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10.3 Data sharing agreement with Chiromo Lane Medical Center 
 
Victoria de Menil, MSc 
PhD Candidate, Social Policy 
London School of Economics 
v.p.de-menil@lse.ac.uk 
+254 (0)70 541 8080 
 
 
 
Non-Disclosure Agreement 
 
 
18 May 2012 
 
 
 
Parties 
 
Victoria de Menil of the London School of Economics, a university registered in England as 
a company limited by guarantee (Reg no. 70527),whose registered address is at Houghton 
Street, London WC2A 2AE +44 (0)207 405 7686 (the Recipient);  
 
and  
 
Chiromo Lane Medical Centre, a registered medical institution in Kenya whose office is at 
Chiromo Lane/ Muthithi Road, Westlands, PO Box 1501 00606 Nairobi (the Discloser): 
 
Agreement 
 
1. The Discloser intends to disclose the confidential information to the Recipient for the 
purpose of scientific research in completion of a doctoral degree (the Purpose). 
 
2. The Recipient undertakes not to use the confidential information for any purpose 
except the stated Purpose without first obtaining the written agreement of the 
Discloser. 
 
3. The Recipient undertakes to keep the confidential information secure and not to 
disclose it to any third party, especially to any local third party in Kenya. The exception 
is supervisors in health economics, who need to know the same for the Purpose, and 
who know they owe a duty of confidence to the Discloser, and who are bound by 
obligations equivalent to those in clause 2 above and this clause 3. 
 
4. The undertakings in clauses 2 and 3 above apply to all of the information disclosed by 
the Discloser to the Recipient, regardless of the way or form in which it is disclosed or 
recorded, but they do not apply to: 
a. Any information which is or in future comes to the public domain (unless as a 
result of the breach of this Agreement); or 
b. Any information which is already known to the Recipient and which was not 
subject to any obligation of confidence before it was disclosed to the Recipient 
by the Discloser. 
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5. Nothing in this Agreement will prevent the Recipient from making any disclosure of 
the confidential information required by law or by any competent authority. 
 
6. The Recipient will, if requested by the Discloser, return all copies and records of the 
confidential information to the Discloser and will not retain any copies or records of 
the confidential information. 
 
7. Neither this Agreement nor the supply of any information grants the Recipient any 
licence, interest or right in respect of any intellectual property rights of the Discloser, 
except the right to copy the confidential information solely for the Purpose. 
 
8. The undertakings in clauses 2 and 3 will continue in force indefinitely from the date of 
this Agreement. 
 
9. This Agreement is governed by, and is to be construed in accordance with Kenyan 
law. The Kenyan Courts will have non-exclusive jurisdiction to deal with any dispute 
which has arisen or may arise out of, or in connection with this Agreement.  
. 
 
Signed and Delivered as a Deed by 
 
 
 
……………………………………. 
 
Victoria de Menil  
PhD Candidate, LSE 
 
 
 
 
As witnessed by: 
 
 
……………………………………. 
 
Dr. Frank Njenga 
Upper Hill Medical Center 
Nairobi 
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10.4 Research Permit  
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10.5 Ethical Clearance for Primary Data Collection 
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10.6 Consent Form for BasicNeeds-UCT Impact Study 
 
 
PART A   CONSENT EXPLANATION  
An evaluation of the Mental Health and Development Model in Rural Kenya: collaboration between the 
Mental Health and Poverty Project (MHaPP) 
 
Name and institutional affiliations of Investigators 
Principal Investigators: Dr Crick Lund, University of Cape Town; Shoba Raja, BasicNeeds 
Co-investigators: Joyce Kingori, Milka Waruguru, Sarah Kippen-Wood Policy and, Saju Mannrath, 
BasicNeeds; Prof Alan J. Flisher, University of Cape Town. 
 
Information to volunteers 
This is a joint evaluation research project being conducted by the University of Cape Town and BasicNeeds 
UK in Kenya. The study aims to evaluate how successful the Mental Health and Development Programme is 
in Meru South and Nyeri North. Participating in the research will benefit you because you will be able to see 
how your mental health improves as you participate in the programme. It will also help us to improve the 
programme and benefit others in society, by improving the programme in other areas. 
 
Procedure to be followed 
It will include a minimum number of 180 mentally ill persons and the eligibility criteria includes; those who 
have been diagnosed by a certified psychiatrist or psychiatric nurse to have mental illness, are above 18 
years of age and will give informed consent and sign the consent form. In this evaluation the participants will 
be required to answer various questions in the five study tools.  
Benefits of study 
The precise interventions to be applied are based on the mental health and development model. Such 
include; Provision of the community mental health programme which is mainstreamed in the government 
health facilities to continue providing the mental health services in the absence of the programme. The 
capacity building of the public health sector in order to ensure that the trained psychiatric personnel are 
available to continuously offer treatment, as well as mainstreaming of livelihoods through self help groups for 
the mentally ill persons who have stabilized. 
There is no potential risk/harm of participation in this study since the study is not intrusive and the persons 
who refuse to participate in the study will continue to benefit from the programme. 
 
Confidentiality of your identity 
Confidential research data and records will be stored securely in lockable metal filing cabinets already 
provided in all the clinics at the project areas and will only be accessible to the  mental health coordinator (in 
the two sites a Psychiatric Nurse). Electronic data will be stored in both flash and compact disks and a 
password installed to limit access. During the course of data analysis, all identifying information will be 
removed from the data, and no identifying information will be provided in the writing up and dissemination of 
research results. 
 
Obtaining additional information 
In case of any questions or concerns about your participation in the study please contact any of the following 
members; 
1. Joyce Kingori, Programme Manager, BasicNeeds UK in Kenya, Mai Mahiu   ,South C 
, P.O.Box 14590-00100, Nairobi, Kenya.   
Email: joyce.kingori@basicneeds.org 
 
2. The Secretary, Kenya Medical Research Institute, National Ethics Review Committee, PO Box 54840-
00200 Nairobi. Tel #: 020 272 2541; 0722205901; 0733400003. 
 
 
PART B CONSENT SEEKING FORM 
  
320 
 
Key information to be communicated to each participant, BEFORE the interview. Please TICK 
appropriately. 
 
Information  Understood? 
I would like to ask you some questions about your health 
and how you have been feeling over the last while. 
 
  
This interview will take about 1 hour of your time today.  
  
We would then like to come back to interview you in 9 
months time and then again in 18 months time. This means 
that we will interview you 3 times in the next one and a half 
years. 
 
  
Everything that you say to me will be confidential.   
  
You do not have to be interviewed. You may leave when you 
choose. If you choose to leave, it will not affect your 
relationship with us or the care you receive from the health 
services or BasicNeeds. If you would like to, you may 
discuss any problems you have with me or with a care 
worker in the programme.   
 
  
Will you participate?   YES NO 
 
If the participant is literate:  
Participant’s name: ……………………………………………Signature: …………………. Date: ………………… 
 
Witness’ name: …………………………………………………Signature: ……………… …Date: ………………… 
 
If the participant is not literate: 
I have communicated the above information to ………………………………………………………… and he/she 
has agreed to be involved in the interviews.  
 
Carer’s name: ………………………………………………..Signature………………………Date: ………………... 
 
Witness’ name: …………………………………………….. Signature:…………………….. Date:…………………  
 
Interviewer’s name:………………………………………… Signature:…………………….. Date: ………………... 
 
Before we begin, do you have any questions you would like to ask?  
 
……………………………………………………………………………………………………. 
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10.7 LSE Research Checklist and Questionnaire 
 
This checklist should be completed for every research project that involves human 
participants, personal, medical or otherwise sensitive data or methodologically 
controversial approaches. It is used to identify whether a full application for ethics 
approval needs to be submitted. The research ethics review process is not designed to 
assess the merits of the research in question, but is merely a device to ensure that external 
risks have been fully considered and that an acceptable research methodology has been 
applied. This checklist applies to research undertaken by both staff and students, but it 
should be noted that the way the checklist is processed differs between these two groups. 
 
For staff: if a full application is required please ensure that you complete the Ethics 
Review Questionnaire for Researchers and send the completed form to Michael Nelson in 
the Research Division (RD.  
 
Please accompany the questionnaire with a copy of this checklist and a copy of the 
research proposal. 
 
For MSc/PhD students: if a full application is required please ensure that you complete 
the Ethics Review Questionnaire for Researchers and discuss the issues raised with your 
student supervisor in the first instance. You should ensure that the completed forms are 
accompanied with a copy of the research proposal to ensure that your supervisor can make 
a fully informed decision on the ethical implications of the research. Where the supervisor 
is satisfied that all ethical concerns have been addressed s/he must sign the checklist and 
ensure that a copy is retained within the department as a record of the decision reached. It 
is appreciated that in certain cases the student supervisor may not be able to reach a 
decision on the ethical concerns raised. In such instances the matter should be referred to 
the Research Ethics Committee (please send all relevant forms and a copy of the proposal 
to Michael Nelson in RD. Only where an informed decision cannot be reached by the 
supervisor should paperwork be submitted to the Research Ethics Committee. 
 
For undergraduate students: After completing the checklist, undergraduate students 
should discuss any issues raised with their supervisor in the first instance. If fully satisfied 
with the research proposal, the supervisor can sign the checklist on behalf of the 
department. A copy of the signed form should be retained by the department as a record of 
the decision reached. It is appreciated that in certain instances the student supervisor may 
not be able to reach a decision on the ethical concerns raised. In such instances the 
application for ethics approval should be referred to the Research Ethics Committee 
(please send all relevant forms and a copy of the proposal to Michael Nelson in RD. Only 
where an informed decision cannot be reached by the supervisor should paperwork be 
submitted to the Research Ethics Committee. 
 
Before completing this form, please refer to the LSE Research Ethics Policy. The 
principal investigator or, where the principal investigator is a student, the supervisor, is 
responsible for exercising appropriate professional judgement in this review. For students, 
your supervisor should be able to provide you with guidance on the ethical implications of 
the research project. If members of staff have any queries regarding the completion of the 
checklist they should address these to Michael Nelson (RD in the first instance.  
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This checklist must be completed before potential participants are approached to take part 
in any research. 
 
 
 
 
 
 
Section I: Applicant Details 
 
Name of researcher: Victoria de Menil 
 
Status(delete as 
appropriate: 
Undergraduate Student/MSc Student/PhD 
Student/Staff 
 
Email address: 
 
v.p.de-menil@lse.ac.uk 
Contact address: 
 
 
25 Alexander Street, London W2 5NT 
Telephone number: 
 
07772 844 607 
 
 
Section II: Project Details 
 
Title of the proposal and brief abstract: The Role and Economic Impact of Non-
State Actors in Kenya’s Mental Health Care 
 
This study is examining the role of four types of non-state actor in Kenya’s mental 
health care provision: formal for-profit; formal not-for-profit; informal for-profit; 
and informal not-for-profit. The study will use mixed methods including secondary 
analysis of quantitative data, and primary collection of data from several hundred 
mental health professionals and an estimated 12 key informants.  
 
 
 
Section III:  Student Details: 
 
Details of study: 
 
 
Supervisor’s name: 
 
Martin Knapp 
Email address: 
 
m.knapp@lse.ac.uk 
Contact address:  
 
Cowdray House, 4
th
 Floor, Portugal Street,  London 
WC2 
 
Section IV: Research Checklist 
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Consent 
 
 Yes No Not 
certain 
Does the study involve participants who are in any way 
vulnerable or may have any difficulty giving consent? If 
you have answered yes or are not certain about this 
please complete Section 1 of the Research 
Questionnaire. 
 
As general guidance, the Research Ethics Committee 
feels that research participants under the age of 18 may 
be vulnerable. 
 
x 
 
 
  
Will it be necessary for participants to take part in the 
study without their knowledge and consent at the time? 
(e.g. covert observation of people in public places If you 
have answered yes or are not certain about this please 
complete Section 1 of the Research Questionnaire. 
 
  
 
x 
 
 
Research Design/Methodology 
 
   
Does the research methodology use deception? If you 
have answered yes or are not certain about this please 
complete Section 2 of the Research Questionnaire. 
 
  
 
x 
 
Are there any significant concerns regarding the design 
of the research project?  
 
If the proposed research relates to the provision 
of social or human services is it feasible and/or 
appropriate that service users or service user 
representatives should be in some way involved 
in or consulted upon the development of the 
project? 
 
Does the project involve the handling of any 
sensitive information? 
 
If you have answered yes or not certain to these 
questions please complete Section 3 of the Research 
Questionnaire. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NA 
 
 
 
x 
 
 
 
Financial Incentives/Sponsorship 
 
   
 
Will the independence of the research be affected by the 
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source of the funding? If you have answered yes or not 
certain about this please complete Section 4 of the 
Research Questionnaire. 
 
x 
 
Are there payments to researchers/participants that may 
have an impact on the objectivity of the research? If you 
have answered yes or not certain about this please 
complete Section 4 of the Research Questionnaire. 
 
  
 
x 
 
Will financial inducements (other than reasonable 
expenses and compensation for time be offered to 
participants? If you have answered yes or not certain 
about this please complete Section 4 of the Research 
Questionnaire. 
 
  
 
x 
 
 
Research Subjects 
 
   
Is pain or more than mild discomfort likely to result 
from the study? If you have answered yes or not certain 
about this please complete Section 5 of the Research 
Questionnaire. 
 
 
 
  
x 
 
Could the study induce unacceptable psychological 
stress or anxiety or cause harm or negative 
consequences beyond the risks encountered in normal 
life? Will the study involve prolonged or repetitive 
testing? If you have answered yes or not certain about 
this please complete Section 5 of the Research 
Questionnaire. 
 
  
 
x 
 
Are drugs, placebos or other substances to be 
administered to the study participants or will the study 
involve invasive, intrusive or potentially harmful 
procedures of any kind? If you have answered yes or not 
certain about this please complete Section 5 of the 
Research Questionnaire. 
 
  
 
x 
 
 
Risk to Researchers 
 
   
Do you have any doubts or concerns regarding your (or 
your colleagues physical or psychological wellbeing 
during the research period? If you have answered yes or 
not certain about this please complete Section 6 of the 
Research Questionnaire. 
 
  
 
x 
 
  
325 
 
 
Confidentiality 
 
   
 
Do you or your supervisor have any concerns regarding 
confidentiality, privacy or data protection? If you have 
answered yes or not certain about this please complete 
Section 7 of the Research Questionnaire. 
 
  
 
x 
 
 
Dissemination 
 
   
 
Are there any particular groups who are likely to be 
harmed by dissemination of the results of this project? If 
you have answered yes or not certain about this please 
complete Section 8 of the Research Questionnaire. 
 
  
 
x 
 
 
If you have answered no to all the questions, staff members should file the completed 
form for their records. Students should retain a copy of the form and submit it with 
their research report or dissertation. 
 
If you have answered yes or not certain to any of the questions you will need to 
describe more fully how you plan to deal with the ethical issues raised by your 
research. You will need to answer the relevant questions in the Ethics Review 
Questionnaire for Researchers form addressing the ethical issues raised by your 
proposal. Staff should ensure that the completed questionnaire is sent to Michael 
Nelson in RD. Students should submit their completed questionnaire to their 
supervisor in the first instance. It will be at the discretion of the supervisor whether 
they feel that the research should be considered by the Research Ethics Committee.  
 
Please note that it is your responsibility to follow the School’s Research Ethics Policy 
and any relevant academic or professional guidelines in the conduct of your study. 
This includes providing details of your proposal and completed questionnaire, and 
ensuring confidentiality in the storage and use of data. 
 
Any significant change in the question, design or conduct over the course of the 
research should be notified to  Michael Nelson in RD. 
 
 
 
I have read and understood the LSE Research Ethics Policy and the questions 
contained in the Research Checklist above. 
 
Academic Research Staff 
 
Principal Investigator Signature: 
Date: 
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Undergraduate/MSc Student/PhD Student 
 
Student Signature: 
 
Student Name (Please print): Victoria de Menil 
Department: Social Policy 
Date: 24 August 2011 
Date of Research Ethics Seminar attended: 11/11/2010 
 
Summary of any ethical issues identified: 
 
 
 
 
Supervisor Signature*: 
Supervisor Name (Please print): Martin Knapp 
Department: Social Policy 
Date: 
 
 
* By signing this document the student supervisor attests to the fact that any ethical 
issues raised have been dealt with adequately. 
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ETHICS REVIEW QUESTIONNAIRE FOR RESEARCHERS  
 
Researchers should consider the following questions when devising research proposals 
involving human participants, personal, medical or otherwise sensitive data or 
methodologically controversial approaches. N.B. not all of these questions will be relevant 
to every study. These questions provide pointers to direct researchers’ thinking about the 
ethical dimensions of their research. It is expected that researchers will already have 
addressed the academic justification for the project in their proposal; the guidance 
questions set out below aim to help researchers address specific ethical issues in so far as 
they relate to participants or data.  
 
In particular, consideration of risks to the research participants versus benefits need to be 
weighed up by researchers. It is important to think through carefully the likely impact on 
participants or vulnerable groups of any data collection methods. Certain groups are 
particularly vulnerable, or will be placed in a vulnerable position in relation to research, 
and may succumb to pressure; for example children or people with learning disability, or 
students when they are participating in research as students. Some participants will have 
diminished capacity to give consent and are therefore less able to protect themselves and 
require specific consideration (see further guidance given on the RPDD web pages 
regarding informed consent). The Research Ethics Committee (REC) recognizes that it is 
not only research with human participants that raises relevant ethical concerns. Researchers 
may be assessing sensitive information, the publication or analysis of which may have 
direct impact on agencies, communities or individuals. For example, collection and use of 
archive, historical, legal, online or visual materials may raise ethical issues (e.g for families 
and friends of people deceased), and research on provision of social or human services 
may impact user provision. Similarly, use of other people’s primary data may need 
clearance or raise concerns about its interpretation. The Research Ethics Committee will 
assess whether the relevant questions have been adequately addressed when it scrutinises 
proposals. Please ensure that each answer provides the Committee with enough 
information to make an informed decision on the ethical dimensions of the proposal. 
  
The LSE Research Ethics Policy and guidance will be reviewed annually and may be 
subject to further development.  
 
The completed questionnaire should only be returned to Michael Nelson in the 
Research Division where specific issues have been identified and the 
supervisor/researcher would like the Research Ethics Committee to consider the 
application. Where you have considered questions to be irrelevant please indicate this 
on the form. 
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I. Project Details 
 
 
Project Title: Non-State Actors in Kenya’s Mental Health Care: Capacity, Access 
and Costs 
 
 
II. Applicant Details 
 
 
Name: 
 
 
Victoria de Menil 
 
Status (delete as applicable) 
 
 
PhD 
 
Email address: 
 
 
v.p.de-menil@lse.ac.uk 
 
Room number/contact 
address: 
 
 
OLD 1.20 
 
III. Research Aims 
 
Please provide brief details of the research aims and the scientific background of the 
research. A full copy of the proposal should be attached to this document. 
 
 
See attached for an executive summary of the thesis proposal. 
 
 
 
 
ONLY COMPLETE THE RELEVANT PARTS OF THIS DOCUMENT. THESE 
WILL HAVE BEEN IDENTIFIED AFTER COMPLETION OF THE RESEARCH 
ETHICS CHECKLIST. 
 
1. Informed consent. 
 
1.1 Will potential participants be asked to give informed consent in writing and will they 
be asked to confirm that they have received and read the information about the study? If 
not, why not?  
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All participants will be asked for informed consent in writing. In addition the form will 
be explained verbally. However, if participants are illiterate, as may be the case for some 
mental health service users, they will be asked to mark an x in the signature box and a 
named witness will be requested to similarly sign the form. Thumb prints are not 
preferred, because of their association with voting. 
 
 
 
 
 
 
 
1.2.  How has the study been discussed or are there plans to discuss the study with those 
likely to be involved, including potential participants or those who may represent their 
views?  
 
The study findings will be presented to selected user group representatives. 
 
 
1.3. Has information (written and oral) about the study been prepared in an appropriate 
form and language for potential participants? (see Informed Consent guidance which lists 
questions to be considered). At what point in the study will this information be offered? 
 
Informed consent has been written in basic English and will be translated into local 
language on site. Informed consent will be delivered prior to interviewing any key 
informants. 
 
 
 
1.4 How will potential participants be informed of whether there will be adverse 
consequences of a decision not to participate? Or of a decision to withdraw during the 
course of the study?  
 
No adverse consequences are forseen from the questions relating to this study.  
Participants will be informed prior to the interview of their right to withdraw. 
 
 
 
1.5 What provision has been made to respond to queries and problems raised by 
participants during the course of the study?  
 
The study is being conducted with the help of a few key contacts, including the director 
of a mental health NGO. Problems raised by participants can be drawn to the attention of 
Joyce Kingori, Director of BasicNeeds Kenya, or of my supervisor, Martin Knapp. The 
contact information of both people will be provided. 
 
 
 
  
330 
 
2. Research methodology. 
 
2.1. How does the research methodology justify the use deception?  
 
 
 
 
 
2.2. If the proposed research involves the deception of persons in vulnerable groups, can 
the information sought be obtained by other means?  
 
 
 
 
 
2.3. How will data be collected during the project? Please provide details of data analysis. 
 
 
 
 
 
 
 
2.4. How have ethical concerns arising from data collection been addressed? 
 
 
 
 
 
 
3. Research design. 
 
3.1 What concerns have been taken into account with regard to the design of the research 
project? If agencies, communities or individuals are directly affected by the research (e.g. 
participants, service users, vulnerable communities or relations), what means have you 
devised to ensure that any harm or distress is minimized and/or that the research is 
sensitive to the particular needs and perspectives of those so affected? 
 
The project has been designed in such a way as to include service users as well as non-
state actors. The questions asked will not be of a sensitive nature. However, if 
participants find the research distressing, they will be advised in the informed consent of 
their right to withdraw. 
 
 
 
3.2. How has the methodology addressed how sensitive information, data or sources will 
be handled? 
 
The most sensitive information that could be anticipated is diagnostic information. All 
data will be confidential, and key informants will be de-identified. Codes will be kept in a 
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password protected document. 
 
 
 
3.3. Have you been able to devise a timetable of research? 
 
 
Please see attached for the preliminary research timetable. 
 
 
 
4. Ethical questions arising from financial support/the provision of incentives  
 
4.1 Are there any real or perceived conflicts of interest which could compromise the 
integrity and/or independence of the research due to the nature of the funding body? 
 
 
 
 
 
4.2 Have any incentives to the investigator been declared?  
 
 
 
 
 
 
 
 
 
4.3 Are there any restrictions on the freedom of the investigator(s) to publish the results of 
the research?  
 
 
 
 
 
4.4 Are any incentives being offered to participants?  
 
 
 
 
 
 
5. Research Subjects 
 
5.1 Who do you identify as the participants in the project? Are other people who are not 
participants likely to be directly impacted by the project? 
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5.2 What arrangements have been made to preserve confidentiality for the participants or 
those potentially affected?  
 
 
 
 
 
5.3. What are the specific risks to research participants or third parties? 
 
 
 
 
 
5.4. If the research involves pain, stress, physical or emotional risk, please detail the steps 
taken to minimize such effects? Explain why this is reasonable within the context of the 
project? 
 
 
 
 
 
 
6. Risk to researchers. 
6.1 Are there any risks to the researcher(s)? Please provide details if risk identified. 
 
 
 
 
 
 
7. Confidentiality  
7.1 Explain the mechanisms in place to ensure confidentiality, privacy and data protection. 
 
 
 
 
 
8. Dissemination  
8.1 Will the results of the study be offered to those participants or other affected parties 
who wish to receive them? If so, what steps have been taken to minimize any 
discomfort or misrepresentation that may result at the dissemination level. 
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10.8 Informed Consent for Psychiatric Private Practice Interview 
Victoria de Menil, MSc 
PhD Candidate, Social Policy 
London School of Economics 
v.p.de-menil@lse.ac.uk 
 
 
Research Project:  
Non-State Actors in Kenya’s Mental Healthcare: Capacity, Access and Economic Impact 
 
Principle Investigator: Victoria de Menil, MSc ; Co-Investigators Professor David Ndetei 
(University of Nairobi) ; Martin Knapp (LSE) ; Milka Waruguru (BasicNeeds) 
 
Information Sheet 
 
Aim 
You are being invited to participate in research led by Victoria de Menil, a postgraduate 
student at the London School of Economics. The goal of the research is to find out what role 
and economic impact non-state actors have in mental health care in Kenya. A non-state actor 
is a person or agency that provides services but is not employed by the government. You are 
being invited to participate because you represent a non-state actor providing mental health 
services.  
 
The main question this research seeks to answer is: What is the capacity and economic impact 
of non-state actors to address Kenya’s mental health treatment gap? The sub-questions are: 
1. What is the capacity of non-state actors to deliver mental health care in Kenya? 
2. Who is accessing non-state mental health care in Kenya? 
3. What are the costs and outcomes of mental health care provided by non-state actors in 
Kenya? 
 
The findings from this research will be written up in a thesis reviewed by a group of 
professors from the London School of Economics. In addition, some of the results will be 
written into papers submitted to scientific journals. The ultimate aim of this research is to find 
ways of increasing quality mental health care for people who need it in Kenya. 
 
Participation 
I am asking to interview you to find out your experiences of mental health care provision and 
your knowledge about available resources. This interview should take about half an hour and 
not longer than an hour. If, for any reason, you do not want to continue the interview, you are 
welcome to stop at any point. Your participation is entirely voluntary and there is no 
compensation for participating.  
 
Risks and Benefits 
There is no expected risk to you in participating in this interview. All the information you tell 
me will remain confidential and will not be associated with your name or identity. The benefit 
of this research is in helping inform decision makers about the capacity of the non-state sector 
to deliver mental health care, so as to design more inclusive policies and improve 
understanding of the mental health system as a whole.   
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Certificate of Consent 
 
 
Full Name (please print) :_____________________________________________________ 
 
 
Please circle your answer choice: 
 
1. Do you understand the purpose of the research?     
Yes  No 
 
2. Do you understand what you are being asked to do?    
Yes  No 
 
3. Do you want to participate in the interview? 
Yes  No 
 
Participant 
I have read the previous information or it has been read to me. I have had the opportunity to ask questions 
about it. I consent voluntarily to participate in this study. 
 
Signature: _____________________________________________ 
Date: _________________________________________________ 
(day/month/year) 
Researcher 
I have read the information sheet to the potential participant and made sure that the participant understands 
what will be done. The participant was given an opportunity to ask questions. The individual has not been 
coerced and consent has been given freely and voluntarily. A copy of this consent form has been given to the 
participant. 
 
Name of researcher: _____________________________________ 
Signature: _____________________________________________ 
Date: _________________________________________________  
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10.9 Case Study Question Guide 
 
Note: These questions are a guide to you, the researcher, as you enter the environment you 
are studying. Not all of them will be relevant, and many of them should not be formulated 
as questions when talking to a person. Some of them, however, may be useful in discussion 
with key individuals. 
 
Domain 1: Environment 
 What are local sociocultural attitudes about and behaviors toward persons with 
mental illness?  
 Is there overt evidence of stigma and discrimination?  
 Are practices such as chaining, caging, and other forms of abuse common?  
 Which conditions are considered to be mental illnesses? Are intellectual disability 
and substance abuse considered mental illness? What about epilepsy? 
 Are any mental illnesses thought to be curable? 
 
Domain 2: Health System 
1. General Health Services 
 Is there a functioning public primary care system? 
 Are there secondary and tertiary facilities? 
 Do poor people have access to care, especially maternal and child health services? 
 
2. Mental Health Services 
 What other psychiatric facilities exist  in or near the program catchment area? If 
yes, what are the conditions in those facilities?  
 How many mental health professionals are in the area? How many work in the 
public sector? In the private sector?  
 Are psychotropic medications readily available and being used in primary care 
clinics? 
 
3. Alternative medicine 
 Do families frequently bring members who are ill with epilepsy or psychosis to 
healers before seeking the services of the program? 
 Do families and/or clients discontinue program services in favor of alternative 
sources of care? If so, what consequences do these actions have for those who are 
ill?  
 Does the program have a policy about working with alternative healers? 
 
Domain 3: Program History 
 When (what year) was the program established? 
 What mental health services were available at the time? Biomedical, psychosocial, or 
both? 
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 Did the country have national mental health legislation, policy, or plan at the time? 
When were these established? 
 Did people with mental disorders have full rights as citizens? Were people with mental 
disorders subject to human rights violations?  
 Where did the program first operate? 
 Why was the program started? What was the key stimulus or defining moment for 
establishing it? 
 Did the program fill a gap in the existing health system? 
 Was the program added to or embedded within an existing program or was it established 
as an independent entity? 
 Who founded the program? Has there been a succession of leadership? If so, was it 
successful? 
 What was necessary to get the program up and running? What resources were necessary? 
From where and how were those resources obtained? 
 How long did it take to start up the program? 
 
Domain 4: Program Framework 
 What services does the program offer? Biomedical treatments or psychosocial 
interventions, or both?  
 Does the program follow an explicit model? 
 Are services geared toward individuals or families or both?  
 Does the program undertake activities to address the need for social inclusion or 
economic development of its clients? 
 Have there been changes over time in the program’s orientation to treatment and 
prevention? 
 Do the program administration and staff consider such issues as access, acceptability and 
equity? If so, how? 
 Does the program use evidence-based practice? Does it have a means for keeping up 
with new evidence?  
 Is the program open to having its services evaluated by assessing the clinical, social, and 
functional outcomes of clients? 
 
Domain 5: Engagement with Broader Systems 
 What relations does the program have with the public mental health system, e.g., local 
health centres; local schools; local hospitals; other service providers? List any activities 
and describe them. What brought about these activities? 
 Has the program influenced policy or clinical practices at district, national or 
international levels?  
 To what extent has the program been a catalyst for change beyond the program? What 
brought about this engagement? 
 
 
Domain 6: Program Resources 
 HR: How many staff work in the program and what are their professional and 
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educational qualifications (include support staff)? 
Are there specific challenges to recruiting and retaining staff? For example, is staffing 
constrained by the program’s ability to pay, or by the availability of qualified people? Is 
employee turn-over high? 
 Volunteers: Are any unsalaried community supporters or low-pay staff involved in the 
program? For example, does the program provide lay mental health workers? If so, what 
sort of supervision is offered? And what are the positive and negative experiences with 
these workers? 
 Salaries: How do staff salaries compare to what staff might make if they were working 
elsewhere? Are staff paid for over-time? Are staff accomplishments recognized? How 
are staff treated by their superiors and administrators? 
 Training: Does the program offer on-going training to its staff in clinical and 
psychosocial interventions? 
 Transportation: Do staff have access to the means of transportation that are required to 
deliver services to large catchment areas or remote locations? 1) Must staff share access 
to the vehicles and, if yes, to what extent does this inhibit their ability to carry out work 
in the community? 2) When staff do not have access to vehicles, it is possible for them 
to carry out other essential duties? 3) Are vehicles generally in working order when 
needed? 4) Are the vehicles safe to drive (functional seat-belts, tires with reasonable 
amount of treads, spare-tire, unbroken windows, helmets for motorbikes)? Must staff use 
their own vehicles for work? If yes, does the program reimburse them? How much time 
do staff spend in transit commuting to the program and delivering services in the 
community? 
 Funding: What are the sources of program funding? Does it receive public funds? Or 
funds from faith-based groups? Is there in-kind support (eg, workers seconded to the 
program, or government-provided transportation)? How much material support is given 
by each source? What is the duration of the funding and what are the chances that it will 
be renewed? 
 Assets: Does the program own buildings or other property? Does the program have 
computers, printers, and access to the internet? Does the program give staff mobile 
phones or must staff use their own? Does the program reimburse staff for phone 
expenses? 
 
Domain 7: Program Management 
 Who manages day-to-day operations? Is there an organigram, or can one be drawn? 
Include support staff. 
 Is there an executive body that has ultimate authority for decision-making processes? 
 Have there been any significant changes in the organizational structure of the program 
since its inception? 
 What is the rate of staff turn-over? 
 How does the program manage its finances? 1) How does a program budget for its 
expenses? What are the main budget allocations? 2) What accounting procedures  are in 
place to ensure that the funds are being used as intended? Are staff salaries always paid 
fully and on time, or are there periods when the program has insufficient funds to meet 
this obligation? Who is responsible for fundraising and how much of their time is spent 
raising funds? 
 Is staff safety adequately informed about safety policy and practices? Are there rules 
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about when staff should not travel alone? Does the program employ security guards for 
its offices? 
 Are staff provided with health insurance or other benefits? 
 Is there a set of program goals and expected results? Is there a strategy/long-term plan to 
achieve those goals? Has the project undergone a process of critically reviewing its 
services and strategically planning for the future? How has that come about? What 
methods have been/are employed in planning and assessment? Does the program have a 
Monitoring & Evaluation system in place? 
 
Domain 8: Client Populations 
 What are the diagnoses of program participants? How many have psychosis, common 
mental disorders, epilepsy, substance abuse or intellectual disability? Among clients 
with psychosis, are there more men than women? Among clients with CMDs, are there 
more women than men? 
 What are the sociodemographic characteristics of the population? What is their age, sex, 
social class, educational level, ethnicity? Does the program provide services to any 
specific populations such as homeless people, desitutes, asylum seekers, refugees, 
orphans? 
 Have there been any changes in the diagnoses or sociodemographics of clients since the 
program began? 
 What is the extent of program coverage? What percentage of the total number of 
potential clients are receiving services from the program? 
 
Domain 9: Pathways to Care 
 Where and with whom do clients or families seek care first? 
 What is the average duration of illness prior to seeking care? 
 What prompts care-seeking? 
 What alternative types of care are available to people in the catchment area? Biomedical 
(specialist and non-specialist; public and private), traditional and spiritual healers, other 
sources of care (e.g., pharmacists)?  
 How do clients come to receive services from the program? Do clients present 
themselves to services or are they identified elsewhere and referred? Or both? If so, 
how? 
 To what extent do the program’s services interact or compete with alternative sources of 
care? Can individuals and families “shop” for care? Do clients typically see other care 
providers while enrolled in the program? 
 What happens when a client is in need of a service that cannot be provided by the 
program? Does the program refer clients for other services they might need? Do clients 
take advantage of the referrals? How quickly are clients seen by those other 
organizations? Does the program make a point of maintaining its referral network or is 
contact only in the event of a referral? 
 Do other organizations, such as hospitals or healers, refer people to the program?  
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Domain 10: Clinical Interventions 
 Who determines diagnosis? How is diagnosis made? According to ICD or DSM criteria? 
Or, broader categories? 
 What is the range of available treatments? 
 Who provides the treatments? 
 Where are treatments given? 
 Does the program have the capacity to provide emergency treatments, e.g., to those in 
the midst of an acute episode? Is ECT offered? And if so, is a muscle relaxant used? 
 What is the intake process, ie how new clients are enrolled once they have been 
identified as in need of an intervention? 
 How are clients are followed over time? For example, do field workers keep track of 
clients in the community? Are clients only seen during routine clinics?  
 Is there attention to the side-effects of interventions? 
 Does the program attempt to find and re-engage clients who have not returned for 
services? If yes, how? 
 Does the program have criteria for discharging or discontinuing services to a client? If 
yes, what? Does the program have a policy about following-up clients who have been 
discharged or who are no longer receiving services? 
 Does the program have protocols and guidelines for its clinical interventions? If yes, 
have these been borrowed or have they been developed specifically for the program? 
 What is the ratio of clinical staff to patients? 
 
Domain 11: Medications 
 Is there a list of the medications used? 
 What criteria are used to determine which medications will be purchased? 
 Are other medications available locally that are not used by program? Why?  
 What are the costs of each medication? 
 What is the adequacy, consistency, and quality of the supply? Have there been any 
recent shortfalls in supplies? 
 Does the program provide the medications it prescribes?  
 If the program does not provide medications, where do clients go to fill their 
medications? 
 If the program provides medications, how does it plan its purchases? Are purchases 
based on anticipated needs for the next month, three months, six months?  
 From what sources are the medications purchased? Local manufacturers? Foreign 
manufacturers? Local pharmacies? What, if any, criteria are used to choose a source? 
Cost?  
 Does the program has implemented methods of inventory control? 
 How are medications stored? Are they in a cool dry place? Are they locked? 
 Is there a dedicated budget line for the purchase of medications? Are funds for 
purchasing medications consistently available when needed? How are these funds 
managed? 
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Domain 12: Psychosocial Interventions 
 What types of psychosocial intervention are provided by the program? For example, are 
any of the following offered, and if so, describe in detail: 
o Individual support 
o Family/carer support 
o Self-help groups 
o Livelihood programs 
 Who provides each of these interventions? 
 Do any of the interventions target a specific group of clients? 
 What sort of support, if any, is provided to caregivers? 
 Does the program support and/or operate prevention and promotion activities? 
 Does the program have protocols and guidelines for its psychosocial interventions? 
 If yes, were these borrowed or were they developed specifically for the program? 
 Is the program regularly assessing and documenting the clinical, functional, and social 
statuses of clients? 
 Has the program established a process for evaluating the effectiveness of psychosocial 
interventions? 
 
Self-help 
How many members do the groups have? 
What are the criteria for membership? 
Does the SHG collect dues? How are the SHG finances managed? How are the funds 
used? 
What are the benefits of membership? 
How often do groups meet? What is done at meetings? 
Do the groups undertake collective activities? Describe 
Having established SHGs, does the program provide them with support? If yes, document 
the following: What does the CMHP do to remain engaged with the SHGs? Does the 
CMHP initiate activities in which the SHGs participate? Does the CMHP help the SHGs 
manage their funds? 
 
Livelihoods 
 Does the program operate a livelihood program? 
 Does the program provide loans? How much are the loans? What is the interest rate? 
What are the criteria for applying for loans? What is the procedure for approving loans? 
How are the loans used? Are the loans being repaid? What are rates of loan repayment? 
Does the program keep careful records of loans, repayments, and subsequent loans? 
 Does the program provide tools to clients so that they can begin a small business, e.g., 
dress-making, wood-working? How does the program decide who will be given tools? 
 Does the program provide opportunities for apprenticeships or occupational training? 
What are the nature of occupational training and apprenticeships? Does the program 
have oversight of the apprenticeships? Does the program make regular visits to the work 
sites to assess clients’ progress? 
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Domain 13: Accessibility 
 
 Where is the clinic located?  
 How far away to clients live on average? 
 At what times and on what days are services offered? 
 Is transportation paid for by the program? 
 How much are the program fees? 
 Are in-home services available to clients who cannot travel? 
 What is the rate of follow-up of clients? 
 
Domain 14: Information Systems 
 What information is being collected? Record all fields that are gathered. For example, 
age, sex, marital status, occupation, diagnoses, date enrolled, functional status, treatment 
prescribed, other physical problems, referral. 
 Who is collecting the data? 
 In what format is it being recorded? Is it paper, electronic, both? 
 How is it being stored, e.g., paper files, on computers, in databases? 
 Are there procedures for generating reports from the data? 
 To whom is the information sent, e.g., funding agency, board? Do they have specific 
reporting requirements? 
 Can the program easily generate descriptive statistics about clients and their use of 
services? 
 Is a unique client ID assigned to individuals?  
 Is there a record of clients who dropped out of treatment, or left before being 
discharged? 
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10.10 Agenda for Site-Visit to Meru and Nyeri  
 
19-20 July 2011 
 
Goals  
 Understand the MHD model as it was delivered in Meru and Nyeri 
 Understand the challenges that have arisen in implementing the MHD model and 
in conducting the research 
 Meet those who collected the data to enable future communication Understand 
the other work done by the partners and who funds them 
 Understand the economic circumstances in the community 
 
 
July 19, 2011 (Meru) 
 
Meetings with: 
1. Milka Waruguru, Research Officer BasicNeeds 
2. Visit of Kajuli Dispensary, Chuka 
a. Rosemary Kabete, Community Health Worker 
b. John Mueti, Psychiatric Nurse 
3. Harriet Kamundi, MHD Coordinator, Maendeleo ya Wanawake  
 
Focus Group Discussion with 7 adults with mental disorders (5 men, 2 women) – translated 
from Kitharaka by Rosemary Kabete 
Focus Group Questions: 
 What has changed in your life since you started the programme – for better or for 
worse? 
 Are you members of a self-help group, and if so, what is your group doing? 
 What are your goals in life? What do you want for yourself? 
 
 
July 20, 2011 (Nyeri) 
 
Meetings with: 
1. Dishon Mutiso, Clinical Officer for Health, Nyeri 
2. Father Boniface, Director, Caritas Nyeri 
3. Helen Wangui, MHD Coordinator, Caritas Nyeri 
 
Self-Help Group Meeting: Mugunda Group (22 participants: 14 women, 8 men) – translated 
from Kikuyu by the group Treasurer 
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10.11 General Health Questionnaire (GHQ-12) 
 
 
much less 
than usual 
same as 
usual 
more 
than 
usual 
much more 
than usual 
1. Been able to concentrate on 
whatever you are doing?  
    
2. Lost much sleep over worry?      
3. Felt that you were playing a useful 
part in things?  
    
4. Felt capable of making decisions 
about things?  
    
5. Felt constantly under strain?      
6. Felt that you couldn't overcome 
your difficulties?  
    
7. Been able to enjoy your normal 
day-to-day activities?  
    
8. Been able to face up to your 
problems?  
    
9. Been feeling unhappy and 
depressed?  
    
10. Been losing self-confidence in 
yourself?  
    
11. Been thinking of yourself as a 
worthless person?  
    
12. Been feeling reasonably happy, all 
things considered?  
    
Total     
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10.12  WHOQOL Bref  
 
Questions are set out here by domain.  
Each question is scored on a Likert scale of 1-5 
 
General 
Qx 1. How would you rate your quality of life? 
Qx 2. How satisfied are you with your health? 
 
Health  
Qx 3. To what extent do you feel that physical pain prevents you from doing what you need 
to do? 
Qx 4. How much do you need any medical treatment to function in your daily life? 
Qx 10. Do you have enough energy for everyday life? 
Qx 15 (mobility) How well are you able to get around? 
Qx 16. How satisfied are you with your sleep? 
Qx 17. How satisfied are you with your ability to perform your daily living activities? 
Qx 18. How satisfied are you with your capacity for work? 
 
Psychology 
Qx 5. How much do you enjoy life? 
Qx 6. To what extent do you feel your life to be meaningful? 
Qx 7. How well are you able to concentrate? 
Qx 11. Are you able to accept your bodily appearance? 
Qx 19. How satisfied are you with yourself? 
 
Social 
Qx 20 How satisfied are you with your personal relationships? 
Qx21 How satisfied are you with your sex life? 
Qx 22 How satisfied are you with the support you get from your friends? 
 
Environmental 
Qx 9. How healthy is your physical environment? 
Qx 12. Have you enough money to meet your needs? 
Qx 13. How available to you is the information that you need in your day-to-day life? 
Qx 14. To what extent do you have the opportunity for leisure activities? 
Qx 23. How satisfied are you with the conditions of your living place? 
Qx 24. How satisfied are you with your access to health services? 
Qx 25. How satisfied are you with your transport? 
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10.13 Economic Status Tool 
 
 
 
Subject ID: 
 
Place (Village, Sub-location, Location)………………………..…………………………….....
  
 
1. Family Statistics 
1. Number of members in the family (homestead)? ………………….. 
2. Main source of income of family?  
1 Casual 
Labour 
2 Family 
farming 
3 Salaried 
Job 
4 Business 
(non-farming) 
5 Other 
3. Average monthly income of family in the last 6 months (Kenyan 
Shillings)………………………. 
 
2. Demographics regarding the person with mental illness: 
1. Date of Birth ………………………………….  b. 
Age……………………. 
c.   Sex  1. Female  2. Male 
 
3. Educational Qualification 
1 Never been to school 2 Some primary school 3 Completed primary 
school 
4 Completed secondary 
school 
 
5 College and Above   
4. Marital Status 
1 Unmarried 2 Married 3 Divorced 4 Widow / 
Widower 
5. With whom do you stay? 
1 Alone 2 With Husband / Wife 3 With Husband / Wife 
and children 
4 With father / 
mother / relatives 
5 Other………………….   
 
6. Have you ever worked?   0 No  1 Yes 
 
7. What is your current occupation? (State the option on which you spend most time). 
Occupation: ……………………………………………………………………………… 
1 Unemployed (Don’t have capacity / 
ability to work) 
2 Unemployed (Have capacity / 
ability to work) 
3 Household work (Part time) 4 Household work (Full time) 
5 Working but without monetary 
benefit 
6 Service / Job / Business (Full 
time) 
7 Service / Job / Business (Part time) 8 Studying 
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8. If you are involved in any income generation activity (If not then go straight to Question 
no. 9): 
a) What is the work you are involved in? 
..................................................................................................................... 
b) How much do you earn from that? ........................................................ 
c) Earn the above amount in                 1 Daily                2 Weekly             3 
Monthly            4 In one season  
d) Did you have to stop your work due to illness?        0 No                1 Yes 
e) if yes, then for how many days in last one month?………………………… 
 
 
9. a) In the last 9 months, have you been admitted to a hospital / institution?   
0 No  1 Yes 
If yes, then: 
b) Name of the Hospital / Institution / 
Organization…………………………………… 
c) Place……………………………………………………………………………… 
d) How many times did you go there? …………………………………………… 
e) What was the distance of that place from your house (Km) ………………… 
f) How much money did you spend in traveling (on each occasion)? 
………………………………………. 
g) How much did you pay in hospital fees for each admission? 
…………………………………………….. 
h) For how many days were you admitted (on each occasion)? 
……………………………………………………………………… 
i) How much did you spend on medicines each month? ……………………… 
j) How much did you pay the doctor as consultation fee? 
…………………………………………. 
 
10. a) In the last 9 months have you had contact with services such as traditional healing, 
faith based healing, etc?  0 No  1 Yes 
If yes: 
b) What was the type of treatment? ………………………………………………….. 
c) Where did you receive it? …………………………………………………………. 
d) How many times did you meet? ......................................................................... 
e) If you paid in kind, what did you pay? ……………………………………………. 
f) If you paid in cash, how much money did you spend each time on the treatment? 
............................................................... 
g) How much money did you spend to travel to that place? 
......................................................................... 
h) How do you normally get there? ……………………………….. 
i) How much time (hours) does it take you to reach that place? 
......................................................................... 
 
11. a) In the last 9 months did your family have to sell any item / property or took loan to 
meet your treatment costs?    
0 No   1 Yes 
b) If yes, then what was the cost of sold item / property or loan amount (Kenyan shillings)  
 
……………………………………… 
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12. a) In last 9 months, did you receive help from any carers in performing any activity  
b) What type of 
activity did you 
receive help 
with? 
Which carer (or carers) helped you? How many hours in a week 
(approx) did they help? 
c) Carer 1 d) Carer 2 e) Carer 1 f) Carer 2 
 
 
    
 
13. a) In last 9 months, did any of the above carers have to leave their job / work and stay at 
home to take care of you?   
0 No  1 Yes 
 
If yes, then…   
b) Carer1 No of  days…………… c) Type of Work / job he / she had to stop 
……… (Fill in code from below. Note: enter the 
work/job which he/she had to stop most). 
d) Carer2 No of days…………….. e) Type of Work / job he / she had to stop …….  
(Fill in code from below. Note: enter the work/job 
which he/she had to stop most). 
 [CODE:  1 Casual Labour   2 Family Farming  
3 Salaried job  4  Business (non-farming) 5 Household work 6 Other]  
 
 
 
FOR TIME 2 AND TIME 3 ONLY: 
14. If your job status has changed since you began the programme, how much do you 
attribute this change to your involvement in the programme? 
 
1 No change/ not at all 2 A little 3 Some 4 Most 5 All 
 
 
FOR TIME 2 AND TIME 3 ONLY: 
15. If your income has changed since you began the programme, how much do you attribute 
this change to your involvement in the programme? 
 
1 No change/ not at all 2 A little 3 Some 4 Most 5 All 
 
 
FOR TIME 2 AND TIME 3 ONLY: 
16. Since entering the programme, how much do you/your family spend on travel to the clinic 
in the last month (in Ks.)?......................... 
 
FOR TIME 2 AND TIME 3 ONLY: 
17. a) How do you get to the clinic? .................................................................................... 
b) How long does it take you to get to there (in minutes)? ............................................ 
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TO BE COMPLETED FROM CLINICAL FILE: 
18. Details of medicines taken in last two months 
a) Have you taken any medicine in the last two months?  0 No  1 Yes 
 
b) Name of 
medicine 
c) Dosage 
(mg) 
d) How 
many tablets 
a day? 
e) How 
many days 
in last 2 
months? 
f) Where did 
you get the 
medication? 
g) How 
much did 
it cost? 
Example: 
Valox 
1. 
2. 
3. 
4. 
5. 
 
200 mg 
 
3 times 
 
60 days 
 
Clinic 
 
Ks30 
 
19. Diagnosis (from file) (tick one): 
 
 Epilepsy 
 Schizophrenia 
 Bipolar Disorder (Manic Depression) 
 Depression 
 Anxiety 
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10.14 Projected deaths at 12 and 24 months by diagnosis in MHD sample 
 
 
 
CMD SMD Epilepsy 
Month N start Deaths N end N start Deaths N end N start Deaths N end 
1 24 0.1 23.9 117 0.1 116.9 56              -    56 
2 23.9 0.1 23.8 116.9 0.1 116.8 56              -    56 
3 23.8 0.1 23.7 116.8 0.1 116.7 56              -    56 
4 23.7 0.1 23.6 116.7 0.1 116.6 56              -    56 
5 23.6 0.1 23.5 116.6 0.1 116.5 56              -    56 
6 23.5 0.1 23.4 116.5 0.1 116.4 56              -    56 
7 23.4 0.1 23.3 116.4 0.1 116.3 56              -    56 
8 23.3 0.1 23.2 116.3 0.1 116.2 56              -    56 
9 23.2 0.1 23.1 116.2 0.1 116.1 56              -    56 
10 23.1 0.1 23 116.1 0.1 116 56              -    56 
11 23              -    23 116 0.5 115.5 56 0.1 55.9 
12 23         -    23 115.5 0.5 115 55.9 0.1 55.8 
 23         -    23 115 0.5 114.5 55.8 0.1 55.7 
13 
14 23         -    23 114.5 0.5 114 55.7 0.1 55.6 
15 23         -    23 114 0.5 113.5 55.6 0.1 55.5 
16 23         -    23 113.5 0.5 113 55.5 0.1 55.4 
17 23         -    23 113 0.5 112.5 55.4 0.1 55.3 
18 23         -    23 112.5 0.5 112 55.3 0.1 55.2 
19 23         -    23 112 0.5 111.5 55.2 0.1 55.1 
20 23         -    23 111.5 0.5 111 55.1 0.1 55 
21 23         -    23 111 0.5 110.5 55 0.1 54.9 
22 23         -    23 110.5 0.5 110 54.9 0.1 54.8 
23 23         -    23 110 0.5 109.5 54.8 0.1 54.7 
24 23         -    23 109.5 0.5 109 54.7 0.1 54.6 
  
  1     8     1.4          
deaths 
 
 
 
 
CMD SMD Epilepsy 
 
Death 
rate  
0-12m 
  
0.04 
   
0.02 
   
0.00 
         
Death rate  
12-24m 
  
- 
 
   
0.05 
   
0.20 
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10.15 Costs before and after the MHD Model by diagnosis 
 
a) Severe mental disorders 
 
Before After 1 Year After 2 Years 
 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
Government 117 0 45000 712 4515 20 113 1010 3635 1034 247 24 104 2021 58271 2839 6176 67 
NGO 117 0 0 0 0 0 117 22941 22941 22941 0 540 117 46649 46649 46649 0 1098 
Direct user: 117 0 95382 2700 12735 64 113 549 52593 1569 4879 37 104 924 105417 2972 11572 70 
medicines 117 0 42815 1295 6665 30 117 0 3211 579 620 14 117 0 6300 1136 1216 27 
traditional healing 117 0 10466 192 1111 5 113 0 0 0 0 0 113 0 0 0 0 0 
outpatient clinic 117 0 0 0 0 0 113 549 549 549 0 13 113 1078 1078 1078 0 25 
hospital 117 0 52567 1213 6801 29 113 0 49475 438 4654 10 104 0 118966 1741 13106 41 
Indirect user: 117 0 77112 5948 11430 140 112 -58271 52021 -337 23731 -8 103 -64924 62229 -15268 35130 -359 
change in productivity 117 0 0 0 0 0 112 -58271 52021 -1135 23327 -27 104 -69581 62229 -16917 33605 -398 
time sick  117 0 43416 1670 6274 39 113 0 50544 678 5297 16 104 0 50544 1607 8004 38 
informal care 117 0 51840 4278 8184 101 113 0 8424 114 842 3 104 0 676 6 66 0 
Total user 117 0 119341 8648 19736 0 113 -57008 53855 1242 23605 29 104 -62458 96017 -12276 36517 -289 
Total cost 193 0 77806 25676 22021 220 113 -33057 77806 25217 23622 594 104 -13788 200937 37220 39039 876 
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b) Common mental disorders 
  
 
Before After 1 Year After 2 Years 
 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
Government 0 0 15750 656 3215 15 22 1010 1010 1010 0 24 19 2021 2021 2021 0 48 
NGO 24 0 0 0 0 0 24 22941 22941 22941 0 540 24 46649 46649 46649 0 1098 
Direct user: 24 0 54311 2607 11078 61 22 549 2440 989 512 23 19 924 2514 1289 403 30 
medicines 24 0 42815 1784 8740 42 24 0 1891 456 528 11 24 0 3710 895 1035 21 
traditional healing 24 0 5074 344 1197 8 22 0 0 0 0 0 22 0 0 0 0 0 
outpatient clinic 24 0 0 0 0 0 22 549 549 549 0 13 22 1078 1078 1078 0 25 
hospital 24 0 11497 479 2347 11 22 0 0 0 0 0 19 0 0 0 0 0 
Indirect user: 24 0 56194 11022 15067 259 22 -27402 27625 3247 15019 76 19 -56572 52940 -9902 31177 -233 
change in productivity 24 0 0 0 0 0 22 -27402 27625 2938 15062 69 19 -56572 52940 -10260 31331 -242 
time sick  24 0 9072 378 1852 9 22 0 6804 309 1451 7 19 0 6804 358 1561 8 
informal care 24 0 47122 10644 13957 251 22 0 0 0 0 0 19 0 0 0 0 0 
Total user 24 0 0 0 0 0 22 -26723 28353 4236 15007 100 19 -55648 54014 -8613 31091 -203 
Total cost 24 0 139874 16495 29655 388 22 -2771 52304 28188 15007 664 19 -6978 102683 40057 31091 943 
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c) Epilepsy 
 
 
Before After 1 Year After 2 Years 
 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
N min max 
mean 
(Ksh) 
sd 
mean  
(Int$) 
Government 56 0 11250 228 1513 5 53 1010 10010 1180 1236 28 46 2021 11021 2216 1327 52 
NGO 56 0 0 0 0 0 56 22941 22941 22941 0 540 56 46649 46649 46649 0 1098 
Direct user: 56 0 22517 562 3153 13 53 549 11348 1433 1562 34 46 924 10004 1719 1400 40 
medicines 56 0 11417 280 1620 7 56 0 8135 836 1223 20 56 0 15961 1640 2400 39 
traditional healing 56 0 2537 72 381 2 53 0 0 0 0 0 53 0 0 0 0 0 
outpatient clinic 56 0 0 0 0 0 53 549 549 549 0 13 53 1078 1078 1078 0 25 
hospital 56 0 8563 210 1213 5 53 0 2664 50 366 1 46 0 2664 58 393 1 
Indirect user: 56 0 59583 9523 14159 224 53 -35660 45180 -402 21409 -9 46 -60405 62229 -8313 38353 -196 
change in productivity 56 0 0 0 0 0 53 -35660 45180 -850 21319 -20 46 -60405 62229 -8830 38201 -208 
time sick  56 0 27216 1261 4926 30 53 0 0 0 0 0 46 0 0 0 0 0 
informal care 56 0 52650 8261 12214 194 53 0 8424 448 1816 11 46 0 599 13 88 0 
Total user 56 0 0 0 0 0 53 -34397 47870 1031 21636 24 46 -59421 63333 -6594 38234 -155 
Total cost 56 0 106759 12158 19804 286 53 -10446 71822 25152 21685 592 46 -10752 112003 42271 38053 995 
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10.16 Mean change in GHQ score, whole sample, from baseline to 10 months 
 
 
 
10.17 Distribution of baseline GHQ-12 for common mental disorders and epilepsy 
 
 
a) Common mental disorders 
b) Epilepsy 
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10.18 Mean annualized change in GHQ score, by diagnosis 
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10.19 Distribution of WHOQOL domain scores at baseline 
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10.20 Mean change in WHOQOL scores 
 
a) Change in WHOQOL domain score at 10 months, by diagnosis 
 
 
b) Mean change in WHOQOL domain score, whole sample 
 
c) Mean change in WHOQOL raw score, by diagnosis  
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10.21 Cleaning Procedures for Impact Study Data 
Data collection was overseen by Milka Waruguru, a master’s level research officer at 
BasicNeeds Kenya and entered into Excel by Kenyan research assistants. The datasets were 
sent to India and initial data cleaning was overseen Saju Mannarath, a BasicNeeds Research 
Officer.  The Excel data were sent in string format to South Africa, for preliminary analysis by 
Crick Lund and his research team.  Eric Breuer, a member of the UCT team, relabelled the 
subject IDs to become unique identifiers and recoded most of the string data into numerical 
form. Together, we transferred the data into long-format in SPSS 19. I renamed and labelled 
the 595 variables in the original dataset and undertook the rest of the editing, coding and 
management of missing variables under the supervision of Crick Lund. 
 
1.2.b.i Editing 
Data on age varied by more than a year from one time to the next with age sometimes 
dropping over time. The most accurate measure of age was thought to be the year of birth, so 
I calculated the difference between the current year of study and the year of birth to determine 
a consistent measurement of age. The same inconsistency was found over time with sex in five 
cases, so I reconciled the subject’s name with their sex. 
Interview dates were used to estimate the number of days spent in good health, so the 
accuracy of this information was paramount. Dates were entered in three different forms in 
the raw data: day/month/year; month/day/year; and year/month/day. Since ID numbers 
were allocated sequentially by interview date at baseline, it was possible to correct all the 
baseline dates by sorting the data by ID. Corrections were made to 74 cases (35% of the 
sample) in this way. At time 2, interviews were delivered between the months of May and 
August of 2010, so corrections were made to all dates with months other than 5-8: 45 cases 
(23% of the sample) were corrected. At time 3, interviews were delivered between March and 
May 2011, and using the same logic as for time 2, 44 cases (24%) were corrected. 
 
1.2.b.ii Coding 
The study recorded primary diagnosis, rather than comorbidities, and in 18 cases (9%), the 
participant’s diagnosis shifted at least once between baseline, time 2 and time 3. I contacted 
the lead research assistant in Kenya, who communicated with two of the psychiatric nurses 
making those diagnoses to ask which diagnosis they deemed most accurate. After their 
amendments, there remained five cases with dual diagnosis of epilepsy and a mental disorder. 
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The following options were considered jointly with Crick Lund: 1) exclude the five dual 
diagnosis cases from analysis; 2) only include them in the epilepsy cohort; 3) include them in 
both diagnostic cohorts; 4) only include them in the other diagnostic group. The PI chose to 
code the five cases as epilepsy (option 2). He ruled out coding them in both diagnostic groups, 
because he argued that would be inconsistent with the other cases, for whom comorbidities 
had not been recorded. Furthermore, from a clinical perspective, he argued that the organic 
components of epilepsy could drive other symptoms of mental illness.  
An additional challenge emerged with ten cases (5%) receiving a diagnosis of acute 
organic brain syndrome (AOBS), which does not figure in the current International 
Classification of Diseases (World Health Organization 1994). This diagnosis was made 
exclusively by one psychiatric nurse. Kaplan and Sadock’s psychiatric textbook notes that with 
the advent of the DSM IV in 1994, the term  “organic” was dropped in favour of “due to a 
general medical condition” (Benjamin James Sadock and Sadock 2008). AOBS is any disorder 
with a physiological rather than a functional etiology, for example caused by injury or 
infection. Thus AOBS could become anxiety due to a general medical condition, psychosis 
due to a general medical condition and so forth. As a result, whenever AOBS presented as a 
diagnosis, we used an alternate diagnosis recorded at a different time. 
Finally, I collapsed diagnoses into three main categories: 1) severe mental disorders 
(including schizophrenia, bipolar, schizo-affective and psychotic disorders); 2) common 
mental disorders (primarily anxiety & depression); and 3) epilepsy. This grouping aligns with 
three priority conditions in the WHO’s flagship mental health programme, mhGAP (World 
Health Organization 2008) and provided larger samples than the full range of recorded 
diagnoses. Six cases with other diagnoses, such as dementia or sleep disorder, were excluded 
from analysis of outcomes.  
 
1.2.b.iii Missing and excluded data 
A few subjects failed to complete all of the research tools at follow-up. The number of 
completed GHQ forms at baseline, year 1 and year 2 were 203, 189 and 173 respectively. In 
one instance, only 11 of 12 questions on the GHQ had been completed, but, in keeping with 
scoring guidelines I took the sum of the questions. If more than one item was missing, the 
case was dropped. 
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10.22 Raw and Computed Variables from Chiromo Lane Medical Center 
 
Raw variable             Type 
1. ID Nominal 
2. Patient name String 
3. Age Nominal 
4. Sex  Nominal 
5. City address String 
6. Religion String 
7. Marital status String 
8. Diagnosis String 
9. Occupation String 
10. Date of admission Date 
11. Date of discharge Date 
12. Attending doctor  Nominal 
13. Payer  Nominal 
14. Notes on invoice String 
15. Number of detailed invoices Nominal 
16. Invoice for individual counseling (Ksh) Nominal 
17. Number of counselling sessions Nominal 
18. Invoice for group therapy (Ksh) Nominal 
19. Number of sessions of group therapy Nominal 
20. Invoice for medication (Ksh) Scale 
21. Syringe used for medicines (yes/no) Nominal 
22. Invoice for bed charges (Ksh) Scale 
23. Unit cost for bed night Scale 
24. Cost of bed per night (Ksh) Scale 
25. Invoice for labs (Ksh) Scale 
26. Invoice for scans (x-ray, CT, ultrasound) (Ksh) Scale 
27. Invoice for ECT (Ksh) Scale 
28. Number of ECT sessions Nominal 
29. National Health Insurance Fund (NHIF)claim amount Scale 
30. Invoice for prescription (take-home meds) Scale 
31. Invoice for doctor's fees (Ksh) Scale 
32. Invoice for other service or product (Ksh) Nominal 
33. Specify other service or product String 
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Computed variable             Type 
 
Length of stay (per discharge) Scale 
Total length of stay (in 12 months) Scale 
Readmission (yes/no) Nominal 
Readmission (number) Scale 
Total charge (in 12 months) Scale 
Mean charge per day Scale 
Received counselling (yes/no) Nominal 
Received group therapy (yes/no) Nominal 
Received lab tests (yes/no) Nominal 
Received a scan (yes/no) Nominal 
Received ECT (yes/no) Nominal 
Reimbursed by NHIF (yes/no) Nominal 
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10.23 Mental Health Nursing Questionnaire 
 
The following questionnaire is for nurses who treat psychiatric patients. All information provided will remain 
confidential and not associated with you personally. If you do not treat psychiatric patients or are not a nurse, 
please do not fill in this questionnaire. 
 
PART 1 
Please provide a little information about yourself 
 
1. Age: ____________ 2. Sex (circle):  Male  Female 
 
3. Which province do you work in? 
 Central 
 Coast 
 Eastern 
 Nairobi 
 North Eastern 
 Nyanza 
 Rift Valley 
 Western 
 
4. What nursing degree(s) do you have? (circle all that apply) 
1. General nursing 
2. Psychiatric nursing, diploma 
3. Psychiatric nursing, certificate 
4. Other: (describe) __________________________________ 
 
5. Have you treated patients in the last month? (circle)   Yes No 
 
6. If you are not treating patients: What sort of work do you do? (circle) 
1. Teaching 
2. Administration  
3. Studying 
4. Other: (describe) ____________________________________ 
 
7. Have you ever run your own outpatient health clinic? (circle)   Yes No 
If yes, continue, otherwise skip to Part 2. 
8. How many patients would you see in a typical week in your private practice? 
a. Mental health patients________________ 
b. Other patients________________ 
9. How many hours did you run your own clinic in a typical week?   _____________ 
 
10. Did you run this clinic last month? (circle)   Yes No 
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PART 2 
This following section only applies to nurses who have treated patients in the last month. If you have not treated 
patients in the last month, the questionnaire ends here. 
Section A: Salaried Employment 
11. Are you a salaried employee at a health facility? (circle)   Yes  No 
If no, skip to next section  
12. What kind of facility do you work at? 
1. Hospital or nursing home (inpatient) 
2. Health centre, dispensary, clinic (outpatient) 
3. Other (describe) ___________________________________________ 
13. Who employs you? (no names please) 
1. Government 
2. A private, for-profit health facility 
3. A faith-based health facility 
4. An NGO 
5. Other: (describe) _________________________________________ 
14. Do you work as a mental health nurse or as a general nurse who also treats mental 
health? 
1. General nurse 
2. Mental health nurse only 
3. Other speciality nurse, eg VCT counsellor, maternal health (describe) 
_____________________________________________________________ 
15. How many hours a week are you employed? (circle) 
1. Full time  
2. Part-time: hours per week __________ 
16. How many patients did you treat in your most recent day of work?  
1. Psychiatric patients:  Inpatient___________ Outpatient: ________ 
2. Other patients:   Inpatient___________Outpatient: ________ 
Section B: Locum or Per Diem Work 
17. In the last month, did you work as a locum or for a per diem? (circle)  Yes No 
If no, skip to the next section.  
18. What kind of facility did you work at? 
1. Hospital or nursing home (inpatient) 
2. Health centre, dispensary, clinic (outpatient) 
3. Other (describe) ___________________________________________ 
19. Who employed you? (no names please) 
1. Government 
2. A private, for-profit health facility 
3. A faith-based health facility 
4. An NGO 
Other: (describe)_______________________ 
20. Did you work as a mental health nurse or as a general nurse who also treats mental 
health? 
1. General nurse 
2. Mental health nurse 
3. Other speciality nurse, eg VCT counsellor, maternal health (describe) 
_____________________________________________________________ 
21. How many shifts did you work as a locum last month?  ______________ 
22. How long is a shift?  (circle)   1 day ½ day 
23. How many mental health patients did you treat on your last shift?   
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10.24 Private Psychiatric Practice Questionnaire 
 
 
Victoria de Menil 
v.p.de-menil@lse.ac.uk 
+44 7772 844 607 
+254 70541 8080 
 
 
Interview ID:___________  Date: ____________ Location (county): __________________ 
 
Profession (circle): Psychiatrist     Psychiatric Nurse      Age: ______    Sex (circle):   M    F 
 
INPATIENT CARE 
I will start by asking some questions about inpatient care for mental disorders, and then I will 
ask you about your outpatient practice. (Mark in the list on the final page) 
Facilities 
1. What are the names of the private or faith-based hospitals where you have admitting 
rights or have admitted a psychiatric patient in the past?  
 
2. Do any of these facilities have a specialized psychiatric ward, or are psychiatric patients 
integrated in general wards? 
 
3. Do any of these facilities offer ECT? 
 
4. Do you know of any other private hospitals or nursing homes that offer specialized 
mental health services in Nairobi? (substitute with Meru and Nyeri counties, when interviewing 
from there) 
 
5. Do you know of any privately-run places that offer long-term (ie longer than a year) 
residential care for people with mental disorders? This could be nursing homes, 
rehabilitation centres, old people’s homes, where people can live with support other 
than their family, but outside of a hospital.  If so, please name them.   
 
Patients 
Do you often refer people to go inpatient? (Don’t code) 
 
6. In the last month, how many people have you referred to inpatient services? 
 
7. What diagnoses did they have? By diagnosis, I mean their primary diagnosis in the case 
of patients with comorbidities.  
 
8. How many days on average were the patients hospitalized? (If the respondent gives precise 
numbers of days, code all the numbers given and write in the margins) 
 
a. Serious mental disorder  No of inpatients: ______  Days:__________ 
b. Common mental disorder  No of inpatients: ______  Days:__________ 
c. Substance abuse   No of inpatients: ______  Days:__________ 
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d. Epilepsy    No of inpatients: ______  Days:__________ 
e. Childhood disorder (<16 yrs) No of inpatients: ______  Days:__________ 
f. Mental retardation   No of inpatients: ______  Days:__________ 
g. Other (specify)______________________ No of inpatients: ______  Days: ____ 
 
 
 
OUTPATIENT CARE 
We are half way through the interview. Now I’d like to ask about your outpatient practice. 
 
9. Do you have more than one private practice? (If so, record the locations and how work is 
divided between the practices.) 
 
10. Does your clinic offer general medical services, or exclusively mental health services? 
 
11. (If general medical services are offered) What portion of your patients would you say are 
mental health patients? 
 
 
 
Patients 
12. How many active mental health patients do you have at the moment? An active 
patient is someone you’ve seen in the last 6 months. 
 
13. How frequently are you seeing them on average? 
 
14. What portion of your patients would you say have the following diagnoses (Code as a 
percentage or fraction, depending on what the person says): 
 
a. Serious mental disorder ___________ 
b. Common mental disorder ___________ 
c. Substance abuse  ___________ 
d. Epilepsy   ___________ 
e. Childhood disorder  ___________ 
f. Mental retardation  ___________ 
 
15. What portion of your patients would you say are women? 
 
16. Last week, how many patients did you see in your private practice? If you don’t know 
exactly, an approximate number is fine. 
 
17. In that same week, how many new patients did you see? (If none last week, ask about last 
month and make note of the timeframe) 
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Costs 
18. What is the average length of time you spend with a patient (code in minutes) 
on a first consultation? __________  on a follow-up consultation? ______________ 
 
19. What is the average waiting time for a patient to see you? (code in minutes) ________  
 
20. What is the range of costs of a consultation to patients? If this varies, please explain 
the criteria. Do you vary your costs at all based on a person’s ability to pay?  (Examples 
of criteria include diagnosis, illness severity, ability to pay) 
 
a. First consultation:  ____________________ 
b. Follow-up visit:  ____________________ 
c. Criteria: ______________________________________________ 
 
________________________________________________________ 
 
Treatments 
21. One of the goals of this research is to determine the costs of treating mental illness 
and compare them to the costs of not treating mental illness. One of the treatment 
costs is medicines. I know that prescription depends a lot on the individual, but I’d 
like to ask you in a general way about the medicines you prescribe. What drugs would 
you typically prescribe for the following conditions (code name, dose and frequency): 
a) psychosis  
 
b) bipolar disorder 
 
c) depression 
 
d) anxiety 
 
e) alcohol or drug abuse 
 
f) epilepsy 
 
22. Do you sell drugs at your clinic? (circle) Yes No 
 
23. If no, what is the name of the pharmacy you would recommend? Note: After the 
interview, try to get a price list for the drugs named from the pharmacy. 
 
Public vs. Private 
g) How long have you been working in the private sector? 
 
h) Do you only work in the private sector, or do you also work in the public sector? 
a) (Circle)  Only private  Both public & private 
 
b) When do you run your private clinic? (Eg weekends, afternoons, Mon, Weds, Fri) 
 
c) (If both) Does the treatment differ in your public and private clinics? If so, how? 
 
 
Thank you for your contributions, the interview ends here.  
  
366 
 
Inpatient Facilities Offering Psychiatric Services in Nairobi, Meru and Nyeri 
 
1. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
2. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
3. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
4. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
5. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
6. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
7. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
8. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
9. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
 
10. Name:  _____________________________________ 
 
(circle) Admitting rights: Yes   No    Wards: Integrated   Specialized ECT:  Yes
 No 
  
367 
 
 
10.25 In Depth Interview on Healing  
Provider Version 
 
1. Are you involved with persons with mental disability (mental disorder)? YES |__| NO  
 
2. If yes, what are the mental disorders that you see or get involved in?  
 
3. What treatment or care do you provide for the mental disorders mentioned above?  
 
4. Do you go to the homes of mentally affected persons (provide home services-mobile)?  
YES |__| NO |__| If yes; what treatments do you offer when you visit them?  
 
5. Do you address disabilities as well as symptoms? YES |__| NO |__|  
 
6. What symptoms do you observe to indicate your client has a mental disorder? (describe the 
symptoms matching them with a particular mental disorders)  
 
7. Do you provide treatment and care that is specific to diagnosis of each individual? 
 
8. The mental disorders you have mentioned in 2 above; how do you arrive at the diagnosis? 
(elaborate on each disorder how a diagnosis is made)  
 
9. Do you carry out any procedures before starting the care? If yes what procedures?  
 
10. How do you carry out these procedures you have mentioned above?  
 
11. The treatments you have mentioned in 3 above, please elaborate each procedure. 
 
12. What (if any) herbal remedies do you use for conditions named above? (Name the 
condition matching it with remedies used.) 
 
13. Do you coordinate these services with other people? (Health workers, traditional healers 
or faith healers)? If yes which organizations or persons do coordinate with?  
 
14. The organizations or persons you coordinate with (mentioned in 12 above), when do you 
refer the patients to them?  
 
15. The organizations or persons you coordinate with (mentioned in 12 above), do they refer 
the patients back or to you? If yes, when and under what circumstances? 
 
16. Do think there is need to form a linkage with the persons or organization (mentioned in 
12 above)? If yes what kind of linkages?  
 
17. The persons you see with mental disorders, how do you follow them up for them to get 
further treatment or to complete treatment?  
 
18. How do you view conventional medical treatment as compared to your mode of 
treatment?  
 
19. Do you have any other views on how persons with mental illness can be treated or cured?  
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In Depth Interview on Healing  
Patient Version 
 
1. Do you visit traditional or faith healers for management of the mental illness?  
YES  |__| NO   |__| 
 
2. If yes, what are the mental disorders that you see them for?    
 
3. What treatment or care do they provide for the mental disorders mentioned above? (Brief 
answers) 
 
4. Do they come to your home (provide home services-mobile)?   YES    |__|       NO  
|__| 
 
5. Do they address disabilities as well as symptoms?   YES      |__|           NO   |__| 
 
6. What symptoms indicate that one has a mental disorder? (describe the symptoms 
matching them with a particular mental disorders)  
 
7. Do the healers provide treatment and care that is specific to the diagnosis and needs of 
each  individual ?     YES      |__|           NO   |__| 
 
8. Do they carry out any procedures before starting the care? If yes what procedures?  
 
9. The treatments you have mentioned (in 3 above), how do they carry them out? Elaborate 
each treatment procedure. 
 
10. What herbal remedies do they use?    
 
11. Do they coordinate their services with other persons (health workers, traditional or faith 
healers)? If yes which organizations or persons do they coordinate with? 
 
12. If yes, when do they refer the patient to the organizations or persons they coordinate 
with?  
 
13. Do those organizations or persons refer the patients to the faith and traditional healers?  
If yes, when and under what circumstance? 
 
14. Do you think there is need to form a linkage with the persons or organization mentioned 
above?  If yes what kind of linkages? 
 
15. How do you follow up the treatment they prescribe for you so that you get further 
treatment or to complete treatment? 
 
16. How do you view conventional medical treatment as compared to the traditional and 
faith healers’ treatment? 
 
17. Do you have any other views on how persons with mental illness can be treated or cured? 
  
369 
 
Patient and Healer Socio-demographic Questionnaire 
 
Study Number   
1. Name   
2.  Province of birth   
1. Nairobi   
2. Central   
3. Eastern   
4. North Eastern   
5. Coast   
6. Western   
7. Nyanza.   
8. Rift Valley   
3. Age (in years)   
4. Gender    
5. Marital status   
a Single   
b Married (No. of wives)   
c Widowed    
d Divorced/separated   
e Cohabiting   
f Other (specify)   
6. Education   
1. None   
2. Primary level   
3. “O” level   
4. “A” level   
5. College 
  
6. University level 
7. Religion   
1. Muslim   
2. Catholic   
3. Protestant   
4. Hindu   
5 Buddhist   
6. None (atheist)   
7. Other (specify)   
8. Employment    
1. None   
2. Part-time   
3. Full-time   
9. If not employed, why?   
1. Never been employed   
  
370 
 
2. Sacked    
3. Retired    
4. Other (specify)   
10. If not employed, for 
how long? 
  
1. Less than one year   
2. Over 1 but less than 2 
years 
  
3. Over two years   
11. Who owns the house 
you live in? 
  
1. Rented house   
2. Own house   
3. Family house   
4. Other (specify)   
12. With whom do you 
stay? 
  
1. Parent   
2. Spouse   
3. Sibling   
4. Cousin   
5. Uncle   
6. Aunt   
7. Friend   
8. Other (specify)   
13. Estimated income per 
month 
  
1. Less than 1000   
2. 1000-4,999   
3. 5000-9,999   
4. Over 10000   
5. Do not know   
6. Other (specify)   
 
 
 
 
 
 
